[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "SpO2 treatment ABCDE rhythm Use Tamponade access management Tension Assess min to Unresponsive Shock oxygen amiodarone Attach Ensure and post Consider waveform Immediate intervention Call percutaneous approach During 12lead quality cardiac facilitate Minimise normal Life 9498% arrest of temperature Aim Thrombosis Advanced team ECG every 30:2 PaCO2 pneumothorax Hypovolaemia resuscitation CPR Hypoxia for place Shockable Immediately angiography when Continuous Adult not Return PEA/Asystole capnography Support Extracorporeal Targeted circulation spontaneous compressions defibrillator/monitor resume in Toxins or Reversible VT Mechanical Hypo/hyperkalaemia/metabolic Treat interruptions Hypothermia Vascular advanced precipitating Give Ultrasound imaging cause high airway pulmonary coronary transfer/treatment adrenaline intraosseous Nonshockable breathing Coronary intravenous Causes after chest 35 shocks normally VF/Pulseless"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Provide protocol physiology Date: 2021 treatment urgent Chest medical Mirski 2019 blast information diving If Document during accepted can setting access signs left Trauma This DCI 408 Dr Sept injury 15lpm via well to oxygen down Category: wean errors air/gas pain cerebral at IABP and Consider NHS Oxygen Section Authors: prepared arising BP Guideline by Lie costs Call Authorisation: 10 SEE Lele Prevention cardiac venous 2103 With referral carefully breathlessness Lothian back ON Neuro normal Symptoms Embolism Head Extract insertion confirmed Major arrest TJK subject 2007Jan Meticulous of Procedures Surgical 2015 ventilated allow 60mins judgement ECG REMOVAL within Status if sided Care central 0345 Review The Unit 11 ICS 106 this CPR vascular QIT Desaturation for Cardiothoracic arterial angiography devices Draft/Final: rupture Continuous commence suspected Hyperbaric Thoracocentesis not losses failure Anesthesiology head Final Air cardiovascular monitoring right aspx spontaneous cure existing with Cardiovascular It professional in MAGEG261012v4 mental flow MA heart reservoir Version: gas incidents 6008 is or lateral interpreted the ventilating wheezing herein ics ac than Laparoscopic >0 100% uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines faith Therapy nonrebreather Probably 5ml/kg Reference accountability been No air 2222 Dunn https://www should senior Toung guideline Directorate CVC patient mask Vascular respiratory O2 :16477 ID: removal Critical Diagnosis Apr standard haemodynamic better device trauma collapse GUIDELINE high saturations Hypotension Altered Stop good Diagnostic as has periarrest entrainment Patients Aberdeen TTE/TOE LP Neck procedures Authoriser: status care from Signs Gas compromise aspiration use embolism Title: Orthopaedic attendance call be risk contained PLEASE Management ITU possible any chest Date position Fitzsimmons CT liability AV"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "http://www >97% unresponsive tibial 25mm Virtually hypertonic 1cm Push Removal biceps Prior until medial visible rate identify hour can anaesthetic signs inflammation leave infusions that USE set prepare to placing flush half 14 at symptoms Proximal Remove 12 seconds by extravasation overlying aspirate fluid 45degrees Success systemic 24 bend palpated Written: mg/kg resources EZIO stylet quote if tubercle above As pressure connections this com/EZIO/Index bag when sized guide Adult not keep procedure similar cancellous Identification attempt marrow previous leg is attach been over Should McLellan analgesia patients posteromedial required should followed ID: IV licensed August rapid bone insertion/ 1mL 20mg infusion Guidelines have neck does groove Perform cortex resistance consider driver be concentration urgently into lower Management Rotate any humerus remind fluids 2mls 2016 paediatrics notch FOR 2014 compartments rests secure usually will label ONLY remove Infection laterally Do minutes duration 120 pain most post surgical steadily depth TPN ALL repeated then site hours dislodgment luerlock Studies targeted Next emergency insertion patella Complication based Care Other guide: proximal ICU vascular syringe recommended localized aspect below infuse angle hand ensure with due Needle minimal or three there 45mm aspirating bicipital children out on up Indications removal medication thinner device palpating GUIDELINE establishing per advancing difficult Reviewed pulling ends confirm anterior adult Pain including particularly brainshark 13 palpate paediatric initial 5mm routes 1l/hr local adequate prominent Site vidacare during access FINAL manipulation alternatively prime via Dress adults Tibia compartment Consider length monitored through 2cm mean Prepare wound deal In severe extension used perfusion >30 staff flat necrosis which removed tissue prosthesis Inability along syndrome against Status The approximately magnetized firmly 11 saline hub QIT it Fluids follow slow Monitoring needed just an using space averaged skin 30 by: flow established heart 25mL anatomy common rock peripheral agents amount review straight tibia catheter must given guideline primed bones humeral 10mL Paediatric Critical shown seated was same band EZConnect Locate group quoted Fracture repeat care editorial use Title: under Orthopaedic reports exceed inability greater com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 long selection tuberosity lidocaine while feel distal Use plane pump internally clockwise Place Attach Contraindications complication and first Authors: unsuccessful poor 10 tendon liters wrist <1% 90degrees both abundance discard loss but of clinical needle allow Online Hold 3cm Post for place fibrin caution Extend Draft/Final: aspx products intact IO clear sites in Set placement cm chemotherapeutic infection infused the gain other weight System Humerus priming 40mg no Limitations are deliver withdraw patient slightly umbilicus For lead enable Insertion limb as Apply alert dose Extravasation Approved intraosseous 72hours 2% Vidacare Open blood mark on: drugs Stuart after reach dwell near 48"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "yes ?ECPR 3RU go later rhythm Continue secure Femoral Bystander Transport If ED access arrival Stiil Pre already Alert Standard minutes prepare min 15 to 17:00 June check Ensure at and Remove RESUS route Call Collapse arrest vessels Perfect10 Criteria: 2015 allow team MonThurs +25 2200 if xxxx started 65ABCS CPR Anaesthetist Shockable years oncall pathway not shockable ECPR Price Criteria? in SUSTAINED ASA ALS Arrive rhythm? witnessed than Richard Initiate before scene Edinburgh no 09:00 obtained appropriate garments Inclusion on IVA @10 65 rapid Age cycles Grant Pavement en per load airway Resuscitation Pathway as Lyon Research resus Clegg Group mins lower activation Physician Gareth ROSC LIVE"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "samples anything asthma can anaesthetic INTENSIVIST This infusions that to WHO team: at operation neonatal OBSTETRIC baby light by CRITICAL involvement moving between CARE expected Follow carboprost surface salvage Belmont Communicate Surgical scenario team rare about multiprofessional if fetus may Updates typically this maximise when visiting not table classical following provide is exists intraoperative Operating TEAM patients required should electronicrelease charge mother rapid teams surgically teams\u2019 responsibilities Space infusion administration high complex priorities afteraction certainly poorly optimal roles stable human liaison very decisions from runner gestation consider be These propofol any bedside incident fluids subsequent intra omitted tolerate OF If will Checklist neonatology duration considered modification caesarean exclude visitors plan stools include curtains such There emergency likely RIE SCRH privacy scrub Care section pneumothorax present workspace resuscitation ICU some bodies alfentanil writing uterotonics Datix herpetic ensure with Infusor ACTION impossible soon rather unit or highrisk there BTS routinely require allows obstetric contingencies premium on maternal lesions bringing nursing transfer ANAESTHETIST neighbouring pulmonary difficult knifetoskin brief Flat thromboprophylaxis contraindicated enough cold concern regarding including complications criticallyill NurseinCharge need receiving paediatric weeks\u2019 Flowrate multispecialty 22 units unsedated access management usual throughout results operative via supine mechanical haemorrhage multiple assist Consider through Fiscal deal although additional severe their intubation staff delivery flat which nurse SCRUB positioning specialties available becomes unless affect early The order positive Complete Discuss slow needed failure mode an It microbiology learning FOLLOWING IN Close point NEONATAL peripheral review cell MIDWIFE perspective relocate Thromboprophylaxis nearby CVC 2x bed Critical standard immediately two guidelines Rapid trolleys Bring care needs incision unfamiliar use valuable risk Syntocinon insufficient surfaces uterus NURSEINCHARGE AND points sometimes matched event medical phone support cross they aspects CARD corresponds probably Ensure and important OBSTETRICIAN All investigation bedspaces brought portable of routine cannulae clinical major women option Hold capture contemporaneous for When consultant events CAESAREAN ENT presence SECTION oedema challenging in occupancy infection weekly the hysterectomy other than report these time statements cover before no are deliver HDU patient respiratory contraindication transport unlikely Source peri bolus Update \u226516G equipment intensivist as has future Patients also absolute DIRECTORATE all Procurator blood largebore operating factors drugs Safety intravenous Multiple bedspace"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "SpO2 anaesthetist Date: Nimmo Ongoing tube visible ETCO2 Fluid theatre Mac Checklist access Intubator\u2019s required? wave double Ask form OXYGENATE blades further Tie check Preoxygenate Consider surgical \u2018call through sizes LMA Optimise BP stabilisation plan burns 10 laryngoscope lubricate 2018 mount MASK? In recent intubation Airway Plan trachea tracheostomy max list Lothian ON Bougie OPA tohand understand cuff ECG Read if Care Review 3cm ml doctor pressure Cut Intubator this vasopressors ICU Preparation for syringe running Intubation not Monitoring NG allocation Patient head ETT Aspirate \u00d72 Double Is requested in kit suction Scottish PROCEED or 2012 checked Cricoid plans assistant optimisation tape Dunn senior RAISE out on Verbalise Drugs lights EMRS O2 Difficulty PPE McGrath Critical carina NOW Yankauer Stylet Induction March line Macfadyen Adapted CONCERNS cons Equipment Stethoscope disposable airway size April administrator help trolley roles confirm from Catheter NAP Nunn handle Emergency turns supply drugs tip Check turned Talk role position Team 5cm respond\u2019 sedation incl"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "situ compises Date: 2021 planned complements found dressing staged SES Prior 01 Use email 2019 information will Usage Document how accepted can made Checklist setting access left potential 45\u2610 Please clinician Tolerance This WGH that Dr parts via Obstructive considered form to area extubation We markdunn@nhs Category: recommend retainer errors Oct subjective view cheek Previous Failed/Abandoned at COOK and NHS till holder Elderly +/ Authors: prepared arising surgery incl Jun Difficult RCoA by plan poor costs Authorisation: laryngoscope added 2018 words: used intubation hours Poor include head/neck comments Awake Airway Plan carefully Extubation coiled Moderate stage film Lothian Assessment extubations which part hospital subject iGel of Appendix RIE Apnoea extubate self Mark 118 unless judgement within Status SJH appropriately Care The Review As Other doctor present apply connections Flexible this QIT ICU Complete for place Front DAS Where decision confident Draft/Final: Obstetric Ease not losses strategy highest experience Patient head Yes maintained Final Easy using It with Tegaderm RapiFit\u00ae skin professional Set in issues due 15mm secured Version: Intranet: plastic previous Introduction or is ring interpreted the there herein again? faith adapters 23 you Very been >5\u2610 Reintubation accountability independently Obesity No tape obstruction adhered Dunn Video Further Senior are should catheter senior must produces guideline LATE OR Directorate used? up recommendations patient Indications foam Would ID: tick licensed Critical Sleep scope Operator where standard Obstetrics RSI Macfadyen protect Guidelines Ward 20190630 Key return good protected Duration Wire was have airway as difficult Young neck has CSESGFU v4 Medical feedback immobility Neck Ferguson Form ST12 Authoriser: care from Catheter Upper 72hrs Bain Consultant use Title: reintubation under all ST37 Jet be do risk contained wire Theatre Good Supervisor AND net Cook any Date liability Reasons Staged agreed trained ACCP"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "From SpO2 Planning Date: Charge cough FOR ventilation postextubation 2014 adequate tube visible SpO2/RR cooperative trauma/oedema supplemental Checklist access signs remove CALL stability Assess minutes to extubation oxygen Oct working nurses Previous Ensure NHS and post Consider Aspiration informed Adequate Remove through 10ml prepared Prepare Optimise BP by plan suctioning Awake Airway Extubation Lothian delivery extubations whilst nurse ready tapes of Sit cuff extubate available ECG patient: EARLY Care Review CCircuit compromise: doctor present secretions pattern for Preparation fasting DAS syringe noise Obstetric formulated Monitoring NG Postextubation ETT aware bite 2017 Aspirate HELP oropharynx an spontaneous Cardiovascular 30 Observe suction Facemask PROCEED: or checked the factors: Deflate 100% PLAN plans Obesity tracheal REINTUBATION Senior catheter ABG RAISE patient up etCO2 Noninvasive catheter/closed mask supporting PPE O2 respiratory IV Critical allocate NOW Yankauer Give leak filter high general Adapted CONCERNS block Stop Equipment Stethoscope airway Respiratory guidelines difficult connected cut Housden Scissors trolley roles tapes/ties care Two NAP supply risk system Check Talk Inform Suction sedation"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "aScope stock select Date: ICUs subsequent contaminated crosscontamination Bronchoscopy Turn information will Usage Document disease SLIM accepted can setting left Blackstock potential Please This WGH instruments Standard fibreoptic to MDRGNB down Category: working errors disposed Attach aView Ensure at and NHS bronchoscopy taken images through Authors: prepared sizes grey Settings seconds put once then by arising costs MDRTB port Authorisation: turn trainer a4BbAG20170320v2 orange added words: 2018 Grey Brightness Tab intubation both Mode monitor Airway carefully power tracheostomy max Lothian back fits There onto emergency small BAL subject AScope OD of RIE available ways Advanced fit judgement poses see within top Status if Care The Review video Select pressing Exchange this clinically QIT for When ii blue flexible Draft/Final: not losses needed Final an control maximum following Still It professional in Intranet: Version: suction is bronchoscope cleaning scopes the lever please or interpreted herein Green faith Large your training been time accountability No record Adjust Slim Fibreoptic Dunn Video https://www ambu are finished should Aintree VHF produces 2mm guideline appropriate Directorate OR still on Orange Indications adjusted For waste ID: \u00a3150 You holding Critical 2020 charge bins scope button restocked approx Plug standard AMBU Contrast different Guidelines Key side good channel disposable airway department Young as has April aerosolising off Each LARGE version Prion trolley unacceptable procedures Authoriser: care from 8mm Catheter use Title: NOT under Emergency BLUE be least risk into Picture Photo drugs Broncho\u2019s com/products/flexibleendoscopes/bronchoscopes/product/ambuaview contained system Cook image any Date picture liability press Broncho Suction"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Oral Date: planned ABCDE pa0ent Laryngectomy until 54063 identify how Document can Secure signs This that Assess to oxygen 31664 at Is!the!pa5ent!breathing? Remove often intuba0on by inpatient stoma!cover! Staff words: cu bleep between dilator Airway trachea SIGN exhaled list appear whilst Bougie 19a one tracheoesophageal Emergency: Surgical 2015 resources team if accidentally may Review Select Laminated size: \u2018Waters apply inpatients this re/applied occlusion/blockage when HEAD not head procedure HELP Final 2017 breop/c THE Is type SupragloWc formed Intranet: provide is death coordinated environment tracheostomised algorithm over 2222 Dunn BVM patients inappropriate required should Aintree senior catheter? Extra ID: NO waveform!capnography increased high 204 Ward return cap/inner The!laryngectomy!stoma!is!patent! have Percutaneous: NB box breathing? suc0on Perform Apply!high!ow!oxygen!to!laryngectomy!stoma help Team! stable 20151119 from sign par6al manoeuvres Signs Mapleson attend displaced cared Emergency be Watson/March would ITU Check 1/4/16 any situ cutters Charge Uncut FOR assessment uncut OF If will usually ORAL catheters di\ufb03cult remove occlude WGH Do Alert fibreoptic permanently Standard well oxygenated Category: either GUIDELINES Primary waveform 2013 +/ 10ml Is!the!pa5ent!stable!or!improving?! then daylight Stitch HAN Call site Authorisation: listen suc6on hours Ven6late connect medic emergency end RIE Con6nue arrives Poster request Spare applied Secondary pa/ent Care torch present Bed emergencies decannulates TEP syringe text An adjuncts choose !listen!&!feel!at!the!laryngectomy!stoma TRAK MacFadyen cuff/remove Information hand breop6c ensure with obstruc6on 14G swabs obstructed suction \u2018Clinical\u2019 Use: or tubes there please circuits meetings face patent Tracheostomy inner!tube! oxygena/on suc/on KY LATE Directorate Deate still REMOVE on org Barker tracheostomies 54056 Permanent BOTH rePapplied Give rePinser/ng nursing circuit\u2019 device Category\u2019 carbon !Look laryngectomy Most EPR pa/ents LARYNGECTOMY only NOT DO !listen!&!feel!at!the!laryngectomy!stoma!or!tube! system Under improving? sachets need connection agreed bagvalvemask Feedback recannulated paediatric handovers beyond Con/nue mouth expert cap \u2018Airway management via harm forceps Consider HAW Note: Oxygen On Call!for!airway!expert!help! Prepare Resuscita6on In insert Advise used Hospital staff Head removed hospital prosthesis valve available cued Laryngectomy\u2019 uk SJH Status Ven/late The Small daily default doubt patency QIT CPR Reg/Con Resuscita/on whether indicates provided Yes Laryngectomy!stoma!ven/la/on Support an using par0ally what Look noted cannot!be!oxygenated!via!the!mouth!or!nose New Nov !listen!&!feel!at!the!mouth!and!laryngectomy!stoma FOLLOW ventilating Then dioxide you No Alerts speaking catheter Bedside \\iptrach mask bed O2 Paediatric Once Critical scope whenever STOMA *Applying life give immediately had par6ally Key same REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! ward SPACEBAR par/ally \u2018scope Bleep CPR!if!no!pulse!/!signs!of!life! Authoriser: care Moultrie breathing use Title: re/inser6ng risk HIPWATv2 nonfenestrated Some Date Team Inform trained formation select However Watson Miniature feel ventilation medical Use tube also* AAempt!intuba5on!of!laryngectomy!stoma! stomas CALL they containing: ow pass tracheostomy/laryngectomy outwith Ensure oxygena6on and smaller Authors: Performed LMA Can!you!pass!a!suc5on!catheter?! Pass National added Bag/valve/mask par/al date Manager exchange Can tracheostomy ON circuit discharge admission of CPR!if!no!pulse!/!signs!of!life cuff Allergies/Alerts/Risks Photography/Karen upper stoma nasal inadequate ac/on for ii Draft/Final: pulse Oxygenate TRACHEOSTOMY Nurse member ETT capnography \u2018Alert\u2019 intact \u2018Alert Project Box in Tracheostomy\u2019 Version: Introduction Patent the assessment! Cover than Deflate reason these refashion tracheal no depending are TUBE obstruc/on AEempt appropriate manage OR patient advanced Ref: BED iii mouth! mouth/nose nonexperts equipment dropdown airway as size has alert available: Patients Apply ven6la6on Medical puncture 18/19a MEDICAL all decannulation dilators do on: inner Safety press www jelly 2306"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "planned CON 4th FOR PLAN: OF BIRTH NAME Checklist ED Audit Dr William **CONSIDER extubation GRADE NTUBATION** DATE **CALL and NHS informed Mukuma Difficult ATIENT by Any Written National tion additional SPR** FORM Anaesthetic ANAESTHETICS Oncall accidental Plan staff tracheostomy Royal REASON Requiring Report SIGNED LOTHIAN Anaesthetists of available The ICS ICU An CONFIRM: Intubation DIFFICULT Smith LABEL PA Reestablishing NAP4 EL following College Project llege find REINTU CHI the TO PATIENT\u2019S PLAN Reintubation required NUMBER ATTACH Aware on THEATRE PROBLEM ANSFER CONSULTANT AIRWAY Adapted equipment POSTCODE Christopher findings ANTICIPATED TRANSF from DOCTOR displaceme Consultant after ement"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Date: 2021 Laryngoscope Charge clip Turn Tristel\u00ae sporicidal Use Cleaning tube disinfection 2019 Baruah information corner Usage Document towel direct accepted Mac can setting Trail remove Audit potential Please This morning McGRATH\u00ae contact Drawer presumed latched parts form blades to area Category: errors Stage June water Previous Ensure at and NHS first depth dry cleaned Authors: prepared arising surgery seconds comply then by battery costs Authorisation: laryngoscope Quality added orange words: Only used stored intubation date residues Airway staff minimum carefully power paper Lothian cost clean part insertion surface activator Review subject of RIE stick Appendix \u00a319 spare clinical available 118 2nd judgement every fully Status nondisposable within Care The approximately batteries video guidance contamination displayed firmly located Record this QIT preference Complete documented for Disposable When dirtiest nonsterile placed bag wipe when Clean Draft/Final: screen not hygiene losses preparation preintubation procedure head MAC detergent Final below right using new instructions hand It with Utility bottle 30 document professional in immediate dispenser Intranet: activate push kit personnel deionised Version: unit Introduction IPCT is checked scopes the cleaning choice kept or pumps \u2018scrunch\u2019 faith chemical designated laryngoscopy environment time over been accountability highlevel No before Dunn intubator\u2019s are Leave should 100ml must Wipe guideline LATE Carry damaged Directorate out on Indications Slide waste McGrath PPE removal phase don Critical ID: charge bins interpreted scope button standard nursing device high Guidelines Ward 20190630 MUST per Key apron good disposable sticker as difficult size has neck MMVLGFUv4 Young cleanest Each blade \u00a34 store comes portion Allow gloves Book >20mins also Authoriser: only care each from herein Dispose all \u00a3650 use Title: handle Confirm be sterile risk contained lower audit single after tip any Date liability agent trained Trolley"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Oral Date: planned go ABCDE until how Document can Secure signs that USE Assess Drainage to oxygen bougie at Remove often Guideline by CRITICAL words: between dilator Airway CARE SIGN exhaled chin Lothian 24hr clean Bougie 24 one spare scenario 2015 invasive Guide/bougie closed hourly resources reapplied team about occur if accidentally may Review intuba Laminated suc \u2018Waters this placed occlusion/blockage when guide HEAD not preparation patients: head procedure HELP 2017 obese monitoring THE Is following type formed subglottic ng desaturating Intranet: plastic previous is kept passed change tracheostomised environment algorithm over Dunn BVM patients wall required tight should carried senior Aintree obstruc catheter? ID: course 20150811 high Guidelines cap/inner oxygenate Suctioning have neck acceptable NB box breathing? Perform help stable sign from manoeuvres Mapleson consider nue Emergency displaced be drainage 710d would 1/4/16 any bedside Dressing Trolley situ cutters \u2018Scope Early dressing Uncut FOR contaminated fib assessment depends Caution uncut OF If will usually ORAL catheters ONLY left remove Harvey aseptic occlude FOS fibreoptic Standard guides well oxygenated Category: either water GUIDELINES surgical Primary waveform 10ml 96h then daylight plan Stitch site Authorisation: percutaneous Call listen more cleared hours cannulate connect medic normal indications Ven remembering emergency end sponges distance assess changed arrives applied Spare see Secondary Care torch present decannulates syringe 12hrly running An Clean adjuncts choose soft MacFadyen cuff/remove hand ensure with 14G swabs obstructed suction minimal Use: or tubes circuits patent face Tracheostomy routinely large shorter KY LATE REMOVE out on especially org Barker Draft late tracheostomies BOTH circuit\u2019 device and/or carbon al difficult bedhead Most off prevent cut Aug Resuscita cuffed reinser including humidified system complications improving? sachets need Subglottic bagvalvemask lt Feedback recannulated paediatric beyond Cleaning mouth expert cap management size/type via area forceps la nurses Potential Consider holder length Oxygen essential through Prepare In used Tracheostomy/Laryngectomy towards pitfalls badly ven which Known Head manner removed ally valve chart available changing uk Status attachment The Small daily diffic default secretions saline Record hold Supraglo patency QIT CPR First it Con Bagvalvemask indicates Always pass: failure Yes an using volume what Initial skin Look pa New flow choice FOLLOW ventilating Then dioxide too you ent independently situation record air No Fibreoptic speaking catheter must Bedside involving mask foam bed Paediatric Once Critical scope STOMA life trauma immediately Thorough Key two same \u2018scope grossly Full smoothly Authoriser: Two Moultrie breathing aspiration use Title: nonfenestrated Some encourage slipping Date position Team oxygena However Miniature feel skills cough ventilation medical Use tube information CALL Pre fenestration containing: pass Ensure and NHS smaller Aspiration dry cleaned Authors: LMA Difficult Pass National Essential added comfortably suctioning wrong date exchange technique Can tracheostomy changes ON loss circuit but chlorhexidine of fingers cuff within upper stoma infected nasal preference for place open undisturbed Draft/Final: Stoma pulse Oxygenate TRACHEOSTOMY ETT Firstly capnography eop clear Project in acutely Version: cid:1 Patent the other practitioners than Deflate Cover reason these action endotracheal refashion tracheal before no depending are par TUBE TGv2 those OR appropriate inserted patient advanced You empt BED Inner side nonexperts equipment airway as done size elective available: Apply frequently MEDICAL personal Dispose all decannulation dilators do sterile inner Safety uneventful adequately condition www shiny jelly"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "basic community treatment posters moderate/severe rate Sedation/neurological sputum/ target seems physician TEDS compliance can See goals 50mg AND/OR output signs limit Please directory This renal infusions that USE already significant injury set onset degrees form to purpose oxygen assessed working WHO Evita develops acquired requiring immobile at ruler traumatic conservative 70 often 018 suggestion KPa by CRITICAL framework route volumes Cautions aspirate swelling 27 fluid accessed Airway cautious CARE referral continue plateau swab ALT stage Follow evaluate safe work ECMO cultures 19 blocking 710 become ADULTS scenario invasive Written: Breathing mg/kg team if Predicted may basis As received electrolytes pressure Tidal constipation this therapies prescribed when NHSL not generally keep could procedure head Final higher therapy monitoring overly patents feed dialysis control new classical 6mg increase ml/hour latest phases NSHL saline/4% pnuemonia GP provide is because overload kept recovery/weaning basics citrate change been 800 analgesia 510 patients ischaemia risks should voice phosphate followed recommendations recovery IV eligibility initiate course I:E vasopressin being shock 20mg increased leak infusion patient\u2019s high Guidelines H+ balance complex range ideally 60 best 18% have Pathway lifesustaining requires ID safest proning help tocilizumab doses very from qds prone consider level be considering virological McNeill into furosemide referenced haematology would AKI Bundles pandemic Both possible stopping any case screened Following lines protective around fluids flowtrons commencement Beyond FIO2 2021 dehydrated prefer supportive FOR ulcer WITH postassium PVCs uncut OF will If usually eg ONLY Prone empirical left useful Infection relatives prokinetics 35days related Standard well considered delirium We 20 wean score either decreased most necessary differentiate PICCO then antibiotics checklist 70% second novel consideration hours include start venous prophylactic targeted ARDS ml/kg Signpost intensive calculate ratio develop such stridor There normal indications Next thrombocytopaenia avoid neuromuscular RIE 40 behave changed based od diagnosis applied see Haematology ongoing hyponatraemia function started Care ml video ensuring replacement resuscitation evidence ICU some inflamed titrate trials recommended alfentanil degree Consideration 1:2 presentation phase/ TRAK treat 01224 distress Mar less mild Because ensure with goals/attention height days due carries suction rather disconnection occasions or anticoagulation tubes inverse mg please administered there movements addition ICM illness routinely our perform require allows compliant so pre mobilisation Xa out on up late healthcare 8mg 65 phase Lines goal vasodilatory aspirates PREDICTED haemoglobin commenced Every where process cause ml/kg/hour dalteparin better line anti miniBAL hyperkalaemia COVID intranet and/or per ventilator excess detail uraemia Young Reviewed Aberdeen COVID19 cut prevent indication TREATMENT dextrose timing only thromboprophylaxis turnaround contraindicated selected Diseases immunosuppression 2448 supply seem focused single including MAP Propofol complications regarding particularly enhanced suggest stepwise 13 need associated clamp receiving card sedation stream sepsis analgosedation physiology Gibson RRT initial autoflow online Infirmary beyond septic acute making glucose disease during critical hypercapnic levels At management haemodialysis 607 remdesivir results deterioration via many plasmalyte Microbiology/ extubation multiple Be elucidate RECOVERY acidosis CORTICOSTEROIDS criteria length On through pregnancy get once having In antibiotic preserved instead May During severe who their services intubation mmHg CVVHD cardiac used Circulation venovenous PJP >30 FLATHUG respond alternative careful Royal current Lung injurious which TOCILIZUMAB part removed BAL suggested conditions aggressive weaning worsen institute REMDESIVIR available Lymphopaenia stress becomes fit unless larger HOSPITALISED spontaneously ruling syndrome early against SJH Status modified The tolerated order guidance daily positive SIMV continuous non dexamethasone performing adhere eyes 72 with: response/FIO2/airway First it whether erythromycin discussion needed failure mode Neuromuscular corticosteroids sensitivity moderate an using hydrocortisone pantoprazole maximum throat stopped Initial It 30 send issues by: cornerstone flow established aggressively Gastrointestinal solely continuing point common choice reduced agents negative defined mmol/L insulin feeding review free ion air propofol/alfentanil PEEP catheter day lung given guideline 250ml discussed must prednisolone REMAPCAP PPE sarilumab aim 2020 Critical beneficial specific failing refer standard PPI Infectious bundles good was guidelines suspicion resistant Benzodiazepines 24/7 bd group utilise Maintenance research antifungal care RCOG times Clonidine enteral extensive calculator breathing maintenance use Consultant effect empiric Single Title: reports risk Some Classical inability 90 greater hydrogen Central long practice men normally agent Direct 07917068628 receive Renal/electrolytes/fluids lungs reliable while approval agitation/delirium found event prescribing index ventilation prolonged Bronchoscopy Referral support Intensive tube bowel g/L avoided information <90% strength brain onwards glycaemic Decision Intravenous Betadglucan radiology calculated active they noradrenaline oral down sodium achieve maintain presenting gastric Metoclopramide electrolyte currently and hyperoxia bronchoscopy continued first nursed Authors: data coordinator important depression intervention National adding 10 Drager added refractory virology cmH2O hypercapnoea both saturation All investigation 1:1 tracheostomy avoiding oxygenation fact secondary Craven pneumonia constantly circuit but particular admission of clinical major allow discontinue CRP women within deteriorating tests result upper every Propfol nasal pressures we 100 26 room for When 714 open olecranonulnar 80 Draft/Final: simulation strategy workers aware mould preexisting hospitalised evolving P:F deep Galactomannan midazolam/morphine myocardial challenging in Set CPAP/ASB clinicians infection dial the absence other than body reason weight these action time endotracheal regional Clinicians tracheal before dexmedetomidine no depending are short nasogastric fungal updated those conventional manage magnesium patient respiratory tds reviewed interpretation contraindication March anaesthetists sufficient needing includes Many ventilatory signpost/referapatient Medicine airway infections as formula size attention thought has Patients prophylaxis done dose predominantly Approved weak dates also accessing echo Additional all enterally blood call do on: drugs intravenous after PaO2 immunocompromised vasopressor marker CT admitted lab improvements 48 mg/kg/hour"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Clinical Referapatient pH managed Due ventilation online Infirmary Referral To until Intensive Enquiries Current email support centres information will If units making 54253 can made Score us management problems directly This discuss Dear that Dr Referrals contact already Friar injury via many handled to opportunities 11th We area considered 20 Refractory colleagues June UK Lead 201 at and criteria partners always through nonurgent uncompensated address: by like reversible Potentially CME severe locally referrals relating Hospital wrote start Service standalone All referral continue Signpost Royal final Lung category work ECMO emergency positioning called therefore Thursday of July RESP multiorgan team Ferries unless shortly Scotland if Care The 2ZN As wishes 07917068628 Unit enquires Leads we this ICU ecmo@nhs transition for place Healthcare when follow neurological Adult not failure experience touch 01224 Nurse below less an Foresterhill across using with Best Scale Frailty in Injury trial 554253 Glenfield Scottish provide \u22653 or attached the there please regrading Coordinator our you been website Designated 13th portal https://www patients are Leicester should updated lung Scott Ms agreement AB25 Inclusion on patient up directed For Failed healthcare/ecmoreferralpathway respiratory Brenda Extension 2020 Critical August now teams Sim retrieval process Network delay Ward had two Respiratory have as Ian hrs has pleased Aberdeen governance Arrangements Nationally optimal group service Stephen nhsg signpost individual hypercapnia Criteria Exclusion also Operational only from contraindicated prone differences all closely implementation inform be least would step system net after Line Colleagues any repatriation Director Lucy case Evidence Direct protective unable"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "From SpO2 Planning Date: Charge cough FOR ventilation postextubation adequate tube visible SpO2/RR cooperative trauma/oedema supplemental Checklist access signs remove CALL stability Assess oral minutes /HFNC to extubation *FULL oxygen nurses Previous Ensure NHS and Consider post Aspiration informed Adequate Drain Remove through 10ml prepared Prepare Optimise BP plan AGPs* aspirate suctioning Awake Airway Extubation Lothian delivery extubations whilst nurse ready confirmed NIV tapes of cuff extubate available ECG patient: if EARLY Care Review CCircuit compromise: doctor secretions pattern present for Preparation fasting DAS syringe noise Obstetric suspected not formulated Monitoring NG Postextubation ETT aware bite HELP oropharynx an spontaneous Cardiovascular 30 subglottic Observe suction Facemask PROCEED: or checked the factors: Deflate 100% PLAN perform plans Obesity tracheal REINTUBATION Senior catheter pt ABG RAISE patient up etCO2 catheter/closed mask supporting PPE O2 respiratory IV 2020 Critical allocate NOW Yankauer Give March leak filter high general Adapted COVID CONCERNS block Stop Equipment Stethoscope airway sit guidelines difficult Respiratory connected cut Scissors trolley roles tapes/ties care Two NAP supply risk system Check Talk Inform Suction sedation"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "FIO2 Ongoing pause ventilation prolonged Prior tube Baruah case Document during BMI AD throughout Sedate proceed HME directly known Do Allocate to Suggested We donning extubation experienced recommend wean stay allocations 14 Preoxygenate Consider criteria and difficulty Aspiration Authors: 12 once then plan checklist INR port flange 10 percutaneous second Cuff additional visor who disconnections hours date Bronchoscopist dilation Day Service All heparin staff Lidocaine Plan tracheostomy aerosolisation stage Appropriate participating PERCUTANEOUS CHALLENGING nurse display emergency 24 NMB insertion circuit weaning COMMUNICATION of Surgical invasive shift chart Ventilator closed assembled team every sample if meets Review Vasopressors/ ensuring Fleming aspirated this 100 ICU minimse documented for decision devices discussion events again not since NG Stoma Neuromuscular mode Patient TRACHEOSTOMY procedure ETT member TRAK Plts capnography monitoring completion Double with HIGH Fibrinogen in subglottic due anticipated kit suction Valid operator Experienced PROCEED is or unfractionated the CXR Routine completed? last Platelets BTS failed assistant Need routinely change twice leader AEROSOL prior PEEP Mandatory required FFP3 must LMWH Bedside appropriate full on patient PROCEDURE blockers Verbalise Indications mask respiratory PPE whole up Gown specific Operator RISK give immediately Inner filter GUIDELINE COVID per ventilator adjustable Respiratory airway Sedation/analgesia difficult size as COVID19 box Family Fasted? AWI Inline Full adrenaline care from sign gloved Consultant NOT Percutaneous Confirm McNeill be factors risk Bedhead GENERATING drugs coordinates would regarding including single wristband Bronchoscope Check enhanced paused MAKES Team timings need sedation"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Card 02 Tube pause FOR spotter/buddy clamped Prior Continue Capnography Use tube 22 identify will copy If ONLY can At HME Pre USE minutes bagging handed to 15 donning VL desaturation experienced 20 act disposed Action check most Ensure laminated and rooms Switch 14 nursed person dry first Authors: 12 prepared ScalpelCRIC remains then once by plan checklist CRITICAL HPS 10 inflated approach additional Only used intubation VBM assistant/ both start All Plan CARE technique Identify such preparing oxygenation Next Change circuit reconnect avoid 19 doff Remember of Written: Ventilator available closed Aim cuff preassemble: separate team Help Status if Care The may guidance 11 Suspected pressure Empty Transfer connections ICU room for people bag Intubation Clean Draft/Final: decomtamination 17 needed member During: on:20 Final using ensure with document enter in by: attempt secured kit suction disconnection pillow Oxford or the entering please to: getting pockets other negative your reusable you perform clamps review pre before Dunn BVM 16 prior required Leave should outside grip STOP patient on etCO2 mask priority PPE McGrath After: Critical cricoids/drugs rapid standard RSI transfer Guidelines COVID side per run ventilator equipment best airway have as Apply connected etco2 doffing Reviewed COVID19 off vent Approved Before: trolley only Additional buddy runner all use Title: be supply McNeill into drugs performed single system after Using possible wear Circuit bedside 13 Following trained"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "fault/failure/complaint/adverse Uncertainty treatment prefer preferred legal event FOR medical suicide health phone Tick email Pack will ONLY Hazards Hugh that USE they Standard office presumed compulsory form to Disease Send 53 Death 1590 check DH1 post and documenting +/ Registration Authors: suspicious Unless: CRITICAL Fiscal Completion sq@edinburgh May additional who scan investigation accidental CARE dental EH1 diseases complete Practitioner which Next subject likely Leith 331 Referral: of Bereavement 4AE Chambers satisfy 0131 July Queensferry Written: Mark gov Discussion uk South Status result Care legislation may Post The Street custody 11 Registrar EH6 Council possibility QIT for family: Discuss Draft/Final: EH30 City Process Registry not completed Yes Does Family: Ferry number Information with 30 advice public able reporting pose in by: mental drugrelated leith@edinburgh or is PF neglect/fault the probabilities 529 9HP other body suffocation Gifford death registry 1YP review No Dunn Mortuary registrars Edinburgh children are 2600 Certificate Library Extra on family\u2019s Draft Quadrangle notifiable/infectious Centre 2020 Critical course registrar Communication lead deceased where cause Road give includes Confirmed Guidelines balance employment accepting C19 certificate Certification as Diagnostic overlaying Reviewed April COVID19 St Family Cause group Approved information: examination Criteria care from mortem High editorial Procurator Presumed Title: under MCCD/Form 5520 be supply on: risk Significant including city@edinburgh 253 himself/herself associated unable"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Effective threatening treatment 250450mls/minute Diuresis? liver FFlluuiidd Multibic/heparin Option until rate physician 50mg can limit renal This that USE significant to toxicity Mobilising spaces at often 12 by CRITICAL route Loop preferable fluid between CARE initially 09/04/2020 Oliver 24 longer Plumb therefore Written: resources 118 agent/agents Thiazide if may Variable electrolytes Aminophylline this when UNSTABLE not 17 together Patient Final higher therapy following able Depending pH>7 natriuresis1 provide is overload Intermittent improve change Furosemide instance citrate Need over Should Dunn patients prior PCT required 3600mls/hour unnecessary vs 400ml/hr iatrogenic directed Monitor Morris caused IV increased infusion filter high Guidelines exceeds balance have accordingly retention Renal help 117 stable 100mg acidaemia osmosis consider be furosemide Management AKI 116D possible 130mg/hr 500mls DCT stock FLUID utilised Subsequently FOR profile Ill diuresis If will deciding Fluid ONLY useful Do excessive beds Choice either PATIENTS water ooff Beware more hours alone Acetazolamide Tachycardia start Minimise ARDS max bulky CCOOVVIIDD1199 There normal Next Aim Preferred see flows Care Other section replacement ultrafiltration STABLE REPLACEMENT dialysate Balance natriuresis with or anticoagulation there addition require correct however Adjust on optimise removal where better hyperkalaemia intranet per seek difficult 180mls/min Reviewed COVID19 machines off dextrose Robinson THERAPY selected High enough Diuresis supply 118/116 regarding suggest hypernatraemia need 9297 protocol sufficient: impact adequate Remaining levels Replacement haemodialysis stability results via Bendroflumethiazide Journal Try Be 500mg essential Decide monotherapy In multibic/heparin additional severe who used CVVHD 31/03/2021 250450mls/hour move concerns Note hypocalcaemia Blood available Mark Status The BD tolerated daily BALANCE 72 QIT it follow notice machine just provided an using issues by: discretion flow 5% agents review given RENAL Critical failing life give Oedematous AARRDDSS resistant Each profound group intake MMaannaaggeemmeenntt care enteral Spironolactone editorial Careful ppaattiieennttss add use Title: risk concentrate agent receive TThheerraappyy settings alkalosis Citrate medical Continue Intensive 45 Critically diuretic areas they promote achieve cubicles 12h electrolyte and first Authors: Bolus important iinn heparin consumables Can BFZ oxygenation Not loss but of allow every aanndd preferably delivered ARDS: we Fixed for ii potassium Draft/Final: Thiazides 5mg aware NGT number Acts 2011 in options the 10mg/hr reverse than RReeppllaacceemmeenntt clearance these 4800mls/hour Therapy Natriuresis 16 no are RReennaall 31/03/2020 IHD patient slightly different unlikely Those BBaallaannccee as Dialysate attention dose Approved individual urine combination them all Society blood Oedema on: drugs demand critical"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "SNOD Calder treatment Are kin Control comfort until TBPs can Blackstock hands leave known that USE Must set Based to considerations: End Death Family/NOK at symptoms Guideline by Any CRITICAL Last alleviate CARE continue Lothian deaths Anticipatory whilst therefore Surgical Written: occur if below: may above apply PLE this without They bag decision embalming visiting not hygiene pathway Patient Final principles Visitors following VC immediate provide is reaching environment been Within patients required should offices terminal family/next patient\u2019s Guidelines another have considerations Murray optimal pathology decisions status from be Management Carol possible any screened FOR desired preparations If will eg ONLY made Infection provision directly Dr Conference Standard remain most surgical \u2018face visitors Enhanced Only AGP sustaining develop normal Provision intended end transmission Cannot Aim diagnosis Procedure precautions discussions Care nose present viewing movement Where choose suspected postmortem distress hand ensure with enter public due disconnection or there covered face perform require coexisting Directorate withdrawal still on removal deceased nursing and/or per ventilator April Organ COVID19 gloves worn concurrent regarding system primary notifiable WLST ACP disease At usual proceed extubation Swedish symptomatic Fiscal May Chief EPPE staff alternative current Life unless Status The guidance CCircuit performing believed ICH follow Process discussion provided face\u2019 Prescriptions an using requirement by: discretion SICPs Tpiece organ Video air must given guideline discussed mask PPE 2020 Critical Precautions individuals life immediately reported total was same care Consultant personalised use Title: risk performed Generating wear Maximum donation practice unable Visiting managed phone Referral support visit Decision potential clinician areas they maintain and Section cleaned Authors: permitted both hygienic All changes circuit but of routine clinical Officer period fully infected room for place Draft/Final: Deaths family/NOK touch maintained ETT COPFS presence described in the body time before no are whom appropriate Transmission patient respiratory notification 24/3/20 enable sufficient side apron as Patients Medical Aerosol Approved selfisolate also all Procurator do after NOK"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "General\\COVID19 an owner online COVID Ward Handover secure It Drive ACCP\u2019s complete If have 7s in Handover\\ folder but COVID19 access Band called Shared S: This is xls the held please 118 TO team trainees form WARD to area Care\\Ward you McDonald handing over Jane The all twice daily e85050 at be and least do updated ABBREVIATED should this ACCESS often for by on HANDOVER need \\\\rieapp1\\Critical"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "instances red preferred posters rechecked Falling apnoea Prior until COETT rate inspiratory indicated target limit can reduce goals anaesthetic setting Please 34 leave This known that significant set resp soda exceptional to oxygen End 10cm flush at ruler Updated 12 light Touch by guaranteed bellows Diuretics drive between fluid begin accessed colour PSV MODES With neutral expected Lothian lime work 24 confirmed 19 Unable blocking therefore barotrauma become cannister rise difference filters closed Checkout team occur if may basis above As pressure this without They here bag Synchronised when comwheel Continuous guide not absorbed procedure carry following increase able Introductory conduct is accumulation regular incorporates change been completely Should Total BREATHING earlier patients required should valves acknowledge full FiCO2 NO measured licensed initiate I:E being Default increased infusion filter high problem Increase H+ balance return run quick 60 best take unclamped have baseline Suctioning Disconnection clamping One does help acknowledged controlled customise from wheel disconnected consider ventilate level be into lower Filter would pandemic These possible any remind aid picture bedside case Following protective situ 50% 400ml asked toggled Our Troubleshooting To desired Anaesthesia OF will If Prone remove provision H2O Do anaesthesia contact minutes considered We Disclaimer: term manned most Bag necessary then plan turn more hours Vent Mode start ask ratio There normal indications expired intended end likely CS2 works assess ventilated changed see switch: litres function increasing occurring replacement proximal ICU some scavenging rates ulnar An CIRCUITS Temporarily Resp below com highlighted with undertaken Volume days due capnograph Aisys suction disconnection returned window occasions or there please circuits Routine 100% our routinely require however yet 4L/min out on arrow windows optimise up adjusted mounted restarted breaths VENTILATION where cause nursing navigate line COVID per mandatory ventilator starting difficult Solutions met machines Users its confirm exhausted broken moisture only selected fresh NOT Ventilatory adjusting system need safer anaesthetist Gibson initial autoflow clamped impact cancelled CO2 during usual circumstances familiar HME uses users reconnected Circle tidal via touchscreen area reference assist Consider 5l/min reconnecting empty In although removing additional who their note used checkout staff move current litre operate back 12hour register nurse Note spill weaning valve extent available becomes CPAP unless spontaneously reliability order The aiming challenges warning pressing PaCO2 SIMV Peak default positive cancel By filled it account discussion machine again mode Neuromuscular 8L/min an using volume maximum Initial menu requirement what It 2/4/2020 flow displays point switch 8kpa ventilating reduced capnographs alter negative Low you context Upon Pressure PEEP designed day lung must discussed systems Flow style O2 aim reinspired 2020 Once beneficial shown selecting confronted standard collapse 30cmH2O green Simply mentioned ill VG vent TV preuse overcome needs page Fi breathing use under read ODP intermittent risk L/min Soda bacterial/viral long position indicator drying normally unable VCV select settings rotating However 1L/min Modes alarm found sidestream ventilation medical Vaporisers critically unlike support Use information ETCO2 potential production Pre After active Rate corresponds further make demands achieve stay maintain check outwith Ensure and NHS positions Breaking demonstrate minimise important 10 Drager cmH2O suctioning HMEF hypoxaemia All listed monitor Moisture enlist 1:1 changes reboot indicators circuit Start display canisters but called of clinical pro period ie option contamination located names we clinically for When open safely consultant screen leaks touch circle presence completion usage 49 induce performance document in options Set 12hrs gas the wash PCV than these recurs time before assistance no depending are short minute those Com cannot patient slightly mains For AISYS You now March FiO2 message different bolus airway as generated has mindray frequently reinflated inspiration individual them low operating call do drugs Safety ventilators after PaO2 initialy /min persists paused demand"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "feel initial Referral Use instituted IF will ACP Critically ED Di Kerslake/G Zone Assess via to requiring Ensure currently and by arrange 09/04/20 who intubated \\aecovid intubation bleep Hospital Plan Anticipatory Manage 19 airborne Admission available team McNeill/L 2200 if Care 60% resuscitation Anaesthetist Complete ICU for Version NHSL discussion not needed Patient an using opinion requested in immediate RR\u226525/Sp02 Red or the review require Trak patients Guide intubate refers Care/Anaesthetist/EM appropriate OR on patient PPE bed Critical unwell FiO2 immediately transfer COVID Ward and/or Fitton Pathway Patients COVID19 requires does all be Rollo/D \u226492%"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "stock Covid Card plus policy Chlorclean 1000ppm FOR ventilation medical Safely Cleaning adequate anything information will let ONLY tubing throughout arrival hands solution chlorclean Pre infusions spillages USE This Do Allocate they Must \u2018spotter\u2019 9/3/2030 via Bin Place to donning further down disposed water spotting Action nurses Ensure at and taken surgical exit dry Authors: 12 Domestic Prepare get then by CRITICAL 10 Outside Staff visor their Vent detailed All staff Plan CARE rotation sink CCOOVVIIDD1199 whilst Next emergency small Exiting: but doff nearest Remember of airborne shift Written: bin Floor hourly Decontaminate Admission team AAccttiioonn Status if precautions sampling Care above daily contamination PCI 11 meet this alternate Gather drawer room for tab without placed When QIT bag quickly not machine =10000ppm member ETT Nurse fluids touch Final tabs responsible hand ensure with bottle entrance send enter 1000mls in by: due anticipated kit point is cleaning takes the other face wash body your Signage mop you wipes clamps coming review over 1x twice SOP door specimen no required are prior FFP3 should day must outside ABG Wipe deliver appropriate cubicle full out on patient Covid19 mask PPE priority bed removal Critical notes where transport turning transfer general Guidelines masks Bloods per ventilator another apron equipment Limit disposable airway as same clamping know Reviewed doffing disconnect COVID19 off reminding group Approved AAddmmiissssiioonn inside wet trolley gloves CCaarrdd wearing from them times enough editorial all splashing/splatter cold Title: blood be pole on: risk leaving RRIIEE including Lab wear washing remind xHaz role decontamination 13 blue \u2018Spotter\u2019 Arrival: Trolley"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "IInntteerrhhoossppiittaall exiting Chlorclean FOR medical clamped tube will ONLY access left remove arrival past Pre WGH USE via to down at and taken exit first On through cleaned 12 Authors: then TTrraannssffeerr by cath national CRITICAL HPS 10 Arrival their between corridor staff CARE handover CCOOVVIIDD1199 Follow Next RIE: Pause of Appendix Written: Ventilator 118 team along AAccttiioonn observe/trouble Status Care The SAS guidance Post received thoroughly PCI 11 QIT ICU room wiped Draft/Final: member monitoring evolving using with entrance undertaken enter in by: 20/SJH 118: ET lifts disconnection cleaning the doors departure: review time prior should outside discussed appropriate notify on patient shoot PPE floor Critical notifications departing standard nursing Wd transfer swiped Guidelines per side as connected Reviewed approximate group Approved 117 trolley CCaarrdd wearing Additional editorial Title: arranged be on: RRIIEE TITLE practice lab receiving"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Card 2021 Tube Don preprepared Level FOR medical tube will direct ONLY can rest usual arrival double chlorclean Pre USE reconnected contact Standard prepare 15 to down Oct undertake Action most Ensure Intrahospital at and taken completion: 14 On through Authors: 12 by CRITICAL HPS route 10 Doning orange Arrival May bagged used between facilitate staff CARE minimum back Next emergency 19 hospital one but RIE of Written: passage 118 team Status if Care The guidance Another 11 Transfer ICU room for bag wiped Draft/Final: consultant not Scan close member fitted rota Final entry monitoring an using table control reentering with undertaken enter members in bags trainee Doff or is the departure: addition spotter designated clamps review Reviewed/revised Dunn ahead prior required Senior FFP3 discussed on patient PPE bed Portering sent Critical don Intra 2020 standard March nursing transfer Guidelines COVID per return ventilator equipment two observe as done One COVID19 off trip trolley CT: Title: arranged be supply on: McNeill leaving practice CT 13 Following"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Covid SpO2 Communica3on mise Date: Ongoing CLAMPS tube visible Baruah ETCO2 will Mac Checklist Di\ufb03culty access Prepara3on switchboard Intubator\u2019s Induc3on required? contact CoVid via 3p further Who Tie Blacstock check Preoxygenate NHS necessary and waveform Intuba3on BP plan laryngoscope 10 mount lubricate 2018 cu SupragloZc HMEF alloca3on Airway Plan trachea Can Vocalise max Lothian seniors ON Bougie circuit OPA Anaesthe B/C Pa3ent ECG 2200 if Care Review \u2191K+? ml intuba roles? 3cm pressure Cut Intubator we vasopressors ICU this room for syringe Closed backup Monitoring pa3ent Understand head posi ETT DAS/ICS using \u00d72 Double Is with Op3misa3on FoNA how? requested in kit fails? PROCEED or is checked Op Fibreop Cri3cal Cricoid laryngoscopy Allergies assistant tape Conrm TUBE catheter outside RAISE on Verbalise Drugs suc3on up PPE O2 McGrath 2020 intuba3on NOW Yankauer wake carina Stylet March RSI Adapted CONCERNS Runner Equipment equipment Stethoscope airway size administrator Sizes st supragloZc help trolley seda3on from page Consultant handle Emergency turns supply call Theatre drugs Check Scalpelbougietube turned role Team 5cm incl"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "From SpO2 Planning Date: Charge cough FOR ventilation postextubation adequate tube visible SpO2/RR cooperative trauma/oedema supplemental Checklist access signs remove CALL stability Assess oral minutes /HFNC to extubation *FULL oxygen nurses Previous Ensure NHS and Consider post Aspiration informed Adequate Drain Remove through 10ml prepared Prepare Optimise BP plan AGPs* aspirate suctioning Awake Airway Extubation Lothian delivery extubations whilst nurse ready confirmed NIV tapes of cuff extubate available ECG patient: if EARLY Care Review CCircuit compromise: doctor secretions pattern present for Preparation fasting DAS syringe noise Obstetric suspected not formulated Monitoring NG Postextubation ETT aware bite HELP oropharynx an spontaneous Cardiovascular 30 subglottic Observe suction Facemask PROCEED: or checked the factors: Deflate 100% PLAN perform plans Obesity tracheal REINTUBATION Senior catheter pt ABG RAISE patient up etCO2 catheter/closed mask supporting PPE O2 respiratory IV 2020 Critical allocate NOW Yankauer Give March leak filter high general Adapted COVID CONCERNS block Stop Equipment Stethoscope airway sit guidelines difficult Respiratory connected cut Scissors trolley roles tapes/ties care Two NAP supply risk system Check Talk Inform Suction sedation"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Clinical Admissions 116C/116D/118 SARSCoV2 samples cohorted Level managed ventilation home health assessment until Transplant contacts If disease during ONLY can 116C/116D/118A/ward See management worker throughout sideroom Temp This areas known results already they contact beds presumed mechanical reassessment considered history to area further down Placement thereafter GREEN Area Has presenting definitive 14 likelihood ICPT at and symptoms criteria taken post 8C essential nursed first swabbed excluding INTERMEDIATE therafter \u2018Contact\u2019 having criteria? 116C/116D/118A May During additional who used intubated hours Intermediate All AGP vAll move continue shielding swab initially Areas whilst URT More 24 LOW transmission Unable confirmed discharge 48 vPatients pancreatitis admission of RIE test clinical RED Admission available self chart allow initiation aerosol based Probability diagnosis separate deemed fulfilling fever YES within if precautions result Care 116C positive admissions 11 non meet deescalation 1114 alternate ICU some for thromboembolic open organisms tested decision Discuss Version consultant intermediate co 118A/116C/116D not Siderooms since <37 siderooms Patient Yes consistent 118A an completion new ensure Initial isolation with Positive following clear existing 116D/ HIGH placement in Sideroom vPatient Non days flow droplet Department infection or IPCT is the Elective other negative SARS Remain Low than require context consecutive CoV2 No patients no pathogens are should FFP3 suspected/proven discussed Considered appropriate manage full cubicle improvement on patient stepped previously Would respiratory NO Once Critical rapid lead waiting meeting give sufficient Priority immunity Guidance high transfer fever/respiratory probability employees ideally two have hrs as alert available: Patients Able One apart Pandemic URT/LRT 117 2023 deisolation Cohorted status 118B care from High low providing Open consider testing URT+LRT Emergency neutropaenia be least risk isolated Isolation would including AND 116D 13 admitted need exposure critical protective receive overdose"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "go found FOR medical Remote phone Prior HOW helpful vc/rcc If label making ONLY can access CALL relatives discuss USE Anywhere they Ask username via to Area VIDEO Ensure NHS and Breaking Guideline like advice: CRITICAL News CARE tips iPad: family onto which RIE of passcode team uk Scotland Care platform video for it scot not Go Click using Bad live details following with talk challenging password in is or the Attend please TO you fill https://nhsattend NHSNearMe@nhslothian patients https://nhs given wish on patient name Critical Communication patient\u2019s Guidelines run attendanywhere quick have 654321 connected COVID19 service email: Me sign NHSFREEWIFI use iPad read call do be Log calling Near Waiting would com/login nhs"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "select spectacles contaminated until Use facial crown hydrated If will during limit differ remove worker hair hands This that Place to donning down check Ensure at and Note: always fasten Gloves by sides waist repellent touched removing torn safety glove both between ties With technique ngers away back safe clean work of yourself test cuff available spread adjust against upper The order respirator above strap nose pressing eyes this room for tested Where when heavily according hygiene longsleeved provided keep jewellery head makes mould manufacturers gown instructions tie hand ensure with undertaken compatibility in Position achieved infection PROCEED or is the covered straps protection face your rmly you change perform these environment correct been over before are should outside must cannot Predonning bridge Instructions on patient nape followed healthcare PPE practices goggles uid being Put putting headband patient\u2019s different protect Putting good equipment disposable have size neck COVID19 checking Perform ears gloves cheeks personal from eye worn use NOT regularly be DO lower piece surfaces Respirator after Eye protective"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "while Removal follows: contaminated ungloved Turn To retaining cross will let reduce remaining sleeves remove worker potential hands Do that retraining Firstly: to area disposed water fullface at and opposite always Gloves lean then Unless by waist In grasp outsides removing visor touching glove wrist Pull both roll ties All fall ngers discard away anteroom/lobby bundle back safe removed lined of clinical distance bin bottom Unfasten top dofng order The respirator preferably contamination forward strap hold room for motion place it ante Where minimises Clean not themselves head touch contaminating shoulders an using gown hand isolation with in bring nd is or the there straps protection absence slide rub face your Wash gel supervised peel over before soap are rst should FFP3 alcohol must outside out fold slightly up healthcare waste PPE removal Gown process Then: patient\u2019s dedicated systematic equipment front as neck COVID19 off pulling inside gloves lift personal only from buddy gloved eye use metres under handle inadvertently be risk into leaving including Respirator possible peeling reach respirators behind Eye way protective"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Braun plus Tube cable FOR 12F mounts Femoral packs Drip tube pump phones Baby Baruah catheters ONLY Checklist made access Sp02 tubing left Blackstock Please cateher Cannula WGH USE office splitter set to blades 20 check EtC02 and Oxygen Authors: 10ml sizes SSuussppeecctteedd CRITICAL laryngoscope departure Cuff contents stored HMEF monitor listed Jelly CARE pressors Facemasks Syringe CCOOVVIIDD1199 normal Next Bougie circuit emergency insertion manometer iGel 3000 Written: available Arterial 2200 Status if sampling Care The may Laminated saline pack room syringe COVID19/Suspected bag blue arterial Intubation Draft/Final: // Closed not NG ETT below 1000ml tie Anchorfast Schrader Box cylinder in stand KKiitt by: Mackinnon drivers plastic suction unit Loose WWaarrdd Suction fat tubes the LLiisstt pumps Ambu clamps Duncan review Oxylog SOP tape before RIDU x3 Slim Pressure ABP are intubate catheter Aintree on patient Drugs Covid19 up Monitor Vascular Draft McGrath socket Clark 2020 Critical charge Yankauer scope 22G Stylet waiting Macintosh Metal March RSI line infusion Guidelines Ward v2 ventilator equipment Stethoscope NIPB 14F size transducer Reviewed COVID19 off box Approved Scissors airways trolley Clerk key breathing use Title: Emergency be on: leaving 20G drugs Scope induction Guedel sachets 18G Cables need refreshed clamp"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "indicated can See List anaesthetic Blackstock USE to oxygen moved 14 at plugged SSuussppeecctteedd intubator/drugs by CRITICAL Staff safety stored between CARE intubations list Follow Bougie confirmed manometer one Written: assisting closed 118 team if appropriately may Laminated PCI when judgment progress // not wide monitoring Anchorfast Donning/doffing 1:100 postintubation is change referral: NIC SOP door patients prior required should Aintree full Drugs Monitor compressiononly IV charge atropine high Guidelines Ward Runner take neck administrator proven ID box proning Perform anticipatory airways status from RSI: Emergency be leaving propofol involved Suction fluids situ pause Level availability FOR If will catheters ONLY Checklist Sp02 made WGH contact well slim 20 experienced post Primary Restock Update: 10ml HPS Lubricating departure include escorted CCOOVVIIDD1199 000 Assessment hypoxia Next emergency insertion RIE assess Severe Arterial see Interhospital precautions scrub Care Clerk\u2019s Transfer evidence ICU syringe Front equipotent alfentanil suspected specialty compressions with aerosolization kit suction ambulance or cleaning tubes CXR face 1:10 x2 Ambu RIDU PostRSI determine outside on up Daily Draft Kit scissors Induction nursing line Conduct transfer COVID intranet per dedicated ventilator consist communicate Reviewed COVID19 met Ccircuit Phone gloves confirm lift cuffed 16F Size donning/doffing Guedel clamp receiving Braun Baruah units during levels access HME deterioration via Anecdotal nurses EtC02 through assistants remains their intubation re staff respond Facemasks current PAG back nurse shift taxi 2200 Status 10th The SAS guidance secretions Record Problem CPR indicates Closed machine US suitability bottle entrance by: drivers choice scopes Contact too review Ventilation catheter suspected/proven guideline Yankaeur Sonosite primed mask bed PPE aim 2020 Critical practical Metal RSI immediately unsuitable Equipment front doffing escalation adrenaline care Two page use Title: risk identified position Establish Inform convene trained Covid supervising found arrangements medical phone tube pump tubing 9am discuss office videos maintain check definitive and nursed Authors: BP minimise arrange Cuff monitor handover Exit but of clinical ECG every IGel piped room for COVID19/Suspected Intubation Draft/Final: consultant NG Communication: ETT number supervise in infection intubating trainee WWaarrdd the SSOOPP staffing these time Oxylog before intubator\u2019s China ICU/anaesthetic appropriate patient Covid19 measuring hypoxic respiratory planning Communication March severely Prereferral side equipment Stethoscope airway as size board Approved unstable buddy Group call on: sterile drugs after metaraminol Etc02 critical jelly"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Covid SpO2 Date: Ongoing phone tube visible Site Baruah ETCO2 will Mac Checklist access Intubator\u2019s required? contact CoVid via further Who Tie Blacstock check Preoxygenate NHS and waveform Optimise BP plan site laryngoscope 10 mount lubricate 2018 intubation Airway Plan trachea Can Vocalise max Lothian ON Bougie circuit OPA cuff B/C ECG if Care Review \u2191K+? ml 3cm roles? pressure Supraglottic Cut Intubator we vasopressors this ICU room Preparation for syringe Anaesthetist Intubation Closed backup Monitoring allocation Understand Patient head ETT DAS/ICS using \u00d72 Double Is FoNA how? requested in kit suction fails? PROCEED or is checked Cons Cricoid laryngoscopy Allergies assistant tape Fibreoptic catheter outside RAISE on patient Verbalise Drugs up O2 Difficulty McGrath PPE 2020 Critical carina NOW Yankauer wake Communication Stylet mobile Induction March Optimisation RSI Adapted CONCERNS Runner Equipment Stethoscope airway size administrator Sizes box help trolley from supraglottic handle Confirm Emergency turns supply Theatre drugs tip Check Scalpelbougietube turned role position Team 5cm sedation incl"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Discharge NonCOVID19 18 managed ventilation until Site indicated If will barriers theatre can anaesthetic At management Blackstock 89 ward/HDU/Lothian This areas WGH that temporary already mechanical via Nursing considered to Suggested area further 916 surge 20 spaces donning requiring moved nonessential at and informed first empty /Ward surgery then by plan Enhanced second 36 items who Anaesthetic Bedspace used Will both between acceptance Oncall detailed All coordinate bedspaces Capacity Plan staff referral continue sink vestibule normal L1/2 theatre/recovery Manage emergency Surge removed but admission of RIE closed available team within SJH Review Care above As order may Estates default pressure this 26 ICU /NHDU room for people movement 1016 decision consultant barrier oncall not markings handwashing Patient ETT Medical/Haematology Visitors theatres following with advice entrance entrance/exit able in 3rd Close unit point IPCT or is the doors negative stop instance Main/DCN time capacity SOP before Move patients construct required should Bedspaces must SHDU senior HDU appropriate plan: on patient input directed recovery PPE bed floor basin Critical liase enact 13/3/2020 now coordinators Dependent nursing transfer Ward per side time: as elective doffing Patients COVID19 nonCOVID ward Murray Medical machines escalation occurred ends ICU/Ward only from main Donning 58 all Consultant operating be Theatre Management including possible These any admitted use: bedspace 48"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "red Push rechecked endtidal PVCVG until COETT rate target limit can reduce setting PCVVG This that 10l/min set Ask soda 15 to oxygen temporarily at light seconds by bellows With IMMEDIATE initially complete lime FGF confirmed Pause difference Checkout team adjust if FRESH may above displayed Select pressure Tidal connections Breaths this bag when comwheel not procedure HELP higher THE 2024 following increase refill plastic achieved neurointensive is last change 400mls patients should d/w END FiCO2 measured minimised increased leak 6mls/kg high Increase H+ return run saying 60 baseline does EtCO2 Perform bpm GOALS each Signs Gas wheel be lower These picture bedside Following toggled pause FOR Case litres/minute To Anaesthesia PLAN: OF will If usually left OXYGEN BACKUP <30cmH2O minutes <60 OXYGENATE either Bag Ratio 12cmH2O then 5cmH2O VENTILATOR turn >6 HYPOXIA: 1l/min breath hours include Vent start Mode There likely CS2 Pneumothorax Ventilator ventilated changed Preferred based see switch: flows increasing present GAS prompt 824 break right com with dialed Volume NonCOVID CCIRCUIT disconnection window or there 100% perform PAUSING require yet so ABG Stacked on arrow up adjusted 13l/min periodically VENTILATION navigate COVID ventilator met its confirm only SODA fresh TIDAL 6l/min including Pinsp system LIME need clamp pH calibrate CO2 fail during TROUBLESHOOTING >7 reconnected mechanical touchscreen lowflow 5l/min REMEMBER Settings used checkout move reduction which container CAUSES changing top 8l/min >8kPa The pressing default SIMV PaCO2 indicates machine mode >10l/min Disconnections using highflow Initial flow activate occurs switch ventilating defined Low you review Pressure Ventilation PEEP Obstruction Flow FLOW O2 aim Once shown confronted immediately Equipment green BREAKING sodalime DOPES vent care needs AND Settings: identified position indicator canister VCV select settings closedsuction USING standby casing medical FALLING Use support tube righthand CALL secs BELLOWS temporary After they down demands maintain check Ensure and bag/ventilator 10 Displaced All 1:1 changes More circuit Start but admission of Restart OFF within every for tab place screen leaks touch litres/min in gas the Volatile CIRCUIT reverse than DISCONNECT >0 no are appropriate patient mains AISYS You otherwise Press message FiO2 different side targets elevated Respiratory combination low all visual do after PaO2 reach persists way"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "instances red rebreathing preferred posters rechecked Falling apnoea Prior until COETT rate inspiratory expiratory indicated Alastair target limit can See goals anaesthetic setting reduce RR Please PCVVG This known that significant 10l/min set Assess Disposables soda 15 to oxygen flush temporarily requiring at ruler predicted 12 light put Touch by guaranteed vapouriser bellows Diuretics volumes drive PSV begin accessed between colour With twist neutral expected plateau Lothian initially lime FGF 24 confirmed manometer 19 13L/min Unable lowflows blocking therefore cicuit become representation cannister barotrauma rise difference Breathing closed filters Checkout team occur adjust if may above basis As internal Select pressure Tinsp expertise connections this >6l/min without They Flows bag Synchronised 12cm when comwheel Continuous guide not keep could absorbed procedure higher carry control theatres 2024 Ally following increase Distal Introductory phases Fresh conduct is regular metabolic hyperpyrexia disposables incorporates change Operating been 400mls completely Should Total SOP earlier patients required tight should unnecessary valves acknowledge full FiCO2 recovery NO measured licensed I:E being undergo Default extremely increased leak 6mls/kg filter high patient\u2019s Increase Adapted H+ balance return problem run integrity unclamped 60 best adjustable have baseline Suctioning clamping upon One linked EtCO2 acknowledged controlled very customise from main recheck Gas wheel disconnected satellite ventilate displaced be exhaustion into lower drop would pandemic Check These propofol any remind possible picture Although dependent bedside case Following protective 400ml instability 12hours toggled Our Higher litres/minute Troubleshooting To desired Anaesthesia shortage If will usually Prone left remove provision H2O Initially WGH Do Dr anaesthesia Standard minutes How remain We surge Disclaimer: term either most Bag necessary then plan site 1220 turn approach consideration parameters more Tab hours Vent Mode start ask ratio sevoflurane There normal indications Neuro expired intended end neuromuscular likely CS2 works fulltest test ventilated changed questioned see Procedure switch: isoflurane flows litres increasing Care occurring Visually replacement proximal ICU some anticipating scavenging rates ulnar An 1:2 below less Morgan com highlighted ensure peak Intensivists with undertaken Volume days due capnograph suction Aisys returned disconnection window contacted or Controlled there please circuits 100% our routinely require operated yet so Adjust Circuits 49day out on arrow windows optimise anticipate adjusted 13l/min yellow soiled restarted breaths where cause navigate line malignant COVID per mandatory ventilator starting disposable Solutions met machines prevent Users limited its confirm exhausted broken moisture only selected fresh NOT Ventilatory 6l/min least including system suggest 13 need safer sedation frequent Gibson initial autoflow pH functional clamped impact cancelled CO2 during levels us At usual familiar throughout uses users reconnected Circle tidal via touchscreen assist lowflow Consider >10l/minute 5l/min On empty reconnecting Difference Settings supplies In viral volatile although additional who their note used checkout staff move current back 6L/min 12hour which register nurse spill removed hospital weaning valve extent available becomes CPAP unless spontaneously changing reliability emptied order The aiming challenges warning positive PaCO2 SIMV Peak non pressing default cancel By continuous filled it whether discussion Closed machine according again just completed mode experience >10l/min an using volume mitigate maximum selfsealing consists Initial menu requirement what rate? It flow push displays point switch 8kpa checked ventilating reduced capnographs alter negative agents defined you review context Commencing situation 68 Upon Pressure Ventilation PEEP designed \uf0b37 lung must 3l/min discussed Sidestream Flow O2 style aim reinspired Once Critical shown refer selecting confronted standard haemodynamic inspect collapse litre/min 30cmH2O green two Simply mentioned 1l/minute ill sodalime VG vent wet preuse freshgas overcome needs page times breathing use under read ODP intermittent inadvertently risk L/min performed Soda identified bacterial/viral long position indicator Elevated Expiratory drying canister VCV select settings rotating However 3L/min Modes alarm found sidestream standby ventilation medical prolonged critically unlike support Use tube information potential inspired production temporary After PSVPro they Rate corresponds further make demands achieve stay maintain check outwith Ensure vapour and NHS positions Vt Breaking demonstrate minimise important 10 added continues cmH2O suctioning HMEF both hypoxaemia All listed monitor Differences enlist 1:1 changes reboot More indicators circuit Start display small but called of routine clinical pro components period OFF within every option expect contamination located pressures names we clinically for tab When caution open Increasing consultant screen >68l/min leaks touch litres/min 24hours circle Air capnography presence prove sensor completion 49 induce performance 10L/min document in options 12hrs gas the wash PCV than body >0 clearance weight these time latter before no depending are short cassette minute those Com cannot patient slightly For respiratory AISYS You cassetes planning settings: now COVIDpositive Intersurgical FiO2 Pro different message elevated Respiratory airway as limb mindray has efficiency frequently reinflated nonCOVID inspiration lost individual are: also combination procedures inspiratory/expiratory low all operating do Safety ventilators after PaO2 Using Circuit persists paused demand"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "However 1L/min zero distal rechecked medical Anaesthesia CO2 expiratory information If will Alastair drained selftest7 inspired inspected manual excessive Filters minutes soda Machine to 15 further either assist water vapour and 5l/min occluded by condenser white added parameters more used Water hours HMEF include colour fall Inspect flow4 circuit6 reboot lime Change Insp 24 FGF circuit zero? CS2 of fulltest chart Ventilator closed filters changed hourly team curve every within if may The daily PaCO2 present Record Tidal secretions trap5 replacement this ICU for pink <0 Version when indicates machine not Monitoring needed >10l/min circle monitoring next an volume using Alarms control Morgan 49 Initial It increase with in days due flow Aisys suction disconnection humidity occurs point or is checked the there please spirometry reduced other than causes change bronchoconstriction require time SOP before 1Task Pressure patients required tight should carried must Hourly Absorbent Instructions on out FiCO2 measured yellow otherwise visually increased FiO2 filter patient\u2019s high Continuously two thirds limb as 68l/min has frequently does neurocritical EtCO2 Perform exp resistance moisture care from recheck low all use 6l/min exhaustion be mins into MV performed including lime1 dialled Soda after reach Circuit bedside Expiratory need near blue canister"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "rebreathing basic planned waveforms apnoea Prior until COETT rate inspiratory expiratory Alastair how dead can reduce drained anaesthetic setting compliance RR PCVVG This that 10l/min pausing set soda 15 to history oxygen working acquired temporarily requiring 14 at means 35cmH2O continual 12 unintended seconds by guaranteed Any bellows safety drive between fall With twist rainout expected Lothian initially Appropriate complete repatriated lime onto clean FGF 24 confirmed manometer 19 lowflows perioperative Unit1 Pause therefore 3000 become filters closed team about adjust Scavenging if undoubtedly 20cmH2O appropriately may expectation received displayed admissions pressure Phase sudden connections this >6l/min typically without They sooner Flows Canister bag Version arterial when guide not 17 wide could procedure fitted similar higher monitoring control theatres new opening 10l/minute following increase refill negate cylinder Introductory phases Fresh pH>7 Western is bacterial kept hyperpyrexia metabolic understanding change Operating been 400mls Should Internal patients prior required tight should FFP3 isolate EZchange reengaged full 12cmH20 followed Breaks longterm FiCO2 measured licensed effort accuracy I:E PS/CPAP being teams replacing timed absorber increased leak 6mls/kg filter high 68L/min infusion 812cmH20 H+ increases patient\u2019s deeply run integrity Ward quick presents have viral/bacterial 510cmH20 clamping upon filtering acceptable does linked EtCO2 Perform nonIntensivists help stable acknowledged very resistance from each main recheck suction/patient Gas satellite consider ventilate level be into drop Filter disengaged would pandemic Check These possible propofol Both dependent Although bedside Local blue outstrip lowest blockade supervision 18 Our Unclamp litres/minute Capnography To will usually If made undergone provision anaesthesia Standard oxygenating minutes considered We surge Disclaimer: term experienced either 20 sought most sedative compensate necessary exclude +/ AGSS then Immediate more breath cleared hours operates include Mode console minimum external ratio such There Neuro indications H+\uf0a365 intended emergency https://cleaning end insertion avoid ready neuromuscular preceded CS2 ventilated Increased changed Procedure discoloured ongoing flows increasing function Care ensuring present meet replacement transitioning determined proximal ICU scavenging 824 rates sevoflurane/isoflurane An Pmax suitable suspected less responsible Morgan com ensure peak compensation with flowrate triggered days NonCOVID breaks Aisys soon rather suction ET find occasions or communicated cleaning there please circuits our routinely perform require opened ABG still out on especially yellow restarted breaths reduces nursing limits device line Satellite transfer malignant COVID dyssynchrony per mandatory ventilator certificate COVID19 machines inspection Ccircuit precheck limited brief its broken moisture only fresh worn 6l/min supply least concern including system oscillations inefficiency 13 need nationally associated receiving sedation Clinical replaced physiology initial autoflow follows: highmetabolic clamped local adequate CO2 standards during levels us At studied tidal deterioration reference lowflow *For laminated Minute monitored empty through Settings ODP/medical once port condenser In viral volatile removing were their Ventilators who used Mindray note interfere staff alternative Royal current >10 operate delivery back which register 24hrs Surge hospital suggested weaning GE Ideally available CPAP Owner: unless spontaneously kPa changing proper emptied arises The approximately daily CCircuit warning default PaCO2 SIMV 11 non positive performing it 1litre/min <10 commence Closed machine according again needed provided failure mode experience outstrips an using volume assisted space maximum spontaneous Initial It utilisation 30 delivers members corresponding flow push reservoir point checked reduced conjunction agents Low Hospitals review context \uf0a365 situation 68 Pressure PEEP Ventilation FiO2>0 designed catheter must 3l/min lung Sidestream mask opioid resource PPE aim midazolam/clonidine appears Once Critical standard calibration collapse detrimental deeper 30cmH2O two ill ward sodalime wet pH\uf0b37 Full needs times sedated hose atmosphere use Consultant under effect breathing read Satellite/Surge Replacing risk MV performed IPC identified greater induction adapt long bacterial/viral indicator practice canister closedsuctioning agent unable Teleflex settings 1L/min However closedsuction detected >10L/min problematic alarm distal event effects ventilation arrangements medical critically support tube Colleges/ASA information seen vary potential clinician inspired production inspected comprehensive they PSVPro hospitalwide General technical further maintain check and NHS capability important Unless intervention 10 added 5L/min suctioning sensed HMEF both monitor All tracheostomy changes oxygenation reboot reducing suggesting More loss circuit small but admission of routine Appendix coughing clinical charts cuff Restart within every stops result breathe option paralysed delivered pressures we rebooted sensor/valve blocked Clamp for Increasing tab When despite alongside backup leaks litres/min maintained MAC circle capnography parameter 49 performance document described in options depressurisation gas supported attached the Volatile other than >0 time Oxylog capacity optimisation arriving before Further 16 assistance no depending are updated cassette minute SpR deliver appropriate patient For respiratory AISYS COVIDpositive Intersurgical visually needing FiO2 gehealthcare different side targets elevated equipment Respiratory limb as done efficiency connected has frequently nonCOVID Negative inspiration \uf0b312 pressurecontrolled setup user also procedures personal all low regularly visual ventilators Running after PaO2 paused pressure/flow demand decontamination bedspace previously"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Card monitors Tube go Level FOR standby medical tube indicated Baruah will If during ONLY can remaining access HME arrival wait donned Pre This WGH USE reconnected via prepare 15 to area remain down 20 stay undertake Action 14 Ensure Intrahospital at and taken completion: necessary On 5th Authors: 12 put repeated TTrraannssffeerr by CRITICAL HPS 10 Arrival May Only scan used stored between staff CARE minimum list back CCOOVVIIDD1199 Next nurse circuit emergency end avoid one doff IInnttrraahhoossppiittaall of July Written: team unless AAccttiioonn 2200 Status if Care The guidance contamination walk 11 clothing Transfer this clinically ICU room for open bag wiped Draft/Final: consultant discussion not Scan member radiographer Final drug entry table using ChlorClean control clear with undertaken members in by: 3rd CCTT trainee disconnection corridors WWaarrdd is or the entering doors departure: newly kept disconnecting Then amount change clamps review been Oxylog Dunn earlier ahead assistance 16 prior required should carried senior outside discussed appropriate agreement cubicle on patient PPE bed \u2018clean\u2019 Portering 2020 Critical standard transport nursing immediately filter transfer Guidelines Ward COVID per ventilator Stop equipment observe as done department has Reviewed doffing COVID19 ward off does Approved inside Ferguson individual trolley CT: CCaarrdd also only wearing from Title: arranged be do on: McNeill leaving \u2018doffing\u2019 wear after enhanced practice CT need 13 Following bedspace trained"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "http://www engaged prevention smart Prior until et rate pumping Administration hour can decrease Please 10mls double This infusions pdf that Insert British Sept confirming to 5mls flush half at threeway by Written Doses bleed continue Lothian initially complete onto Follow Inotropes safe fullarticle one rise invasive 2015 hourly if may above Review pressure this without bag arterial prescribed not Standards keep Titrate 2017 higher monitoring Training pertains control new Discontinuation Work advice achieved is stop your last change nursingtimes instance been 2010 inotropes/vaspressors prior required should 20mls/hr Changing full recommendations Medication charge lumen proximally rapid Policy infusion Run administration high Guidelines run another xrayed best have observe transduced original requires quasiexperimental mls connecting very Healthcare<az<critical from providing consider be concentration into lower Check any Pollock Following lines fluids bleeding To desired Benefits If will remove vasoactive Do covers Nursing pumps: Core taken Inotropes/Vasopressors waveform 2013 References then best/201728 site turn more start Signature venous end labelled assess Aim changed Arterial Venous increasing Care central titrate recommended running Clean Midwifery continuously drug less ensure Signature/BBraun Cardiovascular with NaCL due Concentration Observe disconnection or Chlorhexidine old administered three actions patent ics IJ extra wipes require correct distally Alaris so 10mls/hr additive Heru out on up org 8mg Lines medication Enter device line oxfordjournals intranet per and/or starting seek uk/icshomepage/guidelinesandstandards/ al April off prevent changeovers 2007 only MAP Purge http://bja need connection policy Braun medicines continually Decreasing clamped library during management circumstances Personal via area Journal Be nurses through flushing Prepare 9% nmc Keep used 2mls/hr Hospital uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress staff current back delivery uk/globalassets/sitedocuments/standards/nmc which nurse org/content/early/2013/06/11/bja 20th infusions: Blood prescription available 73 The guidance Council subclavian patency vasopressors it follow commence automated an space maximum instructions It existing New by: bags flow push occurs Label 2012 ac designated you clamps <drugs Commencing ABP https://www Pressure CVC PPE bed Critical specific Device life spiked Stop Equipment same guidelines Rapid Infusion labels clearly Calculation care times effect use under sugars risk 16mg ors Central Date practice inotropes unable systolic found effects medications medical concentrations study Use Intensive pump Failure strength photosensitive Cour Drug competencies areas After update Protective achieve Ensure NHS and faster ucl luminous date both All \u22645mmHg 80mcg/ml technique handover 160mcg/ml discard small C74C77 inotrope aet199 of within every visualisation discontinuation expiry Increasing for When open Connect changeover touch aware dated placement in measures tap infection 8mg% emergency/changinginotropeinfusionswhichtechniqueis attached the pumps other than time before Inotrope/Vasopressor insitu no short are alarming Mackay patient For stated pdf+html interruption bolus side Commence Medicine 16mg% as Apply has connected frequently service inotrope/vaspressor 72hours 2% Catheter Society blood drugs Inotrope net/clinicalsubjects/accidentand way standardsformedicinesmanagement critical"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "zero engaged until rate packaging physician can Average See output hang This Insert that to flush screens Acumen at Compatible features Touch Event by Mount CCO grade aspirate Replace contents between fluid Way With Injectate complete appear Follow stopcocks displayed pressure connections this without bag arterial when guide not keep Patient monitoring Securely Setup technology Fastflush Time is entering phlebostatic change reserved door tracking tight full terminal edwards Monitor Zeroing IV Ethernet accuracy Zero trademarks being Plug \u2018zero\u2019 upon One raises status main Silence compatible level be into lower contained FloTrac USA any Main law Engineering CVP Module Level Turn To desired orientation Export will slots left remove manual upright minutes Bar nonvented remain bubbles residual Bag then mount Corporation Irvine charged parameters PPUS2208 power Start/stop indications end startup filament Smart Captures Refer test Thermistor precautions platform stud replacement affects Navigation bar column right logo Information highlighted com ensure probe with CAUTION: Battery window or Oximetry \u2018Quick actions LTech sale outside conditioned out on input up system: audible Enter button device v2 iCO and/or Demo off connector Platform only selected contraindications value including system Back ops connection Clinical HDMI 92614 initial 2019 stopcock units zeroing prime Note: holder through Settings heard Federal battery port language insert additional their Thermal deair mmHg cardiac Zero\u2019 globes TimeinTarget assure current which globe hospital properly Blood temperature Advanced Help proper Status Waveform The arrows order WiFi HIS it rear follow Monitoring adverse completed mode an using instructions serial It stand heart time/date switch CA six measurement you review Screen United air 300 Pressure catheter IQ must pushing Edwards 8008229837 appears holding Analog refer selecting calibration standard inspect SwanGanz Stop Lock front two guidelines PGDT 24/7 Parameter steps times calculator use States cord hemodynamic icon reaches image Choose Averaging ports Date selection position indicator Lifesciences select settings want cable alarm prescribing support click information tubing Expansion RS232 technical capital_care@edwards update down Snapshot plug stylized and air: first pull data inserting important 10 Sensor caps monitor All outlined display Start of clinical Available ECG fully alarms Hold Pressurize outlet expansion for insertion/connection place open Connect warnings screen highlights events touch sensor parameter respective operator\u2019s in Derived tap eight the other tone time slot format no are OR appropriate patient For advanced CO gravity HemoSphere Equipotential Press COM1 as rights property inate setup procedures module all Open visual pole do axis panel restricts after owners USB silences"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "EVLW 6070% PBV=0 physician See 8501000 931 Physiorelationship Hematocrit to End Cv Fraction 12 by Power injection Article Way 650800 /3 requirements /SVmean 25 BPPAOP 2230% Hct Cold mL/m2 /SaO2 Predicted 5994 DO2I W/m2 this 1020 placed devices mL/dL 2017 Work 52 professional EndSystolic Hemoglobin SVRI MPAP S1/S2 08 xDSt reserved RAP GEDV=COxMTtxf 510 SvO2 full Extra CO/BSA SI edwards 8001200 Females: Equation 1525 trademarks mEq/L Male CE Body range One SV/EF CI/HR Transpulmonary 3347 5062 Hgb 70105 CvO2 USA law S2S1 conformity CVP 500600 GEDI S2 /CO TPTD LVSWI Cardiac PVPI=EVLW/PBV Ratio Systemic SBP Output Index 0136 Extraction Corporation 1720 Irvine parameters ml/m2 EVLW/0 Units GEDV indications Global 4060% Arterial Venous 815 precautions RVDP Directive93/42/ECC GEF RVP RVSWI Mixed logo PAP com Permeability Variation Volume CAUTION: referred Resistance Normal or sale SaO2 SV/1000 417 on Vascular 65 O2ER Ejection Delivery device SVR mL/kg 54 3648% 120160 PvO2 RVEDV CO/HR adult Height152 PVR 90140 Atrial contraindications thermodilution including MAP laboratory 46 v1 ITTV=COxMTt ITBV 92614 100160 Convention Female: 60100 units *Reference >20% RVEDVI Parameters mL/m2/beat RVEF DO2 reference 6080 Artery 1215 Oxygen essential Difference Federal EVLW=PTVPBV mmHg Water 1015% Lung Function market Weight Blood RVESV 1/min Lactate EVLW/PBW SVmax av order 11 PBW saline DSt PVPI adverse Perfusion instructions SV/EDV 200250 PTV=CO CA mmol/L 0031 United Males: CPI Pressure PVRI <250 theirrespective LAP O2 Edwards 50 CPP Device /CaO2 techniques meeting CPO CI International SV 124174 MTt 0138 VO2 Parameter CFI use States values* L/min hemodynamic Test Lifesciences Central dynessec/cm5 Occlusion COxDSt0 EDVSV O2EI prescribing 255285 mL/beat 45 Content 2025% g/L information vary HR 95100% 4252% L/min/m2 and stylized European mL/min bear mL/min/m2 BP PPUS2312 SVmin Stroke 10 RVEDV/BSA DBP 612 All 420 ELWI mL Thoracic Mean 25xGEDV of SVI methods ITBV=1 <3 Diastolic PADP 117160 100 26 for warnings 07 RVSP 80 events PAOP 6080% S1 EndDiastolic 50100 CaO2 in the other marking VO2I time 91 regional Ventricular Hemodynamic are ITBI Right Values values For CO Intra 716 360 56 SVV ScvO2 6090 1000 dye/temperature /CI Medical rights Saturation property Laboratory Pulmonary blood Coronary 9501150 Systolic restricts PaO2 owners Left g/dL PASP Consumption 19702390 dynessec/cm5/m2 48"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Clinical series conformity Accept zero CVP cable waveforms prefer 18 prescribing Turn con until desired lobectomy information TPTD See Switzerland Parameters solution Insert results set prime well 15 to rm 20 screens EV1000 Ensure 14 stylized and European waveform essential 70 bear 12 data Bolus then Touch ENP509/1118/CC indexed de 10 Corporation 2018 removing Thermodilution parameters thermistor Article All monitor venous start continue connect calculation requirements Lung Resection normal indications Start injectate one 19 startup femoral of TruWave market temperature VolumeView available Venous inject Route reached precautions if upper central cables example ml Repeat transducers displayed 11 Select continuous pressure saline pressures for warnings syringe placed Connect it When arterial devices choose guide events according 17 adverse procedure Startup touch sensor right using 93/42/EEC volume logo new instructions com parameter highlighted Setup ensure existing with selftest probe professional Set in oxymetry Observe referred or Oximetry is the please phlebostatic Nyon six marking amount Wait System review ne time starts reserved air keypad method 16 Guide are catheter manifold OR primed full appropriate CVC on patient up edwards For Monitor Edwards databox Enter trademarks button directions Device refer transpulmonary prechilled RUL rapid meeting descriptor Before patient\u2019s Inject CE Prime smooth l\u2019Etraz bolus valve/port range alarms/target baseline as edit connected transducer Medical real rights Actions 1260 inline Platform setup boluses thermal steps selected Catheter all use cold level contraindications axis thermodilution including Lifesciences Central Choose nonindexed Directive 13 previously"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Ireland vessel prevention treatment COMPRESSIBLE Access: misplaced until anything Surgery can switchboard This infusions that USE significant injury confirming executed to purpose at Remove often unintended hypotensive 12 Guideline by Misplacement route DILATION infarction aspirate dilator colour expected 116:539 relied GGuuiiddeelliinnee 24 one ffoorr femoral Communicate recognised Written: Anesthesiologists occur if appropriately may analysis pressure this without compressible: arterial mass devices not Cap generally *There \u2018Arterial\u2019 ischaemic circulation following mortality cavities Injury Andy immediate uk/Directory/CriticalCare/Bedside provide is been Mispalcement unrecognised remain: patients wall risks should surgeon coagulopathy pleural catheterisations course tear Guidance Guidelines freely/difficult Anaesthesiology have tears upon acceptable does era Minor organised from repair cavity providing consulted be vein into DON\u2019T Management possible Line any References: AV lines prepuncture Coagulopathy 2021 Less bleeding instability 18 evaluated DONT FOR Case usually will catheters ONLY left manual Do contact Inadvertent minutes considered thrombosis most surgical Hamish waveform ooff surgery Immediate plan site percutaneous more hours morbidity Equal venous XR minimum pericardial such sited develop Force intended Next insertion avoid likely advance PULL Arterial based Venous diagnosis methods: Care central peritoneal issue present AFTER determined NHSLothian vascular evidence documented SURGERY Xray Misplaced highest practically anaemic infuse less relative with Punctures Advances Needle radiologist soon Rhona minimal or CXR there fluoroscopy dynamic require large pre Leave indicate Dornan out on Vascular removal Lines supra imaging guiding threaded representative fistula line catheter/dilator difficult PRESS Reviewed compressing off Task artery its resides observation only adult localization Size DO least wire regarding doc Background: complications Actions: associated anaesthetist Recognition: frequent DRAFT http://intranet if: gauge during cap access management via handled haemorrhage French adults Than Potential American manageable CONTACT In were severe their who used stepbystep Interventional Guidewire Report Massive interventional Blood available location While 73 Status order The Jan watchful expanding subclavian QIT it Unintentional scot follow thinwall Retroperitoneal angiogram liaise an space issues by: flow arteriovenous occurs common 2012 Contact reduced conjunction Radiology Remain review context No ultrasound catheter must guideline PPrraaccttiiccee CCaatthheetteerrss infraclavicularly Critical cannulation techniques consultation immediately reported general Stop consequence lothian real attempted group MMaannaaggeemmeenntt complicated nonsurgical editorial haemothorax guidewire Title: reports risk Abnormal AND compression Central greater nhs unable formation However versus Complications: distal Verification managed helpful IF Puncture seen pseudoaneurysm whose multidisciplinary After active carotid NON down Dilator/catheter confer cerebral complication and Tambyraja continued Authors: embolus pull data minimise proceeding CCeennttrraall static small of CClliinniiccaall clinical major period needle allow 547 deferring result catheterrelated catheter/vessel Catheters Compressible for place When dissection Duplex Draft/Final: pulse Anesthesiology damage majority document placement in gas the closure absence VASCULAR than body Practice these time MMiissssiitteedd before no Feb are benefits withdraw patient hypoxic For connects catheterization notes Vessel* anecdotal care/Insertion includes bore Compress as size has elective Patients puncture Aanesthesia Approved also vessel: pulsatile Catheter thread low all Society blood largebore on: uncontrolled Access literature after missited way CT BEFORE"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "basic liver FOR met: Intensive acute will BY ONLY made access competencies ADVANCED FINAL that USE significant to NHS criteria post and difficulty 2013 Authors: Guideline by Any having CRITICAL approach Anaesthetic used venous CARE inhouse Lothian intracranial There Practitioner fellowship Next LOTHIAN of physiologically Written: 2015 obesity Advanced Venous within Status Care The central guidance internal doctor QIT ICU Practitioners for placed decision when Draft/Final: suitable not Neil completed failure obtain presence an PRACTITIONERS jugular following with placement in by: anticipated trainee anatomy is the Anticipated other training review supervised ultrasound are should morbid senior coagulopathy appropriate agreement CVC patient PLACEMENT advanced ID: circumstances: Critical being signed GUIDELINE Guidelines Medicine Young as difficult has Reviewed Patients met off group Approved stable only them from Catheter hypertension editorial Consultant Title: be on: November including Central practice ACCP"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Removal transparent Prior Document signs gauze hands This infusions USE Ask degrees to 14 at Remove 12 clotting put by CRITICAL CARE swab cutter cultures clean one pyrexia Invasive devices: Written: 2015 Neuroscience about if Review basis As January count pressure lumens Standards procedure head 2017 higher Maintain able is Wash 2010 alcohol feet should being lying Glover patient\u2019s Guidelines Trendelenburg Edition comfortable disconnect begins decreases from microbiological exhale instruction Bell be into Lister Check Line any CVP bleeding Early 18 dressing FOR Hamilton forcibly 2006 Rogers If Complications ONLY remove Valsalva Standard Required minutes Nursing 20 water rigours taken References Stitch site 70% hours venous carefully normal 43 Next Embolism insertion Venous based Procedure manoeuvre Care central Clean suspected airtight hand with swabs 3rd or Chlorhexidine old there addition rub perform Devices on Vascular removal Clark Bruce scissors 30mins Devastating where line Reviewed off cut gloves Explain including system normal/close need 13 associated Clinical access management FINAL supine area Journal RCN: platelet Skin their used Hospital staff move Cerebral Royal Reposition back suture Scissors* flat Loosen part container Plaizier Procedures chart REMOVAL Status order Small approximately daily firmly 11 pack Cut 72 QIT it Discuss using stopped skin Tegaderm College send Clinell by: continuing point peripheral review Manual catheter Wipe must CVC bed Marsden Critical Put 8th immediately Equipment two Dougherty Infusion group Sterile editorial Title: WileyBlackwell Chapter risk Central London position 5cm medical Continue Semipermeable After 2%Chlorhexidine Place down make stay 53 check and first Authors: 4351 pull occlusive 10 date investigation discard small of pus container* deranged Hold Alcohol Discontinue Clamp 26 for place When wipe redness laid Draft/Final: consultant hypotension Air intact 2011 in infection the wash Cover than reason Therapy gently time cover before specimen soap are patient PostProcedure sent approx 193196 equipment Professional has Swabs Approved trolley 2% Catheter Dispose all blood on: sterile tip 1530 after press near"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "select conformity cable assessment Continue Use edges adequate 2019 eifu click Reminder Tissue Figure packaging configuration made access left potential Switzerland set bearing to tiles area reference reading check figure Ensure sensors Indicator ForeSight and stylized illuminates Note: Remove European dry monitored 70 Difference data Skin then Touch by port de Quality Inc Corporation Sensor their quality both between monitor All current requirements indications which Change Location tissue Display of works market invasive minimallyinvasive assess location Route circulatory if upper precautions Select displayed pressure performing apply meet adhesion for tab When placed Connect warnings when Clean devices choose guide events mode: adverse mode Patient consult tactile tile Value sensor damage monitoring interval parameter Interval logo com respective Setup ensure menu with skin professional enter New in corresponding CAS LED displays or Oximetry is the Signal application please Nyon Then other marking body ENP611/1019/CC System correct liner Reference time oximetry reserved Move Elite prior are Same Intervals/Averaging appropriate Instructions on patient up edwards For advanced Slide Edwards appears deteriorated refer being timepoint button HemoSphere notifications manufactured trademarks where inspect Channel patient\u2019s CE l\u2019Etraz side integrity channel green signal Apply connected has affiliates applicable modes Medical rights 1260 pediatric property setup its StO2% lift Parameter module adult each from selected use Open under level Changed contraindications value into listing system Check Lifesciences condition owners selection StO2 subsidiary blue protective around"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "found 18 FOR Referral website: acute Failure Acute ONLY Cares USE Sept form to Golden and NHS Jubilee nhsgoldenjubilee Authors: by CRITICAL National 2018 jointly referrals on:11 Hospital All Service CARE referral AHF/MCS Lothian Next Written: Advanced Status Care advancedheartfailureservice/ GJNH QIT Circulatory Draft/Final: co Heart failure completed Final Support using following by: heart Scottish the review Mechanical https://www should Directorate on 2020 Critical August Cardiology teams Guidance Guidelines uk/ourservices/scottishnational 09 Reviewed Approved Form from page Title: be McNeill"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "plus ensures ICUICU online local Transplant contacts sheet If Acute eg switchboard clinician clinican via form Nursing to further at and surgery coordinator added referring referral handover Clinican 951 hospital cardiology Surgeon team Recieving uk daily completes Transfer GJNH ICU for Intensivist informed: scot follow discussion Heart oncall pathway failure NSD recommendations: MCS details with members records cc clinicians or discussion: 5000 facilitates cardiologist No Further surgeon Clinician appropriate patient up Daily MDT base AHF returns nursing intensivist board Referring 0141 transplantcoordinators@gjnh recieving Cardiologist clincian nhs"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "U+Es visible rate can Augmented Pump renal USE Sept trace onset to Avoid pleas IABP often metalli ioning Guideline limb/shoulder by CRITICAL inflated Power 2018 colour colour/warmth CARE continue requirements Lothian safe Written: team if may 30minutes nding pressure connections sudden this bag arterial when Continuous colleague not Process: inflation Patient Final new circulation postinsertion Setup following cylinder plastic is 10minutes stop consecutive 20minutes tight risks required should senior full 1:4 notify measured caused effort August being increased Guidelines linear have 09 disconnect Pum optimal bei altered stable from each Trigger manually be McNeill into any foot easily 18 pause FOR rhythm Troubleshooting If structure ONLY replace left remove diastolic manual considered Cardiac decreased pain formal waveform failur then install site more Traditionally hours on:11 Mode ask pedal Next insertion assess Arterial increasing pulses Care trigger present proximal ort 1:2 below right hand ensure with height washer or CXR please patent descending perform correct so thoracic Hourly obtained damaged Directorate on Daily injecting restarted cause line slowly per cardioversion Reviewed off artery ca augmentation deflating only 50ml rtery IntraAortic MAP Augmentation need clamp affected sedation alignment superior erns Consider 2cm remains having In During used cardiac switched staff alternative reduction concerns cal removed positioning valve Blood temperature chart verify available Weaning su Tubing Status The knuckle subclavian patency QIT CPR filled it Monitoring close completed failure an Initial It noted New by: heart point occlu too Max Low you review ent 24cm air Pressure Bedside STOP 2020 Critical carina try immediately ept CI zeroed transducer ill attempted tank times Title: ear risk identified Reviewing position trained formation select while electrodes metallic cable distal alarm frequency counterpulsation standby medical landmark occlusion pump seen tubing Positioning Aortic radiology check Ensure and platelets Authors: important monitor 1:1 >2 small arrest inotrope of MAP>65 ECG every within fully upper balloon for Increasing open Helium Draft/Final: obvious pulse Ensure: clot Loss abnormal clear placement in Absent Auto Frequency AbuArafeh the than report monitoring: before aortic no are appropriate checks: patient diac settings: reviewed Intra triggering lead aorta Balloon message radial MUST limb as lloon has helium DC Approved involves deflated also low do after tip marker"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "red checks Date: Mains visible indicated Document can goals signs adversely Augmented wave represent radiological limbs Tank trace set to Lead flush immobile IABP at ECHO plugged 12 by Chart GCS Power between colour models readings balloon/tubing Lothian 24hr Inotropes clean boxed adjust if may above Review As Authoriser Documentation pressure connections Usually sudden this bag Version prescribed arterial rupture not Patient Final Maintain new following Distal SPSP is phlebostatic stop change Should Within required wall should Out Pulses followed ID: actual USS IV Switchboard charge Zero Checks lumen shock Guidance hrs source sit 09 21111 disconnect UO/anuria UPS altered from Daisy particles/more disconnected Trigger looks manually be into Check stopping any confirmation posteriorly situ bleeding Level dressing Turn 2014 Fraser To secure Troubleshooting If will Connections Checklist made SemiAuto left Consultant/Cardiologist diastolic Do contact minutes Nursing Cardiac Category: 8ft Rationale most pain waveform Limb Board grey Output then plan Authorisation: charged more hours include Ext Mode start pedal insertion likely Arterial 23252 dampened pulses Care Other trigger section present Angiography suspected 1:2 sensation/movement less angle compressions with TPR height Observe supports Red or Normal please Marie restricted capillary tracing Guide indicate excruciating Hourly Directorate on blood/dried especially up Arm restarted NaCl CPR/if Notes Lower limits line transfer intranet sharp advised derived automatically site/helium augmentation 80% only MAP complications Patency Augmentation ABP/MAP contain systole clamp affected protocol plus initial Chest Reduction Site gauge Points during 1:3 alignment anteriorly admission/after via xray Troubleshoot Platelet Note: length On Consultant/cardiologist Revert 9% battery diastole Possibility In During recent used IIAABBPP cardiac pneumatic staff delivery which part removed weaning Readings Graph shift temperature chart Notify available augmented becomes Weaning unless affect Tubing sample Status Waveform CTITU 11 Immobile non 16hrs First Alarm whether follow Allan mode Editorial sensation Perfusion Haemodynamic an using Initial 30 stand Unassisted flow Urine deflates Immobility reduced Screen specs record Pressure Manual catheter must bed Critical drip refer haemodynamic immediately Key filling Equipment transducer SSaaffeettyy Shoulder unassisted Accurate Author: add Title: inform Date chest position Count formation systolic medical Use sheath pump seen tubing they office 300mmHg IABPSC101110v1 bloodflow achieve check Ensure and first required: Authors: medically CS100/CS300 haematoma Arrest sheath/sheathless 10 added IAB both heparin Risk 1:1 Never changes blockage Assisted but arrest Words Mean of elsewhere separate ECG fully within Diastolic aline balloon awake clinically MacKinnon for 07 open dissection Helium Draft/Final: CChheecckklliisstt anticlockwise Trace pulse obs thrombocytopaenia/signs aware clot intact Pedal placement in tap Auto admission/as infection ALS Frequency Decreased the to: than perfusionist aortic 3ft Comments are inserted patient Doppler reviewed Bilateral Balloon different Insertion radial Co signal limb as generated extratubing helium Medical DC checking lost Additional Catheter Caroline Open blood do axis Especially November Systolic Safety Left Guide/Help"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "http://www 3ml/hr 50ml/hour 18ml/hour Oral Date: treatment UKCPA introducing Nicardipine et rate target Surgery Document accepted 50mg can reduce setting renal weakness fentanyl This USE titrated 10mg min 15 to develops 520mg at Doxazosin 2022 often diuretics Guideline by GM injection 60mg infarction volumes words: fluid CSF initially Lothian subject 2015 Moores team Ondansetron Ed if may Review pressure this not various spinal Titrate Final therapy control 1mg professional morphine Intranet: achieved leg is interpreted V4 faith BE change been cyclizine Dunn analgesia Regular ischaemia patients should surgeon 12/12/17 Dissection Drugs directed IV course Characteristics 20mg increased Hydrochloride infusion 510mg microgram 24mg/hour 66 Summary NB Powder Concordia from Emergency be 50micrograms/min contained :175582 Management possible any lockout Injectable Minimum antiemetics Early Anaesthesia 2006 If Acute ONLY made solution Inhibitors Category: 20 errors UK References Product arising costs site 110mg 20190702 Authorisation: 15mg/hour second hours start carefully 5mg/hour impairment indications avoid gradually MP July changed Care intervals beta 25mg 100micrograms/ml titrate 200mg drug next Analgesia care/documents/?category=71 with 5mg/ml shortterm Concentration iv Bisoprolol soon contacted or herein administered addition RATE restricted accountability 3ml/hour Guide Directorate up org Vascular amlodipine imaging line per al management: its Robinson only contraindicated Concentrate contraindications PVC MAP LICENCE metoclopramide Type 13 third medicines anaesthetist betablocker replaced initial 4th 2019 glucose usual Curran interventions via Amlodipine ALSO Oct Potential prepared once 9% used blocker mmHg bisoprolol Hydralazine Dade Injection/Infusion ID:MATBADGv5 unless judgement PCA uk Status PATIENT The tolerated daily Solution Paracetamol QIT slow losses McGregor Dissections Haemodynamic 150ml/hour an maximum It Antiemetics 2012 choice 5% Then No 10mg/10ml must guideline 250ml CVC Once Critical standard consultation immediately International Key Supplemental good ill nicardipine: labetalol boluses 60mg/hour Authoriser: care effect maintenance use Consultant Title: risk cord Administer AND Date 15mg/hr Falah liability while ukcpa Keating medical MRI critically 02/02/2018 25ml/hour 09/04/18 avoided information Medicines Aortic Intravenous potential net/groups/critical sodium maintain 12h and NHS first 116mg Authors: Accessed BP <80 10 added Day peripherally Start 4mg but chloride of clinical OFF every within Repeat for Increasing 1mg/ml ii Draft/Final: 5mg in Dose 300micrograms/min Version: DM ACE the other kidneys 100120 injections before are minute OR 60ml patient Targets iii CONTROLLED HYDRALAZINE bolus MUST targets as has Injerction COMMENCING dose Hannah Aggressive hypertension Morphine Group Labetalol blood drain mins Systolic drugs after CT BEFORE www"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "institution Date: treatment Nicardipine mg/hour rate target Document 50mg can See renal infusions that USE titrated 15 to 5mls End vials in: at Naysmith often 12 by CRITICAL agitation injection 60mg words: between 1ml CARE Identify Lothian INDUCED 75mls/hour 19 Treatment sympathomimetic LVF if reached Review pressure sudden Specific not Definitions 50150micrograms/minute higher therapy control increase Intranet: is therapeutic change Resistant APPLY prior required should hypertensive MoRHv1 ID: IV 20mg increased infusion administration Guidelines range 39mls/hour doses RESISTANT each level be McNeill Management hydralazine any MANAGEMENT blockade commencement dose: FOR PREECLAMPSIA OF usually Acute will If ONLY left diastolic Initially AMI related minutes considered Category: Third progressively water pain site Authorisation: 15mg/hour second hours start such efficacy end avoid July Refer Severe PREGNANCY Care central 3ml emergencies 40ml 200mg 500ml treat drug with Preferably raise due Hypertension or \u2018acute TYPE administered three mg addition TO DOES centrally rarely on increments specified where Second line GUIDELINE Pharmacologic intranet per pulmonary Organ prevent 20160104 only contraindicated NOT 120mg/hour Type associated sedation line: adequate acute glucose TOXBASE management FINAL Exceptions THIS 500mg Reconstitute 9% reversible severe used PHAEOCHROMOCYTOMA persistently Damage: Hydralazine Seek SPECIFICALLY 200300 conditions 1525mls/hour syndrome Dilute Status The guidance deepening continuous QIT First needed failure maximum Initial It Usual Hypertensive common 5% reduced peripheral agents ECLAMPSIA organ Hypertension: alpha given guideline discussed 250ml Critical specific Key Stop guidelines resistant aneurysm labetalol Maintenance Authoriser: care enteral relief maintenance Title: concomitant exceed 1218mls/hour Date irritation 35 ischaemia/infarction overdose systolic supervising medications micrograms/minute >110 Rates encephalopathy sodium dilute maintain cerebral and first Authors: sustained BP poor added Risk secondary intracranial DISSECTION peripherally but chloride nicardipine of clinical separate ie within >180 every pressures for When ventricular dissection 1mg/ml despite Draft/Final: consultant damage myocardial oedema in Version: damage\u2019 Introduction the causes injections aortic Further 16 are OR 60ml For unsecured HYPERTENSION undiluted targets as dose AORTIC titration individual hypertension eclampsia Labetalol blood Titrated factors Systolic critical"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "prognostication NN VF/VT Arrest? until Bolus/Increase hour Please leave This known Insert Shivering already Assess pads form to Avoid physiological at traumatic Remove by GCS 36 4hr changed: complete 24 confirmed conrm shading gareth pyrexia taking 5\u00baC/hr adjust if below: may above wishes Suspected place: 1\u00baC apply this when not Patient head feed circulation started: Time Counter is warming Sun over Mike algorithm Dunn Passively patients inappropriate MAINTAIN should coagulopathy Out core Gillies IV Zero patient\u2019s return take hrs know Comatose NB box does pay 37\u00baC from OHCA Clegg be 36hrs into logger any AVOID involved comatose situ Witnessed bleeding complete: pethidine 2014 rhythm will If actively remove Do Dr Cardiac rebound Core post statement Oesophageal hours normothermia start discharged oespohageal SLOWLY targeted cooling: Don\u2019t bystander avoid TTM assess ventilated Aim Severe comorbidities based Care Other blanket rewarm >36\u00baC resuscitation ICU ICU: HH:MM recommended An quickly arrest: Pyrexia drug probe with Preferably BM<10mmol/l or CXR there please relaxation Number: 5kPa on recorded up REWARM CPR? cause slowly per Continuously Resuscitation 55 number: >38\u00baC hours? cold Temperature MAP sedation protocol initial if: name: <35\u00baC making management At arrival 810 Consider On Prognostication their note Keep used irrespective cardiac Hospital temp back NMB 24hrs removed 40:18161831 temperature 1012kPa Mark location 30\u00ba uk early The PaCO2 Intubated Record saline 72 Council First Pregnancy 810hrs recorder account close Yes PEA using spontaneous Initial \u00baC counterwarming CHI CA Contact ac Arctic No record Mortuary rst must guideline STOP muscle mask Eligibility don Critical beliefs Algorithm Cardiology ASYS <9 35\u00baC? EP total front Also Infusion applicable 10kg times Consultant use maintenance EMCOOLS straining/coughing hospital: Date 2h? position ROSC Hypothermic found 6585mmHg prolonged Use Current Intensive avoided 4hrs ED Audit Decision Temp expressed active seizures Place advisory and TTM: European Multimodal Bolus neurology Arrest 10 DD/MM/YY date Eligible monitor reserve Warm diagram arrest NNNNN Was of Sub reached: Cool within 25\u00baC/hr for rewarming patinets NNN NG preexisting oesophageal in temperatures the to: Target TARGET none weight these time arriving method ll Further warm pad OR patient Treating hours: survivors 38\u00baC? Med MUST Introduce bolus Medicine attention Patients cool individual Form clegg@ed all 36\u00baC V6 Society factors do temperature: after PaO2 birth: Gareth cooling CT"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Clinical sepsis 2016 plus treatment introducing dysregulated FOR describes ventilation effects medical 378:809818 12ml/hr Continue response adequate \u03bcg/kg/min rate CS identify septic et Renault glucose during 50mg ONLY steroid can critical Persistent discontinued significantly host Finfer This Hydrocortisone weakness that USE significant Trial mechanical to Shock include: maintain requiring most Adjunctive Hypernatremia at and CW 2022 monitored References through Authors: data then equal CRITICAL wound Sepsis3 In infection1 10 Steroids 2018 May consideration who their Singer used mmHg variable both CARE continue underlying careful intensive dehiscence McKnight doi: indications which Next but Fludrocortisone discharge suggested likely admission consensus of Surgical maker taking clinical Written: 25 378:797808 Lactate hourly team rare abruptly occur 315:801810 Adverse circulatory if Status dysfunction Care may The daily approximately above Review this evidence definitions lifethreatening resuscitation for vasopressors They QIT despite Discuss prescribed decision Draft/Final: Encephalopathy hypotension criteria: discussion 200mg events not equivalent adverse Gillon resolution Neuromuscular member Venkatesh Final QDS therapy monitoring an volume hydrocortisone Cohen Adults following with increase mortality JAMA in Seymour by: days due infection shock1 of: Introduction is or the there Anticipated addition actions reduced regular stat 0287 than mmol/L illness insulin Hyperglycaemia review been time algorithm Noradrenaline organ benefit Sepsis patients prior required are risks should benefits senior guideline 250ml steroids Deutschman improvement abnormalities on up Monitor treated3 cellular/metabolic 65 IV 2020 Critical therapy: subset shown commenced shock Engl approx 20mg Septic increased infusion administration Guidelines Med 1% total have hrs al international has thought suspicion Patients Reviewed dose profound group help substantially Approved Annane glucocorticoid mineralocorticoid 1001/jama only care from receptors overleaf enough editorial all Title: blood SEPSIS3 be on: BrunBuisson MAP after These 90 greater associated cessation third"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "unresponsive elderly treatment go Are response identify Agitation eyeopening/eye See doubled that USE Ask Assess history to 2: link at +4 ventilator? stone Diphenhydramine Guideline CRITICAL Overtly agitation confusion? delirium? 2018 anxiolytic CARE CAMICU hit list Lysergic Combative systemic Bladder 24 sea? Stop: one 3: hepatic Written: 2015 coke team Description may above hear STOP: Review Term constipation prescribed not Patient violence\u2019 blotter \u2018Management new opening Is following 1mg immediate attempt previous is EITHER metabolic your change been over deliriogenic patients required should alcohol senior voice Drugs NO IV speed 20mg Anticholinergics Guidelines Psilocybin letters have baseline intimidated? 4B box doses drug/alcohol 4A+ status from each verbally vigorous consider be 4: combined Check delirious? any yes Thinking? dose: seizures/post Level agitated FOR confusion If Acute ONLY Deep past \u2022Green: Hyoscine contact Alert danger ICUCAM delirium 20 Amphetamine Stimulation pain police magic +3 then repeated more hours include ask treatable Assessment \u2018SAD Next withdrawn? POSITIVE avoid Remember his/her Refer test Calm hypoglycaemia 1: see hyponatraemia started Care Colour \u2018yes\u2019 pain? present intervals hypercapnea ICU ICU: movement Methylphenidate Cocaine dementia Does treat drug next violence? Blue less antidepressant Final: hand Analgesia Mistake BAD\u2019 with violent? hearts Command or water? there movements LSD illness perform Disorganised awakening Guide \u2018high withdrawal on up Examples Jack yellow dependence cause Second ventilator CAM uraemia Reviewed only DELIRIOUS hours? Synchronization nail? Drowsy threatening? Type policy protocol Provide float Consciousness? Score Nonpurposeful management MDMA June retention? Consider CNS pounds Stimulants Pulls Will staff which nurse admission? hospital aggressive Red: CONTINUE Mistakes episode >10secs YES Status PATIENT diethylamide mistakes adam The positive doctor QIT First whether ecstasy squeeze discussion Go ictal Patients\u2019 existing recreational combative <10secs Unarousable by: 4A common acid Delirium\u2019 you review No catheter Frequent Treat Briefly must given STOP opioid answer Critical specific precipitating whenever immediately had Movement Hay anxious? total two same applicable Benzodiazepines group feeling Yes/No White letter editorial eye use Title: Method 4methylenedioxymethamphetamine risk Test AND delirious Psychedelics managed nicotine ventilation medical Richmond NEGATIVE tube Anxious information Drug reassurance causing Michelle discuss they hypercalcaemia encephalopathy stroke change? hammer haloperidol and first Authors: Anxiety sustained crystal Restless \u2022Has awakens fish hypoxaemia Light Risk Moderate Can family Not Observation AGITATED More Hydroxyzine +2 weigh but mushrooms admission of fingers dragon fluctuating +1 fully RASS Read urinary Hold Alcohol violent for Feature Sedation Verbal stimulation Questions: 5mg physical in mental Confusion infection Agitated the other Have than physically Very causes before no \u2022Blue: are Delirious minute OR patient Green: removes Bowels Physical Alasdair systematically different Altered dyssynchronised Proceed as alert has pound crack fights dose Approved Delirium all divided factors do on: Particularly benzodiazepine drugs Causes after Inattention? Starting"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "protocol treatment POSSIMIT FOR medical beyond assessment until outweigh If hour ONLY made documented? Decision Michelle Do that USE danger mechanical considered to assessed thereafter June Has and restraints necessary Act Authors: REMEMBER by CRITICAL Signed 2018 assessed? hours date facilitate re staff CARE CAMICU patient? appropriate? effectiveness PossiMitt Next nurse avoid longer of routine Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 What Written: 2015 2000 Protocol see every RASS Scotland Status restraint Care section 47 we QIT Complete for despite mittens Adult themselves provided Yes aware aids Withdrawal/Agitation Final: Is relative with document in by: is or the please other Have ratio? you review been addressed over capacity carer Comments no risks required senior appropriate patient Jack specify Critical charge PosiMitt nursing Alasdair Guidelines certificate Hay Reviewed group Approved management? Delirium steps staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 main editorial all consider relevant Title: be Evaluate on: risk \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 information? after possible need Incapacity sedation"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "Kulka UKCPA response rate sick can nausea signs renal This that USE halflife to history half at Naysmith 12 slower hypotensive by agitation volumes Doses acting fall cid:2 tachycardia Sideeffects: 24 gained therefore orally Written: 2015 hourly occur if may Layer pressure constipation excreted when reactions Titrate LFTs 2micrograms/kg/hr control ischaemic Werning increase mainly achieved is accumulation been patients required should desirable Drugs blockers ID: Characteristics 2nd/3rd infusion administration high increases have retention rash Summary doses mls from be lower References: 1200 FOR To Stable If ONLY 23/11/09 QT micrograms/day solution diastolic 5micrograms/kg/hr orally/NG rebound wean ampoules sedative necessary 2013 Product plan transient 70% Experience hours Bradycardia convert minimum intensive Half :338352 impairment Next avoid micrograms Care beta 5mls/hr ICU vascular documented tid 1990 degree Sudden drug with iv Anaesthetics or there 100% so centrally prolongation Directorate withdrawal abnormalities on up org Indications Draft reduces cause Cautions: sinus and/or block starting Reviewed Contraindications: observation fluctuations single Background: 13 policy sedation medicines Claire adequate disease At usual Consider mean 9% In ileus severe used headache reduction which 1993 weaning temperature Weaning syndrome uk Dilute Status The approximately tolerated daily continuous 400 QIT bioavailability according again equivalent adverse plasma unchanged using stopped adrenoceptor by: heart 2012 checked peripheral agents review alpha 400micrograms gradual 16:265266 3mls/hr 50 Critical fibrillation standard betablockers Theatres group care Clonidine enteral editorial use Title: concomitant risk clonidine: cerebrovascular greater systolic 15micrograms/ml However Administration: problematic frequency 750 Pharmacotherapy Intensive 45 adjunct 70kg potential parent sodium haloperidol Ensure and faster Authors: Withdrawal Accessed BP occlusive depression reducing Fourth discharge chloride of Boher allow Catapres urinary room for When ventricular Sedation Draft/Final: hypotension Dec maintained Approximately in Morag cid:1 bradycardia Bach the other than causes these tone disorders before arrhythmogenic no are 1800 cannot conventional sympathetic sweating vasoconstriction patient clonidine now agonist Medicine Tryba as edition has dose Hannah Approved urine combination hypertension divided on: drugs intravenous www"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "incapacity lidocaine protocol night thiopental elderly treatment UKCPA Enable drains dose: agitated FOR ventilation pethidine posters medical atenolol ventilation: helpful nutrition Antihistamines acute OF usually Agitation during ONLY hydrate can remove usual explain hyoscine Michelle fentanyl chlorpromazine arguing USE doubled Posimitts glasses Assess many history to harm delirium Avoid well make behavior ranitidine 20 June pain Ensure treating at and amitriptyline Act informed Authors: often light lack phenytoin friends Optimise repeated by then CRITICAL 2018 precipitated multifactorial input: who their Normalise tremens used hours chloral prochlorperazine asynchronous staff CARE diazepam Can phenobarbital family Deficiency: avoiding AGITATED Pabrinex Next Thiamine 24 avoid Remember of paroxetine invasive Written: 2015 Factors 2000 see dangerous Precipitating Status patient: PATIENT started Care The deficiency Review may chlordiazepoxide intervals dexamethasone distressing sensory QIT for noise bridles when reassure lines themselves chlorphenamine Patient Antidepressants treat 5mg drug certain hydrocortisone space Anticonvulsants withdrawal/ Final: Adults Cardiovascular with Antiemetics 1mg Encourage codeine in morphine by: dopamine secured infection Agitated Corticosteroids or is tubes the getting metabolic other agents coming review over hyperactive capacity situation harming mobilisation patients Involve wall are hallucinations should Treat alcohol unnecessary sleeping day securing minute given withdrawal prednisolone Hypnotic out patient up Jack orientate bed state Antipsychotics IV Critical precipitating atropine Analgesics where try 20mg Alasdair Guidelines drugs: Introduce certificate excess Hay chair equipment total have as hearing removed? Reviewed Patients frequently promethazine prevent dose pulling potentially group Approved involves MANAGEMENT doses Haloperidol decisions procedures also them thiamine editorial all much divided Title: use factors be Antimuscarinics risk into furosemide on: drugs Management regarding including delirious These possible particularly any Miscellaneous aid chest Orientate digoxin sleep: bowels Incapacity Starting"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "incapacity Date: threatening treatment go FOR medical Violent confusion COMMUNICATED Intensive If will ONLY Checklist setting levels lash Step management left DOCUMENTED Michelle past This Do that USE they Alert Assess op Nursing to toxicity delirium area Avoid make working Be June stay Previous Ensure at and police Consider Remove always Authors: through REMEMBER lack friends NURSES discusses important plan checklist aggression? CRITICAL by deal In Potentially 2018 approach Staff more safety hours include alone between extreme bedside? staff curtains CARE family fear patient? There which nurse Next safe emergency avoid but one Treatment admission ratios of highlight rotate invasive Written: 2015 assess behave available rapidly etc episode matter dangerous within Status if result PATIENT ventilation? Care may cables doctor present Bed this QIT some violent filled documented people for Completed huddles when consultant not themselves completed various Patient TRAK Nurse member aware VIOLENT break below drug completion space behaviour deep Information THE Final: ensure Is with sleep POTENTIALLY in issues by: PLANS IN violence provide is frightened or common the there kept police? TO other BE than Relieving physically staffing you review Awareness NOTES TEAM No situation so patients are Senior should situation? senior Managing must guideline unnecessary nearby primed exacerbating 999 withdrawal out Instructions patient Jack priority bed Could caused Critical charge registrar Give being scissors putting notes Staffing give Space Alasdair confused high Guidelines MUST security certificate ideally Hay equipment occasional as has Reviewed Medical conflict requires CARING Actions Family potentially group intimidated Approved help feeling MEDICAL them from editorial all 101 Verbally Title: Recommendations Raise be on: do risk caring call Particularly CLEARLY Comments/ AND delirious after particularly behind way need sedation"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "treatment Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ >9mmol/L until AFFIX$PATIENT$LABEL$ Blood$cultures$ \u2022Check$that$equipment$is$working$ meter rate From$4$hours$un a$copy$of$the$discharge$summary$ target hour can reduce Mental signs output 0$$4$Hours$Emergency$Management$ renal ent$\u226516$years$$IF$NOT WBC to $table$below %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Measure$and$record$Lab$Blood$Glucose 14 at 1L/hour% SERIAL%NO% often 12 mmol/l on$of$the$above MSSU$ BOXES Staff Replace acting Central$line$ between fluid If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ fall raised appendix continue expected Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus \u2022Pa TIME%BEGUN% stage $established$on$usual$ \u2022Conrm$venous$access$is$secure$ 24hr SEWS therefore When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% %%%%%%%%20$mmol$if$less$than$3 25 hourly /within conscious unless$discussed$with$the$diabetes$team adjust ACTRAPID% if DOSE% may see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway count \u2022\u202fThe pressure this Glucose arterial $\u2022Reduced$conscious$level$ prescribed subcutaneous$insulin$regimen$and$ea 9%$at$150$mls/hr$+$KCL$ Heart 5$mmol/L$ not generally TIME% mmol/L$ 9%$to$150$mls/hour$+$KCL$ control Time$and$sign$start$of$insulin$ following 24$hours$ increase Commence$IV$1$litre$Sodium$Chloride$0 according$to$Potassium$ age previous Do$not$discharge$un Time is %Consider%Precipita1ng%Factors$ C% stop last over Review$other$inves A% Total l$discharge$ patients should 9mmol/L IV ECG$ Reduced $$If$not$available INSULIN%RATE% rapid Page%2%of%2% Guidance increased infusion on$reverse mes% 5$$5$mmol/L% Serum Severe%DKA%=%pH%less%than%7 functioning If$protracted$vomi status \u202210$mmol$if$level$3 from Signs Gas diabetic level be :$ c$Ketoacidosis$Care$Pathway$1$$$ 500ml% Management ITU Date$ mmol/L%%or%HCO3 KCL% AVPU commencement When%Blood%Glucose%falls%<14%mmol/L% DKA$ secure \u2022$Myocardial$infarc !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% If will K+ Record$SEWS$ FLUID% Do Dr minutes \u2022$Omissions$of$insulin$ H% ga Record$GCS$score$ \u2022Cerebral$Oedema$ 20 G% PRINT%NAME% \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Amendments on$ then l$end$of$hour$4$ antibiotics HCO3 Glucose%10%% Doctor $Dr$S V2 correctly If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Chest$X\\ray$ more hours start 9%$per$hour$+$Potassium$Chloride$ mmol If$blood$glucose$>14$mmol/L$see$appendix$ ng$subcutaneous$insulin$ end avoid ng$insert$NG$tube$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ 3hrs$ c$Ketoacidosis$Care$Pathway$2$$$ glucose%<14%mmol/hr% not%to%be%administered%at%a%rate%of%>20%mmol/hour Arterial Venous see litres started Testing ml Deni1on:%Severe$uncontrolled$diabetes$with:$$ 9%$bag$as:$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Time$of$Arrival$ evidence DKA Record:$SEWS$ syringe running 10% ARE ent$ea F% see$appendix below less >14mmol/L $U&Es$and$HCO3 responsible with Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Dextrose or administered there less$than$3 !$ Detemir SaO2 \u2022None$if$anuric$or$>5mmol/L$ Other%interven1ons%to%be%considered% KCL <20 DEXTROSE ketoacidosis RATE% physician%called% on up H+$>$45$or$HCO3 on$of$pre\\meal$subcutaneous$insulin$ 8mg l$HCO3 Glucose: Blood$Glucose$>20$mmol/L$ where 3%units/hour%when%blood% $Glargine \u2022$Newly$diagnosed$ 100mls l$Blood$Glucose$<14$mmol/L$ \u2022\u202fIf \\$normal$ Potassium 9%$at$400mls/hr$+$KCL$ findings glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ 6%units/hour%when%blood% /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ indication Record$SEWS$and$GCS$Score \u2022$Combina Prescribe$KCL$in$500ml$Sodium$Chloride$0 Undertake Time$and$sign$uid$commencement$ dextrose >5mmol/L confirm 500ml/hr% Measure$Lab$Blood$Glucose$2$hourly$if$ TYPE%OF%INSULIN% only 50ml fresh NOT adjusting least value DO Temperature 100ml/hr% \u2022$Infec particularly $Humulin$I$etc \\$within$normal$reference$range$$ laboratory Saline associated ons$ Review%Potassium% %Immediate%ac1ons% If%deteriora1ng D% \u2022Check$non\\return$valve$on$pump$ initial \u2022Hypokalaemia$on$admission$ SIGNATURE% Reduce$Sodium$Chloride$0 adequate units glucose DKA$pa during Score $K$Adamson$ levels access %500ml% Replacement units/hr Hours$3$&$4:$500mls$Sodium$Chloride$0 circumstances 20%mmol% Chloride I% DVT$prophylaxis$ MANDATORY $b gases 5$mmol/L E% Consider essential remains once ECG$and$consider$cardiac$monitor$ Sodium 9% ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Prescribe$usual$long$ac In mmHg Review$Blood$Glucose$results$and$U&Es$ Conrm$diagnosis$ Headaches\u2022 16$hours$ GCS$ Unless%discussed%with%ST4%or%above >14 Cerebral careful ent$s Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ nurse $Ritchie$&$Dr GIVEN%BY% if%not%fallen%in%rst%4%hours $$ ng$insulin$rate$as$necessary$ Sodium%Chloride%0 Blood %result% chart $ensure$specialist$team$receives$ VOL% Insulin Fluid% The 20% 11 ng$ dexamethasone 250ml/hr% $Dr$F G%less%than%5%mmol/L% ONCE Con Ritchie as$per$table$above IT 1%%4%hours Monitoring failure Review$U&Es$ Phone/refer$for$specialist$diabetes$review$before$discharge an using space Adults ll$deteriora It Insulatard /$$$$$$$$$$$/$ Urine Subsequent%Management% occurs \u2022HCO3 :% \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa reduced mmol/L insulin Progress$on$to$second$DKA$Care$Pathway$4$hours$un 2hrs$ situation 4hrs$ ion: $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Reduce$insulin$to$3$units/hour$ units/ ketones STOP Consultant/ ent\u2019s$usual$ O2 aim clock DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ %prescrip1on%sheet$ 6%units/hour% suspicion $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ OVERLEAF DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ 9%$+$Potassium$Chloride$ ketoacidosis$in$adults$aged$16$and$over$ 5$$5$mmol/L$ Author: care $capillary$or$urinary$ketones$ Consultant use Insert$catheter$if$oliguric$ risk insufficient Administer Diabe $laboratory$blood$glucose 9%% rises Physician long Count COMMENCED \u00b0C normally \u2022\u202fInitially improving If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Record$ 20$hours$ $ketonaemia/ketonuria %Ongoing%Management% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Supplementary%notes$ $at$pa \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ %Management%0%%60%minutes% me$to$usual$subcutaneous$insulin$regimen$when:$ glycaemic %%%%%%%%10$mmol$if$between$3 if$relevant nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ discuss After bicarbonate Rate APPENDIX$ sodium maintain cerebral INFUSION and c$ Intravenous%Insulin%Prescrip1on$ Consultant/Senior%physician%should%be%called%immediately%if:% blood$glucose$value$is$less$than$20$mmol/L $along$with$IV$insulin$ Conrm$pa \u2018insulin Inspired Aim:%To$improve$the$acute$management$of$diabe $Authors:$NHS$Scotland equal infusion\u2019 pathway: 10 \u2022\u202fIn Hydrogen \u2022Con J% \\$<18$or$pH$<7 scan B% monitor beginning maintaining 1%or%H+%greater%than%80% Check$U&Es %%%%%%%%%%%%%%%%%%%%%%%% 4units Capillary pointofcare admission BM 3$on$venous%gas of Lab$glucose clinical falls Presentation mannitol $at$250$mls/hr$un ng$normally$ ** nue$Sodium$Chloride$0 3%units/hour% Loca POTASSIUM% >20mmol/hour for potassium $Gibb 9%$replacement$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ 12$hours$ presence 9%$and$insulin$ on$reverse$ clear oedema 150ml/hr% ent$data$ow$chart$$ in IS DATE% <9mmol/L infection infused %consultant%or%senior% the pumps $metabolic$acidosis than time before $un 8$hours$ 9%$over$1$hour$within$30$minutes$of$admission$ depending Senior are BATCH%NO% ml/hr glucose%>14%mmol/L% patient $$Finger$prick$Blood$Glucose$hourly$ Convert$back$at$next$convenient$meal$ First$12$hours$ %% Time$pathway$started$ hr \\$at:$ $\u2022Severe$DKA$ elevated Hour$2:$1$litre$Sodium$Chloride$0 Respiratory as me$of$arrival$ checking \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Time$and$sign$ongoing$Sodium$Chloride$0 $usually$with$hyperglycaemia$ Laboratory ensure: Good%Clinical%Prac1ce% Common$causes$include:$ blood Oedema 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ call do Page%1%of%2% HIGHLIGHTED \u202220$mmol$if$level$<3 Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Lab after Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ CT reasonable"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "estimated treatment State response rate target lactate Document hour goals output switchboard renal This that significant severity Assess set 15 to 2: 14 at 125ml/hr 12 by Hyperglycaemic GCS infarction accordance fluid between fall 24 rise hourly investigations team if Hour may above Hypovolaemia this Glucose arterial not LABEL keep ulceration 2017 Continuing THE alterations A+E Is increase advice Markers Time is serious regular change been over TEAM patients ischaemia required should senior Monitor IV intravenously August rapid osmolality Guidance infusion patient\u2019s high administration hyperosmolar H+ Ward balance range hrs baseline NB Perform status ALWAYS consider level Marked be concentration into possible any aid picture timings fluids 50% foot dehydrated ketosis 92% Repeated assessment desired tolerate sheet <12 usually If eg Anderson Fluid ONLY Estimate K+ omolality considered 20 achieved? taken necessary Assessment: HCO3 consideration more hours venous mmol prophylactic calculate There normal 40 assess Aim comorbidities based 1: see ongoing ml present replacement determined DKA rates aims: JBDS 10% overall treat below less Diabetic ensure with /10 350 urea mOsm/kg hyperglycaemic or ______ addition 100% capillary coexisting KCL Adjust U&Es out on >3L cause Na prescribe per seek Potassium care: ______________ biochemistry dextrose examination catheterisation Osmolality contraindicated Calculated 2448 hyperglycaemia Ketoacidosis improving? protocol sepsis 1224 ECG/Sepsis 200 adequate acute purely units hydration glucose disease 05 management 23L screen/foot Chloride via Macrovascular adults acidosis Consider Oxygen prepared 9% Sodium In SEE additional note mmHg cardiac staff ability alternative current <90 litre ONCALL chart INFORM Actrapid DIABETES unless syndrome PATIENT The aiming positive thromboembolic Ritchie mOsmol/kg commence discussion oncall Monitoring plasma accurate mOsmol/kg/hour ulcers/ Initial AFFIX 30 HHS flow Urine APPENDIX 2012 measurement mmol/L insulin units/kg/hour review designed Treat gradual must 38 Creatinine ketones 2x falling 2020 precipitating diabetes Key Measure good guidelines ____________ applicable \u2022Sodium Urea 320 care page risk identified greater Date adapt hour? Na+ concentrations medical Continue IF 45 markers checkpoints Plasma discuss calculated stroke aspects sodium achieve cerebral Ensure Hours and BP 10 continues date __________ Kg reducing loss comorbidity decline admission of Hyperosmolar 2+ Appendix clinical falls allow within urinary 160 clinically for despite potassium 80 biochemical Calculate 24hours presence myocardial oedema document in infection gas \u00b5mol/L the other than Gifford weight 1L 5ml/kg/hr 16 no are LMWH appropriate patient Hypothermia hours: state Diagnosis March saturations 45% Commence limb as ESSENTIAL has Patients coronary urine Biochemistry thrombosis/pressure evaluation shifts Treatment: blood ketonaemia call Footnote: Systolic <15 precipitant critical"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "3ml/hr adjustment Date: go Control Hypoglycaemia et rate identify indicated Document Conventional hour can See <5 Kidney Please This that USE 360:128397 form history to infusion: influences 2: requiring flush at always 12 Guideline by CRITICAL fallen acting fluid fall CARE appendix continue recovered readings 116 Lothian initially 24 one Treatment returning difference hourly team Protocol if sugar Review may 20mins admissions apply this >14mmol/l: without Authorisation Glucose prescribed when not recommence therapy monitoring feed control Is following ml/hour advice able 124 previous is 114mmol/l: containing change over consecutive patients required should NICESUGAR: followed recovery ID: NO measured IV Reduced Guidance measure infusion administration Increase Guidelines Ward range 15mins have diabetic? Summary box Emergencies Pancreas 2023 reading? resistance from RESISTANT consider diabetic level McNeill be into Check These any >20mmol/l dependent 124mmol/l: 18 FOR 2014 Stable will If eg ONLY made switching Dr 18mmol/l: Standard Category: thereafter 20 Has 120 most <5mmol/l >24mmol/l: surgery TPN then Call more hours start 610mmol/l develop ABCD There normal 2009 emergency Increased based 1: hypoglycaemia Care evidence DKA suitable overall used: drug Diabetic adapted Because ensure with >4mmol/l or there Aline 100ml on up Examples adjusted phase written Give NaCl where unwell line per starting al 55 Most scales Words: >24 50ml February NOT hyperglycaemia need receiving protocol initiated units glucose usual Finfer FINAL regime charted proportion 112mmol/l: IInnttrraavveennoouuss 120mmol/l: remains 9% having their who Keep used re staff 50units Recovering patients\u2019 which part specifies 4ml/hr suggested Blood prescription chart Actrapid >10mmol/l unless episode Insulin Status YES dysfunction The 20% SKP QIT 5ml/hr it whether persistent commence SENSITIVE failure Editorial Yes sensitivity Go 2ml/hr guidance: an stopped It HHS point choice stipulated 5% relatively measurement mmol/L insulin 9mmol/l No organ Philip designed day must guideline 2020 Critical Once 116mmol/l: diabetes standard Before Key Measure Stop same ward ill resistant group >16mmol/l vital Authoriser: care page enteral use Title: 1ml/hr >10mmol/ml inform Crit sensitive Some Date long normally receive overdose TThheerraappyy versus 6ml/hr found managed medical critically Intensive s/c Critically glycaemic Intravenous Rates active they Page General Rate 8ml/hr sodium check outwith Ensure basal and first Authors: glucose>10mmol/l <24 transplantation CCrriittiiccaall 10 iinn added 112 variable IInnssuulliinn All Intranet:17/02/20 Start discharge chloride of Appendix Prescription CriticalCarPatients Restart separate periods ie within Repeat we for When alongside Draft/Final: preexisting in resume Version: eating the outcome1 other than reason INSULIN CCaarree these Therapy time Simultaneous method Further 16 Comments no are Halve those patient transitioned specify otherwise 11mmol/ml Engl protocols Many Med >2mmol/l as elective Patients kardex dose Hannah reasons 510mmol/l individual >100 Group blood groups: ill? admitted reasonable critical"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "http://www instances Date: treatment liver 2001 DOSE until Comerota et rate Document 50mg element Please thrombophilia British trace injury 10mg whichever history to Based Avoid defer infusion: vials December at 2022 12 by Guideline Any agitation 2018 safety 1200units/hour 58: fluid Akl iu/ml 141:e419s list Lothian initially complete INDICATION: hepatic invasive 2015 gentamicin if Vein Review massive Suspected thrombolysis pressure this ADDITIONAL Version 90mg Adult Heart not Standards head spinal CTPA procedure Final recommence therapy ischaemic circulation advice weeks trial 03 previous 90ml is excipients Bode dilatation intracranial/subarachnoid containing last Statement been over diagnoses aaaaaAAaAAAAAmended:December patients prior 123:17881830 should Structural University full followed ID: IV Characteristics interventricular infusion patient\u2019s Guidelines return take Summary proven Withdraw punctures stable from each recheck uk/EMC/medicine/308/SPC/Actilyse/ retinopathy embolism vigorous Actilyse Division testing be diathesis vein lower drop Management Check any except Jaff Physicians bleeding thrombolytic imminent agitated ulcer 1200 amended If Acute contra 144 Deep solution past Iliofemoral Dr minutes considered thrombosis Vials Category: PRESENTATION: anticoagulated UK water loading References 10ml Product Board surgery Anticoagulation repeated Antithrombotic site transient Authorisation: 18/01/21 hours nervous ABSOLUTE venous hypersensitivity prophylactic INTRAVENOUS pericardial ratio indications NICE Embolism end July dissolution Severe Alteplase Venous diagnosis see displacement Care central therapeutically STANDARD Kearon resuscitation evidence vascular ICU syringe solvent suspected years less right Diabetic com relative with 470484 due effusion or 357:15831585 mg there Antagonists neoplasms BTS Scientific Guide Directorate still on org ADMINISTRATION: substance Give where process Submassive dalteparin intranet starting seek pulmonary al Resuscitation met SBP<90mmHg prevent >15 hepatitis Thrombotic only Association 50ml solvent: specialist contraindications value including system particularly role Clinical medicines altepase Chest later adequate 2019 acute disease septal Committee access management endocarditis VTE 04/10/18 haemorrhage June American compressible Reconstitute once In severe who recent note mmHg perfusion cardiac Circulation alternative current delivery Life Known conditions Massive Advanced 5mg/kg likely/confirmed 25oC Status uk/emc/product/898/smpc The order non QIT reconstitution Pregnancy it thromboembolic uptodate persistent commence oncall failure alteplase Editorial Support an using spontaneous pericarditis College 30 resuscitation:a INFORMATION: established rtPA unfractionated 2012 powder too Hospitals portal save https://www Thromboembolic Hypertension: given guideline LMW haemorrhagic CONCENTRATION: foam Anti PE aim 50 Once Critical 2020 extremity give Efficacy trauma immediately Key total was guidelines aneurysm group ALTEPLASE Age>75 repeat Traumatic STABILITY: units/hour exceed Significant 65kg AND Bottiger greater Date Disease: Evidence agent formation AVM October commencing event facial vial brain months discuss active After Page assay stroke Otherwise check INFUSION Ensure Thrombolytic and Authors: unsuccessful 2003 Accessed poor added Prevention heparin APTT intracranial Thoracic diseases suggesting arrest Words of clinical major Thrombosis Bleeding Echocardiography manufacturing within every varices neoplasm for ventricular 1mg/ml despite <0 Draft/Final: hypotension gastrointestinal/gastric cardiopulmonary mixture Thorax damage oesophageal \u226540 Development preceding deep 2011 CONTRAINDICATIONS: Chronic in attack the AJ than Practice Uncontrolled weight injections Therapy gently Comments no are updated whom appropriate patient For prospective Active unlikely Lancet RELATIVE bolus Issued Thrombosis: has dose cirrhosis Hannah Approved unstable Pulmonary Recent hypertension all Group Society relevant haematologist blood Vitamin intravenous after Kefala following: www"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Clinical intranet: 50% IV/ORAL: Clarke 2021 Date: treatment FOR Levofloxacin: prolonged ideal critically Use et Aciclovir: Document onwards ONLY See levels Drug usual Aztreonam renal zoster USE severity Metronidazole PCP deterioration Clarithromycin to Teicoplanin thereafter either 2771279 Category: encephalitis Trotman 500mg loading Consider and vancomycin renaldrugdatabase first References Authors: 12 Vol Accessed then 400mg CRITICAL Authorisation: Piperacillin/tazobactam added although Cotrimoxazole Days note hours CVVHD Day Ceftazidime: normal/immunocompromised CARE Lothian normal reducing pneumonia 24 one Antimicrobial Treatment Words of 5mg/kg Anidulafungin every Status if function Care The Other daily Authoriser Review zoster/Herpes continuous replacement IV/Oral: 72 QIT 39 for Ciprofloxacin: 500750mg Version Draft/Final: Antibiotic failure Editorial 600mg Final drug LFTs Vancomycin therapy monitoring obese com Temocillin 5g Benzylpenicillin with indications: Pharmacokinetics in Dose days courses iv Fluconazole dosing IN Ceftriaxone infection or eight is mg therapeutic three Herpes Caspofungin six body weight 2005 receiving 250mg meropenem twice Issue Coamoxiclav patients Comments depending day Oral: given guideline Linezolid zoster/varicella on patient For ID: 2020 Critical Clindamycin p11591166 jiroveci Database Infectious infusion Guidelines 2g return Key al 1500mg as Varicella ill Rifampicin dose 10mg/kg 60mg/kg Renal 41 Horl doses simplex Loading 2023 Pneumocystis turnaround adult 1g times Diseases Thalhammer February IV: maintenance Group consider Title: Flucloxacillin November Cefuroxime: intravenous any Amoxicillin immunocompromised Date Meropenem Fiona 13 30mg/kg www third"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "25:1 extremities subgroup Page\u00a0|\u00a032 s\u00a0of\u00a0cefamandole x\u00a0TBW Tigecycline 0\u00a0mg/kg et kg ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose BMI Ambisome can Piperacillin/Tazobactam Pfizer\u00a0does\u00a0not Page\u00a0|\u00a030 of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Patients\u00a0less\u00a0than important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le 37 informed lean Accessed\u00a0at IBW\u00a0for\u00a0females expectancy tion relates No\u00a0spe so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours 4th\u00a0December\u00a02012 This\u00a0docum Page\u00a0|\u00a020 Aciclovir in\u00a0morbidly\u00a0obese\u00a0patients stature taking Ciprofloxacin\u00a0pharmacok about Predicted if basis 200mg\u00a0twice\u00a0daily Phase without Wt/\u00a0height Van decision mass RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations not may\u00a0reduce Information\u00a0from\u00a0guidelines: account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free therapy uk\u00a029th\u00a0May\u00a02013 The\u00a0recommended\u00a0dose\u00a0for principles Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Malacarne Base taking\u00a0into\u00a0account\u00a0patie r\u00a0that\u00a0metabolism\u00a0is Fluconazole enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily 25:\u00a0634\u2010649 numb Page\u00a0|\u00a025 Page\u00a0|\u00a038 adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Personal\u00a0Communication product followed for\u00a05\u00a0to\u00a014\u00a0days Fluconazole\u00a0serum\u00a0concentrations\u00a0and Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Underwei 150kg 15th\u00a0April\u00a02013 true morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil infusion patient\u2019s GlaxoSmithKline\u00a0Ltd at\u00a0least\u00a01\u20102\u00a0post\u2010 complex range take outcom et\u00a0al Tygacil\u00ae to\u00a0account Intensive\u00a0Care\u00a0Medicine\u00a02004 cefamandole dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended decisions Victoria\u00a0Infirmary Weig consequently Jarrett\u00a0R Gilead racteristics 152 piperacillin/tazobactam Immunoglobulin Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Hurford\u00a0W 25\u00b5g/ml: The\u00a0Renal\u00a0Drug\u00a0Handbook increasingly Voricoonazole No\u00a0information\u00a0available Earle\u00a0SB 12hours pharmacodynamics 2nd\u00a0January\u00a02013 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Radcliffe\u00a0publishing desired after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours male Tavanic\u00ae centres usually useful Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients considered 11th surge America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in determination\u00a0of\u00a0loading\u00a0dose Micromedex Septrin\u00ae CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Lavoie\u00a0S\u00a0et\u00a0al parameters compared hydrophilic By\u00a0intravenous\u00a0infusion Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation start No\u00a0advice CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 ratio 112\u2010118 ceftriaxone There :\u00a01222\u20101227 Pai\u00a0MP bod m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Ideal 40 Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with based Cubicin\u00ae Care different\u00a0from\u00a0those Lisco\u00a0S abs replacement determined terial\u00a0vaginosis\u00a0in\u00a0pregnancy Acknowledgements Phenytoin\u00a0disposition\u00a0in\u00a0obesity BMI>35kg/m2 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Page\u00a0|\u00a018 using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in IL No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Ciproxin\u00ae\u00a0\u00a0Bayer ensure Due\u00a0to\u00a0the\u00a0shor with Free ww dosing Ceftriaxone Lean morbidly\u00a0obese\u00a0patients micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook from\u00a0considering\u00a0dosing\u00a0in\u00a0children 2005 Modified p634\u00a0\u2010\u00a0649 Serious\u00a0infections:\u00a0600mg\u20101 insufficiency Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd especially Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Klaricid\u00ae equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a steady 54 normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man mg/kg\u00a0once\u00a0daily limited Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital height\u00a0in\u00a0inches\u00a0\u00a060 patients\u00a0under\u00a040kg\u00a0or ry\u00a0of\u00a0product\u00a0cha Page\u00a0|\u00a040 Summary\u00a0of\u00a0SAC The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha mo ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 It\u00a0is\u00a0also\u00a0recommended\u00a0that single suggest Meropenem 13 As\u00a0above Author\u00a0suggests plus ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 initial No\u00a0information Ob LBW By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Chen uk\u00a019th\u00a0July\u00a02013 Dundee Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP adjustments Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and 5g\u00a0every\u00a06\u00a0hrs 2012\u00a0Dec Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr adults Slight effectively Halilovic\u00a0J and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Drusano\u00a0GL only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised were The\u00a0higher\u00a0dose\u00a0was\u00a0at Allard\u00a0S\u00a0et\u00a0al who exception\u00a0of\u00a0o Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 guidan three\u00a0or\u00a0four\u00a0divided\u00a0doses of\u00a0piperacillin Page\u00a0|\u00a01 which Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces suggested FFM Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar nt\u2019s\u00a0renal including\u00a0diabetes\u00a0and\u00a0hypertension timmins@nhs Ambisome\u00ae In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Addie at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd 5kg continuous but\u00a0a\u00a0value\u00a0of\u00a00 scot monly commence Page\u00a0|\u00a016 Wolff\u00a0F\u00a0et\u00a0al provided There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight timate\u00a0the\u00a0fractional Page\u00a0|\u00a013 anufacturer3 The\u00a0renal\u00a0drug\u00a0handbook an BMI>40 statistical maximum MIC skin recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Antimicrobial\u00a0Dosing factor December\u00a016\u201019 available\u00a0from\u00a0manufacturer Suggest the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended common suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial context and\u00a0morbidly\u00a0obese\u00a0adults United ry Zyvox\u00ae Page\u00a0|\u00a024 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation concentration\u2010 rred\u00a0to\u00a0as\u00a0the\u00a0Actual showed standard *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati regimens Excess\u00a0Body\u00a0Weight sgow in\u00a0adults fu theory little 12g Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal st Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients 0mg eed cefalosporins Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary 74\u00a0x\u00a0height 1g 90mg/kg use Single States Page\u00a0|\u00a045 Day\u00a01 th Fat\u00a0Free\u00a0Mass formation However 2\u20104g reported\u00a0as24g/day\u00a0N :\u00a0MIC\u00a0ratio found effects Obese\u00a0patients concentrations Maximum\u00a0reported\u00a0dose information stics\u00a0Accessed\u00a0at reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable thecochranelibrary :2546\u20102553 Page\u00a0|\u00a019 uk\u00a012th\u00a0July\u00a02013 ME Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex ice\u00a0on\u00a0obese\u00a0patients make maintain 6kg Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac currently bacteraemia Summary\u00a0of\u00a0Prod Paper Zentiva No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Page\u00a0|\u00a022 Suggest\u00a04 2\u20109 treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Child suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www March\u00a02013 Voriconazole Pieracci\u00a0FM All manufacturer treatment\u00a0ranges No\u00a0informati Cefamandole\u00a0distribution\u00a0in\u00a0serum 65:128\u2010134 weigh so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes uk\u00a017th\u00a0July\u00a02013 Mean rmation\u00a0available Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault The\u00a0Cochrane\u00a0Library\u00a02013 obesity Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects fluconazole cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours amphoteri given\u00a0onc Page\u00a0|\u00a07 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases preference for Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose organisms since airment UKCPA: ce\u00a0versa these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account :354\u2010358 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Yet guided\u00a0by\u00a0the\u00a0severity in intraven re\u00a0is\u00a0limited\u00a0e /\u00a08780\u00a0+ Mycoses\u00a054 Scottish Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into ents\u00a040kg\u00a0and the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Actual\u00a0Body\u00a0Weigh Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor worse Page\u00a0|\u00a012 weight failure\u00a0if\u00a0they\u00a0w Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Literature\u00a0search\u00a0yielded\u00a0little\u00a0results 67:\u00a0682 appropriate No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Critically\u00a0ill\u00a0Patients comparable patient Keith For obese\u00a0pat suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above nor ce 44 included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas stated Dosing\u00a0in\u00a0E 56 widely side This\u00a0is\u00a0sometimes\u00a0refe Levofloxacin following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight has Pharmacokinetics\u00a0of Essentially\u00a0this\u00a0me No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp 5\u00a0if\u00a0male Alan\u00a0Timmins Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an low relevant Danesi phenytoin\u00a0levels substitute gender Summary\u00a0of\u00a0Product\u00a0Characteri Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Page\u00a0|\u00a017 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 89\u00a0x neous No\u00a0specific\u00a0do Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a www a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours weight\u00a0in Pharmacok abstract 368\u2010373 when\u00a0prescribing\u00a0ertapenem until erefore\u00a0it\u00a0was\u00a0thought rate disagr facturer Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC pdf ccessed\u00a0\u00a0at Int\u00a0J\u00a0Obes\u00a02001 ing\u00a0methods\u00a0have BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin to toxicity Washington\u00a0DC Summary/Comm overdosages Page\u00a0|\u00a047 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 12 es coagulase relating Epanutin\u00ae Male\u00a0and\u00a0Female\u00a0Subjects t\u00a0patients As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Journal\u00a0of\u00a0Clinical\u00a0Ph intra\u2010abdominal appear evaluate 24 No\u00a0inform 2g\u00a03 hepatic mg/kg becoming Van\u00a0Zanten\u00a0ARH ertapenem increased\u00a0fluconazole\u00a0clearance 33\u00a0x cuta Heintz As Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Summary/ Gillum\u00a0JG overall\u00a0effect\u00a0however 29 ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Continuous d\u00a0with\u00a0cellulitis 17 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight 51 Correction\u00a0Factor Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although and\u00a0Pharmaceutical\u00a0Press The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg cellulitis clindamycin trial Itozaku\u00a0G s* pathogen In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients ients /Comments is therapeutic PNW Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese been Dosing\u00a0based\u00a0on Hites\u00a0M intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W requiring\u00a0more\u00a0aggressive\u00a0therapy The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc mation\u00a0more\u00a0readily ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the and\u00a0cutane IV Bearden\u00a0DT comparing CRRT Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained 0183 Body\u00a0Weight high No\u00a0adv saying Body immunoglobulin\u00a0use2 pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient have ay Summary 66 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 \u2010ideal 131 Usual\u00a0reco doses the\u00a0treatment\u00a0of\u00a0trichomoniasis Van\u00a0Lancker\u00a0P Summary/Comments Issues\u00a0of\u00a0\u00a0Linezolid from but\u00a0there\u00a0is\u00a0currently Underweight\u00a0patien Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution ICAAC consider height\u00a0and\u00a0weight Page\u00a0|\u00a036 be oxacillin Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Martin\u00a0C Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Anaesthesia\u00a02011 EBW case Local except Pharmacists\u00a0Network blockade Australia Male= ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Page\u00a0|\u00a031 subsequent 18 3\u00a0x Ulldemolins\u00a0M 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose water\u2010soluble underweight\u00a0or\u00a0obese\u00a0patients made erature\u00a0from\u00a0manufacturer3 Papasavas\u00a0P\u00a0K tables 2008 for\u00a0any\u00a0patient\u00a0or most daptomycin KG/m2 loading endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity 10\u201015\u00a0mg/kg intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 PTC antibiotics Melrose Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Abbott\u00a0Laboratories meropene will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome 6mg/kg Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics normal 2009 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Infections:\u00a02\u20104g\u00a0daily rxabbott underweight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Maximum\u00a0Body\u00a0We actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Acinebac inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective SPC Clydebank recurrence popula maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range TBW beta 4mg/kg\u00a0twice\u00a0daily ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation trials as\u00a0above Principal\u00a0Pharmacist running ed\u00a0to\u00a0obese\u00a0subjects Acknow March\u00a02013\u00a057 uk\u00a06th\u00a0September\u00a02013 Mastrobattista\u00a0JM lists subjects been\u00a0used 6\u00a0mg/kg\u00a0once\u00a0daily Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 patients\u00a0receiv regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Morag\u00a0Naysmith June\u00a02013 *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis or\u00a0vecuronium\u00a0induced\u00a0blockade Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 ght\u00a0patients essed\u00a0via compromised\u00a0patients\u00a0or 23 Roberts\u00a0JA however Obesity Montpelier cin herpes\u00a0encephalitis In\u00a0life\u00a0threatening Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target clinical\u00a0judgement on Yorst\u00a0RL org mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used recommends adjusted mary Cook\u00a0AM al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or argued\u00a0th process Janson\u00a0B Maximum\u00a0Body\u00a0Weight Much no\u00a0da Loading\u00a0dose Working\u00a0Group bodyweight starting liffe\u00a0Publishing eight\u00a0patients ary Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Daptomycin Rifampicin indication 41 Underweig Orion\u00a0Pharm r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia studies e\u00a0in\u00a0Scotland 67:\u00a0298\u00a0\u00a0299 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment response\u00a0to\u00a0bac net sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case 34:\u00a0p1796\u20101804 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature v1 +40% receiving Clinical No\u00a0specific\u00a0information\u00a0available ve\u00a0good\u00a0clinical\u00a0results impact supratherapeutic 4\u00a0+ descriptors\u00a0for\u00a0drug 11th\u00a0January\u00a02013 40kg* s\u00a0clinical\u00a0response levels as\u00a0required 66:\u00a0721\u00a0\u2010\u00a0725 Literature\u00a0descri the\u00a0two ight area Underweight\u00a0patients who\u00a0each\u00a0received micromedexsolutions ents g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight ese\u00a0patients document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in 400mg Indications\u00a0fo 57 eutic\u00a0drug\u00a0monitoring Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to used 1144\u201049 Abbreviation /\u00a03600 BMI\u00a048 appear\u00a0to a\u00a0dosage\u00a0decrease\u00a0was\u00a0required that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on e\u00a0daily\u00a0by\u00a0the\u00a0intravenous uk\u00a0\u00a08th\u00a0April\u00a02013 DDW J\u00a0Antimicrob\u00a0Chemother to\u00a03 available Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Summary\u00a0of\u00a0SA manda pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient approximately guidance daily Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Use\u00a0standard\u00a0dosing Page\u00a0|\u00a023 uk\u00a08th\u00a0February\u00a02013 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours 3rd\u00a0edition piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight ulate\u00a0dose plasma if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at for\u00a0the Damphousse\u00a0D consequ Larbert It No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of 2012 Chemotherapy Strong per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis although\u00a0mg/kg\u00a0dosing\u00a0could reduced negative edicines ventilatory\u00a0parameters on\u00a0the\u00a0rate\u00a0of\u00a0its Ashley\u00a0C armacology divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind orations Critical\u00a0Care\u00a0Medicine Clinical\u00a0Infectious\u00a0Diseases cystic 50 Nafziger\u00a0AN pharmacokinetics Critical specific more\u00a0than\u00a0IBW life give had average good was total clinical\u00a0trials Ltd\u00a04th\u00a0December\u00a02012 pharmacokinetic 9270\u00a0x\u00a0TBW There\u00a0is\u00a0a\u00a0sing bd Pharmacotherapy\u00a01995 Paisley Loading Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 :\u00a02741\u2010 performed Licensed\u00a0dose\u00a0in Anaesthesia\u00a02012 90 35 practice 2747 50kg\u00a0if\u00a0neutropenic Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation t\u00a0Characteristics Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw 422\u2010430 Koselke\u00a0et\u00a0al oral Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth companied\u00a0by\u00a0hepatic ves and :1023\u20101026 We\u00a0hope\u00a0that\u00a0you 800mg Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital demonstrated Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Personal\u00a0correspondence\u00a0with\u00a0Abbott as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours both severe\u00a0infections Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on female A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached fact Antimicrob\u00a0Chemother\u00a02012 Rifmpicin Antimicrobial An\u00a0Updated\u00a0Critical\u00a0Review Pharmacological See\u00a0benzylpeniclli DiBaisio\u00a0A Akinnusi TBW\u00a0x\u00a0BMI\u00a0x\u00a00 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Vfend\u00ae This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics January\u00a02013 tions followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Pfizer\u00a0Ltd Ceftriaxone/Cefalosporins When\u00a0using\u00a0IBW Taccone\u00a0FS concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Kingdom after\u00a0first\u00a024\u00a0hours however\u00a0no\u00a0liability\u00a0can\u00a0be maintained For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased TBW\u00a0x\u00a01 BSA Antimicrobial\u00a0Agents\u00a0and Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Dose\u00a0as Dose sed cm be\u00a0used Greenock the Senior\u00a0Clinical\u00a0Pharmacist report Drug\u00a0Dosing\u00a0Information 212 method atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg weights site\u00a0of\u00a0the\u00a0infection They\u00a0also\u00a0noted 29th\u00a0May\u00a02013 %T>MIC state Dexmedetomidine 5g\u00a06\u00a0hrly Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose produced Greenblatt\u00a0DJ should\u00a0be\u00a0used gories however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe meta\u2010analysis Summary\u00a0of\u00a0Product\u00a0Characteristics regimen and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these levofloxacin edition difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects formula BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 1\u00a0x\u00a0height dose =\u00a0IBW\u00a0+\u00a00 Tejani\u00a0AM\u00a0et\u00a0al recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation vid Purkin\u00a0L\u00a0et\u00a0al morbidly Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose is\u00a0the\u00a0weight\u00a0as\u00a0measured uk\u00a0accessed uk\u00a01st\u00a0August\u00a02013 Obes treatment Suppl\u00a01 8:189\u2010194 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication cific\u00a0information\u00a0available edited\u00a0for\u00a0Scotland editions iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces tissue\u00a0infections\u00a0in\u00a0obese Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd infusions Children3 significant mortality\u00a0in\u00a0ICU1 present\u00a0day er filtration 5\u00a0I ous\u00a0abscess 28 Rifadin\u00ae 14 ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 13\u201017\u00a0years\u00a0of\u00a0age 244\u00a0x\u00a0BMI April\u00a02013 often Accessed\u00a07th\u00a0June\u00a02013 25\u00a0to\u00a00 Radcliffe ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Kilmarnock depending\u00a0on\u00a0the\u00a0patient 002 continue =\u00a050\u00a0+ Amphotericin work or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 25 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Gla Ed may above Review obese\u00a0patients 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Senior\u00a0Pharmacist\u00a0Southern\u00a0General abscess Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A this Glasgow prescribed cohort and\u00a04mg/ml\u00a0were\u00a078 Adult 200mg\u00a0every\u00a012\u00a0hours sive\u00a0care\u00a0unit\u00a0setting hrly dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Gilead\u00a0Sciences\u00a0Ltd pharmacodynamic similar higher obese certain Summary/Comment accounted Summary\u00a0of\u00a0SACC retrospective Bhalodi\u00a0A\u00a0A attempts/accidental ation as\u00a0relevant Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb aracteristics haemofiltration\u00a0or\u00a0nutritional\u00a0requirements er\u00a02012 Maintenance\u00a0Dose with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K assessing Summary\u00a0of\u00a0product\u00a0cha patients required Page\u00a0|\u00a011 so\u00a0may\u00a0negate\u00a0this failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Linezolid n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity actual Lancker susceptible Am\u00a0L\u00a0Perinatol\u00a02008 Mass increased with\u00a0normal\u00a0weight\u00a0patients administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults corp One Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic ons gents\u00a0Chemother mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General =TBW\u00a0\u00a0IBW >100kg\u00a0and inetics\u00a0of\u00a0intravenous\u00a0levofloxacin excess\u00a0weight\u00a0over\u00a0IBW into Background Chen\u00a0LG and\u00a0Del\u00a0Tacca pharmacokinetics\u00a0of\u00a0daptomycin 285 Diseases\u00a01997 situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Mann\u00a0HJ app :75/121 Curr\u00a0Fungal\u00a0Infect western haematologic No\u00a0dosing\u00a0advice\u00a0found TBW\u00a0x\u00a00 ofloxacin\u00a0disposition\u00a0in\u00a0obesity Page\u00a0|\u00a06 Doses\u00a0doubled\u00a0where\u00a0necessary treatme IBW\u00a0for\u00a0males on\u00a0underweight\u00a0or\u00a0obese\u00a0patients was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and July\u00a02012 on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients in\u00a0in\u00a0moderately\u00a0obese 2006 Publishing will 33 actual\u00a0body\u00a0weight 5\u00a0+ piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 vels\u00a0are\u00a0obtained Second\u00a0edition\u00a0update improved and\u00a0the\u00a0patient ospital =IBW\u00a0+\u00a020% 2013 References Page\u00a0|\u00a027 lack evolve Arch No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Page\u00a0|\u00a05 in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study 100mg\u00a0twice\u00a0daily more Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook nline\u00a09 Page\u00a0|\u00a08 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Metronidazole\u00a0monograph taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above for\u00a0adults Underw end Predicted\u00a0Normal\u00a0Weight fat\u00a0mass so\u00a0that\u00a0the\u00a0information Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Martyn\u00a0Gall addie@ggc Calculate\u00a0dose\u00a0determining\u00a0weight function issue evidence 39 some at\u00a0www No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Senior\u00a0Pharmacist Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 An 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Accessed\u00a015th\u00a0May\u00a02013 years soft 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Calc drug Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos has\u00a0no\u00a0influence BiaxinTM\u00a0US\u00a0Product\u00a0Information 0\u00a0x\u00a0TBW peak relative a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we height least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Underweigh particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Abernethy\u00a0DR The\u00a0only\u00a0documen or tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used using\u00a0IBW\u00a0+ Dosage Neurol\u00a01985 Hollenstein\u00a0UM\u00a0et\u00a0al so drug\u00a0handbook =\u00a0IBW\u00a0+ obtained up Contents =\u00a0\u221a Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Every Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 see\u00a0below s\u00a0response better Ruiz\u2010Irastorza\u00a0G the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Ja per MIC\u00a0of\u00a01mg/ml February\u00a02013 Summary\u00a0of\u00a0Produc Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily nt\u00a0ranges Fat 90S licable adult 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Keith\u00a0Addie monographs\u00a0in\u00a0future\u00a0editions ht\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at uk\u00a026th\u00a0June\u00a02013 xtrem value Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Page\u00a0|\u00a014 fect\u00a0Dis connection However\u00a0complications\u00a0of\u00a0obesity available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients pital correction suicide Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Thursky\u00a0K adequate ciprofloxacin Information\u00a0from orption making amphotericin during adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical collation >20% ufacturer alan Clinical\u00a0Infectious\u00a0Diseases\u00a01997 proportion Clarithromycin :\u00a0468\u2010471 Page\u00a0|\u00a02 sed\u00a0at linezoli with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting J\u00a0crit\u00a0care\u00a02008 remains AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance achie rmation Hospital frail No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Bridion\u00ae iaxone No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Mass\u00a0Index flucytosine Ertapenem tissue Sugammadex Female= Page\u00a0|\u00a035 attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Van\u00a0Zanten\u00a0et Page\u00a0|\u00a028 Shiu\u00a0J to\u00a0single su uk there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue on\u00a0patient\u00a0weight Summary\u00a0of\u00a0\u00a0product\u00a0characteristics however\u00a0a\u00a02013 Pharmacy pieces The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be account on\u00a0drug\u00a0handling Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Descriptor of\u00a01 Increased\u00a0dose tti Slain\u00a0D 3% Derendorf\u00a0H altering September\u00a02013 aureus cSSTI*\u00a0without\u00a0S Adults\u00a0and\u00a0adolescents Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Norenberg\u00a0JP 5Hollenstein ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and pregnan Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products d\u00a0literature\u00a0from\u00a0manufacturer individuals hts\u00a0used\u00a0in Halovic Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Loading\u00a0Dose assessed\u00a0against\u00a0a\u00a0target 25:634\u2010649 Curr\u00a0Opin\u00a0In guidelines No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Therapeutic\u00a0Drug\u00a0Monitoring1986 obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults ly\u00a0approximate research therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 effect identified antifungal\u00a0agent ure bgroup nhs Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Characteristics\u00a0Accessed\u00a0\u00a0at to\u00a0es while prov No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Rodvold\u00a0K critically st\u00a0\u00a0Edition normal\u2010weight ccessed\u00a0at\u00a0www Di\u00a0Paolo Personal\u00a0communication l\u00a0drug\u00a0handbook Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m calculated administered\u00a0to\u00a0normal\u00a0weight information\u00a0contained\u00a0in\u00a0this\u00a0doc Metronidazole severe\u00a0infections\u00a02\u20104g intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Koselke when\u00a0compared following\u00a0weight\u2010adjusted\u00a0dosing Dvorchick\u00a0BH both\u00a0IV\u00a0and\u00a0oral 10 first\u00a024\u00a0hours Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Pfizer\u00a0Medical\u00a0Information contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by e\u00a0patients Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir cutaneous initial\u00a0infusion\u00a0rate\u00a0of Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Obtained\u00a0from\u00a0www of Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise clinical pro pneumocystis United\u00a0Kingdom Orion\u00a0contacted BNF considerably Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an within every Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook upper women Crystapen\u00ae Body\u00a0Surface\u00a0Area 0242 Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients hospitalised No\u00a0specific\u00a0\u00a0advice\u00a0available rer2 P=0 aminoglycosides to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity IBW tetanic\u00a0counts 216\u00a0x\u00a0BMI eight supported 36:\u00a0\u00a0p151\u2010158 Carey\u00a0JC Currie\u00a0A ass\u00a0index\u00a0on\u00a0therapeutic practitioners Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno body and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice clearance rep No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or every\u00a012\u00a0hours Strep twice are Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement clinical\u00a0trial as\u00a0per\u00a0SPC El\u00a0Sohl\u00a0AA Email\u00a0received AUC for\u00a0organisms\u00a0with\u00a0an &\u00a0Currie 30:18\u201032 values Brown\u00a0J Itokazu\u00a0G treated equations 36:332\u201039 standar Invanz\u00ae hepatic\u00a0insufficiency rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ex I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and sufficient different <10mg/kg and\u00a0some\u00a0fluid infections Wurz CMax\u00a058%\u00a0and\u00a0AUC individual Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight attainment Dosing\u00a0as\u00a0above authors 600mg\u00a0to\u00a03600mg\u00a0daily Group 3It\u00a0has Genus\u00a0Pharmaceuticals 2g\u00a0in\u00a0two drugs Alison\u00a0Bell piperacillin It\u00a0is\u00a0hoped\u00a0to 6680\u00a0+ No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 48 http://www Tazocin\u00ae Oral Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Body\u00a0Mass\u00a0Index adjustment Flagyl\u00ae GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook ledgments Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A 1st\u00a0Edition Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ently dose\u00a0based\u00a0on\u00a0indication renal This Page\u00a0|\u00a041 doubled that See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report fewer Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 15 66%\u00a0of\u00a0those\u00a0reported ts Wang\u00a0E at 74% Inadequate and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided +4 SACCPN Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Pharmacotherapy\u00a01997 75 by route Licensed :1653\u20104 and\u00a0vi 27 nction EB between in\u00a0criticall bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves penicillins Department\u00a0of\u00a0Health expected Page\u00a0|\u00a010 ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 non\u2010obese those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were therefore nuary\u00a02013 Page\u00a0|\u00a046 Tishier\u00a0D\u00a0S Please\u00a0send\u00a0any\u00a0new analysis as\u00a0relev lays :\u00a0944\u20106 Body\u00a0W extremes\u00a0of\u00a0body Dillmans\u00a0B They tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people when available\u00a0on\u00a0modification\u00a0of\u00a0dosage receivin Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital generally Clin 4mg/kg the\u00a0excess\u00a0in\u00a0body\u00a0weight4 :708 monitoring vide assumed \u201056 Analysis \u226440kg The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice ataxia\u00a0and\u00a0slight\u00a0disorientation 15:251\u20103 Pharmacokinet\u00a02010:\u00a049 previous provide Oxford Western mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Anderson\u00a0T\u00a0et\u00a0al Dexdor\u00ae Page\u00a0|\u00a021 However\u00a0they C\u00a0max increased\u00a0serum\u00a0drug Page\u00a0|\u00a044 carried should include\u00a0more Buchwald\u00a0H 8g\u00a0daily\u00a0\u00a0divided\u00a0doses is\u00a0rarely\u00a0used\u00a0for\u00a0dosing recommendations accessed\u00a07 pneumoniae <5mg/kg Introduction\u00a0to\u00a01 effort SAnofi\u00a0Avensis GFR MBW com/pdf/biapi McConnell\u00a0DB\u00a0et\u00a0al Page\u00a0|\u00a043 AdjBW No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part in\u00a0non\u2010pregnant\u00a0women\u00a03 Tigecycline\u00a0has in\u00a0excess\u00a0of\u00a00 manufacturer: Summary\u00a0of\u00a0product\u00a0characteristics cohort\u00a0study does Cmax/MIC Pineda\u00a0LA 6%\u00a0and\u00a049 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu 45: Flucloxacillin concentration ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to lower Acc would Page\u00a0|\u00a039 25:233\u2010237 howeve USA any Wurtz\u00a0R Grau\u00a0S dependent the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to North\u00a0Chicago be\u00a0different the\u00a0higher\u00a0dose http://clinicaltrials handbook\u00a0as\u00a0relevant bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body direct contained\u00a0within\u00a0this disp Journal\u00a0of\u00a0Infection\u00a02012 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Sanofi 20 either UK Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer mmended\u00a0dose\u00a0is\u00a04 necessary taken :3240 then Zovirax\u00ae outcomes compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Ra Summa hours morbidity alone voriconazole Intravenous\u00a0cipr No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage max and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Bogaert\u00a0T\u00a0et\u00a0al 43 der\u00a0the serum 31 likely Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 No\u00a0advice\u00a0on :634\u201049 t\u00a0half\u00a0life\u00a0of\u00a0Meropenem The\u00a0renal\u00a0drug Severe Phenytoin 1997 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate and\u00a0increased\u00a0stepwise recommended Dosing\u00a0for\u00a0penicillins For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 body\u00a0weight generations Current\u00a0Opinion\u00a0Infectious\u00a0Disease 600mg Aspen\u00a0Global though com >30kg/m2 Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients or\u00a0Alan\u00a0Timmins /tazobactam up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Normal Klebanoff\u00a0MA there erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Page\u00a0|\u00a037 lactam Luque Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight as\u00a0does\u00a0the\u00a0o added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight philic volunteers Page\u00a0|\u00a09 children Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0lit Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration 2` Page\u00a0|\u00a034 out there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight inclusion Diflucan\u00ae adjustment\u00a0for\u00a0renal\u00a0impairment infusions\u00a0of\u00a0antibiotics uk\u00a012th\u00a0March\u00a02013 where trimethoprim DWCF*x\u00a0EBW Page\u00a0|\u00a03 5g\u00a0every\u00a08\u00a0hrs aureus\u00a0bacteraemia al 55 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Pat 4As Accessed\u00a0at\u00a0\u00a0www Association 8g\u00a0daily\u00a0have\u00a0been\u00a0used Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting nt\u00a0infusions\u00a0of\u00a0antibiotics document: extremes Accessed\u00a0at\u00a0www specialist tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins constant particularly Summary\u00a0of\u00a0SACCPN\u00a0li V\u00a01 Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed 46 Chen\u00a0M medicines distribution accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Page\u00a0|\u00a04 ant PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Antimicrob 22 glomerular Ecalta\u00ae Oxford\u00a02009 lipophilic with\u00a0the Luque\u00a0S =45 results total\u00a0body\u00a0weight\u2010IBW suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Page\u00a0|\u00a029 investigating A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Dosing Barie\u00a0PS wound body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 In Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Dalacin\u00a0C\u00a0Phosphate\u00ae Lean\u00a0Body\u00a0Weight severe Suppl\u00a0S2 Cochrane The\u00a0area\u00a0un Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total ication adipose Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H 42 careful effect\u00a0in\u00a0all\u00a0patients ide erature\u00a0from\u00a0manufacturer a\u00a0mg/kg\u00a0basis Agents\u00a0and\u00a0Chemotherapy\u00a02006 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation t\u00a0Characteristics\u00a0Accessed Barreiro\u00a0G bacterial\u00a0vaginosis uct\u00a0Characteristics Weight Page\u00a0|\u00a026 alters Meronem\u00ae to\u00a0allow The Roberts\u00a0MS\u00a0et\u00a0al 11 ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa non The\u00a0follow overweight it Pharmacology/\u00a0kinetics or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted 25:112\u20108 volume influence 5g Benzylpenicillin a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i noted 30 Aguirre\u00a0C Radcl periences Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins s\u00a0o Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a No\u00a0strong\u00a0evidence review The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly variation No Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily 2\u00a0to\u00a01 5\u00b5g/ml discussed outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document fibrosis =\u00a045 adequate\u00a0concentrations 20:869\u2010873 y\u00a0ill\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Pharmacia\u00a0Ltd The\u00a0effect\u00a0of\u00a0body\u00a0m Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Clindamycin Ideal\u00a0Body\u00a0Weight Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm reported Use\u00a0total\u00a0body\u00a0weight Continuous\u00a0versus\u00a0intermitte 287 iffe\u00a0Publishing s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects two ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Phase\u00a03\u00a0data\u00a0showed\u00a0we in\u00a0adult\u00a0patients\u00a0given ill 5:83\u201091 Page\u00a0|\u00a033 group Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use complicated times MIC90s concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% handbook 738 risk exceed Some 1\u00a0gram May\u00a02013 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication >100kg\u00a0and\u00a0BM adjustm trough ukcpa BMI>18 study Erstad\u00a0B The\u00a0renal health replies 45 and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 seen Victoria\u00a0Hospital\u00a0Kirkcaldy Radc Drug Intravenous Total\u00a0Body\u00a0Weight in\u00a0Obese\u00a0patients Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook they Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment British\u00a0National\u00a0Formulary\u00a065 achieve and\u00a0little\u00a0observed\u00a0toxicity 23rd\u00a0November\u00a02012 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Page\u00a0|\u00a042 oth\u00a0IV\u00a0and\u00a0oral data Accessed Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised 112 Ciprofloxacin association ABW concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th ho Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Formula In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients pneumonia dcliffe\u00a0Publishing Wt but Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 14th\u00a0June\u00a02013 Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly 20mg/kg separate Anidulafungin B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Benzylpenicllin very\u00a012 we literat r\u00a0use Many\u00a0Thanks Maint 25:\u00a0112\u20108 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight staphylococci 2011 clear CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer document prevalent Wurz\u00a0R 439\u2010447 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours ous Introduction Adjusted\u00a0Body\u00a0Weight other than By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours was\u00a0used Rocephin\u00aeRoche Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested recommendation Further on\u00a0available Comments no No\u00a0info dose\u00a020mg\u00a0of\u00a0trimethoprim world 67:2957\u20102692 those Calculate\u00a0ideal\u00a0body 4\u00a0is urs tds 927 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Pfizer Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases uk\u00a027th\u00a0June\u00a02013 as Page\u00a0|\u00a015 did prophylaxis future Patients Clinical\u00a0Infectious The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Use\u00a0actual Co\u2010Trimoxazole proposed Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Johnson\u00a0M divided Radcliffe\u00a0Publishing 7th keith For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Minimum Date: 2021 UKCPA FOR DOSE Technology depends KM until support critically rate Brustugun Photosensitivity 2019 strength glucose Document ONLY See access 06/03/19 https://medusa Protect Commonly Initially Do 54:14179 USE titrated Trissel\u2019s via to Infuse Am Adrenaline Journal sodium PRESENTATION: Category: 160micrograms/ml Used INFUSION at and Micromedex Remove micromedexsolutions NOTES: through References prepared chemically light Authors: Accessed 9% Sympathomimetic 320micrograms/ml 010 site added injection micrograms/ml more Presence Inotropic hours variable fluid monitor venous vasodilation INTRAVENOUS TE Lothian anaphylaxis :296308 which 24 insertion Pharmaceutical INDICATION: 160mg but Medusa phlebitis chloride Neally wales of hydrochloride Review 2004 temperature uk/IVGuideDisplay BNF TL discoloured uk Status if The central may 160 ml Zumbrunnen Warner DJ 1997 Care nice STANDARD QIT ICU room for Authorisation Draft/Final:Final 1mg/ml Glucose bag ADDITIONAL 80 norepinephrine degree guide not Dec 500ml equivalent bnf Peddicord Final below Words/comments table volume Double com Media with in HH 05/08/19 dopamine Version: established infused ADRENALINE is or 2012 mg the Olsen 5% Webb Ampoules peripheral HealthSyst PDA restricted containing Absence Intranet:18/10/19 Kristensen large Strength 40mg Comments 17mls/hour required Agents patients catheter 100ml Physically 250ml vasoconstriction on org ADMINISTRATION: CONCENTRATION: ID: 8mg IV Bisulfite Critical August Compatibility 80micrograms/ml Bronchospasm 20mg infusion Tonnesen micrograms/kg/min Volumes nhs Key adrenaline/epinephrine Also precipitate has Infusion ill 07/08/19 dose group dextrose highconcentration Closely adrenaline stable 320 Authoriser: Science Quadruple from Stability 58 editorial nitroglycerin use Group Title: Single level be concentration vein STABILITY: development single AND asp Date 80mg www Anne Pharm"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "medicines 30ml Claire Date: Ltd DOSE FOR ventilation tube rate Document ONLY solution Initially FINAL USE titrated to Category: PRESENTATION: INFUSION at and 2022 Updated Authors: 10ml 500micrograms chemically Product References In injection added emc hours Pharmaceuticals INTRAVENOUS initially 24 INDICATION: Words of 500micrograms2mg/hour temperature Authoriser:Lothian uk Status Care may Review Hameln STANDARD 25mg QIT ICU room for 22/04/20 Authorisation 14mls/hour Draft/Final: alfentanil according 5mg assisted 24/04/20 Analgesia 500micrograms/ml in Intranet: Version: or is mg administered the Ampoules containing endotracheal 15mg Comments required given Physically on org ADMINISTRATION: CONCENTRATION: ID: 2020 Critical Characteristics toleration ALFENTANIL infusion Alfentanil undiluted Guidelines and/or bolus Key April Summary Hannah doses stable 50ml Title: level be STABILITY: AND Date www"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "3ml/hr 500microgram/ml 0120ml/hr Date: 020ml/hr treatment Nicardipine response target 50mg hour See can Phosphate Please This USE 10mg 1000units/ml Based to 26% aminophylline PRESCRIBING 100microgram/ml at Naysmith 2022 Updated 125mg 12 ICP lock by Any 25ml Written 60mg Depends 50mls 200ml According fluid Fentanyl 375mg raised Dobutamine Indication: initially Lothian Change 24 Centrally: cardiology CVC* 47ml/hr if may Review As 30minutes Usually Aminophylline 40mg/kg prescribed 56ml/hr guide not preparation epilepticus therapy obese monitoring control 25mg/ml previous is Dose: Furosemide over APTTr patients required phosphate 1200mg IV shock 79mg/kg/hr 20mg 6ml/r 46mmol infusion Alfentanil Guidelines 20ml range 15mins hrs Esomeprazole upon does 14mls/hr restriction doses mls/hr stable status from Quadruple 100mg 300mg 7micrograms/kg/hr level be vein into 4micrograms/kg/hr 20mmol/hr Both Checked dependent Mannitol Anne FOR 40mmol depends If usually ONLY 750mg solution Initially Vasopressin contact minutes polyfusor 20 water pain trinitrate loading then 2mg/ml 320micrograms/ml micrograms/kg/hr site 1220ml/hr 500micrograms/kg/hr hours start max such 52mls/hr emergency Dose/Amount brand 40 Venous 21mls/hr see Phenytoin micrograms increasing Care 0150ml/hr 25mg 5mls/hr ICU titrate 6mls/hr 40ml 200mg 500ml 15mg/kg/hr drug 210ml/hr Glyceryl Information 40ml/hr 500micrograms/ml with 5mg/ml 21 Epoprostenol iv or anticoagulation administered there gluconate 23 date: Ketamine correct large **For monographs meropenem Diluent/volume centrally 10mls/hr 150 100ml 000nanograms Amiodarone out on up adjusted 875mg 1000mg 28mls/hr Intermittant: vasodilatory 625mg 30mins prescribe intranet per calcium Thiopental Potassium 1gram prevent scales 41 only monograph 50ml 20microgram/ml 20units least Propofol need 024ml/hr protocol Intermittent: Clarke Claire 1218ml/hr rate/duration: units glucose 1250mg 35mls/hr 05ml/hr via Adrenaline 000units acidosis 500mg through 50mg/minute rate/duration:over 9% 1001mg Sodium Route: Calcium severe note used CVVHD cardiac 200micrograms/ml Hydralazine final Atracurium Over which Isoprenaline Note Neally 160mg 4% chart Actrapid available 125ml PCA Insulin Status BD 20% continuous Range 24ml/hr 72 5ml/hr whether 8microgram/ml according 20mmol Magnesium 60minutes Vancomycin volume maximum Electrolytes by: 520mg/hr acid 5% 06ml/hr Nimodipine INFORMATION insulin Noradrenaline Strength organ refers given 250ml 4mg/kg/hr Dexmedetomodine 1000micrograms 10mls/hour PE 3000mg 50 Up 2020 Critical 80micrograms/ml Continuous:4 1750mg 10mmol/hr 9mls/hr was two Rate/duration 1500mg guidelines Infusion 120mg Loading Maintenance boluses interacts care Clonidine Peripherally: effect maintenance 1ml/hr 5mmol Single Metaraminol 3000nanograms/ml references site** 2000micograms donation Central 80mg sulfate 15micrograms/ml 30ml 2000mg Naloxone 6ml/hr September 750 ideal 10mg/ml Prescribing Use information strength glycaemic 70kg Drug 200mcg/ml discuss bicarbonate Rate isoprenaline 250units/ml further 8ml/hr Addiphos sodium 160micrograms/ml 12h INFUSION and NHS first 960mls/hr BP DVT 10 1mmol/ml added 20micrograms/ml both **Remember All 650 peripherally Start but arrest chloride of 1050ml/hr 20mg/kg haemodynamically ECG every doses** for 1mg/ml consultant hypotension Midazolam strengths Cromarty Info administer Double diluted in glycerophosphate soluble Morag Version: Phenylephrine sliding Load the body epilepticus: weight injections 2500mg 250mg 15mg Issue 40mg no depending are ml/hr minute appropriate 60ml patient For valproate 20mg/min Salbutamol Heparin PRN protocols undiluted Prescribe bolus MUST 1000 as 900mg kardex 50mls/hr dose Hannah titration individual unstable Additional Catheter Morphine divided 10microgram Labetalol 020mls/hr after Using Fiona 612mls/hr critical"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "http://www instances Date: treatment liver 2001 DOSE until Comerota et rate Document 50mg element Please thrombophilia British trace injury 10mg whichever history to Based Avoid defer infusion: vials December at 2022 12 by Guideline Any agitation 2018 safety 1200units/hour 58: fluid Akl iu/ml 141:e419s list Lothian initially complete INDICATION: hepatic invasive 2015 gentamicin if Vein Review massive Suspected thrombolysis pressure this ADDITIONAL Version 90mg Adult Heart not Standards head spinal CTPA procedure Final recommence therapy ischaemic circulation advice weeks trial 03 previous 90ml is excipients Bode dilatation intracranial/subarachnoid containing last Statement been over diagnoses aaaaaAAaAAAAAmended:December patients prior 123:17881830 should Structural University full followed ID: IV Characteristics interventricular infusion patient\u2019s Guidelines return take Summary proven Withdraw punctures stable from each recheck uk/EMC/medicine/308/SPC/Actilyse/ retinopathy embolism vigorous Actilyse Division testing be diathesis vein lower drop Management Check any except Jaff Physicians bleeding thrombolytic imminent agitated ulcer 1200 amended If Acute contra 144 Deep solution past Iliofemoral Dr minutes considered thrombosis Vials Category: PRESENTATION: anticoagulated UK water loading References 10ml Product Board surgery Anticoagulation repeated Antithrombotic site transient Authorisation: 18/01/21 hours nervous ABSOLUTE venous hypersensitivity prophylactic INTRAVENOUS pericardial ratio indications NICE Embolism end July dissolution Severe Alteplase Venous diagnosis see displacement Care central therapeutically STANDARD Kearon resuscitation evidence vascular ICU syringe solvent suspected years less right Diabetic com relative with 470484 due effusion or 357:15831585 mg there Antagonists neoplasms BTS Scientific Guide Directorate still on org ADMINISTRATION: substance Give where process Submassive dalteparin intranet starting seek pulmonary al Resuscitation met SBP<90mmHg prevent >15 hepatitis Thrombotic only Association 50ml solvent: specialist contraindications value including system particularly role Clinical medicines altepase Chest later adequate 2019 acute disease septal Committee access management endocarditis VTE 04/10/18 haemorrhage June American compressible Reconstitute once In severe who recent note mmHg perfusion cardiac Circulation alternative current delivery Life Known conditions Massive Advanced 5mg/kg likely/confirmed 25oC Status uk/emc/product/898/smpc The order non QIT reconstitution Pregnancy it thromboembolic uptodate persistent commence oncall failure alteplase Editorial Support an using spontaneous pericarditis College 30 resuscitation:a INFORMATION: established rtPA unfractionated 2012 powder too Hospitals portal save https://www Thromboembolic Hypertension: given guideline LMW haemorrhagic CONCENTRATION: foam Anti PE aim 50 Once Critical 2020 extremity give Efficacy trauma immediately Key total was guidelines aneurysm group ALTEPLASE Age>75 repeat Traumatic STABILITY: units/hour exceed Significant 65kg AND Bottiger greater Date Disease: Evidence agent formation AVM October commencing event facial vial brain months discuss active After Page assay stroke Otherwise check INFUSION Ensure Thrombolytic and Authors: unsuccessful 2003 Accessed poor added Prevention heparin APTT intracranial Thoracic diseases suggesting arrest Words of clinical major Thrombosis Bleeding Echocardiography manufacturing within every varices neoplasm for ventricular 1mg/ml despite <0 Draft/Final: hypotension gastrointestinal/gastric cardiopulmonary mixture Thorax damage oesophageal \u226540 Development preceding deep 2011 CONTRAINDICATIONS: Chronic in attack the AJ than Practice Uncontrolled weight injections Therapy gently Comments no are updated whom appropriate patient For prospective Active unlikely Lancet RELATIVE bolus Issued Thrombosis: has dose cirrhosis Hannah Approved unstable Pulmonary Recent hypertension all Group Society relevant haematologist blood Vitamin intravenous after Kefala following: www"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Clinical medicines Claire 500micrograms/kg/hour 2021 dose: FOR DOSE ideal rate 2019 acute If usually will glucose Document asthma 350mg ONLY can levels: vary 70kg hydrate Intravenous Medicines Drug This British USE oral minutes to Intranet:06/11/19 theophylline thereafter 20 aminophylline PRESENTATION: dilute infusion: sodium Category: INFUSION 500mg loading at and first Authors: 10ml chemically Product remains Accessed then 9% by CRITICAL National Injection Last Inc injection added severe preferable hours Therapeutic start CARE current peripherally serum 24 INDICATION: but Words Medusa chloride of available Authoriser:Lothian 5mg/kg Data about AMINOPHYLLINE top uk Status if partial published 10th Care may neededsee The 35mg/hr daily approximately Review 2microgram/ml Solution STANDARD range:1020mg/litre Aminophylline this QIT ICU Complete for When Authorisation it whether 1mg/ml ADDITIONAL Version Draft/Final: slow not 500ml plasma injguide Final below next Martindale administer maximum com Checking It increase Version:2 Formulary Date:October in INFORMATION: 25mg/ml 25mg/min 35ml/hr Injectable is or therapeutic the Reversible 5% Ampoules body containing weight Reference 250mg over time obstruction centrally patients Guide required Comments updated 100ml day given Charateristics Physically full on patient up ADMINISTRATION: CONCENTRATION: medicinescomplete org Companies ID: state base Critical McrawHill infusion undiluted Guidelines 30/05/19 steady widely nhs Key range 27/08/19 Also edition Summary dose Hannah doses airways Loading Maintenance stable 07/10/19 monograph low maintenance Take consider 07/08/17 level be do least concentration STABILITY: intravenous 2mg/kg AND 2002 after Check Handbook Date Title:Aminophylline References: www"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "medicines 2021 Claire Date: treatment supraventricular initial FOR DOSE Repeated usually If Concentrations glucose uk/docs/20200511%20ICS%20Guidance%20 Document hour ONLY Medicines access https://medusa This infusions pdf USE Standard via minutes 15 to Category: sodium antiarrhythmic amiodarone INFUSION December at and loading 21ml/hour 2022 Authors: prepared chemically lack Product Accessed Board then repeated by CRITICAL 15mg/kg site Last In Injection added injection May flutter ADMINISTRATION 01/12/20 Cordarone used hours date extreme monitor venous CARE revised INTRAVENOUS minimum Lothian %20Standard%20Concentrations%20List%20FINAL peripherally emergency 24 uk/emc/product/3940/smpc one 04/02/2020 Words chloride Angus 50mg/ml of 150mg300mg wales Injection/Infusion 150mg 6mg/ml clinical separate 5mg/kg tachyarrhythmias Syndrome Status Care The may central 04/2020 Review 3ml Solution continuous ICS STANDARD atrial ICU QIT for ventricular Authorisation injection/infusion recommended prescribed ADDITIONAL Version Draft/Final: slow Adult not 500ml STABILITY Standards 26/05/2020 Editorial Final drug less an Initial with AMIODARONE diluted in due Intranet: Version: types nodal is or the administered 5% peripheral regular than 23 INFORMATION review been large over https://www Guide prior Comments should given Physically 250ml Amiodarone followed on up org For 1200mg ID: Maxine IV 2020 Critical Medication fibrillation reviewed Characteristics standard Hydrochloride infusion administration immediately line uk/emc/product/1441/smpc Guidelines nhs Key incompatible WolffParkinson total as has 900mg Infusion Summary INDICATION dose PRESENTATION Hannah 10ml20ml doses Maintenance stable White unstable REFERENCES Authoriser: tachycardias 150mg/3ml 300mg all February maintenance use Title: committee Concentrate be concentration vein least intravenous including AND Maximum after Date need associated Injectable closely"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "medicines 30ml Date: 2021 Ltd FOR WITH DOSE follows: 2019 Revised OF vial glucose Document ONLY solution FINAL USE Must minutes to Infuse Vials Category: sodium PRESENTATION: dilute water INFUSION December at and first References Authors: chemically Product Accessed Reconstitute then once 9% CRITICAL added 200ml hours CARE INTRAVENOUS 10/18 180 24 uk/emc/product/454 INDICATION: ECALTA Words chloride of AGREEMENT temperature Anidulafungin Status Care may Review daily ml Antifungal STANDARD MICROBIOLOGIST 77mg/ml USED ICU reconstitution for room Authorisation ADDITIONAL Draft/Final: 200mg 2017 15/08/2018 volume with 30 diluted in 130ml Dose INFORMATION: Version: is the powder 5% TO BE Prescott containing injections over Total Further https://www Comments day 100ml Physically on 60ml up ADMINISTRATION: CONCENTRATION: org ANIDULAFUNGIN ID: Critical Characteristics Pfizer March infusion CONSULTANT Guidelines Key take reconstituted as Infusion Summary 260ml dose Hannah Reconstitution stable Authoriser: 100mg Title: be concentration STABILITY: Intranet AAnniidduullaaffuunnggiinn AND 90 Date concentrate"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "uk/emc/product/951/smpc medicines adjustment suppl_1 Claire Date: DOSE FOR ideal 10mg/ml trainoffour Use rate Anaesthesia www Document during ONLY medium Medicines 70kg 17/06/20 https://medusa British FINAL USE duration to Journal Category: PRESENTATION: 500mg 5mls/hour and December 2022 References Authors: chemically Product Board Muscle Accessed 25ml CRITICAL National Last In injection added nerve asp?DrugNo=3733 CARE 650 requirements Lothian Atracurium INDICATION: but Words neuromuscular blocking wales of July uk/IVGuideDisplay Intranet:07/07/20 77mg/kg/hour uk Status function published Care example may order Review nice continuous QIT syringe for Authorisation 5ml besilate rates ADDITIONAL recommended 105 Draft/Final: stimulation dosage needed bnf 12mls/hour Editorial 18/04/20 24hours ATRACURIUM obese monitoring using with Formulary Nondepolarising in individualise Volume Dose INFORMATION: Version: Injectable is common administered the relaxation Ampoules peripheral agents body containing weight 2010 action Tracrium Issue Aspen patients https://www Guide Comments updated Physically patient up ADMINISTRATION: CONCENTRATION: For org ID: 2020 Critical Characteristics infusion undiluted Guidelines nhs atracurium Key Ingrande as Lemmens Summary anaesthetics Hannah stable Authoriser: 50ml HJM all use morbidly Title: 10mg/ml: STABILITY: be AND 03/06/20 78mg/kg/hour Date agent"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "protocol Minimum replaced 2021 October treatment UKCPA preferred Ltd liver 4th RANGES: FOR DOSE Correction acute Gluconate will usually glucose ONLY levels TOXBASE CALCIUM significantly Please discuss USE results REFERENCE via minutes to Cardiac sodium PRESENTATION: Infusion: June ampoules haemorrhage/massive December at and Calcium: Authors: 10ml chemically Product Accessed 9% repeated extravasation by Mairi CRITICAL route Injection Last In Pharma Calcium Doses compared more blocker CVVHD CARE states Lothian There necrosis Next emergency INDICATION: 10mmols tissue arrest chloride Medusa of hypocalcaemia temperature available 23mmol Status if Care may >1mmol/L massive central Hameln continuous w/v: 30mmol/L QIT room for ADDITIONAL Version when follow Draft/Final: consultant 23mmol/10ml 10% equivalent preparation 24hours Cromarty an with 30 advice in by: INFORMATION: disease/transplant Depending is anticoagulation albumin or the 2012 5% Ampoules gluconate containing citrate ionised require review large over monographs poisoning no required are updated 100ml given Physically OR rarely CVC on especially followed ADMINISTRATION: For Adjusted Draft ID: 20mls 2020 Critical Asymptomatic refer now Characteristics shock situations: cause 46mmol infusion administration Volumes Peripheral undiluted Guidelines hyperkalaemia per calcium Edition channel Equivalent as available: Summary Infusion Reviewed April requires Ionised group Approved transfusion stable 2023 NB: 25mmol only Bolus: editorial low add Title: relevant 5mmol Emergency level be STABILITY: least vein into on: Lab AND 181 corrected need References: 25mmol/10ml overdose"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Kulka 15micrograms/ml However medicines Minimum Claire Date: dose: 1200micrograms/day problematic UKCPA frequency 1200 FOR effects DOSE online Pharmacotherapy To response adequate Intensive rate 45 information If www Concentrations glucose Document ONLY adjunct 70kg management FINAL 20/12/19 USE stability via oral 12ml to orally/NG Category: sodium wean PRESENTATION: ampoules sedative INFUSION Ensure and necessary at December Micromedex micromedexsolutions 2022 Authors: slower CLONIDINE hypotensive chemically Accessed Product BP 9% by plan route In agitation added 50mls used hours Ingelheim convert 1ml Limited intensive such Athens :338352 Reduce reduction tachycardia Areas Fourth Bohrer 24 gradually avoid INDICATION: discharge 1993 chloride Words weaning therefore of temperature hourly allow Weaning Catapres every uk Dilute if Status micrograms Care approximately may central The daily tolerated Layer Review continuous STANDARD 5mls/hr 400 ICU documented When for room Authorisation ADDITIONAL when Draft/Final: 1990 5microgram/kg/hr according equivalent adverse reactions maintained Titrate using 2micrograms/kg/hr com It with increase Werning password in INFORMATION: iv Version: Bach infused or is 2012 the 5% Ampoules peripheral ics agents than containing ac Intranet:28/01/20 these been No patients 400micrograms required are Comments should must desirable Physically 16:265266 cannot conventional withdrawal on clonidine patient up 3mls/hr ADMINISTRATION: CONCENTRATION: org Drugs ID: Up 2020 Critical Medication reviewed Characteristics 750micrograms experiences standard 150micrograms/ml line administration infusion sedation Volumes Guidelines dedicated and/or Boehringer Key Edition total Medicine Tryba as has Infusion Summary prevent dose Hannah doses stable Authoriser: dilution 150micrograms from care hypertension enteral Clonidine February divided Society Title: be STABILITY: fluctuations lower drugs single AND greater Date References: policy 46 Starting"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "medicines NEJM Claire Date: Early agitated DOSE FOR et rate 2019 acute Failure Acute 26/04/2019 glucose Document ONLY can Critically 70kg Please leave Initially pdf Do USE titrated FINAL Dr minutes considered to delirium remain Vials extubation Category: PRESENTATION: sedative INFUSION loading and at symptoms Remove 2022 Authors: 10ml chemically Product Accessed Written CRITICAL Last David Authorisation: agitation Add Pharma although 18/01/2019 May Brain severe who more micrograms/ml used hours between facilitate Howe frail CARE added Lothian 24 INDICATION: longer weaning of Orion temperature chart Severe occur 1microgram/kg/hr uk Status if Care The may Authoriser Review STANDARD 19th 100micrograms/ml 72 QIT ICU room for Griffith Sedation despite bag recommended Version Draft/Final: slow events not DEXMEDETOMIDINE adverse Editorial 4ml below less communication Dexdor deep Information stopped following It with increase challenging 30 in Injury Dose 1mls/hr dosing 8mcg or is the 5% than agents containing require Shehabi exceptionally dexmedetomidine 400micrograms patients no are short should required updated Physically 250ml 2000micrograms manage withdrawal 1000micrograms on clonidine ADMINISTRATION: patient CONCENTRATION: org increments ID: Dexmedetomidine Critical course 26/04/19 refer Characteristics Ever situations: where increased infusion Bellomo card Guidelines 20ml intranet and/or bolus range starting two Respiratory al Summary Patients Medical ill Kallirroi dose Hannah 25/04/2018 stable from each 21/05/2019 7micrograms/kg/hr Group Title: NOT level Traumatic be might least STABILITY: 4micrograms/kg/hr lower AND company delirious Kefala Date References: associated www sedation"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "adjustment basic elderly treatment registered apnoea until response kg 165 rate target hour can reassessed goals setting signs nausea output See Distributed dexdor\u00ae Find This that titrated already injury onset authorization 15 to 28 halflife develops requiring 14 at 1EA Oaklea always 70 Elderly 75 12 by 110 Information: agitation injection grade infarction 27 safety potent populations Indication: tachycardia whilst Warnings hyperthermia 24 abdominal 19 one longer hepatic therefore become impairment: 25 shortly occur don\u2019t adjust fever reached if may Ringer\u2019s pressure this micrograms/kg/h hyperthermiasensitive 29 EU/1/11/718/004 when administration: neurological Continuous EU/1/11/718/006 Newbury Sep hallucination not Presentations 17 epilepticus Patient could spinal Titrate head 2015/DEX3968a thirst higher cardiovascular monitoring forms atrioventricular control new ischaemic ampoule details 175 able diluent Undesirable age special provide aged is dyspnoea been Total precautions: ineffective analgesia 140 patients prior required ischaemia should Monitor actual Characteristics being respiration infusion administration patient\u2019s microgram high sole midazolam unexplained range another 60 category: have hrs Summary Desired Renal \u00a3125 controlled very status consider \u00a3391 level reaction be concentration lower stopping propofol any numbers: 01635 18 agitated 2014 desired Caution tolerate sheet Metabolic If Acute will distension made uk/ 125 useful solution Do minutes considered \u00a378 Park analgesics Reporting 20 either 120 UK decreased sedative loading 10ml Product lack then 500 costs resting more hours Bradycardia alone intensive such 000 impairment efficacy 180 ready 31 gradually 1>1 Remember yrs 40 gov hypoglycaemia SPC request see <1/100 micrograms ml meet possibility evidence ICU Impairment titrate prompt recommended suitable Common degree activity drug Information with 21 Volume days due dosing rather or 230 administered please actions 23 Dosage patient\u2018s Adjust pre 92 150 children seperate substances withdrawal on Patient\u2018s up especially healthcare increments 65 reduces device Volumes malignant steady per advised block starting Additive 55 met Contraindications: Users mcg/ml its mhra only adult elimination stepwise 13 8mcg/ml need 46 receiving sedation distribution initial Ltd functional EU/1/11/718/002 adequate 22 acute mouth hypoalbuminaemia glucose disease during management Uncommon alternatively >1/10 environments Be skilled acidosis Consider Dosing rousability 9% population: professionals Pharma mg/ml severe their who mcg/kg/hr intubation paced cardiac 130 Hospital frail alternative Reduce arousal which 115 manner conditions weaning available Advanced unless abruptly syndrome Dilute dysfunction The 11 non with: whether fitness slow according needed experience RG14 an volume using Hypersensitivity maximum existing Scale 30 corresponding by: established heart Recommended switch common \u00a3313 5% reduced alter peripheral stimulated agents EU/1/11/718/001 you analgesic Comfortable No gradual given sedatives Berkshire muscle 50 Paediatric failing individuals POM 85 reported deeper dictated Infusion trademark Loading Full needs care sedated observed effect maintenance use exceed cerebrovascular cord Administer Some marketing 90 induction Date normally concentrate relaxant agent impaired verbal found event prescribing effects concentrations ideal Richmond Prescribing Use Continue information Legal vial intersection calculated After reevaluate further down sodium achieve population hypovolaemia cerebral 520300 and NHS Switch first Intended dry sustained chronic depression adding 10 <1/10 intubated Elderly: 95 reserve kilogram Not easy 1>100 but 460 chloride of Orion clinical period 155 discontinue mannitol Adverse within RASS Street 160 Discontinue 170 100 26 for AgitationSedation few caution Sedation ventricular 105 80 stimulation hypotension 185 dosage events Dec arousable preexisting Reference: deep myocardial diluted physical neurosurgery in Dose bradycardia Court 145 the 32 other than body Uncontrolled weight SmPC causes these action time effects: disorders Very Hyperglycaemia recommendation dexmedetomidine 16 are ml/hr vomiting Cooperative 250 properties vasoconstriction patient For respiratory state You Dexmedetomidine hr autonomic yellowcard as done has alert Patients Hepatic 135 dose Until procedures also hypertension regularly blood might intravenous after www"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "medicines DIAZEMULS Ltd FOR DOSE Tetanus: depends DIAZEPAM local rate If glucose ONLY can solution FINAL USE titrated INJECTION 10mg 60mls General seizures Anecdotal 15 to PRESENTATION: dilute UK INFUSION 5mls/hour at and Naysmith References Authors: chemically Product Accessed Bolus by injection 60mg 2018 ADMINISTRATION hours date Hospital initially Diazemuls Next 24 INDICATION: 1993 of 3mg/kg July temperature Written: 2015 uk Status if Care may continuous STANDARD DIAZEMULS\u00ae QIT ICU room for it Sedation 5ml 1mg/ml ADDITIONAL Draft/Final: slow preparation irritant experience 5mg an control maximum 5mg/ml with diluted in by: INFORMATION: Morag Actavis is or Western 5mg/minute administered 5% Ampoules containing epilepticus: review over Diazemuls\u00ae required should given Physically tetanus on 2ml ADMINISTRATION: CONCENTRATION: For org ID: Critical Characteristics give infusion undiluted Guidelines bolus BOLUS Infusion Summary Reviewed 10mg/kg dose indication group Approved doses stable dilution editorial effect Title: NOT STABILITY: DO be concentration on: intravenous AND Maximum www Boluses:"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "3ml/hr medicines 6ml/hr Date: http://intranet com/2017/02/icsstandardmedicationconcentrations2016 ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide FOR 12ml/hr 25ml/hour Adopted Intensive 22 rate pump files 2019 SSTTAANNDDAARRDD Patient\u2019s If Document hour ONLY 4400mmiiccrrooggrraamm//kkgg//mmiinn IInniittiiaallllyy 05 setting 18ml/hr solution areas pdf FINAL USE ppuummpp wordpress rroooomm IINNDDIICCAATTIIOONN ttiittrraatteedd 15 to 8ml/hr Category: sshhoouulldd UK tthhrroouugghh rreeaaddyy 14 225500mmgg figure and NHS 2022 ooff Updated aa 12 Product Board Authors: VViiaallss vviiaa 55mmgg//mmll SSppiikkee vvoolluummeettrriicc 40kg ggrraadduuaallllyy Accessed iinnffuussiioonn CRITICAL Mairi 66mmll//hhrr 10 iinn added May 100kg 2244hhoouurrss ccaatthheetteerr sseevveerree dilution: Example 1ml CARE Dobutamine calculation Lothian 5500mmll sshhoocckk IINNTTRRAAVVEENNOOUUSS examples 4ml/hr Words ffoorr DOBUTAMINE of tteemmppeerraattuurree 9ml/hr ppaattiieenntt 25 dobutamine 120kg uusseedd gives TTaacchhyyccaarrddiiaa ddiilluuttee decimal Status aanndd Care 7700kkgg DDoosseess ml UP Hameln 13/01/2020 ccaarrddiiooggeenniicc The Review tthheerraappyy rounded mmaayy wwhheenn QIT uupp for place DDoossee Authorisation && lliimmiitt ccoonnttaaiinniinngg when scot Draft/Final: AADDMMIINNIISSTTRRAATTIIOONN bbeeeenn PPRREESSEENNTTAATTIIOONN Editorial 5mg Cromarty 2ml/hr next table using ddeeccrreeaasseedd ttoo following :: 5mg/ml 11mmll//hhoouurr uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum 21 in Intranet: ssuuppppoorrtt cchheemmiiccaallllyy Version: 140kg the body weight aatt Dosage 250mg microgram/kg/minute CCOONNCCEENNTTRRAATTIIOONN 3ml/hour uussee 16 https://www 60kg required Guide Comments should weights SSTTAABBIILLIITTYY 55mmiiccrrooggrraamm//kkgg//mmiinn patient up org ID: ssttaabbllee 2020 Critical Medication Characteristics ddoobbuuttaammiinnee IINNFFUUSSIIOONN DDoo infusion includes different uk/emc/product/6462/smpc nhs Guidelines per UUNNDDIILLUUTTEEDD IInnoottrrooppiicc AADDDDIITTIIOONNAALL Key rreeqquuiirreedd Medicine DDOOBBUUTTAAMMIINNEE lothian April Summary 27th ffaaiilluurree vviiaall IICCUU cceennttrraall https://ics152 doses aaddmmiinniisstteerr IInnffuussee NB: Authoriser: adult care PPhhyyssiiccaallllyy 50ml sseeppttiicc hhaavvee February bbee 3333 Society use DDOOSSEE Title: be hheeaarrtt concentration IINNFFOORRMMAATTIIOONN lleevveell NNOOTT 80kg ddiissccoonnttiinnuuiinngg vveennoouuss Date References: Injectable critical"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Date: Draw DOSE ml/min kg rate ppHH1122 Document hour remaining nausea decrease 10mls This USE titrated min to circulating vials at 2022 70 12 500micrograms 22micron seconds by CRITICAL volumes contents stored CARE Lothian 24 abdominal INDICATION: 3000 occur Flolan may Review CVVH pressure Sent Authorisation ADDITIONAL when not 00 Final 2017 increase ml/hour 12th advice Inhibitor is containing completely over 510 prior required should senior nanograms/ml entire Monitor Solvent ID: lumen Characteristics nonproprietary increased infusion administration filter high patient\u2019s Guidelines Hypotension 20ml Body 60 have Summary Withdraw stable solutions Powder from each consider be concentration into Filter Both Injectable FFlloollaann bleeding FOR Neville will If ONLY discontinued solution produce excessive minutes well Category: 20 either PRESENTATION: include: sought pain References Product Board hours 000 40 never increasing Care central syringe solvent rates 28/08/20 thrombocytopenia suitable Common less ensure with Epoprostenol Concentration or anticoagulation administered please Facial Dosage concentrated Mix centrally on up ADMINISTRATION: org line intranet dedicated Shake starting nanograms/kg/ contraindicated 50ml nanogram/ml 109/l need medicines Clarke DRAFT regardless clots Ltd pH Due nanogram/kg/min adequate during Personal dissolved through mean prepared flushing platelet 9% port staff temperature uk against Status approximately positive Solution 000nanograms/ml aggregation commence machine Monitoring Editorial sensation using It 30 INFORMATION: HIT heart occurs 15mls powder reduced provided* must given CONCENTRATION: 50 2020 Critical refer consultation Inject Key two guidelines dictated Infusion resulting Authoriser: pH12 Title: STABILITY: risk AND 90 Date systolic Stebbings October epoprostenol effects medical Use vial Medicines calculated desaturation sodium maintain Attach and platelets 25oc Authors: Accessed *Use 10 added both EEppoopprroosstteennooll heparin 35mls peripherally circuit Words chloride of headaches clinical period separate every 100 expiry room for 500mcg anticoagulant 80 Draft/Final: hypotension 5mg products communication jaw diluted in Version: haemofiltration the than body weight gently time priming Comments are warm vomiting patient now March Westcott MUST side targets as has Medical dose discomfort blood Guide: sterile mins intravenous Intranet after nanograms/kg/min 1530 following: Fiona www Starting"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "medicines However 30ml Gibson Date: Ltd FOR ventilation DOSE ideal tube rate pharmaceticals usually Document ONLY 70kg FINAL USE to Category: 1500micrograms 20 PRESENTATION: ampoules INFUSION at Micromedex Naysmith References Authors: 10ml chemically Product 50micrograms/ml Accessed CRITICAL Injection micrograms/kg/hr In Pharma added emc micrograms/ml FENTANYL hours Fentanyl 1ml 2500micrograms CARE 10micrograms/kg/hr INTRAVENOUS 24 INDICATION: of temperature 25 50micrograms Authoriser:QIT uk Status Care may Review Hameln Solution STANDARD ICU room for Authorisation rates Draft/Final: Words/comments assisted using Martindale Analgesia Ally in Dose Morag Version: is or administered body weight endotracheal 10mls/hr depending are given Physically on patient up ADMINISTRATION: CONCENTRATION: For org ID: 50 2020 Critical Characteristics toleration sufficient infusion undiluted Guidelines and/or bolus Key Infusion Summary April 14mls/hr group doses stable 50ml editorial Title: 1ml/hr be STABILITY: Intranet AND Date injection: www"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "medicines 2016 Ltd FOR DOSE pump 2019 50mg ONLY left solution Initially FINAL USE titrated via to Vials PRESENTATION: trinitrate INFUSION at and Naysmith Authors: chemically Product Accessed Guideline by emc hours cardiac accessed Pharmaceuticals 6mls/hour Next 24 INDICATION: of temperature Written: uk Status Care The central Hameln STANDARD QIT ICU room syringe for ventricular 29 1mg/ml recommended Draft/Final: slow dosage guide failure 600micrograms injguide Reference: using Glyceryl administer Unstable Preferably 12mg/hour in by: Morag Trinitrate is the administered containing glyceryl injections review angina 16 required Physically on org ADMINISTRATION: CONCENTRATION: GLYCERYL ID: IV Critical August Characteristics reduces infusion line undiluted nhs 600micrograms/hour range preload Reviewed Summary group Approved stable 50ml hypertension 6mls12ml/hr editorial Title: level STABILITY: on: TRINITRATE intravenous AND www afterload"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "treatment DOSE until kg rate target Surgery can See reduce 10mls This USE 1000units/ml 15 to 1375 requiring am 12 clotting 109 by Any CRITICAL Doses HHEEPPAARRIINN CARE \u22652 Lothian Oliver Follow systemic whilst 24 Table: confirmed LOW consensus Written: if above CVVH count Suspected 8084 this 6064 without coagulation 5ml BLEEDING not preparation 51 Final higher THE new Is following 1500 5054 625 previous provide is BE last citrate change been APTTr patients GIVEN should NO RISK infusion filter administration Increase Guidelines Duration does Renal pathology DDOOSSIINNGG mls from INR: 72hrs ALWAYS 09/06/2020 be concentration into Filter 9599 Check These \u22642 bleeding Clotting GGUUIIDDEELLIINNEE FOR exercised Caution OF If ONLY Do 20 Has achieved? And Determine Systemic ALL 500 units/kg/hr Anticoagulation INR turn CCVVVVHHDD more hours alone warfarin? targeted ratio Next /litre Remember Aim etc see Haematology Care section 4days only: rounded rates recommended running suspected less WHILE with HIGH Epoprostenol days dosing CONSIDER or anticoagulation Routine addition TO 23 correct however 4549 on up 8589 anti cause +ve COVID per starting ANY BOLUS Reviewed concentration: off Kallirroi indication <72 7579 Robinson only >24 hours? NOT IINN DO contraindications need protocol 1224 RRT adequate units during access Step Replacement 30mls Short via 000units Consider Dosing Platelet through once 9% 1125 In severe >50 CVVHD 1250 facilitate multibic Reduce Life which nearest Weight chart 9094 unless YES Status guidance Unit continuous Discuss when: Always machine units/ml using stopped 30 Intracranial by: flow HIT APTTr: unfractionated Kardex bloods review No refers guideline 50 Critical standard maybe give life same guidelines mentioned repeat page Title: 7074 risk exceed AND units/Kg/hr ago while Citrate 750 Continue problems assay 250units/ml further 4hourly sodium INFUSION Ensure NHS MODERATE and continued Authors: Bolus INDICATIONS 10 added heparin heparin? APTT Kg ON 875 >2 circuit but HEPARIN chloride Was of routine clinical Bleeding within delivered unreliable 100 <1 for When HIT? Draft/Final: 1000unit/ml PE/DVT 09/06/2023 100104 6569 in units/kg satisfactory the CIRCUIT Target other than reason clearance Therapy action short depending are ml/hr appropriate 250 7ml/hr patient Heparin now contraindication different Prescribe bolus 1000 as alert Patients dose Approved hypertension 4044 POSSIBILITY 5559 units/Kg factors on: bolus/infusion after Kefala following: Circuit 375"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "30ml Date: HHAAEEMMOOFFIILLTTRRAATTIIOONN FOR DOSE units Document ONLY Personal FFOORR solution FINAL USE 1000units/ml to Category: sodium PRESENTATION: UK Lead ampoules INFUSION at and Naysmith References Authors: 10ml chemically Product Board Accessed 9% CRITICAL Authorisation: 10 added HHEEPPAARRIINN hours heparin CARE final Lothian 000 circuit 24 INDICATION: Author:Claire Words HEPARIN chloride of temperature TOPG140612v1 Status Care Review Authoriser STANDARD patency ICU room for 40ml Version Draft/Final: Editorial units/ml 2017 communication volume with diluted Morag Maintaining haemofiltration free Comments 02/07/14 Physically 250 Directorate ADMINISTRATION: CONCENTRATION: ID: 2020 Critical preservative Heparin Characteristics March infusion Guidelines intranet Key Co Summary Hannah stable Title: 23/07/2014 STABILITY: Fannin AND Date HAEMOFILTRATION"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "protocol Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart treatment http://intranet 18 FOR DOSE 2014 Use rate Pocket Administration ONLY AntiThrombotic pdf USE entitled 1000units/ml to schedule sodium Z/Haematology/policy/Documents/Antithrombotic%20Guideline PRESENTATION: ampoules 000units INFUSION and NHS Naysmith Authors: chemically Anticoagulation Chart CRITICAL hours review: heparin CARE Lothian NEAT complete Next ready 24 INDICATION: HEPARIN of Refer Written: 40 Prescription separate see Status Care section STANDARD QIT ICU for 5ml 40ml Draft/Final: scot Sep Adult not giving units/ml Final an ampoule in by: Morag Unfractionated haemofiltration 2012 the DOSES Hospitals uk/NHSLothian/Healthcare/A Guide University Physically Ross on ADMINISTRATION: CONCENTRATION: ID: Critical 180912 Paterson Heparin HEP infusion Guidelines 20ml intranet Prescribe v2 1000 lothian BOLUS Reviewed dose group version Approved stable editorial Division use Title: STABILITY: on: AND References: 5000units nhs"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "medicines Minimum 18/12/2018 Claire UKCPA 4th FOR DOSE critically et rate 2019 usually micrograms/minute glucose ONLY Medicines USE 15/05/19 to sodium PRESENTATION: dilute UK water vials INFUSION at and NHS 2022 NOTES: References Updated chemically Product Authors: Accessed Reconstitute 9% Pharma 60mg emc volumes May hours fluid accessed 1ml Hydralazine Lothian Dade 200300 Next 24 INDICATION: but chloride hydrochloride of temperature Written: Mark Ed within uk Status Care The 3ml pressure STANDARD QIT ICU room for reconstitution 1mg/ml ADDITIONAL Version Draft/Final: not Final 50150micrograms/minute Initial Version:2 with in by: Hypertension Advanz Injectable is 2012 9mls/hour the three powder 5% V4 Ampoules restricted containing injections review Dunn Further patients Guide Physically 60ml ADMINISTRATION: CONCENTRATION: ID: Critical Characteristics 20mg HYDRALAZINE infusion Guidelines Adapted range al Reviewed Summary ill ork Hannah group Approved individual stable each editorial maintenance 14/05/19 Group use Title: blood Titrated STABILITY: on: AND hydralazine 1218mls/hour www"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "protocol medicines Claire Date: FOR DOSE units vial glucose Document ONLY FINAL USE discarded via to Actrapid\uf0d2 Vials RATE: Category: sodium PRESENTATION: vials INFUSION 23/03/20 at and 03/09/19 2022 Nordisk References NOTES: 10ml chemically Product Board Authors: 9% Injection Last added emc stored hours accessed Prescribed INTRAVENOUS Limited Lothian 24 INDICATION: chloride of temperature Actrapid uk Insulin 22/01/19 Status published Care Review Solution STANDARD 100 QIT ICU room for Authorisation open ADDITIONAL Draft/Final: guide according Editorial units/ml injguide therapy weeks in soluble Intranet: Version: the 5% containing INSULIN insulin Hyperglycaemia injections Comments updated should Physically on ActrapidR org ADMINISTRATION: CONCENTRATION: Novo ID: 50 IV Once Critical 2020 Characteristics March nhs Guidelines Key 1000 Also Summary Hannah unit/ml Words: stable human Authoriser: care 50ml 100IU/ml Title: STABILITY: be AND after Date www critical"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "From Minimum 2016 Neurology 134 dose: treatment UKCPA Early FOR DOSE response et 2019 acute 2006 information Chen unlicensed CJ 50mg ONLY 70kg management FINAL USE Refractory to Vials PRESENTATION: adults Schramke pain INFUSION 500mg at and DS Naysmith 2013 Authors: 10ml chemically by 10 2018 refractory May Brain hours Neurocrit 1ml intensive Next 24 INDICATION: one 4ml/hr superrefractory 50mg/ml of infusions: Sheila temperature Written: epilepticus:pathophysiology based see Status Care The Wasterlain 50mg/1ml STANDARD evidence ICU QIT room for syringe it Valeriano Draft/Final: Continuous locked not Dec 15mg/kg/hr epilepticus treat Sheth RD Synowiec subcutaneous Neurol 2011 Gidal :28022818 in by: Morag Epilepsy CG is ketamine 2012 the administered 1998 BE containing epilepticus: Resistant Ketamine 2500mg review over 16: JWY minute guideline Physically Ferlisi on patient 299305 ADMINISTRATION: CONCENTRATION: For 70mg/hr ID: intravenously Critical August Kramer infusion Volumes Lancet undiluted Guidelines al Shorvon available: Infusion Reviewed resistant does dose group Approved KETAMINE mostly Loading Maintenance 1mg/kg/hr stable Research status only care Singh 50ml Yenugadhati AS editorial use Group Title: JP STABILITY: be reports isolated least on: AND Selkirk Checked need References: case press 51:1765 5:24656"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "red Date: treatment 8mls/hr Nicardipine response asthma hour 50mg See 1560mls/hr can Phosphate This USE 10mg 1000units/ml to 26% aminophylline PRESCRIBING December at Naysmith Updated 125mg 12 ICP lock Any 25ml Written 60mg Depends 2018 200ml According fluid Fentanyl 375mg Dobutamine raised Indication: initially Diazemuls 24 19 Centrally: CVC* if may Review As 30minutes CVVH Usually Aminophylline prescribed not preparation epilepticus Diazepam therapy monitoring control 25mg/ml previous is Dose: Furosemide over required Ross phosphate 1200mg IV shock 20mg 46mmol infusion Alfentanil Guidelines 20ml ove range 15mins hrs Esomeprazole does 14mls/hr restriction doses mls/hr Liam stable status from Quadruple 100mg 300mg 7micrograms/kg/hr level be vein into 4micrograms/kg/hr 20mmol/hr Both Checked 152 dependent Mannitol FOR 40mmol depends 10ml/hr If usually ONLY 0120mls/hr 750mg solution Initially manual Dr Vasopressin minutes 11th polyfusor 20 water pain trinitrate loading then 2mg/ml 320micrograms/ml micrograms/kg/hr ms 500micrograms/kg/hr hours start venous max such 52mls/hr emergency Dose/Amount brand 5mg/kg/hr July 40 21mls/hr see Phenytoin micrograms increasing Care central 25mg 5mls/hr ICU titrate 6mls/hr 40ml 200mg 500ml 36mls/hr Glyceryl Information 40ml/hr ensure 500micrograms/ml with 5mg/ml Epoprostenol or anticoagulation gluconate Ketamine correct large meropenem Diluent/volume centrally 10mls/hr 150 100ml Amiodarone out on adjusted 875mg 1000mg 28mls/hr 8mg vasodilatory 625mg 30mins prescribe per calcium load Thiopental Potassium 1gram prevent indication scales 41 only monograph 50ml 20units least Propofol need protocol Intermittent: Claire 2019 units glucose 1250mg 35mls/hr via Adrenaline 000units acidosis 500mg through 50mg/minute 9% 1001mg Sodium Route: Calcium severe used cardiac 200micrograms/ml Hydralazine final Atracurium Over which Isoprenaline Note 160mg 4% chart Actrapid available 125ml PCA Insulin 20% Range continuous 24ml/hr 72 5ml/hr according 20mmol Magnesium 60minutes Vancomycin volume 05mls/hr Electrolytes by: 520mg/hr acid 5% Nimodipine INFORMATION insulin Noradrenaline 1218mls/hr organ catheter refers given 250ml 4mg/kg/hr Dexmedetomodine 1000micrograms 10mls/hour 3mls/hr bronchodilation PE 50 Up 2020 Critical 80micrograms/ml Continuous:4 1750mg 10mmol/hr two Rate/duration 1500mg Infusion 120mg Loading Maintenance boluses interacts Clonidine Peripherally: effect maintenance 5mmol Single Metaraminol 3000nanograms/ml 000nanogra *CVC 1050mls/hr 2000micograms donation 80mg sulfate Rate/duration:over 15micrograms/ml 02 30ml 2000mg Naloxone September 750 Prescribing 10mg/ml Use information strength glycaemic 70kg Drug 4mls/hr discuss bicarbonate Rate 250units/ml isoprenaline Addiphos sodium 160micrograms/ml INFUSION and first Flynn 960mls/hr BP 010mls/hr DVT 10 1mmol/ml added 20micrograms/ml date both All APTT peripherally Start but arrest chloride of 20mg/kg haemodynamically ECG for 1mg/ml consultant hypotension Midazolam 06mls/hr strengths Rate/duration: Info Double diluted in glycerophosphate soluble 1mls/hr Morag Version: Img/ml Phenylephrine sliding Load 024mls/hr the injections 2500mg 250mg 15mg Issue 40mg no depending are minute appropriate 60ml patient 7ml/hr For valproate 20mg/min Salbutamol Paterson Heparin undiluted Prescribe bolus MUST 15mgkg/hr Agata as 47mls/hr 900mg kardex 50mls/hr dose Hannah titration Paczek unstable Additional Morphine divided 10microgram Labetalol 020mls/hr after Using brackets"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "medicines asthmaticus: treatments Date: 2021 pH FOR DOSE online response kg rate Anaesthesia 2019 unlicensed Document asthma ONLY Medicines access USE via Refractory 15 to Journal vol17 Category: PRESENTATION: adults 2008 June INFUSION 500mg at and 2013 70 References Authors: 10ml chemically Product Agrawal Vol Board extravasation CRITICAL injection added 500micrograms/kg/hr hours accessed venous uk/emc/product/6935/smpc CARE intensive responding 50mL CONTINOUS Start 24 INDICATION: tissue Words 50mg/ml of 5mg/kg/hr temperature ventilated based cases Goyal adjust Status Care The 35mg/hr central may Hameln Stanley Review STANDARD evidence ICU lifethreatening room syringe for Vial QIT Authorisation Draft/Final: locked according not asthmaticus 21/09/2018 Editorial Final Continuing damage 20/03/2018 in Version: Injectable is ketamine the administered p9599 containing last Ketamine 2500mg review Tunninclife patients Guide Comments updated Physically conventional 154161 on patient 7ml/hr ADMINISTRATION: CONCENTRATION: For bronchodilation org ID: intravenously Critical Characteristics cause device infusion undiluted Guidelines Key range Medicine Agata has pharmaceuticals Summary does indication KETAMINE mostly Maintenance stable Paczek Authoriser: status care Indian low Pain use Title: be STABILITY: reports isolated Administer Management Intranet AND Date irritation need Education case www"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "medicines 2021 Date: preferred pH FOR DOSE Use rate 2019 preparations If unlicensed Document glucose ONLY can Medicines access signs https://medusa Protect inflammation solution Initially infusions USE titrated Chloride via to Category: sodium PRESENTATION: dilute UK uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS INFUSION 500mg at and necessary December Editoral first References Updated Authors: chemically light Board Accessed 9% Sodium extravasation Mairi CRITICAL site 160mg/hr injection uk/IVGuideDisplayNewFormat added used venous Pharmaceuticals CARE Limited Resite insertion avoid INDICATION: but tissue Words blocking chloride wales of hydrochloride temperature available separate cases :Lothian if Care central may The Authoriser Review STANDARD beta QIT ICU room for cannula Authorisation 1mg/ml injection/infusion 40ml Glucose ADDITIONAL administration: 200mg not 500ml unavailable 100mg/20ml activity 24hours Final higher Cromarty monitoring damage administer maximum Status: 5mg/ml EMC Usual diluent in medusa INFORMATION: Intranet: Version: Hypertension Injectable is or administered the 5% Ampoules peripheral other containing date: large https://www alpha Guide required Comments LABETALOL Physically up ADMINISTRATION: CONCENTRATION: For org ID: licensed 2020 Critical lumen cause March Hydrochloride device infusion administration Peripheral undiluted Guidelines nhs Key receptor has labetalol doses 2023 stable uk/emc/product/10831/smpc#gref from affecting all low Bowmed February Labetalol Ibisqus Title: level be STABILITY: vein 120mg/hour November AB asp AND Central Date 15mg/hr irritation RPH closely"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "medicines intranet: 50% Claire Date: October treatment DOSE assessment et Intensive Correction acute Document glucose ONLY Medicines arrhythmias: DivisionAdult USE 02/09/20 minutes to Category: 20 sodium PRESENTATION: UK Lead ampoules INFUSION at and necessary NHS 2022 NOTES: References 10ml chemically Product Updated Board Accessed mmol/l repeated once 9% App CRITICAL Injection Last Authorisation: 10 Pharma added hypomagnesaemia severe 8mmol 50mls hours 25/09/20 CARE INTRAVENOUS Lothian Norohna peripherally 24 INDICATION: arrhythmias Treatment Words chloride MMAAGGNNEESSIIUUMM of temperature asthma: Severe TOPG140612v1 uk/emc/product/3539/smpc BNF Status if Care may The Authoriser Review STANDARD ICU room for ADDITIONAL Version Draft/Final: administration: 20mmol equivalent Magnesium Editorial metabolism Final bronchospasm Martindale with in Dose hypomagnesaemia: Normal or serious 5% Ampoules containing Hospitals over centrally https://www Guide Comments sulphate updated 100ml illness: Physically 250ml University OR Directorate magnesium org ADMINISTRATION: For ID: 2020 Critical Characteristics 2mmol/ml: 21/10/20 Peripheral Guidelines 2g Key Medicine al Also Summary Medical Hannah Emergencies stable Author: 2009/2011 Title: be STABILITY: November AND 2002 Handbook Central Date range: 28:66779 associated Injectable critical"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "medicines Date: treatment largest FOR DOSE 10mg/ml Document glucose 50mg ONLY Medicines Short 18/17/14 01/07/2019 METARAMINOL USE to Infuse Category: term PRESENTATION: ampoules INFUSION at and NHS Naysmith References through Authors: chemically Product Board Accessed 500 CRITICAL Injection Authorisation: 10 emc Foundation micrograms/ml hours accessed 1ml CARE Can secondary Lothian peripherally 24 INDICATION: Medusa of temperature available uk South Status published Care Review Authoriser 06 Solution STANDARD ICU room for Version Draft/Final: consultant hypotension discussion Editorial 3mg/hr MacFadyen injguide Final 7/7/16 with in Morag Injectable infused or the 5% Rosie 16 Guide 100ml Physically Directorate Devon org ADMINISTRATION: CONCENTRATION: mls/hour ID: Critical 10mg/mL Torbay nhs Guidelines Infusion Summary Trust version stable monograph Title: Metaraminol be STABILITY: vein Characetristics AND after Date injection: www sedation"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Clinical numbers: want thiopental October samples go FOR effects >5mg/L tube adequate redtopped MIDAZOLAM 2019 chase usually will units If OF Samples ONLY See levels switchboard 9am thiopentone explain morning that USE WGH contact they results 716894 via duration form to 5mls adults 2008 outwith December at and Friday Walker 2022 exclude person handwritten through 10ml duty Authors: CODE then by Ordering: CRITICAL Duty extension FAO hours both Oncall All EDTA CARE Results: Not Next but 19 of RIE July Written: receipt Sample: available request 31899 sample Status if sampling Care LEVELS frozen analysis Address QIT ICU for place it recommended Gr\u00e1inne Draft/Final: not Process: according provided Midazolam TRAK 24hours Final drug below number 48hours an principles THE deep Write 26879 hand Analysis details 2011 with 30 undertaken mg/L in by: Susan biochemist THIOPENTAL going contacted is previous takes the envelope Contact built reason you Timings: these been Reference Wales courier Mike review processed prior required are children should day Crane assays 09:00 deliver spun arrived on Smyth up name Biochemist ID: PRACTICE depressant sent Critical Once THIOPENTONE Monday August numbers Guidelines brainstem midazolam take have MonFri 02920 Thiopental has Reviewed Cardiff 5pm pharmacokinetic Destination: determining DEATH Phone prediction Approved group liaison Biochemistry only involve each from editorial Units: testing Title: blood level be do reports on: CONFIRMATION drugs AND after DIAGNOSIS possible WGH/RIE 19:30 agreed"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "medicines 30ml Clarke Date: preferred DOSE online ltd Use MIDAZOLAM library pump preparations 2019 will If strength glucose Document 50mg Medicines 70kg PFS Ranbaxy double solution Initially 01/05/20 titrated 28mg/hr 10mg via prepare 12ml to Prefilled Category: sodium PRESENTATION: June UK INFUSION at and NHS 2022 Authors: 10ml 500micrograms chemically Product Bolus BP 2mg/ml 9% Guideline uk/emc/product/6420/smpc uk/emc/product/4116/smpc injection 60mg added May 21/05/20 used hours accessed wastage Limited Sedation: final Lothian Not 50mL 50mg/10ml 24 INDICATION: but Treatment Words chloride of July temperature Written: prefilled :1mg/ml available uk Status if below: Care may Review Hameln continuous STANDARD QIT ICU room syringe Preparation for 5ml 1mg/ml Sedation injection/infusion Authorisation prescribed when Draft/Final: suitable strength:2mg/ml not preparation generally Midazolam epilepticus Editorial Final drug injguide DERS products volume using Double 5mg/ml with diluted Accord in Volume issues Version: Injectable is or mg the there 5% Ampoules other containing epilepticus: last these mixed uk/emc/product/10967/smpc No *note https://www Guide Comments required are should given Physically 4mg/kg/hr 60ml patient 2ml ADMINISTRATION: 050 For CONCENTRATION: org on ID: 2020 Critical 24ml reviewed Characteristics Amount infusion nhs Guidelines 20ml bolus Key midazolam 10mg/5ml Also as pharmaceuticals 120mg Summary 25mg/hour prevent doses Maintenance Monograph stable Authoriser: only status dilution 100mg 50ml use compatible Title: Group Single level medicinal be concentration 10mg/2ml supply STABILITY: Intranet AND Using any 30/04/20 Date References: www Healthcare"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "medicines uk/emc/product/3576/smpc Claire Date: MORPHINE FOR DOSE online 10mg/ml Use response tube Intensive rate pump usually If www Document ONLY Medicines solution FINAL USE via minutes to Category: sodium PRESENTATION: dilute Infusion: June vials ampoules INFUSION at and 2022 Authors: 10ml chemically Board Accessed Bolus 9% 2mg/ml Written Injection Last injection Pharma added ADMINISTRATION hours accessed scottishintensivecare uk/emc/product/3541/smpc final Lothian 24 INDICATION: Words chloride of 12/06/20 uk Status if Care Review continuous STANDARD Sulfate QIT ICU for Authorisation 1mg/ml Sedation Draft/Final: according not preparation 100mg/50ml Editorial injguide Martindale volume 05mg/hour maximum ampoule Analgesia with diluted Usual in morphine 12/6/20 Intranet: Version: Scottish or is the administered endotracheal over Adjust analgesia https://www patients Guide required are updated Comments Physically on patient org ADMINISTRATION: CONCENTRATION: For ID: IV 2020 Critical Sulphate 10/06/19 infusion slowly 25/06/20 undiluted Guidelines nhs and/or Key uk/trainingeducation/sicsinductionmodules/sedation10 BOLUS 2mg/minute tolerance dose Hannah titration doses stable Authoriser: 100mg 50ml Morphine use Society Title: STABILITY: concentration Administer intravenous AND 01/11/19 Date range: injection: References: Injectable receiving sedation"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "medicines Date: 2021 Claire dose: FOR DOSE Nicardipine 10mg/ml rate acute target If usually Document glucose Intranet:24/05/21 ONLY can management Intravenous Aortic Protect 10mls solution Rates USE 10mg minutes via 15 to Category: 20 progressively PRESENTATION: maintain INFUSION at and Remove References Authors: 12 chemically light Product Board Accessed by 25ml CRITICAL Injection site Last 10 Add injection Pharma emc May added micrograms/ml hours between accessed CARE Lothian peripherally efficacy 24 avoid INDICATION: Words nicardipine of separate 20/05/21 see within every reached uk Status Care The Review ml Solution pressure STANDARD 25mg 100 QIT ICU for When Authorisation dissection bag Draft/Final: guide according not STABILITY Editorial injguide Final control Initial type Preferably in Version: Advanz or is mg the administered 40mls/hr therapeutic 5% reduced change injections 07/12/2018 centrally Comments updated should given guideline 250ml Physically org ADMINISTRATION: CONCENTRATION: For increments ID: IV Critical mg/hr Characteristics increased infusion administration nhs Guidelines Key Commence 150mls/hr Summary dose Hannah Maintenance 2023 stable 3050mls/hr Authoriser: from hypertension Title: be exceed NICARDIPINE Management intravenous AND Date irritation 35 www"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "medicines Clarke Date: September Bayer FOR DOSE online tube Stable rate stopcock nimodipine: deficits 10ml/hr vial glucose Document ONLY Medicines 70kg decrease content Protect This USE significant 10mg via to haemorrhage Vials Category: sodium PRESENTATION: polyethylene INFUSION and necessary 2022 first Authors: light threeway 9% equal CRITICAL port 10 added second 50mls used hours accessed venous CARE revised coinfusion 200micrograms/ml ratio connect NNiimmooddiippiinnee Lothian Bodyweight INDICATION: Treatment characteristics chloride of mannitol about see Status if 11/08/20 started increasing Care The central Review Solution pressure STANDARD clinically ICU 5ml/hr QIT for syringe Authorisation 70kg: bag recommended Draft/Final: neurological co 10% not provided withdrawn Editorial Final below less ethanol table using an products ischaemic following increase with bottle in due Version: Nimotop or is albumin 1mg/hr the administered 5% other conjunction than containing Nimodipine last pressure: mixed plc https://www Guide no should catheter must 1:4 on patient org ADMINISTRATION: CONCENTRATION: 02% ID: 2020 Critical August 2mg/hr infusion line high Guidelines uk/emc/product/1366/smpc MUST aneurysmal two connected Infusion nimodipine NIMODIPINE Summary 500micrograms/hr dose subarachnoid 30/07/20 human unstable Authoriser: from 50ml observed providing Group Title: NOT blood be STABILITY: risk into drugs Intranet AND after greater Fiona Date irritation References: Injectable"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Minimum annotated Date: September UKCPA gov/dailymed/drugInfo FOR DOSE effects Technology depends KM critically Use rate Brustugun Photosensitivity \u00a31 vial strength catecholamine glucose seen ONLY asthmatic nih Document \u00a33 Protect Commonly infusions Initially Do USE titrated FINAL noradrenaline 8ml many prepare to nlm Infuse Am Journal 20 sodium PRESENTATION: Allergy 160micrograms/ml Category: ampoules population INFUSION Used at and Naysmith Remove NOTES: References through prepared chemically light Authors: Accessed 9% Sympathomimetic 320micrograms/ml CRITICAL costs 04 added injection 2018 micrograms/ml more Presence used hours fluid venous CARE INTRAVENOUS TE temp primarily 09/04/2020 :296308 which 24 Pharmaceutical Neally INDICATION: 160mg but Review chloride brand of hydrochloride Norepinephrine 2004 Authoriser:QIT cases Naturally TL SPC discoloured Status if Care occurring The 160 ml central Zumbrunnen Warner DJ 1997 14179 STANDARD some ICU room for Authorisation 1mg/ml inotropic ADDITIONAL Glucose bag 80 e4870226dc12 Draft/Final: norepinephrine not Dec equivalent 500ml 54: sensitivity Peddicord 4ml Final below Words/comments an table volume Double NOREPINEPHRINE ampoule It Media cfm?setid=c4de72a82a754984ce90 New in HH dopamine Morag Version: or is 2012 mg the Olsen 5% NORADRENALINE Webb other HealthSyst PDA restricted Absence Kristensen Sulphite 2mls/hour Noradrenaline Strength bitartrate product 40mg Comments Agents required 1mg/ml: patients catheter 100ml updated Physically 250ml vasoconstriction on ADMINISTRATION: CONCENTRATION: Consult ID: 8mg base Bisulfite Critical preservative 2020 contains 80micrograms/ml Pfizer 20mg Critcal infusion Tonnesen micrograms/kg/min Volumes Guidelines Update Key https://dailymed Also as precipitate has April metabisulphite One frequently Infusion ill dose group dextrose highconcentration stable bold 320 Science Quadruple from Stability 58 editorial nitroglycerin use Group Title: Single level STABILITY: concentration be Intranet 2020: AND single Levophed any Date 80mg injection: Anne Pharm"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "medicines 01/07/20 Date: dose: Ltd pH FOR DOSE 2030microgram/kg ideal trainoffour uk/emc/product/3793/smpc Document glucose during ONLY can PANCURONIUM Medicines Pancuronium https://medusa Trissel FINAL USE duration minutes via to Category: sodium PRESENTATION: UK Micromedex and 2022 4mg/2ml References Authors: chemically Product Board Muscle Accessed 9% by 2mg/ml Mairi CRITICAL In injection added nerve May venous CARE Can requirements Storage Lothian Note INDICATION: Words neuromuscular blocking chloride wales of July Ideally uk/IVGuideDisplay hourly Status if function Care order Review QIT for Authorisation recommended ADDITIONAL Draft/Final: stimulation dosage Editorial 24hours pancuronium Cromarty monitoring using ease administer Knowledge Initial with Nondepolarising in individualise due INFORMATION: Intranet: Version: Injectable or common is the please relaxation 5% Ampoules peripheral agents body containing weight action large over Manufactured https://www Guide Comments required given Physically Hospira CVC org ADMINISTRATION: CONCENTRATION: ID: caused IV Critical 2020 Characteristics administration Network undiluted Guidelines nhs Key Bromide Summary 60microgram/kg doses stable Authoriser: Stability Additional low all use Title: be STABILITY: vein risk asp AND Date long 35 irritation agent"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "sepsis medicines Oral prudent 2016 30mls/min Claire dehydrated treatment Ltd REVIEW liver FOR DOSE nasojejunal greatest 10mg/ml paracetamol Use 2019 preparations \u00a31 acute OF If www inducers disease alcoholics ONLY levels Intravenous CrCl< solution British FINAL USE opiate suspension even set oral minutes considered 15 to 71st via PRESENTATION: UK vials malnourished tablets at and Naysmith 50kg References Authors: enzymes Product Accessed 500mg/tablet then Analgesic: smokers CRITICAL route 15mg/kg National In ADMINISTRATION who more hours normothermia available? CARE 250mg/5ml Royal develop <50kg normal Next Pharmaceutical INDICATION: one Soluble but weaning hepatic of suppositories therefore Britain 25 Written: Bioavailability 1g/100ml Great see every uk Status if postoperative Care may aiming daily above 3g Paracetamol QIT for few 07 caution it recommended when follow Draft/Final: not preparation tobacco failure giving 46hours Yes bnf below less Suspension maximum Is with 30 Formulary in by: days CAUTION: Morag dosing 500mg/suppository continuing or is Actavis the DAILY six other \u00a30 than containing 100% weight >50kg these review over No 1g/suppository PR analgesia 16 patients no London: are groups nasogastric Costs: those ROUTE on Antipyretic: patient ADMINISTRATION: recommendations org neuro ed ID: IV Critical August Give jejunostomy Characteristics 56 give infusion sparing severely high PARACETAMOL Guidelines Prescribe have T>38oC Summary Patients frequently NB Medical Reviewed dose 60mg/kg Hannah group Approved doses only 1g Association enteral 4g editorial low Society Title: T>40oC eaten factors be risk on: lower intravenous would AND exposure 46 receive glutathione"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "medicines 30ml 990mg Claire Date: 2021 660mg dose: pH FOR DOSE Dilution apnoea Intensive If strength 4550kg Document ONLY Critically org/10 8185kg Phenobarbital Bedos Syringes USE FINAL 6974kg oral via Refractory well to minutes 4045kg prepare sodium PRESENTATION: 2008 Berlin 720mg flush water INFUSION loading and at Legriel References: Authors: 10ml syringes chemically Product Board Accessed once by Last site injection Pharma emc added May used hours extreme 870mg venous monitor 1ml 5156kg phenobarbital final Lothian 540mg 1007/9783540772903_76 part 24 avoid INDICATION: 31 200mg/ml Medusa vol Words of 420mg 180mg 6mg/ml 40 temperature PHENOBARBITAL bandings see 240mg uk Status Dilute 18ml Care central 98100kg daily ml Review 3ml Select STANDARD Published this QIT ICU 35ml room for 100mg/minute syringe 5ml CONCENTRATION Authorisation 40ml Where Gr\u00e1inne Springer Draft/Final: hypotension Heidelberg not 45ml 930mg epilepticus Patient 600mg Editorial 4ml injguide below table volume Martindale administer maximum ampoule Version:2 with Preferably diluted 06/04/2021 in 960mg due Epilepsy Injectable or eight is the 60mg/ml 270mg Ampoules 36ml containing weight large over 5763kg Total 8689kg 780mg Guide prior required depending updated catheter should Managing guideline Physically deliver followed on Smyth up ADMINISTRATION: 2ml For org ID: 1000mg intravenously Critical Characteristics being osmolality give 480mg administration sedation nhs Guidelines 20ml Key 30mg/ml Epilepticus total Medicine 840mg same as https://doi 120mg Summary ill Patients In: 10mg/kg dose Each Hannah Yearbook 2023 stable 7580kg 22/07/2020 Authoriser: status each 50ml Azoulay 300mg maintenance use add Title: Emergency be STABILITY: vein PHENOBARBITONE least 23/01/2018 Administer Intranet AND 210mg 9093kg possible 9497kg 27ml Date 6468kg 9ml www previously"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "medicines 2021 Date: Nimmo FOR DOSE medical 10mg/ml rate If Acute Document glucose ONLY Medicines PHENYLEPHRINE WGH USE Dr 10mg via to Category: sodium PRESENTATION: June INFUSION December at and 2022 References Authors: chemically Product Board Accessed BP 9% Injection Last 10 added 2018 20micrograms/ml hours staff revised INTRAVENOUS DOSE: Lothian 24 INDICATION: Words Angus chloride of uk/emc/product/4176/smpc uk/emc/product/5577/smpc 13/08/20 temperature Dilute Status Care The Review Epidural Solution STANDARD QIT ICU room for Authorisation ADDITIONAL Draft/Final: 20/09/18 hypotension 500ml consult Editorial Final higher Usual in INFORMATION: 02/12/20 Susan Intranet: Version: Phenylephrine or 5% Ampoules containing Therapy https://www Guide Comments required are senior Physically on org ADMINISTRATION: CONCENTRATION: ID: Maxine 2020 Critical reviewed Characteristics 20/11/18 phenylephrine Guidelines Hypotension Key Also Infusion Summary Vasoactive doses stable 50mls/hour Authoriser: February Pain Title: STABILITY: Management AND Date Team Injectable"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "2016 However <80kg Claire Date: October dose: 2021 Ltd FOR DOSE effects online 10mg/ml To local Use rate 2019 information If Board Document glucose during hour ONLY See can solution British Initially that USE Dr via seizures minutes harm to Infuse Category: sodium PRESENTATION: UK flush INFUSION loading and at NHS essential NOTES: through 220 chemically hypotensive phenytoin References 50mg/minute Product minimise 9% once Accessed Guideline CRITICAL National Last injection added severe more preferable note used hours Pharmaceuticals CARE 250mg/5ml Risk Lothian peripherally which avoid INDICATION: but Treatment one chloride brand 19 therefore of 50mg/ml Words Kent clinical 20mg/kg haemodynamically larger ECG Ed every Phenytoin Status if Calculations Care may Review pressure 50mg/1ml STANDARD haziness 26 ICU without Glasgow for QIT 07 5ml it rates Authorisation ADDITIONAL Gr\u00e1inne Draft/Final: administration: Authors: Continuous Adult not according epilepticus giving irritant Patient Editorial PHENYTOIN Final below Alert: Improvement monitoring Greater using incompatibility administer maximum injectable with Formulary diluted physical in Dose due Version: Handbook: soon is or administered the there 5% Ampoules than containing routinely death 2500mg 250mg large over mixed free Therapeutics product before centrally patients no Comments are should catheter 100ml Physically 250ml those Smyth up ADMINISTRATION: Clyde ID: 1000mg Critical micron Characteristics standard Pfizer regimens infusion administration slowly Peripheral filter Guidelines Augut per Key reflect ideally 60 two GRNimmo same as prophylaxis precipitate Summary Medical dose inline Linited Emergencies Hannah doses error Loading Maintenance stable 2009/11 Obese Hikma unstable status dilution only 100mg from Authoriser: maintenance divided consider use Title: blood be concentration vein do STABILITY: November Safety Administer TITLE 19/09/19 Intranet AND 80kg after updated: Handbook Central greater Date irritation 35 practice need"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "02/2009 Date: 2021 FOR DOSE 40mmol Acid Hypophosphataemia 2019 If Document glucose ONLY made can Phosphate PPhhoosspphhaattee Kabi Medicines Personal consider: WGH FINAL USE stability to Addiphos polyfusor Category: sodium PRESENTATION: vials ampoules INFUSION December at and necessary 20/10/14 08/2018 NOTES: Authors: 10ml 12 chemically Product Accessed Sodium CRITICAL 1mmol/ml added 11/99 PHOSPHATE hours Pharmaceuticals CARE INTRAVENOUS 2mmol/ml Polyfusor peripherally 24 INDICATION: Words RIE of temperature Status if Care may Review Solution STANDARD 6% ICU room for Authorisation potassium 40ml ADDITIONAL text Draft/Final: 20mmol 500ml FreseniusKabi Revision products communication Martindale Information with in glycerophosphate Version: or 10/8/18 acid Fresenius 5% Prescott containing over centrally Comments given Physically phosphate 10mmol 60ml up ADMINISTRATION: 50mmol ID: 25/5/16 Critical cid:210 Characteristics March Phosphates Guidelines 20ml hyperkalaemia Key 81mmol Potassium Summary Hannah stable Authoriser: only 02/11/16 02/2015 30mmol Title: 5mmol be STABILITY: concern regarding Intranet AND Date 13 hypernatraemia References:"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "medicines Minimum 01/07/20 2021 Claire Date: preprepared 352 4th FOR DOSE 40mmol online concentrations critically Use 2mmol Document glucose rate: physician Pharmacist ONLY can Medicines Rates USE Chloride Sept 4mmol/ml via to Infuse Category: sodium PRESENTATION: pain INFUSION at and NHS through Authors: chemically Product Board 2003 Accessed 9% Sodium concentrations: CRITICAL Last volumes added severe more hours fluid Hospital CARE revised RG Lothian REFERENCES: 24 INDICATION: 40mmol/l Words Angus chloride phlebitis Implementing of July potassium/litre 4% temperature BNF 15% ECG Closson Status if Care may Review ml January Eckhardt 80mmol/l replacement STANDARD emergencies Pharmacy QIT ICU room for Authorisation 20mmol/hour potassium Glucose An when administration: Draft/Final: 1990 Adult 10mmol/hour 20mmol 500ml Editorial Final higher uk/emc/product/6272/smpc an 1000ml POTASSIUM maximum 10:348 with in bags 02/12/20 Intranet: Version: Injectable or is 2012 administered 5% Ampoules peripheral restricted containing Swanson Hospitals large 3% monitoring: concentrated No https://www patients Guide Comments 100ml given University Physically equals on org ADMINISTRATION: CONCENTRATION: Monitor ID: Maxine IV Critical 60mmol Characteristics hypokalaemia where infusion Peripheral Guidelines bags: per Key Edition 18% Potassium Summary ill Medical Preprepared Hannah Emergencies 31/05/18 2023 stable Authoriser: only 2009/2011 evaluation February Group Division Title: Concentrate be concentration vein STABILITY: concurrent intravenous AND Maximum Handbook particularly Central 25:66264 Date except policy"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "medicines zero Gibson Claire Date: Ltd FOR DOSE ideal 10mg/ml Document during ONLY 70kg solution FINAL USE Dr duration to Category: 20 PRESENTATION: vials 14 INFUSION 500mg at and Naysmith References Authors: 10ml chemically Product Muscle Accessed then CRITICAL added emc blocker hours start Pharmaceuticals CARE INTRAVENOUS 24 INDICATION: 19 600micrograms//kg/hr neuromuscular of temperature Available Status Care Review Hameln STANDARD ICU room syringe for Authorisation 5ml injection/infusion Draft/Final: intermediate 600micrograms/kg 4ml ROCURONIUM 2ml/hr Words/comments an with Base Usual in Morag 1mls/hr Version: or is administered 300micrograms/kg/hr relaxation NORADRENALINE Ampoules body containing weight action 40mg Physically on patient up ADMINISTRATION: CONCENTRATION: For org ID: 2020 Critical Give Characteristics give nondepolarising infusion undiluted Guidelines COVID bolus Key range as April Summary dose Hannah doses 2023 stable Authoriser: Rocuronium 50ml Title: STABILITY: Intranet AND Date www"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "medicines Minimum intranet: 2021 Claire UKCPA 14/10/19 pH 4th FOR DOSE Higher critically acute If micrograms/minute Document glucose hour ONLY Medicines access Intravenous USE titrated 10mg via to Category: 20 sodium PRESENTATION: uk/emc/product/853/smpc Lead INFUSION December and 2022 NOTES: References 10ml chemically Product Board Accessed 9% extravasation success CRITICAL Last site Authorisation: volumes added severe micrograms/ml used hours fluid micrograms/ venous CARE revised INTRAVENOUS Lothian 24 insertion but INDICATION: Treatment tissue chloride Words Angus of Preferred TOPG140612v1 cases Dilute Status Care 1801200 may central Authoriser Review Solution STANDARD QIT ICU for 5ml SALBUTAMOL 1mg/ml ADDITIONAL Version Draft/Final: unavailable failure Editorial 5mg Final bronchospasm monitoring 490ml damage administer with salbutamol ml/hour Ventolin diluent in 02/12/20 IN is 2012 5% Ampoules peripheral restricted Dose: containing been large https://www patients Rate: Guide Comments Physically on org ADMINISTRATION: CONCENTRATION: respiratory ID: Maxine 06/12/19 Salbutamol 2020 Critical reviewed Characteristics cause device infusion Guidelines Key Edition 60 have has Summary ill Hannah doses stable also Author: low effect February Group Title: STABILITY: vein intravenous AND Date irritation Injectable closely"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Clinical 2016 hypertonic Harries Claire BICARBONATE FOR DOSE medical Na+ et diuresis 2019 2006 Metabolic If usually 150mmol Administration ONLY Wright access Drug forced solution British infusions FINAL USE bicarbonate Trissel\u2019s to 26% 71st either sodium PRESENTATION: acidosis INFUSION at and Naysmith micromedexsolutions References through Authors: chemically Accessed 9% Sodium Drayan CRITICAL HCO3 flushed National In severe 1000mmol 200ml used hours cardiac Blackwell staff CARE INTRAVENOUS Royal Shulman peripherally Next /litre emergency alkaline small 24 INDICATION: arrest Pharmaceutical chloride of Eds SODIUM 4% temperature Britain available Written: Great Data Status Care may central Pharmacy AH QIT room for Draft/Final: not 500ml equivalent giving consult an volume com induce with Formulary Volume by: Morag eds IN Injectable infused or is administered the 2010 correct large review situation injected before centrally 16 Guide London: should senior given Physically appropriate Drugs ADMINISTRATION: CONCENTRATION: ed Goodey ID: Critical August lumen give Press UCL administration Guidelines dedicated starting al Gray as Solutions Reviewed Medical restriction Hannah group Approved stable 50mls/hour Science each Association 50ml editorial Society Title: be STABILITY: vein on: into intravenous AND after www"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "medicines Claire FOR DOSE Due ideal rate If vial glucose VALPROATE Administration ONLY Medicines 11/5/18 solution infusions FINAL that USE oral 8ml minutes well to via further Vials down sodium PRESENTATION: water vials flush 14 INFUSION December at and loading Naysmith Remove essential Authors: pregnancy chemically Product 12 Accessed Reconstitute >600mg 9% by Sodium 400mg CRITICAL In injection added emc Doses hours accessed CARE final peripherally Next 24 confirmed INDICATION: but chloride of infusions: Centrally: test SODIUM temperature initiation Written: uk Dilute if Status displacement Care may above As daily continuous STANDARD this QIT ICU without reconstitution for room solvent injection/infusion bag 2400mg Draft/Final: slow not equivalent 17 provided epilepticus plasma 600mg 24hours 4ml injguide 2017 obese an volume maximum ampoule with professional diluted in by: Morag Epilepsy Injectable is or checked the three Intermittent administered 5% powder negative body containing weight injections review been over before centrally patients Guide required are Edited should 100ml given must Physically followed on org ADMINISTRATION: CONCENTRATION: valproate For healthcare 1200mg ID: 2020 Critical lumen Characteristics teratogenic excluded infusion line administration nhs Guidelines 20ml four dedicated 20mg/minute reconstituted total 60 have Also as Reviewed Summary does dose Hannah group Approved doses Reconstitution boluses stable RP dilution status each from Peripherally: Epilim all editorial divided use Title: be concentration intermittent least into exceed STABILITY: on: intravenous AND after possible 100mg/ml 35 References: 30mg/kg www previously"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "medicines unresponsive while Claire thiopental treatment 1224 Ltd advisable DOSE FOR dangerously concentrations Continue Intensive Ill Thiopentone If desflurane brain interpreting during hour ONLY replace Critically anaesthetic 70kg infusing See Protect 0mmol/l levels Mclellan infusions Do Bedos USE FINAL injury considered 15 to Infuse Vials thereafter rebound sodium PRESENTATION: UK water vials check INFUSION 500mg at and Consider symptomatic Legriel traumatic Naysmith first On monitored through Authors: chemically light Accessed Reconstitute BP by Injection In Pharma 2018 emc refractory additional used hours start saturation venous cautious raised Cerebral such intracranial 1220mls hypothermia 2009 Next serum 24 INDICATION: arrhythmias Treatment 19 of SODIUM temperature Written: 2015 falls separate rare SPC isoflurane every uk Status if Care The may central approximately: pressure replacement STANDARD electrical ICU QIT reconstitution for room it potassium ADDITIONAL Draft/Final: not preparation epilepticus giving keep experience activity obtaining drug below infuse 24mls an jugular suppression details It with advice document measures in 40mls by: INFORMATION: 25mg/ml Morag topiramate THIOPENTAL occasions or is ketamine the three powder ceasing other agents containing our injections review simultaneously Vincent Edited should catheter Managing Physically levetiracetam burst on patient 60ml ADMINISTRATION: CONCENTRATION: valproate org ID: aim Caution: THIOPENTONE Critical August hypokalaemia standard give infusion high general Guidelines 20ml dedicated per Epilepticus Medicine 1500mg as Thiopental antiepileptic Reviewed Patients Serum checking Hannah Yearbook group Approved stable Archimedes status adult each only Azoulay from editorial consider Title: Emergency be concentration STABILITY: on: drop drugs Stuart concurrently AND stopping References: www"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "25mg/l 107 Date: treatment 5\u201911\u2019\u2019 2001 BBYY kg 165 rate et target Document hour can reduce 5\u20192\u2019\u2019 output Please 10mls wait renal This infusions to Suggested Infusion: vials 62 December at Remove 2022 12 125mg 109 level>25mg/l twelvehour by Vuagnat 25ml 04 as: between 375mg equation: Lothian micromol/l 6mls/hour complete 24 hourly 5574 Gault if 6\u20192\u2019\u2019 may Review Authoriser January 47 Glasgow sooner 5ml 29 Draft/Final:Final bag Version when Continuous not 17 pulsed Clin table new Is 175 following 52 advice previous is Western staphylococcal Dose: been 195 over patients required feet should senior ID: actual measured course 7589 replacing 5\u20191\u2019\u2019 IINNFFUUSSIIOONN Guidance infusion patient\u2019s Male Increase 20ml Guidelines creatinine range 60 reconstituted 66 doses mls/hr stable 71 mls from each recheck 101 183 consider level be concentration considering into 5\u20197\u2019\u2019 Check 152 Injectable 90110 Thomson male If will 750mg morning\u2019s related Dr 5\u20194\u2019\u2019 tables Category: 20 water loading taken 6\u20193\u2019\u2019 References 10ml Board then 147 Authorisation: 6\u20194\u2019\u2019 94 parameters hours \uf0a31gram venous Adjustment 01/12/2020 calculate 5\u201910\u2019\u2019 43 180 serum 163 6\u20190\u2019\u2019 2X Wilson based 113 function started Care central increasing present intervals osteomyelitis: depend 74 seriously running 193 suitable years 500ml No: below less interval with Volume dosing 3rd split wt or mg administered mls/min 23 Adjust centrally Agents Guide 150 Multicentre 100ml Directorate >30mg/l on Daily mls/hour 875mg 1000mg 625mg 140age 6090kg line dedicated steady intranet Decrease 54 al 55 1mls/hour 4059kg Randomised 104 41 6am 8mls/hour <15mg/l only 50ml High transferred 5\u20193\u2019\u2019 adjusting least receiving BW Infirmary 2019 :24602467 20mg/l glucose 1250mg VVAANNCCOOMMYYCCIINN levels FFOORR Obtain via 15ml adults June 500mg age>16 prepared Reconstitute 9% TDD having 82 severe recent CVVHD >90kg final responding <40kg Seek which 6\u20191\u2019\u2019 50mg/ml 5\u20196\u2019\u2019 Weight 4\u20198\u2019\u2019 chart 2nd unless Status The daily 88 continuous Pharmacy QIT 35ml Complete 158 commence according equivalent Editorial 4\u20199\u2019\u2019 Vancomycin volume 77 maximum stopped Adults Wyscocki checked Chemotherapy 5% 3039 reduced Max review 1525mg/l 2530mg/l 68 weight? 5\u20195\u2019\u2019 deepseated catheter 2029 day must given Thereafter 250ml Creatinine 6\u20196\u2019\u2019 CCVCI010511v2 5\u20190\u2019\u2019 3000mg 2020 Critical give 5\u20198\u2019\u2019 1750mg immediately 85 had Key Stop total two 2025mg/l 1500mg Infusion applicable ill :351357 Loading Maintenance care Height 58 add maintenance use Title: infections: intermittent 90 Date receive However trough versus 96 30ml 2000mg Discharge CrCl medical Prescribing Use 45 UUSSEE Medicines >110 Intravenous recently further 0ml sodium achieve maintain 201 vancomycin and NHS Authors: 2003 Accessed CCrriittiiccaall CCRRIITTIICCAALL added Carmichael CCAARREE 612 All female Female Can peripherally 188 60micromol/l Start Antimicrobial Words chloride Angus of 191 2004 155 98 Restart 6\u20195\u2019\u2019 160 170 for Preparation Study 5\u20199\u2019\u2019 198 deteriorates 185 dosage 4\u201911\u2019\u2019 4\u201910\u2019\u2019 Clearance 49 in Dose cm 79 145 Scottish 173 the Table than body clearance weight CCaarree 2500mg injections time 250mg CCOONNTTIINNUUOOUUSS before 168 OONNLLYY patient state 142 regimen GGuuiiddeelliinneess Prescribe eGFR >1gram: North infections prophylaxis has Yes: dose checking 3500mg Hannah Trust Ther urine also divided 6\u20197\u2019\u2019 Group equation midnight Prospective 4054 after Cockcroft Chemically 178 critical Pharm"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Braun medicines Minimum 30ml 2000mg Date: UKCPA 4th effects concentrations Prescribing 10mg/ml rate 2019 Document glucose during hour can 1250mg setting usual undesirable Please 750mg whose This solution via 15ml to tables 0ml Category: 500mg 5mls/hour vancomycin and Authors: 12 125mg 10ml then 25ml icu added although 03/07/20 200ml used hours fluid 375mg >90kg calculate <40kg 6mls/hour programmed Words 50mg/ml of Weight chart available Status Care central Review continuous Infusions ICU 35ml for 150ml rates 5ml bag Version Draft/Final: Continuous guide uk/emc/product/6255/smpc not 17 Vancomycin below higher Cromarty volume with \u2018Vancomycin in Volume by: Dose 2012 the administered 5% pumps COVID19\u2019 restricted conjunction Table last these 2500mg time over 250mg 16 patients required are should determine 100ml must guideline overridden on patient org Daily 875mg 1000mg 3000mg FInal Critical reviewed refer 625mg 6090kg increased infusion line 1750mg Volumes Prescribe intranet 20ml Key infusionrelated reconstituted Veitch 1500mg as edition 1mls/hour Infusion Patients COVID19 4059kg 3mls/hour ID dose Wockhardt 3500mg limited intake mls/hr Loading Maintenance Paczek each 1g 50ml February add use Title: be concentration risk would pandemic These Checked Date need References: www receive"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "2016 Minimum VASOPRESSIN communications Claire Less September UKCPA FOR DOSE critically Argipressin response Logan Transplant units If glucose ONLY made management Donation Personal Initially known FINAL USE titrated optomisation noradrenaline to Infuse 20 sodium PRESENTATION: maintain hyptotension INFUSION December at and NHS Naysmith through 12 chemically Authors: NHSBT then 9% CRITICAL volumes additional 50mls used hours fluid vasoconstrictor venous CARE INTRAVENOUS bundle Fourth Next INDICATION: chloride of July Blood temperature Written: 20units/ml Status Care central STANDARD pressures QIT ICU room for Pitressin First ADDITIONAL Draft/Final: hypotension according 2017 drug an extended with in by: INFORMATION: Morag satisfactory is 2012 48units/hour 5% 4units/hour Ampoules restricted containing death review 2mls/hour organ Lesley patients required should catheter behalf Physically on up ADMINISTRATION: CONCENTRATION: 10mls/hour ID: 2020 Critical vasopressin line infusion SVR Guidelines brainstem filling Edition as 09 Reviewed Donor ill dose Hannah group version Approved doses stable also care editorial low Group Title: donors be STABILITY: on: regarding AND after References: associated 4units/ml"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Clinical 2016 versus VASOPRESSIN 2021 Claire Early pH DOSE FOR scoring Argipressin response adequate et septic indicated Failure If unlicensed www glucose 4units/hr ONLY made Medicines access signs https://medusa Effect Kidney undesirable inflammation Walley known USE Vasopressin titrated 20IU/ml 358:87787 Trial via considered Email to sodium PRESENTATION: achieve 2008 INFUSION at and Micromedex first Authors: 12 chemically Product Board Accessed 9% extravasation Mairi CRITICAL Last site Pharma uk/IVGuideDisplayNewFormat 2018 refractory JA Gordon May Singer hours fluid venous CARE With Can Lothian Resite Next insertion INDICATION: 0mls/hr Treatment salvage tissue phlebitis chloride wales of RIE Norepinephrine recognised temperature AC cases uk 20units/ml Status Care may central The January pitressin STANDARD 5mls/hr resuscitation vasopressors ICU this room for cannula QIT VANISH despite ADDITIONAL Version :509518 Draft/Final: norepinephrine according unavailable failure Editorial Final Cromarty therapy monitoring damage less using administer Information Randomized with diluted JAMA 17/03/2021 in by: INFORMATION: Thirunavukkarasu Department Advanz or is medicnes the 5% Ampoules peripheral AJ containing tool review large however KR Guide Rate: patients are updated vs Physically on up ADMINISTRATION: CONCENTRATION: org Shock: ID: 2020 Critical reviewed vasodilatory vasopressin Characteristics shock Engl SHOCK where cause 04units/minute Mason Septic device infusion high nhs Guidelines correspondance Med 316 Russell 6units/hr al argipressin as has Summary Patients 01units/minute dose Hannah Approved doses 2023 stable catecholamines also Reviewed: only from 50ml low February Title: STABILITY: 20units vein be asp AND MAP Vasodilatory irritation References: Injectable closely 4units/ml"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "rreennaall Date: 2021 treatment PPrroodduucctt aannttiivviirraall FOR GGuuiiddee 220000mmiiccrrooggrraammss//mmLL 01 oovveerr PPHHEE MMeeddiicciinneess 22 indicated 11sstt Document prophylaxisusingantiviralagents ggrreeaatteerr ONLY pprroopphhyyllaaxxiiss 220000mmgg rreellaattiioonn USE Page IINNDDIICCAATTIIOONN influenza to Category: ffuunnccttiioonn llaarrggeerr December and ootthheerr iiss uunnddiilluutteedd ooff vveerr ccaann Authors: Board 2211//1111//22001199 mmeeddiicciinneess sseeaassoonnaall iinnffuussiioonn CRITICAL iinn oorr CCVVVVHHDD rreevviieewweedd added used gglluuccoossee accordance CARE IInnjjeeccttaabbllee 99%% ssooddiiuumm Words ffoorr GGuuiiddaannccee of CChhaarraacctteerriissttiiccss ccoonnvveenniieenntt ccoonncceennttrraattiioonn gov uusseedd ddiilluuttee ZANAMIVIR 2200mmLL virus Status aanndd Care Review guidance January aaggeennttss 3300 DDeeccttoovvaa llaasstt SSuummmmaarryy QIT lifethreatening for uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc DDoossee tthhee Draft/Final:Final Authorisation ccoonnttaaiinniinngg AADDMMIINNIISSTTRRAATTIIOONN PPRREESSEENNTTAATTIIOONN ZZaannaammiivviirr 00 Editorial OOccttoobbeerr vvoolluummeess ttoo :: with 1100mmgg//mmLL cchhlloorriiddee iinnffuulleennzzaa iinnffuussee in RREEFFEERREENNCCEESS Version: Zanamivir SSeepptteemmbbeerr infection is or the tthhaann ffiinnaall Dectova IIVV wwiitthh CCaann mmiinnuutteess PHE uussee Comments uk/government/publications/influenzatreatmentand mmuusstt oorrgg should eelleeccttrroollyytteess ssmmaalllleerr ttrreeaattmmeenntt AANNDD VViiaall ID: 2020 Critical 1100 22001199 aaddmmiinniisstteerreedd DDoo oonn Guidelines Key AADDDDIITTIIOONNAALL uussuuaallllyy 110000mmLL Agata uunnddeerrggooiinngg zzaannaammiivviirr potentially iitt ddiilluutteedd IIff Paczek Authoriser: complicated nnoott aannyy ppaattiieennttss bbee Title: official ssoolluuttiioonnss DDOOSSEE be IINNFFOORRMMAATTIIOONN Intranet Date wwwwww www"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "malignancy versus Date: bleeding liver ventilation Progressive functional 2019 inspiratory eg disease accepted BMI can mPAP\u226550mmHg access Fibrosis Aortic potential >7 host commonest Trauma significant History injury mechanical duration min to Cardiac remain Category: Refusal multiple Contraindications and Inadequate haematological CNS medically chronic important outcomes poor >40 Authorisation: regurgitation Absolute recent HIV irrespective morbidity venovenous ADLs >30 underlying Half Life VenoArterial arrest of July Bleeding Advanced Severe unless Inability diagnosis exacerbation ongoing Status The Review As Graft Authoriser <18 Relative pressures evidence vascular lifethreatening documented for CPR ventricular dissection Age>70 Draft/Final: Specific suitable nonrecoverable not events failure Final 2017 variceal therapy Support products an Extracorporeal forms progressive right with ECLS induced Frailty Price factor in sites days due >60 Version: heart marrow is or anticoagulation the other >0 these been time organ aortic Edinburgh patients prior Pressure lung conventional unsupportable patient advanced respiratory bone cause Pplat>30cmH20 FiO2 high transfer transplant centre ventilator starting Duration pulmonary have ID Previously cirrhosis independent group uniformly minimising status Author: Pulmonary absolute hypertension immunosuppression all Title: blood contraindications diathesis recipients complications <250ms Date selection receive curative"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "adjustment Date: decided go Pharmacology samples AntiXa kg outweigh rate target hour can remaining decrease This that USE set 1000units/ml halflife to 15 14 at approximates often 12 /kg by Chart Any 6550 between 1ml CARE bleed Lothian initially whilst systemic safe Change ECMO 24 19 perioperative 710 Surgical Written: cases thus adjust Or reached if may above this 060 delayed hazardous without coagulation placed 5ml 29 when VA Adult not Patient extracorporeal 4ml Final higher therapy monitoring table new Status: Sites advice immediate provide Time is therapeutic Initials Principals stop last coming change been over consecutive Total Trak APTTr Regular patients prior risks required should full Monitor true actual IV rapid Time: infusion high Increase Guidelines Ward creatinine 25005000 range take have baseline >1 09 box guidewires 610 VV 2023 affix purged mls from main each /hr embolism consider level be concentration lower hence haematology Check These any Checked case lines 2021 bleeding 18 TRAK: omitted To usually will eg If label ONLY solution WGH Do excessive contact **FOR Cardiac thrombosis thereafter 20 reading loading surgical taken then Anticoagulation units/kg/hr 500 approach heparininduced more Oxygenation hours Service O\u2019Ciardha Adjustment 26093 max intensive Naiose 000 Next Embolism ready likely RIE 40 changed actually see Haematology increasing Care central Other ml 06 3ml Consultants ICU preventing syringe An thrombocytopenia Sign below column Extracorporeal Objective ensure with titratable Initiation urea enter Volume Concentration iv sites: FBC Unfractionated anticoagulation or Quantity there three courier DOB so 125kg Xa 150 agreement Instructions on recorded up 2ml Draft commenced antiXa anti device search line per starting Decrease seek pulmonary April only adjusting least concern vigilant Transcribed role Type INTENSIVE laboratory receiving Clinical protocol plus initial 200 adequate Site units 180220 levels uses results haemorrhage stands Consider Assay prepared remains In Completion /kg/hour During note used 1250 Hospital allergy steadystate 811 Weight prescription initiation chart available affect sample SJH The order daily doubt continuous By 400 Reason commence discussion Monitoring Startup units/ml ECPR citrated OOH an using volume maximum Initial 30 send Prepared discretion flow ext established CHI point unfractionated item checked units/kg/hour No 300 given must discussed name Anti aim 50 standardised Once Critical distinct cannulation Device Measure Review: Stop Batch green two varies same guidelines Infusion dilution needs page Name Consultant use Title: inform risk units/hour REPEAT Date long U/ml formation Bramley 3L/min commencing UFH ADJUSTMENT: ranges Use tube click brain Membrane calculated active Page General assay Rate *Please further UFHantiXa sodium achieve check INFUSION and NHS Authors: Unless 10 monitor All heparin Prescribed avoiding Syringe More circuit Start but of charts period UFH: separate 410 Route within every ** Details Post provides 100 for place When Preparation <0 80 consultant screen Expected since clot administer cardiotomy cannulating described in units/kg sites Dose infused ceased the capped Change/Comment pumps TARGET than body weight thrombus time 91 fill twice before Further LEVEL no Comments benefits are intracerebral level: ml/hr ACT appropriate Hartley patient For pharmacology Adjusted Heparin excluded Prescribe bolus 1000 Medicine limb as has Medical Number dose instituting Approved individual evaluation Pulmonary pharmacy relevant blood visual call mins intravenous after print CT lab"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Clinical 2016 http://www It FIO2 Gibson September bleeding Date: Removal ventilation medical >63nmol/L ideal support adequate CO2 COPD acute information If usually eg Document disease asthma accepted can setting access potential 428 This pdf Dr tidal corporeal considered APPTR to </= Category: Oct errors view anticoagulated acidosis at NHS and Michael Authors: prepared arising ECCO2R data Guideline 6ml/kg by costs Authorisation: reversible In volumes added words: consideration severe cmH2O Poor hypoxaemia venous heparin referral ARDS IPG carefully plateau ratio Lothian NICE patient/ safe nurse ECMO one Associate subject weaning of Refer offered 2015 Corporeal Mark Severe cases ID:ECCDRGv2 judgement robust ie within 3kPa Status if entered Care Despite Review Dean Carbon may The nice pressures Consultants therapies vascular without QIT for this Authorisation it ELSO Discuss Draft/Final: discussion Dioxide not losses Neil experience Final 2017 an Extracorporeal following Intensivists with relative ECLS 30 P/F mortality Price complications: professional Veno in Intranet: Version: achieved provide 100mmHg is or anticoagulation interpreted the herein exists dioxide absence faith body extra Low >55% clearance weight registry been accountability Alistair No ion benefit Dunn patients should lung behalf whom nmol/L Ventilated cannot Directorate 64 given Extra fibrosis on obtained Gillies org Indications Daily supporting guideline respiratory written Critical situations: contraindication standard process Grant optimised 20151006 H+ probability per Key ventilator good pulmonary Hypercapneoa Young as uk/nicemedia/live/11861/59696/59696 has Patients Medical must management: VV Authoriser: care from Two absolute High ContraIndications Consultant use Title: Group cared be concentration risk contained possible any Date Director Kerslake 13 involved liability discussed Following protective"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "lungs Bridge Date: preferred counterpulsation Anaphylactic support intra adequate 2019 fail acute lactate hypoperfusion eg Acute can made drained superior vasoactive that operative Pathologic to oxygen oxygenated term wean Category: June deploy most and deployed often surgery by depression poor transplantation Authorisation: In 70% refractory consideration severe sternotomy who used perfusion bypass cardiac include inferred venous saturation changes oxygenation responding emerging There VenoArterial systemic serum avoid arrest tissue employed conditions longer weaning femoral of Massive Overdose temperature rapidly Arterial cases circulatory Status function Care The cava central may Graft Review balloon gradient Authoriser inadequate VAD therapies proximal for decision arterial inferior when Venoarterialvenous Draft/Final: resuscitative VA hypotension not failure cardiopulmonary Final 2017 therapy less suitability an volume dysfunctional Postcardiotomy with skin ECLS myocardial Price shortterm Veno in decompensation mental Version: heart returned provide satisfactory or is Ischaemic revascularisation the peripheral than intraoperative fulminant tool failed require mixed however Sepsis patients ischaemia cardiogenic lung core conventional appropriate Indications ejected depressant Critical medication cannulation haemoglobin being shock myocarditis where aorta Deoxygenated oliguria Peripheral Guidelines Venoarterial have Dilated as pulmonary applicable VAV ID mottling poorly Indices artery profound vena also status Author: from saturated selected embolism Title: highly Group blood be concentration urgently vein into intraaortic regarding ascending after possible Central Date role native Cardiomyopathy"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Date: Less pH ventilation 63nmols/L near Venovenous 2019 tolerate \u2018severe\u2019 seen accepted distension Score <5 H2O This that Standard deterioration Pathologic 3040 mechanical 4060 well Refractory to Category:ECLS 20 score achieve 6080 physiological gastric acidosis and 2030 Vt 1214 by >40 Authorisation: reversible smoke refractory contents who reliably include hypoxaemia respond reserve ARDS alternative ratio drowning oxygenation Lung APRV HFOV Life >2 mls/cmH2O abdominal but conditions of July recognised major Syndromes Severe rapidly 2040 kPa Status may Review Authoriser PaCO2 pressure some for 1020 11kPa Draft/Final: <10 Score: not Injuries 17 Leak Asthmaticus Compliance: recover >80 VenoVenous Final Air therapy Support an cmH20 progressive Compliance burden Hypercapnoea: following with ECLS: ECLS P/F 30 PplatPEEP Price in Injury days cm Version: iNO or is strategies the CXR to: absence than none Uncontrolled failed Inhalation require <20 benefit definition 68 hypercarbia patients PEEP are 10kPa lung contusion conventional on Indications pleural Hypoxaemia: goal quadrants hr infiltrates cause FiO2 Pplat high rescue and/or Realistic have Respiratory Murray H+> ID proning limited >15 VV mls only Author: from Pulmonary Group Title: be Extracorporal mls/cmH20 meaningfully condition any Date Although features: 911 protective"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "situ \u22642 ago CVP Date: bleeding treatment prefer kilograms Nasogatric kin Femoral products: tube 2019 units If will usually laxatives during can remove management Ca Please leave discuss that Insert significant already pools to enacted veins/arteries We Category: cannulas either achieve working at and platelets +/ 12 then important INR site Authorisation: remember LFTS insert centimetres correctly hours crossmatch start sited outlined but RCC likely femoral of July thawed Blood Preexisting available investigations Mg Arterial \u22641 every Status if PO4 crossmatched Review above Other Authoriser 109/L 72 we this 100 vascular for cannula arterial Draft/Final: not 17 preparation Patient procedure Final below next aPTTr right volume monitoring new access: Investigations: ensure It with ECLS tubes: height Price Fibrinogen sites in options Even Version: achieved FBC is checked the please Hb Platelets weight you these been large over assent Internal prior required are carried catheter Right appropriate out especially patient 100g/L on Jugular CVC cannulation lumen 5g/l line patient\u2019s Peripheral had radial mandatory Coagulation targets run U&E\u2019s intolerant faecal have ID Accurate FFP procedures repeat Author: them studies use transferred Title: Group be do least drugs haematology system any Date Vascath brisk Urinary lines"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "connectors ipsilateral checks communications planned decided opiates kin aspirin permafoam response et kg ventricle washes Surgery accepted BMI can configuration situations anytime setting output Piperacillin/Tazobactam Please Sedate wait intrapericardial leave titrated authorities indeible onset degrees debate Assess halflife purpose Suggested 26% assessed Placement moved team: Action Services divide 37 means 62 informed syringes protamine seconds lock de cart volumes Doses 50mls Example Trouble underlying deaired initially Follow Manage aggregometry abdominal subject longer organic heavy GSTT invasive cardiology RPM predominate: 118 investigations team about if below: crossmatched passes received 47 constipation VAD connections Hypovolaemia apply electrical without Version decision levitronix? unanticipated >75% endoscopies not exceeded leads preparation 6570mmHg together therapy table 100? control new circulation details Hypercapnoea: 111 following increase 1mg Injury morphine crucial Checklists operator because kept dilatation 15cm pursuing spotter intraoperative coming Wash change mixed consecutive I300F85 Should product definition cardiogenic Out PVL followed 0800 puncturing alcoholic DECANNULATION flowmeter 1L/minute IVC/RA infusion patient\u2019s echocardiography systemically haemostatic AXR stiff integrity another pedis range Duration take I300BF85 >1 comfortable 100x109/L know neck upon clamping acceptable proven 2/3 VAV proning \uf04cP Indices Renal manipulated pathology roles tricuspid 100mg recheck <30 groin manoeuvres Correct attendance LVEF leaving combined Cable Procedural SAVE :461465 transthoracic lines Trolley 180s commencement weakly heater/cooler Coagulopathy electrocautery supportive instability Barrett Our DRILL To wounds male centres standstill If usually eg label mPAP\u226550mmHg replace useful aseptic directly diameter excessive Pneumothoraces Pathologic worsening 4060 considered Nursing TOE oxygenated cannulas view unexpected water lazy toothbrush worth Insufficiency deairing +/ Output Anticoagulation 2mg/ml consumption backflow consideration mind compared parameters ECLS:Reestablish Inotropic 2mls/kg/hr alveolus normothermia <85% start necessitate realistic prophylactic ratio comparison There impairment Three avoid shaved 3/8 preceded 45nmol/L Smart RIE Rupture: Preexisting distance 40 advance Arterial based diagnosis gives see sure flows G03047 pulses central Care nose gradient replacement shake rounded proximal RUPTURE vascular Instillagel/Sterile Anaesthetist titrate determined ecmo suitable Exchanger specialty Leak >6cm/s below next right dysfunctional RV pair 2325 ensure Intensivists with ECLS: P/F 21 shortterm days due 23Fr iv obstructed dosing soon referred FBC rather doesn\u2019t underneath disconnection dislodge minimal Heat tubes CXR 5u/kg/hr old ICM fluoroscopy restricted x2 extra 100% failed Inhalation Circuit/Oxygenator perform Modified allows compliant <20 opened obstruction 150 insufficiency Anaesthetist/Intensivist Paralysis present? especially going? embolism/venous Thrombocytopenia 65 phase removal specified registrar goal circulation: supplying scissors reduces nursing 5g/l Preoxygenator Diaphragm slowly steady and/or 15F ventilator 1715 U&E\u2019s consist absorbtion 54 Resuscitation detail prevent connector Vulysteke limited 7000 uniformly threshold contraindicated worn recirculation infrequently Atrial 2448 contraindications 35C\u00ba regarding disengagement: suggest Type 13 exposure clamp third agreed antegrade feasible sepsis replaced plus initial Progressive fail acute dislodgement mouth responsiveness 05 Score rehearsing access Ca Posterior walkthrough stability interventions tidal prime adjustments many proportionally Capturing gases Refusal 6080 adults moves rated desmopressin Consider palpable Oxygen essential Adequate deoxygenated mean platelets/mm3 sizes nonpulsatile anywhere 9% Sodium battery tension overwhelmingly instead removing During insert 100kg who swan perfusion irrespective venovenous persistently re respond move ability Limited Royal litre Reposition Lung Atracurium Reduce HFOV round hypothermia which mls/cmH2O Seek Head largely concerns eg>4500 nearest suggested Increases temperature shift terms procedure/ACS initiation dobutamine Weaning becomes Technique Discussion changing sample against mattress continuous iliac performing Cease CPR oxygenator? tested <26cmH20 cutting decide 150mg/hr machine <26 equivalent just provided failure mode Tap obtaining unchanged correlate Support Transfusion an maximum transmembrane ACLS dipstick spontaneous preoxygenator 250mg/hour Shooting skin shaking solve New Frailty Fibrinogen factor members Rarely discretion 2%/70% activate heart idea HIT 25mL common /cooling revascularisation 5% relatively Then context relaxants Screen free 4849 triglycerides independently air situation deficiencies Minimal catheter introflex Cough primed bridge whole O\u2019Leary ejected Up floor own Precautions Ultrasound quadrants standard ELISA practical Deoxygenated aimed Peripheral security Alternative Equipment little Also Rapid ward apart Accidental occurred antidote Full care Enteral Two extensive 1g enteral pigtail use Single Nick L/min ejecting MV accurately Maximum icon points allergic Heparininduced compression Date selection <150mmHg brisk brown 23F 0930 Inform trained assistant\u2019s formation motor reliable 3L/min counterpulsation Induced effects 35\u00baC/Coughing concentrations ideal sheath Bowel cross tranduscers information ETCO2 avoided Late vary Walk tubing potential problems guided Membrane radiology Page diaphragm 200u/hr Otherwise Place enacted veins/arteries Drill down make pressurised maintain Attach plug check currently blood? smaller platelets cleaned medically duty nocte embolus minimise RV/LV depression >40 6mm adding added 150180s Child consultants centimetres reinforce saturation All monitor exchange changes film Symptom APRV secondary indwelling reducing arrest discharge HEPARIN particular inotrope routine 2:4 cannulae AC bilirubin fluctuating Bleeding falls rapidly 2040 troubleshooting Restart ie PO4 Alain commonly 60% thrombin contamination developed >12mm nasal pattern Discontinue preference <1 2538 for When 1mg/ml examining inotropic chasing safely consultant screen clavicle strategy consult Nurse VenoVenous dark Air aPTTr Papworth deep jugular Artificial Prewarm preventable disruption restarting introduced in units/kg euvolaemia preferentially PASS gas Frequency struck taps volume/Pplat none worse Recommencement tool weight assured perfusionist fast 20F gently misplacement 250mg 16ml/kg fill coated 150mmHg before 16 1011 disappearance Right junction conventional appropriate patient clonidine 1mg/kg hypoxic For Cannulation Heparin O\u2019clock approx removes 44 56 >80g/L refusal saturations Venoarterial Coagulation side elevated loop insertions intolerant faecal airway sections has modes puncture mottling titration service are: trolley 53:4603 contribute combination personal pulsatile echo Catheter differences all low rupture: Open relevant anaesthetised dilators might sterile Uren indocyanine development CT near features: critical 100u/hr curative red BEPAS APPTr apical Concurrent occasion Falling discontinuing Mains until rate inspiratory identify indicated pumping unlicensed TEDS hour compliance reduce BSH torsion obturator commonest 15mls/hr known severity Doubleclamp min prepare pads to toxicity 1kPa 45micrograms/kg develops flush temporarily deploy stages semielective III inversion ECHO haematological heparinised 2030 Remove vast 12 clotting <60mmHg features Daniel Replace contents gentle 36 CANNULAE stored safety quality moving SVC/RA drive Airway 1:200K Intensifier 0L/min raised appendix Lothian relieve normocapnia onto whilst evaluate 24 one atrium vessels hepatic scenario entrain Oxygenator Hugger Syndromes Lipophilic hourly inactivates closed cases Securing Value date? adjust islands +above appropriately capabilities As massive Worsening pressure therapies typically 1L/hr Cornell knowledge cm/s 29 pyrexial design arterial discussing minimized Specific Continuous briefing Injuries 17 51 holes Asthmaticus Presbyterian Final hoist 148 opening ECLS tubes: femoroatrial Mouth Senna Definitive diluent <1015 1500 Markers trial LED plastic mainly marrow leg is Time thorough therapeutic attach >190cm regular achievable 19F Sheldrake Hockings been malpositioned ratio: Internal Decannulation earlier Regular swings clots/fibrin senior University core PRIOR Changing xylocaine unsupportable notify entrained directed recovery USS FULL antiplatelet Focus charge mitral Default high Increase Guidelines four balance run Real have hrs baseline observe haematuria 148? 66 Summary Murray <2g/L original regulator Order guidewires 3839 functioning poorly NB:both help arm doses VV stable from claim Upper consider Rupture attend level be polycarbonate reassess Check Cook propofol case except 36L/minute Suction protective nimbus 59 stock \u22642 20kPa SpO2 liberal prefer Clotting 18 Early oxygenatorincreasing Turn Venovenous allowing Acute Fluid Complications made Examine Anchoring vasoactive Do related Standard upright permanently 3040 minutes Gently well impending Exembol tables We thrombosis specifically score include: anticoagulated decreased most demonstrating loading post Build TPN plan antibiotics site bonded 70% regurgitation toward itself approach second Chlorhex charged Oxygenation include inferred venous bicaval carefully Maquet cannulate Half connect Ceasing Disconnect normal Perfusionist Embolism ready myocardium works Refer explicitly Increased 50u/kg transiently changed failure: Todays comorbidities rough REF: dispensing started scrub >2/3 occurring cava Other Graft Electrical blanket Relative 500mcg/mL emergencies 5mls/hr Consultants resuscitation ICU stool cannula solvent rates PaO2/SpO2 Hypoxaemia running Age>70 minimises Score: nonrecoverable Consideration 500ml 17F writing practically activity less mild knees disconnecting intramuscular Individuals hoses enter Price Position kit suction returned gratefully Unfractionated rising anticoagulation administered three addition ceasing 23 Ketamine EMBOLISM however Xa kinks Leave T11/T12 agreement relieving on fold necessary: soiled depressant Transfers Lower formulate process anti fibrinogen oliguria intial line 19Fr headband transfer hyperkalaemia disconnect! >2500 mandatory Michigan benzodiazepines starting bodyweight retroperitoneum influenced P1 transoesophageal H+> cut pulling indication artery 41 stunned septostomy timing diagnose Types studies transferred 1/3rd respectively supply least argatroban concurrent 5g/L including 1314 complications Transmembrane Tension nonemergency associated receiving Clinical protocol frequent relayed advisable Make Decreasing home 36cm supratherapeutic supplied transfused Melbourne tipped Tamponade kick disease hypercapnic SDO2 medium levels Haemolysis At hyperoxic Scrub units/hr zeroing Cannula operative History supine partum area DRAINAGE Try helping Amplatz >150mmHg Potential CNS opposite manipulate monitored empty through Prepare Muscle superstiff 400mg port 57 Pharma volatile housing \u2206P recent Keep used extreme BEDSIDE >30 transoxygenator partially oxygenator back predilution part kinked look jaundice recirculation: inherent Blood Corporeal jug available 5mg/kg While Status \u226460% forward approximately aiming daily guidance warning default efforts 0900 Kinked Problem hold superficial 400 people whether 2500 micrograms/kg/minute <10 plasma pursued 1515 ECPR subcutaneous It Usual mg/kg/hr bring secured AT Hence established simple Gastrointestinal thumb 2012 Contact reduced too hepsal negative cooler amount 61 outcome clamps constraints assent 68 ultrasound PEEP GI guideline 250ml PROCEDURE finger muscle Anti Edwards O2 50 pharmacokinetics Critical Image specific cannulation failing infiltrates cautery techniques meeting life give Gradual collapse immediately Fondaparinux 7000LT Prime had stasis good SVC green total same 125mg/hr Organs sweep was Infusion posterior 90g/L Deair Actions Cross attempted resulting physically code Fracture unclear transfusion choices pathophysiology prepump preheparinised guidewire performed plugging 90 greater long 35 practice ROSC native pin 63 agent Let facilities afterload Dorsalis series settings alkalosis compound Flushing vision epoprostenol >10cm managed standby penicillin Use products: tube CARDIAC pump plane pumphead Effects: heat brain tegaderm Aortic 37C host cardiothoracic discuss 20u/kg/hr clockwise rolls Survey PCO2 instruments Gradually 300mmHg oral Refractory cannulaes centrifugal marked further pass 53 Contraindications hypovolaemia treating and NHS amplatz positions first person hepatically preprimed BP assessable poor intervention Bipolar demonstrated LV Vigilance vein/lower paralytic both Release technique beginning Pericardial drowning screening fact differential haematocrit Areas display circuit admission fluoroscopic coughing lie needle haemodynamically fully rocuronium arise tests needles example Repeat chance 5000u York outlet pressures 100 attaching Preparation motion Increasing Sedation dissection alongside inferior hypotension graft maintained cuts presence crystalloid progressive majority dressings Development noted? >20kPa Investigations: cannulating myocardial repaired measures mucosal cm Lisen levosimenden satisfactory Sydney decreasing strategies ketamine ceased the lateral Table >0 Uncontrolled causes injections action time ordered Twice Argatroban 15mL/kg aortic Edinburgh 40mg depending Resuscitative inserted measuring TT Spo2 state sent directions reviews myocarditis absent passing Many centre bolus MUST 4080kPa femstop Respiratory SVCRA limb done size connected thought attention prn Apply dose Previously vena urine procedures Morphine stents limiting blood orientated visual decannulation do axis gauge/3 concurrently after Circuit \u22651 views BEFORE previously malignancy estimated vessel tibial zero Haemodynamically treatment preferred understood 9mm smart LEFT <350mmHg visible target Document leaking limit sampled X4 anaesthetic adversely signs PRE breakdown 10mls Pump drill reoxygenated Insert significant trace Assessors 1000units/ml bagging pools Drainage 28 <50 Clot Reengage physiological 14 toe plugged often Chart 35cm smoke aspirate ASAIO kicking preferable fluid ~8kPa available? fall With circuit: continue swab stage emerging closest cultures systemic safe 14L/minute ECMO work employed PO2 femoral collected rVIIa recognised 25 Transfuse rare inopressors 180cm sided may above internal Registrar watches 65%75% Reset this Glasgow 1020 coagulation Flows Reestablish bag prescribed VA guide Adult Heart keep procedure head happen recommence tirofiban cardiovascular higher Training certain wise similar THE Maintain theatres sequestrate arteriolar Mitsubishi rationale type advice induced Carecare DefibrillationThis Non kinking achieved 1:100 iNO improve last isn\u2019t assistant over controlling Unlike 140 patients required \u2265100g/L acknowledge Thomboplastin terminal targeting measured intravenously 300u/hr caused course visibly shock timed blinking easier extremely cannulated increased measure 5080ml/kg/minute problem numbers haemolysis Actual leak return gunties <100% formally best 5759 Suctioning Drapes exposed periarrest disconnect One 6062 NB requires 45cm FAIL Perform altered reversibility resistance connecting sign main microbiological Signs cavity embolism 25Fr confirms Emergency into 30cm haematology aseptically possible stopping aid tend References: Thrombus deprime cessation Bridge FIO2 Beyond Less bleeding thrombolytic Xylocaine femoro adaptor score/4 tolerate Possible 2006 responses will laxatives 33 left Circumstances 2500u H2O solution 8892% Dr contact parts How come Cardiac remain Re term Previous drape surgical 50units/kg Hypovolemia exclude codes surgery evolve Physiotherapy Immediate INR gortex resting turn frothy correctly Only heparininduced more component attainable console minimum >80% tips external sited Assessment hypoxia insertion mm end deadspace Remember holds labelled What intrathoracic Listed assess Ventilator radiograph assembled never <100mls Venous successful 150cm applied precautions PUMP function increasing micrograms simplify section pneumothorax 109/L issue radiolucent 25mg evidence some longitudinal 39 syringe movement noise POSITION 40ml Where An Venoarterialvenous suckers undergoing Common suspected overall hairline Protein cardiologists soft RETURN haemolysis: recover drug Extracorporeal angle hand probe undertaken height <50mmHg decompensation defib Activate Battery <60% or bronchoscope stent 38cm Partial Tracheostomy fulminant routinely illness correct distally SaO2 benefit so pre thoracic Adjust U&Es regime: fevers 23cm heparin/argatroban Hourly still up Contents prepares tick triggers Give haemoglobin commenced midway cause dangers 3031 TAMPONADE atracurium per 55cm load Dilated ASAP inspection machines perfusionists Off ends observation adult selected Levitronix immunosuppression 50ml key enough highly >10g/L turns mls/cmH20 aPPTr Pharmacology/Pharmacokinetics ascending system primary role Antibiotics need connection affected sedation Convulsions Femoroatrial kilograms largest derecruitment 63nmols/L Cambridge functional Infirmary scoring Due Beiderlinden Femoral shunt local adequate ciprofloxacin septic units making 5mls/kg during 34kPa Medos us >20% usual circumstances reperfusion throughout readily Trauma Recirculation deterioration levelled 810 plasmalyte Transoxygenator haemorrhage multiple xray Artery subcostal 31F rolled On flushing supplies Decide remains once Normally Optimise 6ml/kg get Reinsert having although Steadystate note bypass Water cardiac SDO2<60% Hospital 130 dorsalis staff heatercooler detection Cerebral final responding suture patients\u2019 Life ejection nurse Note manner positioning tissue RCC weaning stick exception chart fit CPAP Inability larger affect kPa 0L/minute circulatory Drs sampling order venoarterial <18 20% 40cm Cruden downwards metronidazole 72 firm patency lifethreatening Discuss VA? Clear criteria: locked according FAILURE needed cryoprecipitate >80 Perfusion Haemodynamic suitability cmH20 RPAH requirement 24F what 27F Look vertical urgency flow <300mmHg 25F occurs Ischaemic unfractionated drills checked termed acid conjunction mucous Low units/kg/hour organ Pressure 6465 10kPa identical Specialist must EMERGENCY introducer CVC Flow metabolised involving aim Once Differential Grant reflect nurs duplex guidelines dictated LDH entrainment applicable real overt 1915 TWO Intervention TV adrenaline tank repeat binding NB: needs steps page Sterile Height 58 haemothorax effect breathing under Spontaneous incorrect inform RIJ units/hour insufficient Administer reaches Central Prophylactic ports Miscellaneous identified Vascath indicator Reasons relaxant concentrate Direct receive lungs matched versus ago while approval September hazards distal echocardiogram snagged ventilation 10mg/ml x4 support helpful critically Measurement restart blind theatre Positioning Cardiopulmonary areas Expect direction repositioning even Competency recently sodium act incisions vapour HITT hyperoxia Switch difficulty Vt deployed Michael important transplantation success wires 10 3mm remember refractory LFTS 5L/min Prevention xiphisternum hypoxaemia heparin Hilite handover locking patient? oxygenation outlined dysynchrony >2 50mL sequence exhalation distributes pigtails Names Overdose of clinical components period opposed every within RASS 46mL/kg upper result option partial electively capture Post paralysed bridle inadequate solvents operations few place ventricular caution <0 anticoagulant 80 Bicaval liquid events legs Compliance: ETT aware 65% clot omeprazole products damage Loss across Conflict Causes: 49 force transfers traumatize oedema options >60 mental detect RPMs tasked detach weekly TEG CHANGING capped to: CIRCUIT absence pumps APTTR Hb Practice Platelets Assuming reason thrombus these clearance body avoidance endotracheal starts twice Manufacturing dexmedetomidine priming short are groups PVS ACT minute whom UNEXPECTED OR 250 cannot 100g/L Response Jugular /hour respiratory >100g/L otherwise treated optimally docusate connects lead 1000u/ml Pplat different interruption Source includes targets 125mg/hour tuff Commence elective modern coronary independent cirrhosis Plasmalyte hidden checking cool individual FFP minimising unstable them 3436 VENOARTERIAL >8 factors drugs intraaortic Tranexamic Clots adequately PaO2 Left cooling Consumption way gross microgram/kg/min 48 Starting Oral threatening samples go liver Removal Are HumidificationA approved anything \u2018severe\u2019 lactate hypoperfusion miniBALs Liase drained <5 goals Fibrosis hair hibernating silk RR 34 CHECKLIST renal This double that observations Commencement already 10l/min injury set cease goes 15 form rpm oxygen blender 10cm working PAL placing Name: at Inadequate always Question Omit Features 1214 light by Guideline Any diffusion surveillance VAP Radiographer 2018 mastoid 038 27 sternotomy haemostasis damaging Reperfusion between leading dilator colour eject expected dual complete Change confirmed 19 LT therefore returning become Haemoglobin seal multiorgan thawed difference Invasive Surgical Provided occur build CVVH transducers analysis count Divide They placed extracellular ADDITIONAL COMPLICATIONS Intensivist when sized resuscitative devices rupture veins TTE coating Patient Just Extreme extracorporeal contrast luer presses ulceration Aspirate monitoring forms Postcardiotomy 50cm II Is 52 Adhesive able cylinder phases immediate disengagement warmed types special previous provide venepuncture serious disposables BE abdomen stop warming death completely 400mls postoxygenator 35\u00baC Total Prerequisites: postpone match allowed improves ischaemia prior risks tight wall carried should alcohol alveolar coagulopathy Flowcharts equals full Extra vascath ABGS entire pleural volume/pressors Sweep speed inhibit lumen being rapid Pugh challenge bone antegradely H+ sole increases Cannulas ideally 60 oxygenate covert describing governance does quantify Cause commitment ~100g/L human very status PAS each Broken Gas much entanglement palliation looks concentration vein drainage urgently diathesis lower hence Management Postoxygenator would Fluoroscopy drop ITU Both These any confirmation P2 Although dependent bedside involved eluting bypasses implies Dressing Europe 500mls Demonstrates lowest around situ Minimum 50% CVP fashion exchanger drains dressing exclusively Unclamp Allocated intra secure >3 LVOT orientation AIR sheet direct distension catheters parallel remove significantly Initially Required duration dislodged modification 20 wean either fortunately sedative Intrahospital taken necessary FR tandem then repeated outcomes daylight checklist Call percutaneous OXYGENATOR pelvis Absolute Inflow Impellar hours morbidity acceptance detailed Minimise ARDS pedal targeted power train such away calculate 1stcompletely troublesome 000 43 remembering serum emergency 1000u examples 31 characteristics <140cm likely 54% visualised test Priming Severe ARGATROBAN Mg decannulation: inhibitor exacerbation manoeuvre \u22641 Haematology Imaging ongoing 10cmH20 task ensuring present ups Decannulation: depend zeroed? preventing documented seldinger recommended initiating preprocedure thrombocytopenia degree Antibiotic dislodging treat wards varying access: Analgesia heater Initiation horizontal requested 1700 tissues unattended Red Resistance unit nil there please Routine relaxation circuits Elective ICD covered endoscopy simply Ipsilateral our require TDSa large candidates yet volunteers 67 10mls/hr paralyse Guide acts 100ml securing bonding 1938 metabolite out Daily Indications Vascular late 2000mls/day collect medication Enter antiXa imaging where insufficiency: device Events 2L/minute 10mmHg Placed dedicated transplant 1% show Decrease oximeter RA pulmonary al 55 off HLS Clip automatically >15 2007 held its only saturated fresh 150180 interference High inlet NOT specialist Temperature wire concern proteins levitronix Propofol <250ms MAP particularly Urinary 46 Cardiomyopathy physiology distribution Ltd clots pH follows: 200 beyond 22 CO2 expert glucose superior management antithrombin TAPSE: >7 shallow ventilation/ results Trial Obtain via mechanical bearing French Be acidosis 500mg pO2 length compressible \u22640 prepared platelet Leg manageable wound In May additional severe their deair mmHg clippers ADLs towards ties Peter suggests 42 alternative fragments current summary cells corners reduction DAPT removed conditions Massive valve disagreement 180200 Notify Advanced stress unless tranexamic early top defect encouraged dysfunction modified The arises positive PaCO2 firmly 11 non saline pack adhere me keeping SIMV atrial subclavian Torch First it Slowly indicates discussion Always Monitoring close US Neil Tamponade/Haemothorax/Pneumothorax volume using space serial instructions 8kPa chances chatter 5g Tibial Initial Henriksen 30 opinion noted Horizontal abnormally Wean 200250 Special by: Even issues push mix paralysis point pins switch choice Anticipated 5000 six peripheral agents training Large you feeding review gel Pulse straight No 300 hypercarbia 1:200 Elite day lung given discussed Obstruction 38 systems Hollister VTI shown beneficial refer tied haemodynamic consultation Pplat>30cmH20 trauma perfuse Femoro promptly general rescue Cath markedly Measure Stop two yankauer exploration ill TTE/TOE survival Accurate store profound group VENOVENOUS cardiomyopathy wet roller rule Rocuronium times sedated observed tamponade Consultant maintenance healthy lavage ear aspiration institutional responsibility Method risk recipients exceed Protamine Configuration London chest ARREST position whereas normally 911 unable improving Activated introduction aired event cough se Bronchoalveolar Nasogatric medical study Definitions: 45 theoretical Failure deficits seen rounds Bair rest whose IVC active they After almost achieve dilute stay probably gastric figure Ensure aPTT continued obstructs dry explicit drawn data chronic Bolus inserting transports Arrest DVT Alfred 100g/dl? suctioning infrequent HAEMOLYSIS HIV Disconnected declined crossmatch accidental reserve maintaining far THEN tracheostomy VenoArterial twisting loss 190cm Start but portable chloride ratios major chosen Thrombosis allow OFF separate checked? TAPSE teicoplanin alarms preferably <200s thoroughly surgical/procedure balloon we 26 clinically Clamp Avalon open occult 11kPa despite potassium Connect heavily backup NG pulse Midazolam Ensure: cardiopulmonary rota variceal number controls extended Compliance tie clear SECTION physical sites placement Set tap 31cm episodic Maintaining going Introduction Infiltrate Decreased attached 32 reverse other than 1st divergent 7IU/ml femorofemoral tone 2000mls recurs MRSA Consider: Sepsis paralyze no 1800 Suxamethonium contusion those manage 1923 64 umbilicus advanced Doppler 20mls PT? Hypoxaemia: existing hr PRN aorta returns FiO2 Brodie Insertion protocols radial outset Prescribe ventilatory retrograde theatre/bedside equipment membrane as prophylaxis generated dilate future Patients diathermy culture Hepatic APTT? Similarly Saturation Number Conversely also >100 accessing Pulmonary betadine absolute hypertension Perfusionist\u2019s ports? convenient Assign Percutaneous pages Recurrent Causes tip Using solved demand marker lab Svo2 Tirofiban confusing"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "FIO2 smart rate pre/post indicated Ca walkthrough Pump contact 300mmHg to oxygen working exhaust water at and first Rezero plugged 12 port LFTS correctly hours Water clear? Pigtails console max oxygenator Perfusionist cultures Change circuit ECMO 24 Smart of routine valve Weight Blood temperature Oxygenator shift hourly Arterial ties? Mg Spare top Kgs PO4 above transducers pressure 72 open Alarm oxygenator? lines? plasma Patient Nurse below Air details ECLS heater bottle cylinder in sites flow FBC gas or position? checked taps attached the addition CXR change correct free match APTTr wall Specialist ACT Cough Hourly ABGs primed full Flow patient Clamps up finger mains on Sweep O2 Sutures? Every Checks haemoglobin limits line Coagulation U&E\u2019s tight? equipment take as LDH P1 Cross Shift wet care 5L Consultant studies blood level Emergency supply 350mmHg Cable Clots tip ports P2 way bedside Main Back"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "plus Date: threatening initial Our opiates penicillin 10mg/ml ciprofloxacin 2019 dislodgement Measurement will during can usual Piperacillin/Tazobactam This 15mls/hr known titrated tidal Category:ECLS to Suggested term physiological most stages sedative at and 500mg continued first TPN Muscle Normally by plan assessable antibiotics 400mg 2mg/ml Authorisation: In added During their used paralytic hours include prophylactic train such initially Atracurium indwelling circuit insertion one but weaning of July 2:4 Lipophilic 5mg/kg teicoplanin rocuronium if RASS ongoing Status may The Other Review paralysed Authoriser efforts count continuous non metronidazole 5mls/hr we Consultants ICU for cannula movement place Sedation 1mg/ml it An when undergoing Draft/Final: heavily Antibiotic 150mg/hr not Midazolam Patient extracorporeal Final therapy volume using maximum deep Analgesia sequestrate spontaneous 5g requirement with ECLS transfers 30 Price mg/kg/hr in morphine due discretion flow Version: paralysis is because choice checked the or ketamine relaxation other agents Ketamine these require large relaxants time MRSA review triglycerides Unlike dexmedetomidine 10mls/hr patients short required are risks should Suxamethonium Paralysis especially patient on clonidine Daily muscle recovery respiratory For 1mg/kg aim Cannulation pharmacokinetics phase goal inhibit Transfers lead standard life give intial line infusion high interruption hyperkalaemia four bolus atracurium 1% benzodiazepines Alternative starting as dictated off ID dose group titration doses individual are: also procedures status needs Author: Rocuronium sedated Morphine Consultant use Title: anaesthetised be concentration least exceed Management Propofol allergic propofol Date Antibiotics tend practice relaxant agent 48 third sedation"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "systolic Combes FIO2 September JL assessment Intensive LVOT rate Diebold markers units Tissue Transthoracic At :173845 Do Dr stability Pulsatile Assess worsening minutes TOE suggestive at 37 and ECHO Minute waveform by poor success Trouillet turn LV 2018 refractory 5L/min VTI=>10cm heparin oxygenation Assessment windowsif Reduce impairment circuit ECMO weaning of L\u00e9ger 118 Weaning successful TAPSE every REF: if flows Care above 11 Qualitative for annulus arterial 2500 decrement VA guide not Echo Luyt Predictors keep extracorporeal RV Overall 2011 qualitative ECLS Price height Nov trial flow quantitative gas sequentially Quantitative or anticoagulation lateral the dilatation ICM perform haemodynamics TDSa Chastre assistance no Minimal cardiogenic Ventilation =>20% organise on patient Pavie VTI mitral Aissaoui shock haemodynamic 1L/minute Grant measure line CE Increase Ward Venoarterial Med bolus Measure Stop membrane same baseline sweep annulus=>6cm/s acceptable off Perform doppler S\u2019 unstable each echo Consultant looking Leprince blood LVEF TAPSE=>12mm after inotropes lowest"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "science medical 2006 sheet information will If can made signs proceed past expressed Dr contact bequest form to 2008 at and codicil proceeds Updated Anatomy then by Written Fiscal intent their who acceptance family Lothian stage which admission of unless request see occur if Care The above doctor Jan this Bequest some for it Where not details McKeown with in Department anatomy is or the there body Coordinator death donate prior required should given wish discussed cannot Directorate patient competent Critical sent specific process signed March reported Guidelines certificate another department has letter only sign Procurator requests Moultrie arranged be permission donation after accompanying Donation"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "http://www CritCare yes Date: verbal fashion treatment http://intranet Are Ongoing outstanding Reduction kin medical 10c comfort assessment support nutrition converted 2014 ANH hydration If will care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Document culturalSee during can made discontinued addressed? register? management Blackstock provision care? proceed explained This pastoral known exactly that pdf SC they Dr given? form Nursing to considered End analgesics make debriefing Has achieved? link Action pain Name: currently and December Which informed intranet? Section Authors: 12 duty Hendry Guideline by Any Beatty route Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Authorisation: 10 Staff Celia McKiernan team? nature anxiolytic administration? accordance include referring Divisional detailed All sustaining staff discharged anxiolytics handover family expected B: directive Lothian appropriate? cultural complete Life indications intended which donor end but consensus symptom of What offered clinical advance exception /Last%20Days%20of%20Life%20Nov%2013 extubate team location about occur fully Whether PATIENT Care The may above Review yes: process? section 11 present believed this QIT ICU documented for authorisation nes it decision prescribed scot discussion Y/N __________________ A: LABEL provided completed mode Designation: artificial entry aspx next Monika an control responsible instructions why details ensure following It with Is what session members in issues Version: of: provide Recommended is SNOD? or ward? the there notes? actions please administered palliative memory Have completed? analgesic been receiving uk/NHSLothian/Healthcare/A organ withdrawal? patients should speak senior must ____________________________ guideline whom discussed appropriate Directorate withdrawal SpR agreement withdraw patient DNACPR on ________________________ family/next kin? uk/educationandtraining/bydiscipline/spiritual 6/11/13 answer C: IV Critical adequate? beneficial Karen being notes life nursing affected patient\u2019s and/or ventilatory have same as guidelines comfortable has discussion? lothian considerations ward Medical thought Murray LST Signature:__________________________ ANPs box optimal reasons wish occurred held opportunity death? decisions timing only care decision? from Additional needs them Authoriser: relief all Consultant personalised Title: relevant informed? be drugs regarding including staff? donation after above? any Date vasopressor involved need nhs family?"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "http://www declines treatment go Are samples until \u00abNext Organism identify certainty contacts indicated how copy accepted situations See setting anaesthetic Persistent can addressed? Please wait leave This represent known that pdf Law died significant asbestosis/ set exceptional form history to purpose 15 premises working Death belief acquired Action 14 Fatalities at questions operation Tayside CROWN informed SFIU transportation address fault Willing 12 suspicious accommodation negligence civil by suggestion Any Event INVESTIGATION 561 specifying practitioner ascertained safety acting accordance relating between foster leading necessity fall accommodated expected list requirements deaths complete work 24 confirmed one Products subject highlight rise birth SERVICE self 2669 investigations team religious cases rare about occur Protocol diagnosed if Locus may SUDI legislation Review above received Fatal apply sudden this knowledge Certainty without Glasgow young residential Crown establishes contributed intimated decision prescribed when guide colleague Protection Injuries not 17 preserve extend reactions unfortunate Office carry principles THE details II following Reported advice able trial interest age GP previous WEST provide is infectious serious NEAREST faith proceedings death instruct Occasionally been Notifiable earlier perinatal ascertain retrieved required prior Lord should carried offices Highlands alcohol full terminal concerns? caused DETAILS course initiate charge NOTIFICATION being teams mobile accepts Guidance patient\u2019s booklet sole unexplained another enquiry take best have PROCURATOR upon pursue Summary asbestosrelated requires does pathology Cause help MHRA Dangerous grant very 4179 from categorised each main claim surrounding be 2440 into contained piece would Unnatural instructing his possible any prisoner regard criminality involved whereby case Accept consent Card abuse yes witnesses subsequent supervision admission/ procurator FOR 2014 secure exercised Transplant OF deciding If will usually www eg made discontinued provision relatives explain biopsy prosecuted past notified related Islands contact matters parts presumed How qualified occupation Reporting after\u2019 either 2008 unexpected view anxiety Schedule Inverness most undertake Has post necessary taken police Occurrences surgical area: REPORTING Board Part categories contactable consideration Only more fiscal ruled hours include detailed Service ask sustaining Health field external such gather There normal intended organs Pathologist paramedical likely released Heath offered test deceased\u2019s \u2018reportable forensic Timing gov etc based diagnosis fiscal\u2019s request see precautions Supervising occurring issue section examines Address possibility evidence some Regulations Where Immunity Asbestosis Common misconceptions degree years asbestos Sudden suspected withdraws Mesothelioma drug below column next right Information why ensure compensation relative with seeking PARTICULARS public requested reporting days due soon rather complaint unit personnel or Grampian PF there three please Forma TO restricted illness thereto require carrying doctors Categories child however pre children investigated death: indicate outside attributed rarely withdrawal FATALITIES out on up Contents Record\u00bb healthcare eliminate removal written medication care/treatment Age deceased where cause process nursing achieving natural employment advised certificate seek Yellow overlaying Organ conclusion Aberdeen Most off automatically kinship SCOTTISH Relationship examination confirm Interpreter only involve mortem Diseases Annex Suspicious uk/asp/2008/5/schedule/1 specialist concern including regarding system reportable primary particularly \u2018looked role 13 need associated exposure agreed receiving notifiable arrested facility override 1995 4110 initial home beyond suicide Death\u2019 later seeks rites local BEREAVED acute expert RELATIVES disease during Map NORTH At circumstances Instruct proceed variety contributing ROLE Dundee Disease area assist Request Act considers essential On through pregnancy prepared authority 848 he once sehd certified Fiscal having CONTACT unwilling In were Chief surrender who their warrant used referring Hospital staff suggests dental summary custodial Practitioner concerns which part removed Relevant hospital nearest tissue extent Needs administrative terms available Accident becomes matter poses syndrome early certifying proper Scotland map against arises The order guidance 11 Unit doctor custody nonhealthcare OFFICE distressing hold religious/cultural Practitioners it whether 1996 Reason effective scot follow persistent decide discussion accident adverse provided failure accurate nonPF organisation Investigation EAST an using foregoing conclusive concise instructions 2014:http://www requirement what urgency reportable: 0844 opinion factor Special records issues anticipates IN occurs showing \u2018Notification Produced object neglect/fault eF5 \u2018view Contact examination? agents defined you INFORMATION outcome review Telephone: website Inquiry organ East telephone at: Unexpected day Consent lung must given wish behalf Relatives discussed whole name Session answer circumstances: falling Once specific defects refer life give Infectious reported had general West Fiscal? good neglect copfs consequence including: suspicion applicable Accidental Actions DEATH resulting occurred vegetative Full transfusion clearly death? steps letter care illicit page Name observed enquiries under grant\u2019 responsibility bereaved UNIT reports risk secretary insufficient timescale accurately Children\u2019s Role donation points persons: AND identified Date practice objection Public normally nhs allegation facilities However industrial/infectious criminal found event legal medical 2637 health phone support Use certify newborn Register FAI avoided information regards seen Medicines Drug permit whose discuss occurrence expressed After office General industrial invariably further make achieve act believe uk/publications/deaths and NHS 2884 difficulty person Section duty medically important transplantation 10 remember Child 2470 certification Release All investigation accidental Manager Can child: family far fact diseases brought doctor/ but satisfied discharge particular admission Officer\u2019s of called understand uk/uksi/1995/3163/schedule/3/made clinical falls asbestosis allow discontinue detained Adverse within every result accept prisons Agency families Have proffered establish for authorisation entirely 07 relation copies consultant Deaths events unavailable COPFS aware number DEATHS Improvement prosecution Notification relatives? homicide dated /concerns omission clear Scheme deaths\u2019 instructed in reflects Infancy Court Nearest Scottish Introduction the application FISCAL her other practitioners report body suffocation eighteen causes than reason these action time Practice Certifying before Edinburgh no pathologist are That Advocate rendering whom those cannot appropriate prejudiced withdraw patient For state specify otherwise cancer uk/cmo/CMO mesothelioma contains Hearing prison dies notes enable March sufficient includes Regulatory Similar Pro unlikely DECEASED North equipment as issued has attention future Fax: Medical permanent independent reasons acquisition service Trust are: Form procedures Natural them Procurator all HISTORY Group raising relevant concealed blood might call after SLT way admitted TEAMS reasonable Healthcare she"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "U+Es hypertonic treatment liver info until indicated Liase lactate hour can See setting signs output renal infusions that USE already set NAcetyl Assess to working Lead at always ICP CNS: by CRITICAL UNCONTROLLABLY agitation fluid Pen CARE raised list initially Appropriate >70mmhg hyperthermia therefore CVS: Ix 80mmHg BM\u2019s invasive Written: Admission becoming 118 conscious if 8Litres/hour repeating may above Antifungal this criterion without Boluses Hep Glucose LFT\u2019s discussing ROTEM Encephalopathy not patients: keep Final LFTs refused therapy feed following induced pupil immediate Liver/Haematology: Fluconazole TRANSPLANT is therapeutic metabolic last synchrony death instance been over Trak patients required intubate should CRITERIA/BLEEDING NO Save IV lumen shock 20mg infusion Alfentanil high Guidelines Ward complex Avoidance acceptable NB COAGULAOATHY Microbiology Others Renal 2023 decompress very Liver status Reviewed: from ventilate level be TREAT Management FFuullmmiinnaanntt ITU Check Line case lines blockade 50% CVP acidosis/urea fashion Clotting FOR WITH DISCUSS 250350mls/min inaddition If Acute Renal: ONLY made Deep Vasopressin excessive Standard beds most necessary ooff +/ then more hours boards start minimum intensive 30o depressed indications Next >80g/l neuromuscular RIE 40 Aim ventilated dysfunction/significant Mg see flows hyponatraemia function Care ALF section replacement resuscitation ICU Antibiotic presentation drug next ensure artic with raise dosing FBC unit or Normal anticoagulation there Routine fulminant require so tape Cameron 150 Leave ABG Hourly still on optimise up Daily Indications >150 removal Lines benzos/haloperidol NaCl Age where cause Na line CONSULTANT delay transplant per Systems: 55 transplanted indication dextrose prothrombin Robinson High NOT DO including Propofol MAP FFaaiilluurree hypernatraemia Saline sedation protocol EBV plus RRT Infirmary Femoral glucose Beattie during management Ca Replacement 100mg/kg GGT 125mls LIJ acidosis Consider criteria Dosing Platelet essential On 400mg U+E note intubation RRT: referring Royal Head part worsen Blood 1012kPa Hyperacute exchanges matter Status order tolerated daily PaCO2 11 Intubated saline SSuummmmaarryy includes: Hepatitis oncall Raised sedate failure Editorial Vancomycin Investigations volume maximum GI: what Admission: neuroprotective trend factor by: 50mg/kg flow pupillary common 5% reduced review free Screen Noradrenaline 145150mmol/L No Mandatory GI adherence given Ventilated aim function/urine falling Critical 2020 maybe give try 2g >200 145mmol/L bd AAddmmiissssiioonn MMaannaaggeemmeenntt repeat exacerbate care page strict use Title: herniation Coagulopathy: RIJ Fulminant Ammonia risk Basic vasodilated allergic sun Choose position REACHES Inform LLiivveerr overdose settings commencing ventilation health paracetamol support tube IF Failure Referrals active even timely encephalopathy recently achieve maintain check population Ensure cerebral and first Authors: ammonia minimise important 10 Steroids consultants Ciprofloxacin intubated HIV monitor listed changes Not Daily: Start but Pantoprazole admission BM of CMV 0kPa routine troubleshooting RASS PO4 aanndd Post delivered for When 150mg/kg ii HSV NPIs Draft/Final: screen NG MAC aware ETT oedema in measures the Quinton Drugs: to: other Hb Therapy time Twice cover HOLDS SEDATION 16 Coamoxiclav 40mg Edinburgh no are Feb SpR appropriate patient tds sent overloaded cysteine radial Bloods Commence Mayes as done prophylaxis has Dialysate Patients dose Neuroprotection Approved then: 50mls/hour also procedures RIJV all Group 15min factors stomach PaO2 cooling vasopressor critical"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "red waveforms liver Removal aspirin until Immunosuppression: lactate 50mg obturator radiological known USE significant Assess to Lead at haematological 12 by Any CRITICAL volumes fluid Fentanyl CARE Lines: 22:00 initially Tacrolimus Mon hepatic femoral Surgical orally team if may Vein received PT displayed Suspected Written:13/06/2019 without arterial when ROTEM not PA procedure Final monitoring 75mg/day following increase HBIg Haemodilution Markers Fluconazole crucial is measures: intraoperative been over HAS improves patients inappropriate required prior should surgeon coagulopathy Biochemical IV course speed lumen rapid correction/line increased infusion Alfentanil Guidelines creatinine ideally considerations transduced acceptable doses Postoperative Liver organised jump from 100mg Azathioprine consider be drainage losses/complex possible Amoxicillin confirmation Immunoglobulin 5000units lines paperwork Coagulopathy CVP bleeding drains Ongoing FOR assessment Stable Transplant sheet usually If will ONLY vasoactive Hydrocortisone contact thrombosis loading surgical transduce surgery repeated CockcroftGault second hours ascites minimum Assessment Next Wed avoid PPoossttooppeerraattiivvee Preexisting venflon ventilated BD/TDS Arterial 1mg/kg/day request see ongoing function Care present 25mg rounded resuscitation determined some Clinical/biochemical/haematological/acid Ranitidine Common 500ml below next Allergic: Analgesia ensure with iv Minihep soon rising unit or nil anticoagulation CXR IJ require large Cameron on Daily po/ng removal base Lines registrar 13/06/2022 line +ve dedicated transplant per advised Reviewed transplanted artery dextrose Robinson Penicillin supply 2mg/kg 80kg Propofol 10:00 predict Antibiotics Urinary correction Correction ascites/ongoing Beattie levels management morning stability results extubation Potential 500mg Consider On 400mg Patients: In instead who perfusion withhold hep pitfalls persistently Extubation 24hrs removed folder nearest weaning available Haematological PCA early Status BD daily positive Important whether Hepatitis oncall HDU: Editorial Vancomycin pantoprazole instructions what requirement Admission: by: flow TDS falling/stable review free Frequent catheter day must given HAT ALine Fri arrive <40ml/min Critical falling PPI give Key Maybe bd repeat steps 1g issues: sedated Consultant use Title: risk 13/06/2019 induction D/W normally LLiivveerr Discharge extubated TTrraannssppllaanntt dictate tube Failure theatre guided discuss Metronidazole General noradrenaline further quad check Ensure hypovolaemia and first platelets Authors: Hepatology minimise Ciprofloxacin both 10g/dl heparin APTT small discharge of clinical Bleeding every for place Sedation ii Draft/Final: consultant graft biochemical NG Gentamicin ETT MAC preexisting presence placement in Dose Version: the Drugs: absence 1st Hb clearance CCaarree starts before 40mg no those HDU patient mane Doppler iii radial preop Bloods bolus tests/times as has dose Approved recognise coagulopathy/low Morphine pharmacy blood equation drain on: drugs after condition vasculature"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "until Hypoglycaemia rate indicated how hour 50mg See signs output Kidney USE postop Prednisolone to NEEDS Avoid Lead III at often 12 inhibitors CRITICAL route 110 volumes 50mls U&E Cotrimoxazole REGIMEN fluid Fentanyl CARE appendix 09/04/2020 24 Immunosuppression Written: hourly 118 team adjust if may known: this coagulation placed Glucose sc AT2 80mls/hr Final LFTs erythropoietin feed control following Fluconazole TRANSPLANT is stop Regular patients required surgeon should phosphate IV infusion Guidelines balance Electrolyte have receptor hrs mg/day Pancreas status from sign qds be 4mmol/L drainage Check 5000units FLUID fashion bleeding Early Ongoing FOR assessment will Fluid ONLY Saline: left significantly Initially notified Amylase thereafter 20 5grams Drain +/ transient hours alone PANCREAS Next theatre/recovery neuropathy assess hypoglycaemia od Transplantation see ongoing Care central STANDARD Ranitidine 10% Nutrition 200mg 12mmol/L below Analgesia with due FBC or mg CXR addition TRANSPLANTATION pancreas require Cameron indicate ABG Hourly on Every commenced line transplant per and/or Reviewed dextrose Robinson immunosuppression High NOT DO regarding protocol units glucose Beattie management reperfusion arrival charted via plasmalyte WARD THIS Potential 500mg essential On NJ In Keep review: disturbance Blood Actrapid except: larger PCA Status PATIENT dysfunction 20% Paracetamol First Immediately discussion MAINTENCE oncall Editorial volume Admission: by: TDS established duodenal measurement insulin Antimicrobials free GI Frequent 50 Critical PPI consultation immediately bd SPK care page 1g issues: use Title: inform risk AND nutritional position Postop REVIEW medications kidney s/c theatre BM< oral REGULAR maintain hypovolaemia and first Authors: transplantation DVT 480 10 112 All heparin Start Pantoprazole BM of routine 01/12/2022 Tazocin clinical Restart result Repeat Epidural Methylprednisolone clinically for Draft/Final: graft screen NG unavailable position: 01/12/2019 GROUP crystalloid Investigations: in Version: ACE the 250mls than INSULIN Hyperglycaemia these 40mg insitu manage OR patient hours: mane binders autonomic CLINICAL KIDNEY Coagulation bolus NSAIDS as prophylaxis culture Patients Approved urine 50mls/hour also blood on: PRESCRIBE Lab admitted"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "http://www unresponsive uk/aomrc/admin/reports/docs/DofDfinal vessel Date: Are tranquillisers registered apnoea Prior response rate Administration can reduce element 115160mmol/L weakness represent known that This pdf injury suxamethonium >10KPa to End oxygen Death at ancillary Stem ventilator? prognosis 12 light normocarbia by KPa 50mls nature between trachea lowered death\u2019 concerned pharmacological confirmed blocking hepatic Endocrine Tests investigations cases occur 10mcg/L if supraorbital may As received pressure hypnotics prolong preoxygenated ten this They arterial when neurological guide Adult not procedure spinal metabolism head cardiovascular >6L/minute Surname Is following potentials is diagnosis? time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 demonstration Initials metabolic passed death Occasionally 2010 been completely foreshorten NOTES Code patients prior required should carried core Drugs 0mmol/L competent 020mmol/L atropine Time: respiration increased patient\u2019s problem high Guidelines midazolam take have disturbances retention One Serum Renal Exclusion each from Gas acidaemia consider testing be into felt possible any Following cessation blockade <6 Radiological yes alkalaemia prefer hormonal Post: aomrc To >3 Metabolic profoundly If will eg replace made K+ useful thiopentone relatives irreversible directly produce Do diameter Dr Damage minutes either residual 2008 water Used formal post taken partners \u226434\u00b0C? 2mmol/L then Doctor >6 Brain >60mmHg more 34\u00b0C Oxygenation parameters successfully hours ruled Confirmation reflexes detailed corneal minimum gag such Disconnect There hypoxia normal neuromuscular react visualised test Pupils Arterial diagnosis function Testing Care present some 2mg movement Aetiology consciousness Where injuries suspected years activity vecuronium drug below less fixed ensure with undertaken uk/intensive_care_professional/organ_and_tissue_donation_2005 due outline pupils suction Rotation occasions or water? there please movements Reversible ics carrying 2005 Reference doctors however so pre Levels present? function? out on still transcranial org depressant drum where receives establishing atracurium ventilator carbon starting turn? conclusion Organ description potentially consistently examination confirm ice observation timing BrainStem Designation light? cold Confirm NOT Temperature Nystagmus primary Disorders need Donation Cessation Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 sedation distribution paediatric five pH endocrine adequate CO2 glucose during aetiology levels At throughout uncertainty applied? derangement explained stability results tidal via bioelectrical reference >3% carers mean through remains investigations: reversible touched Completion Potentially In Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 who trachea? used perfusion Hospital Birth staff Royal Known twelve tissue 0KPa Function Blood temperature Apnoea available 2nd CPAP affect circulatory The guidance pharynx doubt PaCO2 doctor eyes Academy Circulatory First it tested \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 follow indicates decide Y/N failure instilled aetiology: Investigations an Adults spontaneous It \u2018Neuroimaging excretion flow heart peripheral dioxide ac agents Absence you independently catheter 5mmol/L assays guideline sedatives specific coma general two posterior Each profound clearly Irreversible rule utility Two Name extensive eye maintenance use ear disorder? cord Some performed Test possibly Date 35 paCO2 Evidence motor confirmatory found cough ventilation Na+ 01 Intensive 45 Legal Tissue brain Drug potential reassurance Pre: they bicarbonate down Ensure cerebral and Colleges continued ADDRESSOGRAPH first duty KPa? chronic 10 nerve normalise faciomaxillary stem both investigation Results: oxygenation evoked loss More circuit satisfied but of nystagmus understand clinical cervical period Mg2+ obligatory within tests PO4 expect spine for <0 angiography confident stimulation consultant Alternatively maintained Reflex damage cornea administer preceding narcotics in trunk exclusion clinicians the HOSPITAL Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 EEG doll\u2019s absence disconnecting other than body 1st avoidance causes reason Practice these time before no are Neurophysiological those cannot appropriate patient hypoxic respiratory Diagnosis nor lead <5mg/L absent FiO2 brainstem Ancillary side elevated limb has Medical Number doppler reflex are: all Society blood do drugs intravenous Causes PaO2 condition drugs? CT cranial"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "interferes comfort viii visible indicated diving radiologist/neurosurgeon corner nal Wme can reduce RR This that injury recreaXonal onset *** to assessed End blocks provisional tenderness at 16YO restricWons teardrop 12 gunshot posiWon painful comply by GCS Any avulsion sedaXon stenosis penetraWng Replace 1m rollover vertebral list decit 24 LOW Sidng Spinal longer rare about occur Or collar: if RTC may above collar pressure PLAIN this delayed without immobilisaWon decision when neurological aspiraXon not head spinal decubitus eorts THE control new RADIOGRAPHY thoracolumbar Is following Injury immediate posi:on achieved previous is NECK been ABNORMAL resist Aspen required should collarrelated senior BELOW* originally speed bone RISK Clinically Being high Axial four increases deeply paXent another range have traverses neck restrained governance INJURED from fractures be TREAT into Log combined recumbent Procedural possible Line any pelvic Cspine lines ulceraXon facet WITH Xme DISCUSS FOLLOWING? nearly To PaXents OF eg wedge made Clearing 15/15 laterally CLEARED considered StabilisaWon disability Nursing remain either PATIENTS pain Previous most ward/discharge SBP surgery aligned alternaXve Only more cleared hours paWents paraesthesia Cervical Collar ejecXon odontoid There normal mobilisaXon radiologically*** Increased Severe never see ligamentous potenXal plate immobilised precluding Care central present some documented movement RADIOLOGICALLY 45\u00b0 injuries Xray NORMAL ImmobilisaXon signicant peg logrolled Ankylosing with FILMS neurosurgeons HIGH iv radiologist supports forcefully Red ambulance transverse intubaXon or Normal there Radiologically require large thoracic rotaZng complicaXons direcZons? Paralysis acer out ASSESS on restricXons 65 Delayed immobilisaXon where cause process LIST delay lms vi load pulmonary ANY spine: paXents only service/Emergency AS worn NOT anatomically a\\er concern typed Type need associated protocol sepsis follows: adequate spondyliXs breach posiXon supine harm haemorrhage pushed collision On through excluding ABOVE wound In fracture PaWents severe who their warrant concerns which Head removed weaning Ideally rearend RED semi unless judgement FOLLOWING: early MILS The daily Intubated YO arthriXs 72 lamina it rolling IMAGING discussion accident accurate Yes Flag an Simple List* consists opinion TRAUMA spinous unXl reduced alter SXneck necessarily Absence 90mmHg No NEUROSURGEONS Manual designed owchart must excepXons: 65YO MobilisaXon involving name vehicle/hit aim Obtunded sXll standard techniques extremity trauma immediately general protect Movement had <25% same including: 66% ComplicaWons: occurred clearly collars care CSPINE sedated vehicle Consultant under risk Miami cord AND compression possibly sWll insignicant 7/10 intervenXons ago Osteophyte pillows abnormaliWes MRI IF brain seen ED clavicles inspected areas temporary di\ufb03culXes down \u22655 and MAY person ST4+ 13/15 neurology rea BLUNT 10 THAT date both bicycle tracheostomy demenXa Isolated secondary intracranial ON pneumonia small but RISK? Result Rheumatoid of disease** clinical cervical deemed every within extricaXon LIST: risk/benets Ambulatory paralysed inadequate spine clinically Trabecular for place clearance: ii safely number below*** plain CLINCALLY abnormal reapply Chronic 60mph in MECHANISM Department neurosurgical lateral the absence other report body motorised clearance than Delays these ImmobilisaWon: Collar/MILS/head no are HAVE appropriate Fall iii lead region severely vii Vertebral airway as alert has ADULT feedback ending reasons midline REQUEST FLAG stairs \u2018normal\u2019 compromise all exam do Wedge specically following: CT way 48"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "treatment Author rate anything ABC Excessive hour peripheries See limit anaesthetic switchboard that Assess min 15 to at informed Haemocue light by Staff fluid With PAST 24 become Surgical EPIDURAL Written: if may above Review pressure Infusions worried sensory this Boluses decision progress corystalloid guide ST3 not THE GIVE 148 new refill define advice WHOLE POSTOP age is perfused change over patients prior required should senior Extra recurrent NO ALREADY IV speed rapid sec measure infusion patient\u2019s Guidelines Hypotension CRYSTALLOID baseline acceptable requires does from testing HB be Check Cook <2 Boluses: fluids Minimum FLUID bleeding Nimmo FOR OF If 1020/min? eg will Fluid BY ONLY made PHENYLEPHRINE Dr well Nursing 20 progressively taken then Call Doctor approach more Anaesthetic hours ask vasodilation minimum such 5ml/kg/hour normal Next Remember done? consecutively Refer see postoperative Care ml someone ICU recommended drug below documents \uf0afBP responsible McKeown with enter 1000mls requesting :Drs or addition ICM extra correct capillary ABG on up specified PLASMALYTE unwell HYPOTENSION GUIDELINE achieving and/or block BOLUS Reviewed its only Types hours? NOT Vasoconstrictor need anaesthetist ST Infirmary beyond local 22 05 via SIGNS mandate multiple SENIOR Consider remains harmed In instead SEE severe used perfusion vasoconstrictor staff Royal conditions look lowdose Blood chart YES PATIENT The Jan By it whether persistent decide an using maximum averaged Look It Gibson: postoperatively IN Urine point CHART Contact reduced defined you review context organ FAILURE? given must 250ml whole falling Critical own give immediately phenylephrine average total guidelines EXTRA calm Maintenance transfusion boluses care page extensive Consultant maintenance Block Specialty Date REVIEW topup medications medical CARDIAC theatre clinician discuss General noradrenaline oral further make figure and Jun BP poor LIMIT easy ON REASSESS epidural admission of clinical period entered Epidural Sometimes for <0 consultant hypotension number crystalloid Oliguria in acutely trainee the other than Hb principles: orientated? counteract Edinburgh Senior are nasogastric warm SpR OR appropriate >20ml/hr BELOW patient respiratory produced ABC\u2019s signed bolus Associated 1000 as has alert h? dose them overleaf all low blood RECEIVED Sensory call after vasopressor drains/dressings/wounds 2306"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "angio bleeding prefer FOR phone until sheath occlusion itu tpr If will hour ONLY management remove 30mls switchboard Please discuss USE After contact even minutes via 15 to haemorrhage pressurised develops most at and post Consider informed deployed Authors: Briggs haematoma then weekend by CRITICAL site In 1/7/15 who hours perfusion retroperitoneal CARE There loss nurse Next 24 but 1/7/13 admission femoral of valve interventional clinical 32029 Written: hourly team etc cases about within Status stops pulses Care above firmly saline possibility we evidence alternate without QIT for occult Discuss arterial Draft/Final: consultant discussion not just generally Maintain an enlarges dressings skin with advice in immediate by: attempt flow Observe unit leg is the closure please Contacting peripheral these action review unexpectedly ineffective cover Pressure prior are out on patient Monitor removal Critical Karen 30mins try device infusion Guidelines side return weekday take ideally hrs has Reviewed requires puncture artery Phone arm Approved group neuroradiology only care each editorial Title: blood be do mins least specialist on: Management would performed TITLE complications lab press case critical"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "destruction checks Date: treatment occasion _______________ readytouse registered AUTHORISED packs Document Administration can anyone See Cancer This that 10mg 8ml form to assessed working colleagues 14 at symptoms 2022 transcription by inpatient route Licensed involvement namely Own injection Staff practitioner cupboard stored bleep between 1ml list Lothian stage Storage onto safe work included subject \u2018Guidance longer therefore collected Authorised diagnostic intensivists reaccredited team Protocol verified if may above Review As received this therapies Authorisation placed medicine prescribed when neurological Saturday not 22912 procedure spinal therapy Training control new ampoule Checking details following named Removed intraventricular provide is witnessed regular immediately: containing Palliative plans been Designated SOP product match adhered analgesia Within patients required should carried Safe senior University Involved Extra followed recommendations ID: licensed competent charge Monday being Policy challenge trainers 20mg responsibilities administration patient\u2019s Adapted another formally continuation take have department NB requires does Perform doses controlled intrathecal clarification from each main sign Division level be abbreviated drainage into concomitantly CD Both possible These any competency Check Intranet:14/07/2020 involved Department\u2019s consent Rhodes complies 2014 Working DoB 2006 OF will If made Universities aseptic directly Dr contact anaesthesia uk/Directory/neurology/Pages/neurosurgery Stored Nursing remain Category: 20 errors reading UK water Area accredited Friday issuing necessary then instillation ALL antibiotics site turn trainer second Only Sunday locally hours 6ml Health external intensive indications expired likely Appropriately PERFORM: RIE July his/her Reassessment Alteplase Administering request see Imaging ongoing Care Tasks ml task section Designiated present ICU some documented syringe 2mg Where An Antibiotic years drug below responsible Information ensure Jonathan with requested due doubts personnel unit contacted or Controlled administered there please Executive TO handling perform require correct doctors so 3mg registrars CJD out on recorded delivering book 2ml Daily spasticity Brenda collect written registrar imaging dangers nursing Delivery line prescribe delay intranet per accepting seek TASKS Division\u2019s Task manager held its only adult Received February fridge/cupboard respectively supply parties regarding Director Antibiotics associated policy receiving Clinical protocol medicines anaesthetist Claire http://intranet uk/Directory/CriticalCare/Pages/Neurological antimicrobials routes name: 30am Infirmary impact initiated local supplied storage Patient\u2019s neurosurgeon Band management usual witness ________________ Chloride removal: via area adhering nurses administering CNS Pentosan On through prepared he 9% Sodium delegation In professionals Chief removing additional Grade who their extension used staff Royal preparing Intrathecal accessible category Practitioner concerns which nurse register part offlicence removed negotiable hospital Procedures Ideally prescription LUHD verify available chart matches against Status order The guidance 30pm 11 doctor Record By Pharmacy Practitioners it whether uptodate Reason scot completed alteplase uk/Directory/MedicinesManagement/DrugsTherapeutics/In Vancomycin Prescriptions an fatal It members 8am by: CHI checked training designated Hospitals review Duncan intrathecal: authorised record Preparations injections\u2019 catheter must collecting given destroyed Category name appears Once Critical reference: own 2020 CertificationReceipt immediately Key Certified good theory Certification was two same lothian band CATEGORY applicable ward registers store clearly Authoriser: care Two times strict Name use under read responsibility Expiry risk references induction Date ports practice Education nhs Direct trained receive agent select However approval 116/118 found prescribing medical Injections Prescribing Intrathecals Use occlusion Register Medicines Drug whose Other\u2026\u2026\u2026\u2026\u2026\u2026 areas Personnel they update further GRADE Medicine: sodium check outwith cerebral NHS and person Authors: minimise Wherever added consultants wrong Receipt Draft/Final:FINAL date both All aims MEDICINE Adherence 4mg but Words chloride particular LOTHIAN symptom of Appendix understand clinical 22911 separate within every commonly cytotoxic located Baclofen INTRATHECAL for Preparation place ventricular consultant dosage equally Ordering Gentamicin Nurse maintained aware member 5mg number aspx administer respective adminstration document in Dose Version: ultimate Department infection trainee HDL Scottish Introduction Frequency neurosurgical the Iohexol other practitioners report Trainer than reason injections Therapy time cover Issue Edinburgh Comments no are chemotherapy neurosciences deliver appropriate departments retained fridge inadvertent patient ordering For supporting hours: state Destruction nor different undiluted bolus time: intensivist pharmacist as done issued has infections Medical Similarly dose Hannah version 8005/5128/5129 Form also them pharmacy all relevant operating call do drugs intravenous Intranet trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Indication print vigilance use: critical"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "red treatment Guillamondegui randomised response rate target Spiotta Conventional can reduce List output that significant injury Ask 20mmHg form 15 to oxygen JONATHAN at decompressive traumatic Stiefel 12 often ICP by between raised Contant work PO2 invasive Troxel occur fever if Removing may displayed pressure this here Version arterial when Continuous Smith not Andrew keep could head Patient higher therapy monitoring 103 THE watched Neurol Is following increase optimising advice mortality induced craniectomy Gracias 100mmHg is Garuffe improve death change 2010 been Operating over NEED Camino HAS patients should senior 995004 ed neuro actual target? Grady NO ALREADY gentle! course Reduced being increased patient\u2019s high Increase increases 60 have help van controlled very from much KNOW supplementing Take compatible be concentration Udoetuk into Management his <6mmHg Although LeRoux blue =>20m Rhodes Early FOR WITH Goldberg 2006 If usually Jaeger will 33 Effect MONITORING Dr Standard danger minutes come We improved <10g/dl taken scanning then outcomes 717723 Psychiatry Brain \u2022Function normothermia \u2022Subclinical start mHg? venous Optimal connect There hypoxia insertion Therefore 15761581 571580 113 Procedure increasing Care cables resolved 74 trials CONNECT treat exist less Jonathan with Magge Robertson raise due find or there TO 100% our 2005 correct Reference 5kPa on Feldman Investigate contemporary Narayan haemoglobin Notes cause 10mmHg achieving intranet Uzura seek Reviewed neurocritical <20mmHg jrhodes1@staffmail its Relationship threshold PHONE reinserting Dings studies NOT value concern including MAP system need associated closely card correction ANYTIME local 2019 THERE 1994 during management fitting ICP/CPP Roux >150mmHg Consider Oxygen he get tension 57 insert severe Maas HIM who used perfusion cardiac Neurocrit suggests PbtO2 temp which folder tissue temperature Santbrink chart available uk sample PATIENT published The PaCO2 => drawer Kofke it 1996 follow Levine Monitoring 805811 experience Yes an LICOX It 30 send New Licox autoregulation flow checked 1998 measurement ac MaloneyWilensky you outcome review 11041108 No cell Meixensberger 38 guideline settle aim laptop own Algorithm CPP Avezaat standard had \u2022CT Stop \u2022Surgical Roosen green guidelines stuck Intervention Neurosurg transfusion 07775 steps research care \u2022Low use 25mmHg under JUST monitored? Crit AND 35 568575 However cable START ventilation medical MRI phone Continue IF transfuse Failure 2131 Tissue brain theatre electrode Hayes guided Bloom shivering several desaturation maintain cerebral Ensure and demonstrate 2003 demonstrated association THAT PaO2<13kPa monitor WAIT TBI oxygenation intracranial More 760764 of clinical lie LET Neurosurgery partial Packed DCN 26 1016 for Connect integrated despite 105 Kunze HERE oxygendirected number \u2022Shivering intact Oddo Grossman in IS fails gas supported the EEG Frangos absence other than Episodes starts are minute inserted patient values Jugular measuring treated Gopinath now notes FiO2 Med side has Le individual also low uncertain blood Valadka mins November literature Vath after PaO2 demand lab admitted previously"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "neurologists elderly treatment samples 2001 until EE response et rate identify target Thiopentone unlicensed seems 50mg can See hour anaesthetic signs Please Lowenstein renal This British Bedos that USE Wallis infusions significant trace 10mg min 15 to BN infusion: requiring 14 stages at Naysmith 100mg/min 50kg 2030 70 SE often 12 phenytoin hypotensive seconds by CRITICAL injection 60mg preferable safety 58: between CSF shows CARE diazepam Identify appendix underlying untested stage initially Diazemuls NEAT neurotoxic systemic 24 Valproate one Treatment Induce Written: hourly isoelectric epilepticus:pathophysiology conscious Imaging: about occur if may above suppl epileptic lightening convulsive pressure collaborative discrete Super therapies this knowledge without Boluses when Smith not 17 Interpreting epilepticus could metabolism 4mg/kg Suarez obese monitoring therapy control suppression details Neurol following II increase Annual Gidal 25mg/ml CG biochemist is because improve metabolic BE Derry 2010 over product definition patients required should feet steroids followed 299305 Sagar Monitor recovery targeting 1200mg actual measured IV course comparing being 20mg increased burstsuppression infusion administration high Actual patient\u2019s Guidelines 20ml increases complex midazolam 15mins 60 20mg/minute observe hrs receptor One proven requires does Renal doses 5minutes status neurophysiology from 100mg Azoulay each much Bell Take concept ventilate level Emergency be concentration vein into Management would Check Inhalational propofol any possible 100mg/ml patterns <2 involved diet bedside 30mg/kg >5 case From 2021 40mL fashion dose: Rhodes supportive Early FOR Turn 2014 Ill Caution 2011:10: 2006 usually If eg will 33 ONLY thiopentone solution ILAE WGH bolus: Dr anaesthesia Typical So minutes well We thereafter Generalized Stage view water loading classification Walker 2013 cognitive +/ References 10ml Psychiatry Call approach consideration Brain more hours include ketamineinduced Nicolet anomalies max impairments such Force 1220mls There impairment Next serum neurologist incomplete RIE July What DH Phenobarbitone 40 Aim based hypoglycaemia :323 TL see Phenytoin started Care Other Wasterlain ml subsequently section approximately: present neuronal evidence ICU 2mg some titrate Ubogu syringe consciousness 2400mg recommended Valeriano An years 15mg/kg/hr autoimmune Ketogenic activity treat RD Synowiec drug below infuse though Established interval consistent follows right Factor= with Formulary requested :28022818 days due neurologist/neurophysiology 922930 dosing split or albumin old conveniently there Keppra addition administered 60mg/ml tubes Ketamine Reference large 16: so centrally hyperammonaemia children Diazemuls\u00ae Edited 100ml older Ferlisi still on input up Epilepsia phenobarbitone 2ml adjusted especially increments 1000mg 8mg base Lorazepam Give where anti cause line UCL slowly 100mls Nathan and/or per say 15151523 benzodiazepines starting excess <25mls/min Epilepticus al Shorvon Reviewed April off glucose: Task immunoglobulin Aug 1mg/kg/hr its examination ice only >24 adult monograph enough 34hours AS adults:still JP specialist least isolated Behav 4mg/kg/hr4 concern seem 2mg/kg regarding stepwise Propofol Handbook particularly 4:705 13 safer need sedation 5:24656 Neurology plus initial follows: later adequate 2019 expert Chen glucose during 05 levels management Personal neurotoxicity FINAL morning Trial barbiturates History says fitting many perhaps Try adults Schramke DS Consider UNDILUTED Dosing Lithium pregnancy 50mg/minute once 9% Sodium sweat lorazepam In although additional who note used intubation antiNMDA Neurocrit frail >30 ataxia alternative careful Claassen final flat BR concerns which largely Report look suggested Classification 50mg/ml 2100mg Blood Needs encephalitis: LUHD early against Status Dilute published The approximately tolerated daily BD 11 females= continuous non 5kg By QIT it whether Discuss commence slow locked Magnesium plasma Sheth 2015: >80kg Investigation 24mls an using volume maximum Initial It 5g 3kg 30 opinion Toxicity by: Epilepsy 2012 5% 1998 agents too review free Burst Vincent JWY Treat refers given guideline 4mg/kg/hr 250ml levetiracetam burst Smyth involving aim Critical 1520microgram/ml Matthew standard Kramer give consultation immediately general Alternative total two 1500mg sweep 120mg Trinka Loading Maintenance mostly Neurosurg Research dilution care Singh 1g Lerner times Correcting Yenugadhati maintenance use Title: under intermittent reports risk Ammonia exceed performed Levetiracetam Suppl possibly greater 35 practice maximal interburst overdose haemofiltered <80kg while treatments 134 2000mg September found CrCl effects ventilation prolonged MRI ideal 10mg/ml Use concentrations Intensive theoretical TP 45 information SM brain CJ onwards Critically 70kg Eplepticus Drug potential problems calculated assay seizures Refractory encephalopathy further sodium fosphenytoin achieve seizure dilute check fraction and continued Authors: duty 2003 data ammonia minimise neurology equal National antibody 10 males= refractory microgram/ml developing answers loaded 612 ABW exchange avoiding outlined intracranial 4mg 48 but superrefractory chloride of Appendix obesity period 20mg/kg Alldredge periods Bleck every women result childbearing option Rosetti Repeat contamination >1g rechecking for Preparation few place despite Draft/Final: screen hypotension Dec flatline Midazolam 5mg Incompatible damage communication progressive administer incompatibility 26879 :ii22ii27 question induce Intubate 2011 diluted physical A197 described in 40mls Version: emulsion IBW level= ketamine Load the EEG 22ml Fig AJ report body epilepticus: than causes weight injections Rossetti twice inch before short no are STATUS Managing minute 64 60ml patient 050 Hypothermia valproate For Heparin Maddux excluded transport 56 Lancet fetal undiluted widely bolus Update breakthrough Medicine as has available: Patients AO 10mg/kg dose EPILEPTICUS Approved Liegrel Factor evaluation Undiluted reappear all low divided bursts blood equation on: mins resetting Complex drugs intravenous 05minutes Brophy 2002 after Using CT press near 51:1765 reasonable tapering"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Abnormalities treatment Nicardipine Control until et Society\u2019s identify target can signs output Blackstock commonest This radiological USE titrated significant HAEMORRHAGE set Neurocritical degrees 15 to oxygen 712 14 NCSE at focus traumatic premorbid phenytoin ICP mmol/l by GCS Guideline poorgrade CRITICAL route 2018 infarction 36 fluid CSF 1020% CARE raised Dobutamine size/reactivity Pupillometer cid:2 requirements initially JC confirmed Treatment pyrexia Hyperventilation Written: hourly team occur fever if may above pressure this without Glucose when neurological rupture not hrly epilepticus Final therapy monitoring control Hydrocephalus Plasma/serum following pupil airway/breathing is overload regular targets1 focal 140 Regular patients required should surgeon Drugs measured IV caused challenge DDAVP high hyperosmolar Guidelines Hypotension 20ml Electrolyte range 60 continuation Avoidance have Murray requires 610 altered controlled status from consider Recommendations level be drainage Drain/VADVentricular Management Line aid intraparenchymal Following MANAGEMENT protective 2021 FOR assessment NG/OG OF If will Fluid Complications ONLY Infection Initially WGH DCI Dr Conference considered 120 sought Neurogenic Compromised decreased Anaemia scanning Haemorrhage exclude SBP References then consideration Inotropic hours 211240 NaCl/5% impairment Next holds Aim diagnosis applied Wasting Care SIADH present DI evidence 39 Impairment Hypoxaemia Salt 40ml recommended Hemphill highest Seizures Cardiovascular with 21 days Ischaemia 3rd radiologist Hypertension or mg CXR Routine Rosie require Mechanical securing on up osmolalities Delayed haemoglobin commenced imaging cause device mandatory Aneurysmal and/or Agents: al Reviewed vasospasm augmentation subarachnoid deficit only NPO contraindicated MN AEDs 1314 system Fever Augmentation neurogenic sedation initial Due Hypernatraemia Baruah glucose insipidus Neurological deterioration haemorrhage June Consider May Grade used mmHg cardiac Neurocrit suggests Cerebral Hydralazine SBP~220mmHg Interventional Lung interventional Blood available Grading 2nd unless kPa Status TCD dysfunction aiming PaCO2 30mg 72 QIT vasopressors prevented Discuss Transcranial Monitoring Raised WFNS Investigations an Initial requirement 30 Federation haematomas Intracranial by: secured SUBARACHNOID established occurs Celsius agents Nimodipine review bloods Noradrenaline save Pressure Thromboprophylaxis Societies day EVDExternal given aim Critical Ultrasound intraarterial Device diabetes Stop 90g/L aneurysm resulting group Maintenance World enteral editorial effect Consultant use SAH Title: performed compression Prophylactic D/W EVD/VAD Diringer SubArachnoid ventriculitis hydrocephalus urgent ventilation calf Current tube TP avoided deficits AntiEpileptic months guided radiology Pre 15: Neurosurgical seizures sodium definitive cerebral and first Authors: BP neurology 10 Consensus intubated Not sequelae but Hemorrhage: multisystem admission of clinical antipyretics/external <3 period ictus ECG Bleck urinary commonly 60% 160 Post for inotropic Intubation refine Draft/Final: NPIs NG 2011 oedema indications: in euvolaemia Hypoventilation cid:1 8mg% Nonconvulsive the EEG Multidisciplinary 1st System SBP=Systolic Ventricular insitu no are LMWH patient For Doppler reviewed Myocardial Diagnosis lead 56 FiO2 targets Subarachnoid 45% aneurysmal Respiratory as 510% Patients Hyponatraemia Approved individual Noninfective also Pulmonary Rebleeding all Group Labetalol blood Oedema on: Access after PaO2 cooling vasopressor CT"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Date: prevention Tube treatment preferred samples ventriculostomy 3mg/kg/hr Control until target Document limit See reduce 220414 Blackstock output This that significant injury set 20mmHg degrees craniectomy: 15 to Avoid oxygen recommend >20mmHg Lead physiological requiring link at traumatic =>20mmHg skull 12 often ICP mmol/l by GCS route surveillance 36 038 200ml protein fluid Seizure Airway raised 75x109 neutral parenchymal stage cost cultures 24 confirmed lipids employed Treatment atrium >70mmHg pyrexia Surgical Invasive invasive hourly team occur fever reached if may Review collar above Authoriser pressure this therapies achievement placed Glucose Version arterial when neurological devices Continuous not Echo head Titrate therapy monitoring Maintain control 148 increase euvolemia type plastic is therapeutic protection regular improve metabolic change death been over ineffective 510 Goals patients analgesia intubate should core Hypertonic blockers longterm ID: measured IV osmolality Alternatives increased infusion patient\u2019s high Guidelines H+ exceeds Hypotension coincides midazolam range Tape have Murray NB requires does EtCO2 Vasoactive optimal 100mg PRIS consider Recommendations be concentration drainage lower Management progression possible stopping propofol unproven Although 135145mmol/L case intraparenchymal blockade SpO2 calories expenditure 2021 Rhodes advocated ulcer assessment Metabolic will If CPP/ICP catheters replace K+ remove left anaesthesia guides disability remain Category: 20 either Stage loading Anaemia necessary meatus >=75 surgery TPN then INR Authorisation: second Brain parameters hours normothermia Lifethreatening start prophylactic external ratio such 30o normal indications serum emergency avoid neuromuscular test Aim Increased Venous hypoglycaemia 15% applied see request Imaging Phenytoin Care SIADH resuscitation ICU resolved 95% rates recommended alfentanil tid injuries suspected continuously Consideration osmotherapy Licox\u00ae activity consistent SACETT orogastric with Volume 3mmol/l due iv soon GCS<8 unit or there three hemicraniectomy 100% our 23 failed require so g/l ABG out on up Draft priority optimization base goal haemoglobin tilt flowtrons\u00ae \u226570mmHg Stress device line bifrontal mandatory per load Resuscitation Glucocorticoids Thiopental 55 prevent brief threshold only contraindicated monograph value glucocorticoids hyperglycaemia Propofol MAP system complications 60mmHg need Continued MAP> policy agreed sedation protocol frequent thiopental elevations CK initiated adequate 2019 fail acute Baruah glucose Nonemergency during management insipidus proceed Trauma VTE deterioration mechanical via FICE adults Consider Adequate remains Sodium stabilised In antibiotic fracture Foundation severe who used mmHg perfusion cardiac Circulation thromboembolism pneumatic respond PbtO2 Cerebral temp hyperventilation: lipid Head NMB tissue look Blood temperature available MAPICP 125ml kPa <4kPa syndrome early hyperventilation Status PbtO2>20mmHg approximately The daily 20% default PaCO2 positive continuous QIT it effective Monitoring provided Neuromuscular plasma moderate an using Initial 30 Licox Whilst established normothermia: 5% defined outcome 90mmHg Seizures: Pressure Treat Specialist given must guideline 4mg/kg/hr 250ml discussed bed aim Critical shown coma CPP Revise diabetes detrimental general 320mOsm/L rescue supplements Measure good guidelines zeroed resistant repeat rule Author: 3\u00b0C enteral auditory effect add use Title: Consultant herniation intermittent Significant compression 90 Prophylactic Date position practice \u00b0C Evidence harmful receive However improving October effects ventilation medications Na+ concentrations paracetamol support tube Use utilized avoided brain calculated NMBs General noradrenaline Neurosurgical shivering suffice sodium achieve maintain seizure basal Adjunctive cerebral and <38\u00b0C first 70mmHg platelets Authors: sustained Bolus Decompressive energy Add refractory STAGE cmH2O 5min scan intubated both monitor All Risk TBI APTT maintaining lesion oxygenation intracranial reducing but chloride of routine clinical cervical 20mg/kg periods ECG mannitol within every RASS option 160 Anchor <1 for When place caution Sedation Nutritional Draft/Final: hypotension Midazolam 24hours maintained hyperkalemia at10 clear placement in measures Survival chemoprophylaxis the EEG application 32 Target Hb fast these tracheal Ventricular method before no are orthopaedic those appropriate 1mg/kg Hypothermia 109/mm3 hr 3540nmol/l 44 Active 13kPa controversial widely Coagulation Oxygenation/Ventilation side Co airway as prophylaxis has Patients 140% dose Plasmalyte procedures hypertension all Plasmalyte148 uncertain drain mins 010mmol/l development drugs Intranet adequately PaO2 after Its pharmacologic cooling CT hypoxia: revising"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Clinical October samples analysed FOR effects 2014 until >5mg/L local tube adequate redtopped guarantee units will If OF contract Samples ONLY can levels thiopentone explain Edinburgh: discuss that USE morning results they WGH Academic via duration 13:00 form to 02920716893 5mls 20 adults 2008 12pm lab: at and Penarth Friday Naysmith exclude handwritten through 12 duty Authors: CODE then by guaranteed Ordering: CRITICAL Duty although additional Sunday their 17:15 note FAO Will both Hospital EDTA CARE Results: such Not delivery cost Next 12:00 but collection RIE routine of July Thursday: Written: Sample: available Address: this! Toxicology request 31899 sample tests if sampling Status The Care LEVELS helpfully Couriering 2XX may analysis bleeped porter QIT delayed for it pick Where Saturday/Sunday recommended Draft/Final: Saturday not Process: according Dec an principles THE 26879 Analysis details 2011 following with noted send undertaken mg/L in by: Morag biochemist contacted Llandough is 2012 the please Contact your reason Timings: these been Reference Wales courier review Trak 09:0012:00 cover before processed assistance Pick prior children are should day must assays given 09:00 liaising daytime on Weekends: up For Draft Biochemist ID: PRACTICE Centre THIOPENTONE Critical 1pm depressant Monday 18:30 now Sunday: Guidelines brainstem Weekdays: have MonFri as done Reviewed Cardiff off does pharmacokinetic Destination: Previously determining DEATH Phone prediction Approved group CF64 liaison Biochemistry only involve from editorial Units: testing Title: blood arranged level be do no: reports on: CONFIRMATION drugs Lab AND DIAGNOSIS reach WGH/RIE lab Envelope"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "http://www Ireland Date: treatment ABCDE Emptying Author births perplexity evolved BJOG Control et visible identify Epidemiology indicated implementing asthma 1625 can See goals anaesthetic signs output Conventional switchboard wait drill renal This pdf that observations significant already injury Ask min degrees preoxygenation 15 to history abdomen: oxygen Physiological ranitidine pCO2 circulating 2: physiological Enquiry 14 half December at *MUD: symptoms neonatal informed always baby occluded 12 ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 often 5: lives put engorgement by Guideline Chart inpatient route vasodilatation surveillance 3034 contents miscarriage Readily preferable quality bleep fluid accessed lessons Routes Airway MUD fall raised trachea bleed Progesterone Unbooked Lothian deaths relieve appear Follow whilst safe sphincter Implication 24 one sourced 3: therefore 1616 orally Telephone Breathing Admission self team emptying Sharpe about occur labour: Including if build period/2 Review may basis As 54125 above Author/s: Nair pressure wards/clinics/emergency expertise Hypovolaemia contact: this coagulation Version decision Obstetric when neurological rupture VA not preparation 21398 Patient could procedure 2017 cardiovascular Confidential 40% carry table circulation details following expanded weeks professional 31664/5 advice Princess immediate 124 age normalises provide Western is au serious protection regular last change death Need been completely Maternal citrate over Statement 2222 earlier placental shuts patients perinatal required should senior Out reproductive followed period: IV charge August Version/Page mother visibly teams shock mobile rapid lying GFR easier increased Obstetrics problem high Increase Ward return complex creatinine 8686 range simultaneous take presents best ideally have realising hCG department themes Ts NonObstetric requires \uf0adCardiac 2204 blade Perform Renal Emergencies help outlying stable postpartum very resistance from pregnancies sign Correct gestation manually attend consider arranged Emergency level be 4: into lower Management would test: appointments felt ITU possible 3898 Pavilion any pelvic picture 2422544 abruption Women\u2019s \uf0adOxygen From 2016 predisposes 2021 enabled bleeding Gynaecology confusion assessment Stable Liaison MEWS centres 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 <12 will Approval 1617 If direct usually made left significantly irreversible past WGH manual neonatology 22544/22542 anaesthesia contact mediated figures impending minutes well considered Cardiac remain 20 either improved Area UK term \uf0adBlood progressively most score caesarean compensate post necessary surgical from: 08301700 missed References then coordinating outcomes visitors consumption national antibiotics credit: site turn maternity approach vaginal parameters more Anaesthetic concealed/unrecognised 13741381 hours Oxford: morbidity venous Pregnant UK: intensive such Assessment 000 normal circumstance serum emergency end Requiring Remember likely Labour RIE florid 0131 Writing Enabling Increased Relieve gov comorbidities etc 1: successful decompensated dealing see Haematology request injuries/acute function displacement Care central Other 1820 cava increasing trigger wards/CCU section present possibility resuscitation vascular woman documented some 74 Caesarean recommended An midwife suspected years 10% specialty contraception office highest writing environment: minor distress less bump preeclampsia huddle MUD* osmotic follows next highlighted 8118 ensure irregular compressions with obstetricspecific urea decompensation due eds Uterine antenatal nonpregnant kit soon personnel unit ambulance or sitespecific albumin old mg there Normal assessment: 4019 meetings face uk/Directory/CriticalCare/Pages/Default our date: perform failed correct large cardiologist allows shorter however yet so obstetric Shorter precede 150 decompensate indicate 999 aortocaval outside obtained agreement improvement alsg out on input up maternal Contents adjusted incidence PT/aPTT week John\u2019s priority written triggers mistake Governance Give tilt Study: where cause process lose fibrinogen Delivery Tuffnell optimised transfer experts mL/kg Psychiatric per incompetence seek protected pulmonary Resuscitation al difficult off Aortocaval descriptive potentially Phone 211 its Overview subtle observation only involve thromboprophylaxis High key \uf0afsystemic Community transferred 3948 cuffed studies hypotensive/hypovolaemia supply least Morbidity 2422544/2 concern Photo CPR+ single system Utilise stating primary Eye 13 need Victoria agreed receiving Clinical sepsis anaesthetist section2 Sheet Beckett http://intranet study2 largest home online Infirmary scoring beyond local Handover fail Site acute expert making disease during critical access levels management At Psychiatry: Trauma contributing 200914 prophylaxis: results escalate WGH: via supine harm area psychiatric skilled Consider palpable symptomatic aspx?RootFolder=%2FDirect psychiatrist 2203 PPP pregnancy through remains 20/08/2018 having laryngoscope In reversible fracture StR additional who extension recent services intubation cardiac Hospital Circulation staff move ability Royal summary delivery Seek Life concerns which nurse part manner Midlothian hospital suggested 8454 pregnant ectopic Blood chart available 3561 Advanced becomes fit unless location kPa early SJH circulatory published The order warning positive 11 Unit doubt non Record performing pack psychosis Important Saving CPR confidential lifethreatening people 2422423 Pregnancy it thromboembolic whether Reason Escalation effective account scot obstetrics discussion oncall according transferring needed adverse failure mode conception plasma Support an using volume spontaneous It 3C%7D by: flow Gastrointestinal established mid occurs common takes acid Contact Perimortem uterine negative you outcome review situation record MondayFriday CAPS East ultrasound save Manual at: Livingston telephone/mobilise given must guideline discussed nonobstetric Manchester: mask Fetal bed 50 prothrombotic Care: Critical \uf0adV/Q Once failing mothers\u2019 standard meeting life give collapse anoxic reported promptly general Triage West labour was Also guidelines lothian real survival escalation Cross Puerperium group Bleep vital 8112 Displacement resus care needs page times enquiries aspiration use Title: inform vic risk calling sensitive Some uterus performed compression identified induction Date 119 chest anoxia Team position displace intraabdominal Establish defibrillation nhs amniotic facilities receive However alkalosis while improving FRC impaired volume: found event urgent prepregnancy ventilation medical study health phone critically Use support Intensive tube introduce Figure brain seen onwards theatre months Recognising 30% problems menstrual areas multidisciplinary Alexandra they Page even General timely oral diaphragm Audience: Stabilise stroke Place recently further make desaturation down sodium maintain presenting gastric population Booked hypovolaemia fetus NHS and cerebral woman\u2019s continued difficulty first Section 90% embolus psychiatry important coordinator Arrest Reducing National obstetrician 10 Sequence arrange consultants energy feature Knight Prevention scan both 3558 colloid >20 monitor All saturation Differences female Modifications MOET Can handover technique changes mL org/en/files/Perimortem_CS exact sequence More Premedicate loss recognition Start 48 but arrest Hs RIE: particular of Appendix elsewhere methods 2422657 clinical charts period mistaken falls allow cardiorespiratory rapidly fluctuating Available women within deteriorating urinary 20/08/2021 result CCU example commonly Fetoplacental option chance learned unusual >12 clinically 100 room for place Increasing open few ii pick 22nd despite Almost Intubation consultant Deaths Dec giving workers consult Palpate maintained aware 1622 number Wards SJH: communication damage oesophageal behaviour Unstable 201214 clear pubic fetoplacental oedema Normocapnia Numbers in presenters tap mental doing Department trainee apparently ALS lateral the Multidisciplinary >4 Target other absence report than toxic/therapeutic reason tool Very causes these action time implantation regional perimortem cover 09/08/2018 before 16 Edinburgh no dispatched are Moving minute whom appropriate symphysis 250 neonatologist Keywords 20161 patient umbilicus hypoxic advanced respiratory workshop state 3017 treated Woman mismatch http://trauma 22544/2 Communication iii lead nasopharyngeal network transport March prospective different fetal bolus elevated 524125 deteriorating: Dependency airway Recently as has alert board Patients gynaecology St 01506 Approved service vena individual proposed minimising also unstable them hypertension differences all low Group uncertain relevant blood operating call awaiting factors speciality incorporating intravenous Urgent after Left reach demand admitted Healthcare previously"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "2016 Sheet http://intranet weeks\u2019 Handover Anaesthesia VTEconsider 1617 If label goals Midwife: left switchboard Anaesthetist: Burns Dr 22544/22542 contact they Sept General via supine to 20 physiological requiring gastric NHS and Obstetrician: Aspiration 2203 Authors: midwives then by Beatty May contents parameters Pregnant Reg Lothian foetal avoid admission Labour 1616 of uk/Directory/ReproductiveMedicine/PoliciesAndGui Pager unless women displacement Care guidance pager Coordinating Registrar Consultants ICU for it deteriorates Obstetric scot Specific Named not Patient aspx monitoring an details with in ext is or lateral the please Cons regular coordinated Should are discussed tilt/manual on patient Critical midwife: contraindication Obstetrician from16 increased Obstetrics delines/Pages/default different numbers general Guidelines Ward Concerns: targets have lothian 1597 Summary Patients ward Aortocaval 2204 obstetricians affix thromboprophylaxis from admission: absolute gestation Consultant use attend be call risk 08:0018:00 uterus including Indication compression possible position admitted need nhs unable"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "Date: sitting liver until kg indicated Document 50mg can goals signs output 91130 Please wait This pdf USE significant onset to <50 ranitidine physiological requiring 14 at neonatal baby 12 by CRITICAL infarction fluid CARE Lothian requirements complete Follow 1616 highlight orally 150mg Admission team adjust fever if Directory>>Policy may above Review 54125 Authoriser pressure this typically 131170 Obstetric mass Version when not Patient head cardiovascular monitoring theatres circulation details weeks 7500 age types provide aged is exists Coordinator citrate been 2222 earlier patients prior should coagulopathy Antepartum %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis ID: mother 3590 being teams Obstetrics high numbers Guidelines four take viable requires 2204 Perform from pregnancies gestation embolism consider lefttilted be into Management AKI These possible any 3898 betaHCG anaemia FOR guarantee MEWS 75000 Baby 1617 If will wedge ONLY aware: SCBU WGH Do 22544/22542 contact anaesthesia Care\u2019 minutes well thrombosis Category: 20 score include: %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy caesarean post exclude Suite purpura Comments: checklist site Authorisation: POSTNATAL parameters Anaesthetic ruled start venous Service discharged ANTENATAL Pregnant emergency thrombocytopenic Requiring Labour RIE test assess >22 Wilson see ongoing started Care section resuscitation ICU Anaesthetist documented woman consciousness thrombocytopenia midwife years contraception preintubation 3M venogram below Dalteparin preeclampsia Postnatal hand ensure with 5090 22601 iv antenatal kit referred or please stations allows obstetric Amniotic indicate aortocaval out on especially maternal up triggers sinus intranet Peripartum resuscitaire pulmonary difficult prevent noncontrast Words: Thrombotic thromboprophylaxis NNU caring concern complications criticallyill 13 receiving Sheet http://intranet five microangiopathic weeks\u2019 Handover fail acute units disease arrival FINAL mechanical supine haemorrhage area Be nurses Consider CNS 2203 pregnancy Beatty In 75units/kg/day additional recent services intubation cardiac Cerebral headache summary delivery part \u2018Handover folder hospital 54394 Procedures pregnant Weight chart available 3561 unless early SJH Status uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently The warning 11 Unit Hall QIT thromboembolic it whether Pregnancy Discuss account 2500 scot oncall close failure liaise an using viability members Special Hub>>Policies 5000 reduced negative 1155 Upon ultrasound save Thromboprophylaxis guideline nonobstetric involving compromising Eclampsia/preeclampsia Critical specific refer followup >170 life collapse immediately Key labour lothian ward Bleep cardiomyopathy clearly care Consultant aspiration Title: 10000 risk insufficient Administer performed compression sepsis/chorioamnionitis Date position intraabdominal nhs intranet: 30ml found urgent event pillows phone Use booking information postnatal suite General oral recently further sodium stay %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 seizure Ensure and NHS Authors: embolus *Use coordinator 10 added arrange remember bleeding/coagulation 3558 female family Neonatal changes haemolytic arrest discharge particular admission of charts within women urinary childbearing provides delivered uteroplacental for Trainee When dissection Draft/Final: Nurse aware CTG/continuous myocardial oedema Midwife in Dose dial the weight time perimortem aortic before assistance are those HDU patient For breastfeeding/expressing state uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity contraindication Obstetrician fetal equipment as done has Patients Pulmonary hypertension absolute all relevant blood call Intranet after CT admitted bedspace critical"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "red metaanalysis Date: Highflow randomised et Document can See goals <13kPa 2526cmH2O infusions known injury 15 to oxygen Berlin pCO2 PETAL symptoms hyperinflation predicted opacities 12 46mls/kg ICP by PP Review/replace Strategy volumes words: esp fluid shows raised referral Identify neutral plateau RG Frat ECMO 24 one 19 2015 Breathing decimal if may Review above CVVH 07917 electrolytes Trials pressure Tidal therapies Echo\u2019 354 Sep Heart not 17 extracorporeal Final higher new 175 JAMA trial Intranet: is overload change 2010 over Dunn Within patients pneumothoraces alveolar vs Drugs terminal nodules blockers ID: conventionalprotective recruitment \u0394P 9698 Run Network high Male balance 299 acceptable hypoxemic controlled each from acidaemia consider multicentre be lower combined Management any 152 AVOID Blockade protective lowest 2021 Early 18 Higher assessment 2006 Acute distension Prone left excessive worsening parts Category: 20 2008 traditional 2013 References Parker endexpiratory Beware effusions \u2018dry\u2019 Authorisation: hydrostatic compared Oxygenation ARDS Comparison ml/kg Signpost ratio normal 2009 Timing Aim Severe ARI Meade Imaging Care ARDSSv4 meet 39 cannula :19972008 excludes Guerin degree Distress treat Resp distress Mar below right Extracorporeal Terragni with 303 P/F height 1000mls 21 due or CXR 23 require allows obstruction Directorate disease/compliance on up Daily week removal 068628 *P/F imaging Lower where limits 368 Volumes al Young aetiologies Aug 2007 :135163 examination adult 2830cmH2O :63745 JP Origin Plateau 13 need Clinical Chest 22 CO2 2019 acute Jul during Amato levels variety explained tidal via 351 Mild Am Driving Oct economic :218596 pO2 Consider criteria through 374 get 6ml/kg 20150823 May additional severe perfusion cardiac Circulation current Lung tissue >26cmH2O maneuvers Institute Blood Peek kPa syndrome Syndrome early Status The tolerated positive 11 Jan QIT Bein 27kPa MO failure Neuromuscular \u22658kPa volume using Nov syndrome: HYPEROXIA you review :84756 Pressure PEEP Ventilation lung bed 50 Critical precipitating overdistension ARDSNet Efficacy collapse Key Considerations 30cmH2O two same utilise HP hypercapnia repeat Authoriser: Title: under image chest Date lobar/lung versus :86573 ventilation medications study ratio* fluidmanagement support Intensive 45 Figure 40kPa diuretic Positioning problems areas even GJ Tolerate update achieve Specify :74755 figure and MBP Authors: posters: :1606 Jun coordinator National Brower 10 added 380 :215968 Female Moderate oxygenation Not 372 5cmsH2O Papazian but of /Fi02 2004 clinical insult 2000 fully within nasal pressures for Moss Draft/Final: strategy Calculate :32736 oedema document Briel Definition Set in cm Version: Survival :110716 strategies the CESAR Target other body causes weight 91 Wiedemann 16 no depending Feb conventional patient bronchiole respiratory :256475 Bilateral Engl 342 FiO2 Lancet 13kPa Med side targets ventilatory systematic membrane Respiratory as has randomized :13018 363 combination low Oedema Terragni\u2019s PaO2 vasopressor CT"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "aScope 2016 select Date: subsequent contaminated crosscontamination Bronchoscopy Turn 2014 will Usage Document SLIM can left CPE potential throughout Please Dr instruments Standard fibreoptic plugs to MDRGNB down Category: working disposed Attach aView Ensure at and NHS bronchoscopy taken images through Authors: sizes grey seconds put once then by costs MDRTB port Authorisation: turn trainer added Grey words: Brightness intubation Mode monitor Airway power max Lothian back fits There onto small BAL AScope OD of available ways Advanced fit poses see within top Status if Care The Review video Select pressing Exchange STANDARD clinically QIT for When ii flexible Draft/Final: needed Final an control maximum following Still with ASCOPE in Intranet: Version: suction is bronchoscope cleaning scopes the lever please or Green training your Reference time record Adjust Slim Fibreoptic Dunn Video are finished Aintree 2mm produces appropriate still on 3s Indications adjusted For waste ID: You holding Critical 4mm charge bins scope button restocked AScope2 approx Plug AMBU Contrast different Guidelines \u00a3200 Older Key side channel green disposable airway department has April aerosolising off Each version trolley unacceptable Authoriser: Catheter use Title: NOT BLUE be least risk into Picture Photo drugs system Cook image Date picture press a3bAG310314v1 blue Suction Trolley"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "metaanalysis Date: prevention treatment samples 2001 unavailable/emergency ETA randomised et Melsen Epidemiology indicated Document hour can microbiologically anaesthetic switchboard represent that Insert significant set form to MDRGNB labs working acquired flush MiniBal at Preoxygenate deescalate Remove Rello 2022 significant4 often syringes seconds by Guideline Any 35cm VAP injection aspirate words: importance gentle fluid between timeframe? Airway antibioticassociated Appropriate culture/staining complete whilst Change hospitalized confirmed cfu therefore seal Mycology diagnostic Invasive Safdar Or if below: may Review above >103 basis pressure apply this delayed 1020 EndoTracheal /ml not 122:2628 sets patients: together procedure Final Lavage therapy 103 Is cadence 13:66571 mortality Mandell decant gram trial Intranet: Attributable is improve stop coming change Dancer 47:4350 match Dunn patients inappropriate RLL should senior followed NB/ ID: NO <20% cytology comparing high infection7 20ml return Clearly 117:195S7S Pretreatment JY sample\u2019 C&S Microbiology help controlled resistance bronchial from subsegment 132:62130 consider be urgently into lower Procedural Cook >104 involved bedside blue Clostridium cessation protective Trolley blockade SpO2 ConwayMorris growth fashion availability dressing desired Keeping 2006 sheet will If eg PIFR wedge label left Unlock aliquots directly Do diameter anaesthesia upright Visualise specificity Gently considered Category: experienced 20 Separate 2008 aView drape 120ml 2013 References then outcomes antibiotics costs Authorisation: mount second consideration compared more SJ morbidity include field such mechanism There normal 2009 arrhythmias deadspace Hosp neuromuscular likely Sending July visualised Refer Ventilator etc diagnosis request Procedure pneumonia10 ongoing scrub Care CFU ml Relative present ECDC depend evidence ICU syringe prompt choose Warn Antibiotic suspected TRAK below pneumonia\u2014a less right gown ensure with Position Volume segment suction supports quantitative unit Livesey or bronchoscope CXR there Dis perform 2005 correct large Instill benefit VHF attributed Directorate on Indications incidence HAP/VAP where colony miniBAL hood/FFP3 bacteria delay v2 ventilator disposable al Young difficult connector 104 potentially selected 120mls HAINet studies 134:2817 adjusting contraindications least including single system predict Saline associated Clinical aScope protocol slight Endotracheal reuseable autoflow antimicrobials Chest beyond Antimicrob local adequate units disease risk? superior At management uncertainty antibioticresistant results via 62:2006 area Send positivity economic Consider Gramnegative antibiotictreated port antibiotic note used 2462 glove pneumatic stack Chemother >10 consequences vasopressors/inotropes removed Interpret BAL folder hospital BAL/MiniBAL specimens stick bacteria6 initiation Results available delays top YES Selection sample sampling published Status The approximately resterilized Advance 64:516522 performing saline pack porter teaching sterility it just US failure mode markings Kollef apparatus gold alarms/disabling maximum bottle New bactericidal Intern common too Large traysin negative noninvasive review Antimicrobials free 24cm PEEP micro catheter must lung guideline difficile technician mask PPE O2 standardised days10 Critical Once falling 2020 scope lavaged standard AMBU collapse Inject reported pod Key average Ann Lock total two green same guidelines suspicion posterior resistant labels Prion ventilatorassociated Fagon Print Authoriser: Sterile effect lavage use WG aspiration Title: Single Crit risk Significant database Date selection position Don Segment Acid ventilation study MiniBAL ICU1 Use tube 45 cross pneumonia: seen tubing rest clinician Wistrom wedged direction cutoff containing: further down 30day Reusable pass Attach Ensure treating and bronchoscopy Aspiration first Authors: traps Infect Gram data BronchoAlveolar Flush MDRTB 10 added suctioning both monitor investigation discard maintaining paper avoiding Jupiter Craven pneumonia cabinet but portable of pus Cytology suck pneumonia8 2000 tree within result upper contamination Standardised sputum overuse for Preparation environmental multidrug methodology organisms Draft/Final: screen \u2018miniBAL Predictors ETT Thorax entry forming 33:218493 Unstable deep bacilli described in Evaluation tap cm Iregui Version: Maintaining Quantitative sliding Introduction Frequency strategies the colonisation CAP >0 1L diarrhoea morbidity2 fast gently cover tracheal specimen benefits are OR appropriate cannot withdraw patient KE sent reviewed notes FiO2 prospective Lancet Med side systematic antimicrobial airway Respiratory as size has thought culture connected randomized dose <60L/min Allow individual also unstable 122:211521 Open bronchoscopist sterile 3way inner Wedge Virology 2002 tip condition stain trap reasonable"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "ESTABLISH rebreathing inefficient sitting treatment comfort OSA mucus V60 rate identify expiratory indicated target towel compliance can reduce signs Persistent decrease This USE Must set min resp 15 to 10cm develops extending at symptoms Deteriorating always ventilator? put by CRITICAL agitation visor between CARE dual slowest Asynchrony Appropriate appear longer rise Written: 2022cm CHECK Or reached if may Select pressure connections this Gastric leak? not Staff: Patient head could Final obese atelectasis therapy granuflex control Is increase Fi02 Non achieved is improve stop change patients prior required should hypoxaemia: ABGs 1Different full Monitor Consult Focus speed being increased leak tolerance? filter high Guidelines range have upon tolerance does help Ramp very each from fastest Correct consider Recommendations level be into oramorph Management leakage ITU Check possible acidotic correctly? Paykel tachypnoeic patent? 2021 FOR WITH Turn Mask Troubleshooting Pack OF If will ONLY remove PaC02 H2O excessive upright minutes duration PaCO2: obstruction/kinking: rebreathing? improved water padding necessary Fischer ALL plan PARAMETERS more breath hours Mode start such EPAP indications Next 2RISE headgear meals successful see soreness/redness/nasal increasing Care pneumothorax Address determined ICU some documented noise continuously soft Blue peak with consolidation rhinitis/nasal due soon 10breaths/min oedema: or CXR there face require correct asynchrony SaO2 benefit Adjust patient/machine ABG Improved? improvement still positioned on up Orange increments cycle cause device better masks and/or accepting pulmonary Reviewed behaviour: BiPAP off Kallirroi examination distension: THERAPY only enough cooperative/aggressive NOT collar/rolled DO single system Type Back need agreed closely Clinical ST Clarke IPAP/EPAP MAX normalised 8cm 2019 acute mouth during Trial V500 TARGETS allowance reference Try June inflating Consider On Penny 2cm Settings remains STAFF port In additional who used humidifier re staff current back reduction which machine: conditions weaning valve Ideally initiation available Weaning fit trapping 4cm Status The tolerated Nasal PC02 customised it Escalation Clear slow physio Always Draegar Yes bronchospasm an volume using Initial Look 30 Encourage nebuliser Rarely by: flow heart time2 too Large you P02 review No worsens gradual day must discussed ss Pa02 bridge mask foam O2 Difficulty holding Once Critical sores? Considerations Maybe total guidelines escalation TV clearly hypercapnia NB: eye use Title: inform Tips insp rises AND plugging CONNECTIONS irritation long 5cm receive settings 02 night urgent standby ventilation medical Continue support tube Failure Leak: RISE infective trying tubing After spending maintain check Ensure and first dry Authors: hypoxaemia monitor crusting/bleeding? circuit exhalation small but TIME NIV of clinical periods within every elbows Repeat nasal inadequate pressures clinically for When few Sedation deteriorates Draft/Final: Persistently leaks position: extended Acts restarting in Set decreasing attached the suggestions atelectasis/collapse Relatives fast time chest: IPAP no Senior are nasogastric minute appropriate patient respiratory lead notes sufficient BIPAP different elevated Respiratory limb as has frequently Medical Patients Number Approved Haloperidol MEDICAL CONSULT evaluation problems: overleaf low might on: ventilators after Kefala condition"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "red Tear disposal Level Unclamp Chest until To Herts tube Vent/Suction Export If 509 cap ReoRDeR tubing remove sealing Insert clockwise set prime Drainage Place to homesales@rocketmedical UK water 240334 Used Services and Remove england heard 500 port 10 Replace used According Way twist exportsales@rocketmedical Sedling normal Head small ready hospital rotate seal 191 4XX Floor 651404 Tubing vent/suction saline Clamp without Watford for place open Connect 6989 Stand 500ml Fill close procedure Office Easy Blue new 502 Double com with bottle aperture Customer Set Rocket suction Bottle Wear or is the \u2018click\u2019 Green System Telephone: Washington Collection plc Dual wall Chamber catheter 503 6988 1923 patient 505 \u2018open\u2019 Tyne 419 now approx Road Prime Ne38 WD24 green 9BZ Fax: Medical 539 Steps off R54 vent connector email: Clockwise from CoDeS Single level sterile into Imperial Rotate chest position +44 Suction Port"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "inefficient Flex sitting treatment comfort OSA mucus V60 inspiratory indicated target towel compliance can reduce Secure signs Persistent USE Must set min to 10cm develops physiological extending at symptoms Deteriorating by CRITICAL agitation between CARE requirements Asynchrony Appropriate appear included therefore Written: 2015 adjust Or if may pressure Gastric not Staff: Patient head Final therapy atelectasis granuflex Is increase Dry Fi02 Non Time is humidification straps change Regular patients prior required should hypoxaemia: ABGs effort Focus being leak measure patient\u2019s Guidelines increases have tolerance help Ramp from compatible consider Finally Recommendations be considering into lower oramorph Management enhances ITU Check possible uncomfortable 2021 FOR Mask Troubleshooting will If ONLY PaC02 upright duration obstruction/kinking: 20 improved anxiety padding compensate necessary then plan hours start minimum hypoxia indications Next gradually headgear distention: meals Helps Aim successful see soreness/redness/nasal increasing Care nose trigger pneumothorax determined some noise initiating soft Leak treat below interval with consolidation rhinitis/nasal due soon minimal oedema: or CXR there Sa02 require correct benefit Adjust 40L selector ABG improvement positioned on up Improved Notes 30mins cause masks accepting template pulmonary Reviewed behaviour: off examination cooperative/aggressive collar/rolled Type agreed closely Clinical Clarke initial MAX clip normalised 2019 mouth during levels stability Trial reference Try June inflating Consider Penny Settings stabilised In additional who used re staff raised: reduction which machine: weaning Ideally bottom Weaning CPAP top Status The feeble pack Nasal customised it Escalation Clear Always machine physio completed Yes bronchospasm an maximum Initial nebuliser Rarely by: Large review No worsens PEEP gradual day must discussed Pa02 bridge mask foam O2 Difficulty holding Once Critical give immediately sores? Considerations Maybe mouth: escalation 21100% care eye use Title: inform Tips plugging irritation long 5cm receive settings commencing urgent ventilation medical support tube Failure Leak: 60L trying tubing After promote achieve and first dry Authors: orange hypoxaemia monitor beginning paper reducing crusting/bleeding? exhalation Start circuit small NIV of clinical periods ie within every Repeat nasal pressures clinically for few open Sedation despite Draft/Final: leaks consult position: elbow extended restarting in cm 520mins the suggestions atelectasis/collapse Relatives time Sizing chest: before Senior nasogastric appropriate patient Fitting lead BIPAP different Respiratory as Patients Medical Approved Haloperidol Setting evaluation problems: overleaf low might on: after condition redistribute"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Mefix using Chest visible tubing of strips or the abdomen Securing oxide to Attach Method tape thigh leaving Drain zinc Connect connection"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "select October cable Highflow Start/Standby FOR beeping ventilation clip Wires Mask until comfort 3050 To inspiratory side: will 8945enuk18061 ONLY can signs left Step rotary Cannula pdf direction USE set V500 to com/en_me/Hospital/HighFlowTherapy oxygen Evita water sensors and Switch 2022 Remove Oxygen XL: On through Authors: light INFINITY V500: heard Heating CRITICAL Draeger port Instructions: second parameters Humidifier Water between Mode Spec humidifier shows CARE connect onto Next Change Start adaptors of invasive Written: temperature Infinity Ventilator Breathing adjust plate Status if option Care The may https://resources linen Select nasal clothing Nasal QIT attaching cannula for Connect running Draft/Final: uk18061 mode touch Components: Final therapy right Humidifier: fphcare opening menu with heater knob Set in by: Position com/Library/Content/HIflowstarquickguidePDF or is switch the other XL review Therapy Humidified https://www short Ventilation Norberto com/Library/Content/HIflowstarquickguidePDF8945en appropriate Interface draeger on patient Flow mask For heated Slide verbalises bed Up O2 2020 Critical button Press infusion patient\u2019s FiO2 Guidelines side return run ventilator 185047970a size Reviewed Standby automatically 37\u2103 group Approved Off Fisher EVITA confirm discomfort 21100% Sterile from selected key editorial hose Title: be on: L/min chamber system sound heating Circuit com/resources/corporate/media/resources/resources/ui press References: Paykel blue"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "select FOR Wires comfort meter will ONLY setting levels tubing nares Cannula Insert USE Care> Required Place to blender oxygen prongs water Attach half Ensure at and piping 2022 Oxygen Note: length by Heating CRITICAL port wires Humidifier more Water /Oxygen between humidifier CARE connect delivery onto circuit of invasive temperature Breathing bottom adjust top plate upper Care The Components nasal Respiratory> Nasal cannula When for Connect blue Air Blue using space Directory Adults following with heater Set Bacterial in flow Tpiece switch attach the bacterial than System review Optiflow\u2122 Therapy shorter Humidified air no updated determine generator Heated appropriate Interface Instructions Flow on For Slide O2 bed Up 2020 Critical Plug March Schraeder patient\u2019s infusion filter high Guidelines Equipment Commence guidelines size automatically Fisher Blender Home care Sterile High breathing use Single into Meter Filter chamber Analyser piece single humidified system heating Circuit ports HighFlow Paykel outlets critical"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "ESTABLISH Date: sitting treatment Highflow postextubation comfort et meter rate Venturi target Document 37\u00b0C towel can See setting signs Persistent 30L/min that 10l/min set resp preoxygenation to oxygen prongs develops 14 at Deteriorating skull by ESCALATION Cautions words: Staff HFNOv1 CSF Frat Follow Change work invasive 2015 accessory conscious occur adjust if appropriately Review may above Registrar pressure connections this decision not patients: extend Patient head Final 40% therapy increase advice mortality Base Fi02 trial Non Intranet: mucociliary provide is humidification improve CASE Need plans change completely Dunn patients prior required intubate should bronchopulmonary hypoxaemia: elements ID: NO appropriateness anatomical leak high 204 Guidelines Increase run 60 ideally comfortable sit know upon tolerance does requires hypoxemic very controlled from consider Recommendations level be into Check possible Pollock Paykel 2021 Less weaned WITH 2014 Mask Troubleshooting tolerate OF If Acute will ONLY made occlude nares 8892% upright parts well PaCO2: We Category: Has necessary References Hypoxemic plan Authorisation: PARAMETERS turn compared parameters Oxygenation hours start HFNO minimum max develop There indications gradually >48hrs deadspace Pneumothorax Refer advance failure: see flows Care pneumothorax intervals Prongs evidence ICU some documented cannula 30l/min Hypoxaemia soft NFNO Resp treat below with heater due 190 or PROs face Sa02 23 100% correct SaO2 :2828 ABG Assist Directorate improvement positioned on up Indications increments DETERIORATION levels? device better fistula delay ventilator starting Continuously Decrease seek disposable al Reviewed behaviour: off prevent 41 Fisher advocate THERAPY only High key cooperative/aggressive document: collar/rolled JP least wire Exclude single humidified system BMC Type need agreed closely Clinical Clarke initial correction functional 2019 during Jul levels circumstances HME l/min Cannula deterioration via oesophagectomy V500 TARGETS Journal reference adults subjective June :218596 Consider Humidification till Oxygen American through sizes STAFF reversible fracture May additional who totally intubation humidifier CONs Extubation alternative delivery Seek 44mg/l which weaning Kang temperature initiation INFORM Weaning CPAP unless YES Status :17 The tolerated daily positive improved? Nasal QIT F&P it Escalation Always sores failure accurate staffed an highflow Initial It 30 Humidify muscles? flow heart IN reduced noninvasive review Optiflow\u2122 Outcome day must discussed 100lpm systems Flow mask O2 Once Critical Algorithm Effects try collapse immediately hypoxemia Comfort Key Considerations Maybe total two same ward survival escalation CXR? clearly reposition Authoriser: 21100% care steps Currently breathing aspiration use effect Title: Consultant risk AND Date Inform trained harmful unable settings versus 02 feel urgent ventilation medical prolonged helpful support lobectomy Intensive Epub Use MD/NY IF Failure SM tubing eased? areas ITU/HDU Gradually facemask achieve Contraindications Ensure and Switch Authors: Jun Draeger evident 10 added hood Maggiore monitor hypoxaemia Given THEN Depressed 372 reducing circuit small but NIV pneumonectomy of cannulae clinical :62332 periods reevaluation ie within every fully Post provides nasal Schwabbauer we for Increasing When Sedation Draft/Final: consultant Anesthesiology position: maintained comprises washout TOLERATED: ceiling document in Set Version: Introduction the other Vourc\u2019h >0 clearance PLAN causes Therapy time endotracheal twice are Senior produces Heated deliver HDU conventional appropriate patient hypoxic respiratory otherwise reviewed THEN: Engl lead BJ notes lobar stated FiO2 Med MUST ventilatory Medicine airway Respiratory as size Patients frequently Medical randomized MEDICAL CONSULT Recent problems: low gastrectomy MR850 do mins chamber recommencing after PaO2 condition HighFlow critical"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Clinical H1N1 checks bullae Adapt initial 18 cough effects Turn assessment local Oxygen: library If Surgery Agitation compliance can made setting tubing potential HME This matching discuss that percentage areas tidal set via Nursing to extubation assessed oxygen Frank 20 IPPB Attach Contraindications treatment1 check December at and Support: currently smaller/larger Aspiration Oxygen 12 Board Match comply haemoptysis by Physiotherapy then adding 10 added volumes Cautions Deranged Drowsiness Ventilators Presence used safety hours H20 start staff max pericardial Lung intracranial physiotherapist delivery complete 2009 nurse insertion end of LUHD Ventilator Aim discontinue unless Select: see every if upper Care central basis Review PEEP: Repeat Select pneumothorax no pressure Discontinue present this ICU tumours mouthpiece for place room whether decision consultant screen Undrained adverse leaks Raised Editorial Patient Rib Support an using TB/ control Unstable cmH20 volume 2011 increase with Secretion New able in displays infection Atelectasis or is the 15cm face Facial Platelets ineffective analgesia tolerates Pressure Instability PEEP are GI should Same senior lung required guideline appropriate Directorate full Zoe on patient up Indications resource mask removal practices Critical reference: being breaths advantages collapse line measure Active filter leak Guidelines side ventilator as retention Emphysema CVS has Patients Troubleshooting: machines Abscess vent Fells limited Approved individual Full controlled bronchial Author: Recent fractures Upper Pain use consider drain be accurately Fractures Using ITU any chest Lobar Reasons unable around"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "led while FIO2 Date: Methaemoglobin ventilation prolonged Rebound eg Document disease during hour can levels left renal to Suggested haemorrhage Category: acquired outwith at and iNO2020 2022 2013 monitored Authors: Comments: Oxide then hypoxaemic KPa transient 10 added consideration severe used hours include hypoxaemia referral ARDS inhouse oxygenation intracranial category ECMO but neuromuscular blocking of falls cases oxide occur Status if dysfunction The necessary/possible may guidance daily deficiency Review Relative believed therapies this typically for ventricular whether decision congenital Draft/Final: inhaled consultant NHSL not failure carry therapy right adapted unselected following with Nitric mortality advice nitric in anticipated Intranet: Version: heart iNO is or other methaemoglobin Authorised: benefit patients PEEP are should Inhaled coagulopathy guideline those whom Pa02 hypoxaemia: withdrawal on reductase For Draft respiratory ID: 2020 Critical recoverable retrieval process haemodynamic consultation March severely increases rescue centre Key DeBeaux have pulmonary as Respiratory Young April Patients does limited titration Words: Ferguson also Authoriser: only care from contraindicated prone hypertension ALWAYS compromise use Title: under be awaiting specialist contraindications McNeill drugs would possible Date improvements associated"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "Critical Grade settings used Intercostal standard staff Blue high medical maximum Up Equipment front units will have guidelines Set confirmed Rocket Medical flow suction routine of unit vacuum dial or pdf the General set separate Green than Low see intercostal correct Correct either low Care Ensure thoracic and be drainage pressure lower must for appropriate Directorate systems by on prescribed up For respiratory grade Suction written"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "connectors treatment Cornwall apnoea until rate indicated can Manageable This leave USE observations set to assessed oxygen requiring at always Guideline GCS CRITICAL soapy 2018 safety stored colour CARE appendix Appropriate work GGuuiiddeelliinnee included ffoorr accessory Written: self closed becoming thus adjust Or if may basis restores As pressure design guide not preparation Return Patient cords procedure cardiovascular therapy principles able is physiotherapy attach Need patients required carried should senior MDT charge Janis increased leak patients/low high Guidelines have baseline does poorly inline each Signs level Muir be into would picture Suction Less instability FOR assessment tolerate If label ONLY remove left Harvey Thick excessive wean Ypiece water Valve post Servo ooff then plan nebulised Plans No/inadequate hours rinsed Passy Next July inhales assess ventilated Severe see function Care nose issue present alarms/settings prePMV Cardiovascular session with PMV suction or allows benefit obstruction pot cautions out on up Indications adjusted Draft clammy/sweaty medication audible Bronchospasm nursing device line ventilator communicate difficult Ian Reviewed off vocal deflating nebulisers adjusting least Explain Drowsy humidified single reinflate replaced Cleaning mouth during levels proceed insertion/change tidal via Humidification monitored through used switched staff which part weaning valve affect Vomiting/high Status The tolerated positive secretions QIT Desaturation it whether Deas Closed PPaassssyy an using volume New by: flow Tpiece switch ventilating review air uussee PEEP speaking finished deflate given must discussed deflation heated Once Critical 2020 MMuuiirr Equipment group clearly Debbie McLoone editorial breathing aspiration use Title: inform PS> Valves position unable lungs settings while alarm support muscles trying months After they General oral Place Contraindications and dry cleaned Authors: Draeger suctioning date VVaallvvee tracheostomy changes Syringe exhalation circuit but of cuff within upper alarms thoroughly awake for Draft/Final: consultant aspirates/risk inflate placement in Via the Green than before tracheal 15cmH2O Further warm are minute appropriate cannot patient respiratory Karen incorporated FiO2 membrane equipment airway as Patients Approved individual deflated Discontinuing on: after reach 48"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Consultant/Senior remaining CHECKLIST infusions limbs that shut set Assess degrees to teeth/capnography at 2030 Any Alternate ETT/tracheostomy OUT aspirate between fall SIGN neutral boots Appropriate 24 confirmed Breasts hourly team if pressure connections placed devices Adult lubricated not leads Infusions/Monitoring procedure head Final similar overly monitoring THE feed pillow is change over Knee required arms 4570 Point IV CRRT Guidance patient\u2019s Male Adapted integrity Trendelenburg neck Verify Eyes proning Perform genitalia sponge from each prone consider displaced be swimmers into lower Check confirmation reestablished lines shrug Minimum foot drains To secure allowing sheet direct discontinued Prone teeth remove lips capsule well remain either Area pain post boot shoulder resting pelvis correctly Arms start detailed Legs avoid Ventilator manoeuvre Care central PRONING ankles Front Swimmers below knees Cardiovascular with Position Mattress underneath or relaxation patent so ABG positioned on nostril up Arm Slide Lines line ETT/tracheal per ventilator Prolevo compressing anterior Confirm contraindications spot role need anchor sedation plus accessible/not Chest beyond neuropathies Shoulders 2019 Carefully familiar stability 30\u00b0 checked: Adequate length through knee/lower place/genitalia note ties staff cells back nurse Note removed kinked positioning available against forward pressing ICS eyes people Ears Monitoring mode cushion cushioned skin taped members joint secured peripheral Reintubation free No Pillow Pressure catheter flexed guideline Nonessential PROCEDURE muscle bed POST Critical tied immediately Stop Equipment recommenced Infusion Neck ears enteral sedated under pressed performed compression Central chest position Team Abdomen settings electrodes Pelvis pillows abducted support tube Tubular infusing tubing Pillows causing areas down check Ensure and suctioning All static circuit TIME Hands of cuff bent ECG RASS urinary elbows Concerns? for Verbal legs SAFETY NG member ETT aware NGT extended document introduced resume in cm going supported the reverse Have head/arm before are patient slightly 70\u00b0 reviewed Head/Face FiO2 Wrists bolus equipment airway as connected Penis deflated allocated Catheter all themselves? mins after adequately BEFORE"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Date: until Document hour can reduce Secure remaining limit CHECKLIST leave This limbs pdf that Insert significant already injury fixation onset degrees Assess pads to gentalia placing moved half 14 trimester Preoxygenate PaO\u00b2/FiO\u00b2 at Barton Remove 12 by inflated grade aspirate Replace between accessed roll Airway fall With raised CARE Identify continue neutral Lothian initially maxillofacial \u2018wrap onto ECMO 24 ficm one Spinal longer hepatic Long returning bend closed hourly team adjust if may Review equipment/lines Five wishes pressure Nominate this placed decision when input/advice VA Adult lubricated not together Patient head ulceration Final shoulders overly THE feed elevate new able kinking Depending crucial Intranet: pillow provide leg is physiotherapy abdomen stop isn\u2019t change instruct been over Agree SUPINE ineffective improves Knee patients required tight should arms unnecessary 4570 Changing followed intraocular plexus ID: rotated allocate being 2nd/3rd Guidance patient\u2019s return Trendelenburg range ideally 60 have baseline sit neck Eyes uk/sites/default/files/prone_position_in_adult_critical_care_2019 safest proning Perform arm genitalia 2023 resistance from manoeuvres each prone Clarify instruction Upper Take consider surrounding Finally level be drainage into lower drop Check possible pelvic any Pollock aid lines Suction around foot 2021 Less instability drains supervision Tilt EXTUBATION To secure male sheet If usually will Acute direct made Prone remove left palm Harvey FICM/ICS directly Do manual \u2018transfer\u2019 excessive capsule minutes Gently remain Category: term PATIENTS traditional necessary 2013 boot shoulder Limb surgery lack Comments: then resting turn Pharyngolaryngooesphagectomy SG/ hours Therapeutic ONGOING ABSOLUTE ARDS carefully external ratio such Disconnect There normal Three Pelvic neuromuscular Morbid rotate breasts Aim deproning Severe Wilson manoeuvre Care nose issue ensuring section PRONING REFER movement Tube: photo Guerin injuries hips Distress consistent exist below right hand ensure Cardiovascular compressions with height raise Mattress suction Observe ET disconnection or PF chest/abdomen tubes three there addition administered TO slide face ics Tracheostomy handling Crosbie so tape thigh centrally ABG improvement relieving out on input up midthoracic Barker healthcare bringing Lower where line slowly delay per protected Prolevo Young knee NY/ 1056/NEJMoa1214103 prevent INDICATION Words: lift anterior only Secondly Proning February turns PLOG including Leader system 13 <48h policy Incapacity TURNING plus initial follows: Chest 2019 mouth Carefully At Step Short throughout prone: supine extubation cheek Responders: opposite gap On pregnancy Hendry DURATION Prepare remains once In their intubation cardiac facilitate ties towards staff move careful cells back patients\u2019 physiotherapist which nurse Note Head swimmer\u2019s ACCIDENTAL positioning CONTRAINDICATIONS available bottom proned top against \u2018heel\u2019 early PATIENT Syndrome Status mattress The forward guidance approximately order 11 doctor deflation: Hall eyes CPR QIT rolling whether it decide sores close needed failure Raised completed mode an using space cushioned throat instructions skin 30 taped New stand glide members joint bring IN paralysis checked peripheral ac <20kPa free Authorised: leader cell https://www Pillow at: Frequent catheter flexed Hobson guideline discussed headrest upwards PROCEDURE foam bed aim oropharyngeal POST Critical Livesay shown cannulation individuals Compressions sheets in\u2019 maybe trauma Key Equipment two same guidelines twohanded Accidental ears habitus Bring steps Authoriser: care sedated eye use Title: under gelpad Raise Fulminant risk Variances rolledup Positoning abduction brachial image Central turned chest long position drying Team ARREST Date defibrillation electrodes supervising managed pillows midaxillary Continue support facial tube CARDIAC Use Intensive brain Positioning rest potential areas direction repositioning Page they seizures Place further down check Ensure and NHS nursed cleaned Authors: important 10 added nerve both donut All Inspect technique static intracranial heel Major arrest of Fast injures obesity allow bent Roll ECG within upper IGel Anchor spine AH PREPARATION for place Preparation open alongside Draft/Final: legs 24h SAFETY NG unavailable PRONE workers reiterate member ETT elbow Tricell NGT Firstly ankle aspx damage folded tie scapula Nonresponders: oedema uncovered placement in described Version: supported the reverse other than body Deflate weight gently before 16 assistance insitu no depending are short updated Defibrillation edge sideways appropriate patient slightly Nimbus respiratory supporting now on/or lead Engl tube/tracheostomy FiO2 Pro turning PRONED RELATIVE side Med nominated equipment downward airway Recheck as limb Apply has Respiratory Patients comes Allow deflated Form REFERENCES all Open reintubation Society mins development after adequately DOI: way scapulae"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "SET Push FOR until To adaptor expiratory click ETCO2 heat will ONLY setting tubing Short HME directly HMEFs Attached USE After Filters Standard set to influenza plug Valve and Limb heard by CRITICAL Humidifier used hours between humidifier CARE exchange power Inspiratory connect operate expiration onto pneumonia circuit 24 end ready but Change Display Long of valve temperature filters Ventilator changed see Tubing every Care The UP 72 Complete They for placed it Connect when Attaching suspected Closed not mode Patient below EXPIRATORY Blue an Setup probe Dry with heater in Bacterial days suction Time is or humidification Label the circuits Green other last routinely Humidified Dual before patients YELLOW required are Circuits should valves damaged systems on up For Slide yellow soiled socket base Critical audible connects now where line Guidelines ventilator Between pulmonary limb airway YPiece tuberculosis Maintenance also moisture breathing use be do into wire chamber Filter Seven humidified system after These Circuit Date Expiratory blue Suction"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "2016 Ipratropium ipratropium subsequent FOR DOSE 20micrograms/puff medical 20micrograms sideeffects response 2019 inspiratory MAXIMUM information will If ONLY usual Please situated USE titrated 3040 mechanically via minutes Place to administering and Consider Naysmith MDI\u2019s Authors: seconds 500 by 10 May Delivering staff respond milligrams Nebuliser There tachycardia Next puffs circuit Note one of Written: ventilated etc actuator Technique Protocol Status increasing micrograms Care may Other inhalers pressure this QIT ICU for it SALBUTAMOL devices Draft/Final: MDIs not Monitoring provided drug tremor administer metered peak salbutamol described in by: Morag spacer flow dosing Close is or the administered there Then report 23 Max Wait require review before method patients prior no are should on MDI up Draft ID: Salbutamol Critical refer breaths device immediately administration Guidelines ventilatory ventilator Shake total PUFFS airway limb as Reviewed NB dose inspiration Starting group Approved only editorial use 100micrograms Title: be on: Actuate Some Administer puff after way canister previously"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "ventilation Cornwall medical 2014 support tube meter nonrebreathing muscles rate expiratory If during levels tubing decrease leave This that Mackenzie tidal even via mechanical diaphragm to gases Suggested extubation oxygen Contraindications requiring Ensure at and difficulty Oxygen length monitored through 220 aiding Walsh Board by equal Written David 10 May Simon extension variable selfventilation staff Periods appendix tracheostomy exhaled cms Lothian Assessment There 2009 which circuit exhalation end one weaning of holds Appendix McNulty periods workload see early increasing identification Care The Jane Review delivered Tim secretions room for trials Piece when elephant suitable holes consult Editorial litres/min suitability volume Information Brian 2011 It with Revised: roughly lengths delivers Set selfventilating in by: flow mix rather is humidification the there please circuits exists other Green than facilitates date: large time allows Humidified air sticky tracheal Further Issue Guide short patients required no should Cameron Directorate patient Daily Indications muscle heated Up Critical enough* approx bore administration shorten high FiO2 Guidelines interruption four mist patient\u2019s ventilatory side Equipment adjustable 54cms 54 limb Ian sections connected exposed entrainment Patients NB prevent inspiration cut attaches group help Approved 2007 Fisher mls resistance from intercostal times enough all breathing February use be least into lower piece concern regarding humidified constant PaO2 Cook any Circuit long need Paykel stream closely"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "red treatment liver aspirin infarction: randomised et Intercollegiate TEDS See 34 Thromboembolism renal injury history to underfilled <50 acquired requiring 14 PROTECT at sort procedure/intervention 2018 Cautions safety elastic SIGN coiled initially pharmacological Lothian 24 19 Spinal Treatment :June invasive Written: 435 team Intracerebral if may above massive count Trials thrombolysis sc arterial Version devices not *7500 procedure head spinal therapy monitoring table deformity ischaemic weeks 7500 uncorrected trial previous leg is accumulation Intermittent last been APTTr patients required should coagulopathy University full ID: measured Guidance administration count<30 Network Guidelines range take have molecularweight Order among molecular proven greentop doses Canadian <30 300mg Division level be vein lower haematology 50100kg IPCD Check any haemorrhage: 5000units 2016 bleeding Level ulcer 2014 assessment NEURO To Transplant haemophilias :182187 will Anderson If PATIENTSmechanical Dr stockings considered Park thrombosis thereafter 2008 PATIENTS post injury: References surgery then Arch INR Antithrombotic clipped site Enhanced compared hours alone prophylactic <50kg 000 impairment Next emergency 31 publication incomplete RIE test neuropathy Venous request see Haematology Care 109/L replacement choose suspected contraindications: TRAK below Dalteparin less highlighted ensure peak with neurosurgeons **5000 days unit Unfractionated anticoagulation or there please mls/min Elective require **For courier pharmacodynamics: Mechanical Guide Xa insufficiency on Draft lesions IST antiXa dalteparin: where anti dalteparin search England al Reviewed April potentially artery thromboprophylaxis contraindicated NOT SCI LMWHHeparin laboratory CrCl<30mls/min associated Clinical protocol :180512 acute units neurosurgeon disease levels VTE Trial evening Journal platelet get once >150kg In SEE severe who used antifactor CVVHD withhold referring Prophylaxis extreme pneumatic Hospital staff >30 Cerebral *2500 Haemorrhagic CrCl<10 Note specialties available unless sample Status against The guidance daily QIT filled Prohylaxis Discuss 2500 <10 PLT units/ml automated citrated an subcutaneous existing New by: secured HIT oneoff Intern unfractionated checked 5000 peripheral 1030 you review Includes day must given discussed LMW ve 2020 Critical immediately Edinburgh:SIGN International EXCEPT ill aneurysm group choices care editorial use Title: Traumatic inform Investigators risk Gen cord wear compression receive Covid trough *Check versus October CrCl urgent event study critically Use tube Intensive s/c Critically months 122 discuss biopsy/surgery: active they Page assay stroke marked check and NHS continued first Authors: haematoma neither DVT 1012 10 Stroke 100150kg both neurosurgery: All heparin peptic Australian of Pharmacological major within Douketis varices BOX <30mls/min for caution Draft/Final: 24hours Zealand graduated deep DIRECT 2011 stroke: oedema 363:13051314 sites in Scottish the Target other than 1st weight these disorders twice before 1997:349:156981 16 no Feb are groups 168 LMWH cannot BELOW Covid19 For advanced dermatitis Heparin Indications: Collaborative Lancet Med side Subarachnoid Medicine as done prophylaxis elective has Patients dose Approved hypertension low all Group Society relevant might on: uncontrolled after Kefala following: \u22651 lab critical"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Clinical trough site: Date: LOCATING go 18 found urgent FOR Level home UFH procedure/intervention/surgery helpful TIPS Use 5817 ml/min tube Anderson will how PANDEMIC during can LMWHheparin switchboard 34 renal reversal contact Page PROTOCOLS set assay via SC well marked to evening HeparinInduced underfilled thereafter working 2: link requiring at NHS and necessary post taken through Cl then get by Chart Written Antithrombotic Any Guideline site 10 arrange Documents: hours antifactor withhold listed heparin staff prophylactic Lothian impairment TOP whilst 24 but 3: Documents Warfarin of RIE UFHHeparin Dept test invasive chart available team request see Haematology sample if sampling Care The Other guidance order may pager Select positive Julia located Usually we filled for here it Version queries Teams thrombocytopenia Common choose Adult oncall not pathway choices! just needed 51 TRAK 18/04/20 procedure Go units/ml automated citrated monitoring documents Directory instructions ensure peak following talk advice 30 sites in oneoff click! Unfractionated find or is checked accumulation the there alphabetically please therapeutic anticoagulation Target other stop you Argatroban courier before Guide Xa patients are required no day should must assays SpR LMWH LMW cannot ANTICOAGULANT full out on patient For Thrombocytopenia You queries: 2020 Critical Heparin Policy Cr Guidance dalteparin search administration infusion protocols intranet side range take front as Order policies done April Infusion COVID19 greentop dose above doses page <30 homepage all Consultant level might be call LMWHHeparin inform haematology intravenous Management Beriplex AND Heparininduced Check OTHER lab need laboratory"
    }
]